1001 14499271 2003 FLPLLAGLAANFLPTIICKISYKC GGN6 24 Cyclic(C18-C24) L None Free Free Antibacterial Gaegurin A-549 Lung Cancer MTT/MTS assay IC50=6.49 µg/ml 96-h Lung None None CCHHHHHHHSCSSTTCTTCGGGTC
1009 14499271 2003 FLPLLAGLAANFLPTIICKISYKC GGN6 24 Cyclic(C18-C24) L None Free Free Antibacterial Gaegurin 293 Renal Cancer MTT/MTS assay IC50=5.62 µg/ml 96-h Renal None None CCHHHHHHHSCSSTTCTTCGGGTC
1017 14499271 2003 FLPLLAGLAANFLPTIICKISYKC GGN6 24 Cyclic(C18-C24) L None Free Free Antibacterial Gaegurin 293 Renal Cancer MTT/MTS assay IC50=5.75 µg/ml 96-h Renal None None CCHHHHHHHSCSSTTCTTCGGGTC
1025 14499271 2003 FLPLLAGLAANFLPTIICKISYKC GGN6 24 Cyclic(C18-C24) L None Free Free Antibacterial Gaegurin Hep3B Liver Cancer MTT/MTS assay IC50=4.91 µg/ml 96-h Liver None None CCHHHHHHHSCSSTTCTTCGGGTC
1033 14499271 2003 FLPLLAGLAANFLPTIICKISYKC GGN6 24 Cyclic(C18-C24) L None Free Free Antibacterial Gaegurin MCF-7 Breast Cancer MTT/MTS assay IC50=4.88 µg/ml 96-h Breast None None CCHHHHHHHSCSSTTCTTCGGGTC
1002 14499271 2003 LLAGLAANFLPTIICKISYKC PTP1 21 Cyclic(C15-C21) L None Free Free Antibacterial Gaegurin A-549 Lung Cancer MTT/MTS assay IC50= >100 µg/ml 96-h Lung None None CGGGCCSSSCTTSTTCTTTCC
1010 14499271 2003 LLAGLAANFLPTIICKISYKC PTP1 21 Cyclic(C15-C21) L None Free Free Antibacterial Gaegurin 293 Renal Cancer MTT/MTS assay IC50=>100 µg/ml 96-h Renal None None CGGGCCSSSCTTSTTCTTTCC
1018 14499271 2003 LLAGLAANFLPTIICKISYKC PTP1 21 Cyclic(C15-C21) L None Free Free Antibacterial Gaegurin 293 Renal Cancer MTT/MTS assay IC50=>100 µg/ml 96-h Renal None None CGGGCCSSSCTTSTTCTTTCC
1026 14499271 2003 LLAGLAANFLPTIICKISYKC PTP1 21 Cyclic(C15-C21) L None Free Free Antibacterial Gaegurin Hep3B Liver Cancer MTT/MTS assay IC50=>100 µg/ml 96-h Liver None None CGGGCCSSSCTTSTTCTTTCC
1034 14499271 2003 LLAGLAANFLPTIICKISYKC PTP1 21 Cyclic(C15-C21) L None Free Free Antibacterial Gaegurin MCF-7 Breast Cancer MTT/MTS assay IC50=>100 µg/ml 96-h Breast None None CGGGCCSSSCTTSTTCTTTCC
1003 14499271 2003 FAGLAANFLPTIICKISYKC PTP2 20 Cyclic(C14-C20) L None Free Free Antibacterial Gaegurin A-549 Lung Cancer MTT/MTS assay IC50=>100 µg/ml 96-h Lung None None CTTTSCSSCGGGTCSSSSCC
1011 14499271 2003 FAGLAANFLPTIICKISYKC PTP2 20 Cyclic(C14-C20) L None Free Free Antibacterial Gaegurin 293 Renal Cancer MTT/MTS assay IC50=>100 µg/ml 96-h Renal None None CTTTSCSSCGGGTCSSSSCC
1019 14499271 2003 FAGLAANFLPTIICKISYKC PTP2 20 Cyclic(C14-C20) L None Free Free Antibacterial Gaegurin 293 Renal Cancer MTT/MTS assay IC50=>100 µg/ml 96-h Renal None None CTTTSCSSCGGGTCSSSSCC
1027 14499271 2003 FAGLAANFLPTIICKISYKC PTP2 20 Cyclic(C14-C20) L None Free Free Antibacterial Gaegurin Hep3B Liver Cancer MTT/MTS assay IC50=>100 µg/ml 96-h Liver None None CTTTSCSSCGGGTCSSSSCC
1035 14499271 2003 FAGLAANFLPTIICKISYKC PTP2 20 Cyclic(C14-C20) L None Free Free Antibacterial Gaegurin MCF-7 Breast Cancer MTT/MTS assay IC50=>100 µg/ml 96-h Breast None None CTTTSCSSCGGGTCSSSSCC
1004 14499271 2003 FLKLLKKLAAKFLPTIICKISYKC PTP4 24 Linear L None Free Free Antibacterial Gaegurin A-549 Lung Cancer MTT/MTS assay IC50=13.71 µg/ml 96-h Lung None None CHHHHHHHHGGGSCTTSSSSSCCC
1012 14499271 2003 FLKLLKKLAAKFLPTIICKISYKC PTP4 24 Linear L None Free Free Antibacterial Gaegurin 293 Renal Cancer MTT/MTS assay IC50=26.15 µg/ml 96-h Renal None None CHHHHHHHHGGGSCTTSSSSSCCC
1020 14499271 2003 FLKLLKKLAAKFLPTIICKISYKC PTP4 24 Linear L None Free Free Antibacterial Gaegurin PC-3 Prostate Cancer MTT/MTS assay IC50=18.63 µg/ml 96-h Prostate None None CHHHHHHHHGGGSCTTSSSSSCCC
1028 14499271 2003 FLKLLKKLAAKFLPTIICKISYKC PTP4 24 Linear L None Free Free Antibacterial Gaegurin Hep3B Liver Cancer MTT/MTS assay IC50=18.18 µg/ml 96-h Liver None None CHHHHHHHHGGGSCTTSSSSSCCC
1036 14499271 2003 FLKLLKKLAAKFLPTIICKISYKC PTP4 24 Linear L None Free Free Antibacterial Gaegurin MCF-7 Breast Cancer MTT/MTS assay IC50=18.1 µg/ml 96-h Breast None None CHHHHHHHHGGGSCTTSSSSSCCC
1005 14499271 2003 FLKLLKKLAAKLF PTP5 13 Linear L None Free Free Antibacterial Gaegurin A-549 Lung Cancer MTT/MTS assay IC50=9.09 µg/ml 96-h Lung None None CHHHHHHHHHHHC
1006 14499271 2003 FLKLLKKLAAKLF PTP6 13 Linear L None Free Free Antibacterial Gaegurin A-549 Lung Cancer MTT/MTS assay IC50=13.94 µg/ml 96-h Lung None None CHHHHHHHHHHHC
1013 14499271 2003 FLKLLKKLAAKLF PTP5 13 Linear L None Free Free Antibacterial Gaegurin 293 Renal Cancer MTT/MTS assay IC50=15.11 µg/ml 96-h Renal None None CHHHHHHHHHHHC
1014 14499271 2003 FLKLLKKLAAKLF PTP6 13 Linear L None Free Free Antibacterial Gaegurin 293 Renal Cancer MTT/MTS assay IC50=14 µg/ml 96-h Renal None None CHHHHHHHHHHHC
1021 14499271 2003 FLKLLKKLAAKLF PTP5 13 Linear L None Free Free Antibacterial Gaegurin PC-3 Prostate Cancer MTT/MTS assay Not Available 96-h Prostate None None CHHHHHHHHHHHC
1022 14499271 2003 FLKLLKKLAAKLF PTP6 13 Linear L None Free Free Antibacterial Gaegurin PC-3 Prostate Cancer MTT/MTS assay IC50=13.27 µg/ml 96-h Prostate None None CHHHHHHHHHHHC
1029 14499271 2003 FLKLLKKLAAKLF PTP5 13 Linear L None Free Free Antibacterial Gaegurin Hep3B Liver Cancer MTT/MTS assay Not Available 96-h Liver None None CHHHHHHHHHHHC
1030 14499271 2003 FLKLLKKLAAKLF PTP6 13 Linear L None Free Free Antibacterial Gaegurin Hep3B Liver Cancer MTT/MTS assay IC50=15.07 µg/ml 96-h Liver None None CHHHHHHHHHHHC
1037 14499271 2003 FLKLLKKLAAKLF PTP5 13 Linear L None Free Free Antibacterial Gaegurin MCF-7 Breast Cancer MTT/MTS assay IC50=5.43 µg/ml 96-h Breast None None CHHHHHHHHHHHC
1038 14499271 2003 FLKLLKKLAAKLF PTP6 13 Linear L None Free Free Antibacterial Gaegurin MCF-7 Breast Cancer MTT/MTS assay IC50=17.56 µg/ml 96-h Breast None None CHHHHHHHHHHHC
1007 14499271 2003 FLGALFKALSKLL PTP7 13 Linear L None Free Free Antibacterial Gaegurin A-549 Lung Cancer MTT/MTS assay IC50=8.01 µg/ml 96-h Lung None None CHHHHHHHHTTCC
1015 14499271 2003 FLGALFKALSKLL PTP7 13 Linear L None Free Free Antibacterial Gaegurin 293 Renal Cancer MTT/MTS assay IC50=6.71 µg/ml 96-h Renal None None CHHHHHHHHTTCC
1023 14499271 2003 FLGALFKALSKLL PTP7 13 Linear L None Free Free Antibacterial Gaegurin PC-3 Prostate Cancer MTT/MTS assay IC50=5.01 µg/ml 96-h Prostate None None CHHHHHHHHTTCC
1031 14499271 2003 FLGALFKALSKLL PTP7 13 Linear L None Free Free Antibacterial Gaegurin Hep3B Liver Cancer MTT/MTS assay IC50=5.4 µg/ml 96-h Liver None None CHHHHHHHHTTCC
1039 14499271 2003 FLGALFKALSKLL PTP7 13 Linear L None Free Free Antibacterial Gaegurin MCF-7 Breast Cancer MTT/MTS assay IC50=5.25 µg/ml 96-h Breast None None CHHHHHHHHTTCC
1008 14499271 2003 FLKLLAGLLKNFA PTP8 13 Linear L None Free Free Antibacterial Gaegurin A-549 Lung Cancer MTT/MTS assay IC50=24.58 µg/ml 96-h Lung None None CHHHHHHTGGGTC
1016 14499271 2003 FLKLLAGLLKNFA PTP8 13 Linear L None Free Free Antibacterial Gaegurin 293 Renal Cancer MTT/MTS assay IC50=26.8 µg/ml 96-h Renal None None CHHHHHHTGGGTC
1024 14499271 2003 FLKLLAGLLKNFA PTP8 13 Linear L None Free Free Antibacterial Gaegurin PC-3 Prostate Cancer MTT/MTS assay IC50=28.9 µg/ml 96-h Prostate None None CHHHHHHTGGGTC
1032 14499271 2003 FLKLLAGLLKNFA PTP8 13 Linear L None Free Free Antibacterial Gaegurin Hep3B Liver Cancer MTT/MTS assay IC50=30.79 µg/ml 96-h Liver None None CHHHHHHTGGGTC
1040 14499271 2003 FLKLLAGLLKNFA PTP8 13 Linear L None Free Free Antibacterial Gaegurin MCF-7 Breast Cancer MTT/MTS assay IC50=32.23 µg/ml 96-h Breast None None CHHHHHHTGGGTC
1041 1319823, 2285300 1992 AIGKFLHSAKKFGKAFVGEIMNS Magainin A 23 Linear L None Amidation Beta-alanine Antibacterial African clawed frog Xenopus laevis skin NCI-H182 Lung Cancer MTT/MTS assay IC50=7.28 µM 24-h Lung 2285300 None CCTHHHHHHHHHHHHTTTTHHHHC
1042 1319823, 2285300 1992 AIGKFLHSAKKFGKAFVGEIMNS Magainin A 23 Linear L None Amidation Beta-alanine Antibacterial African clawed frog Xenopus laevis skin NCI-H526 Lung Cancer MTT/MTS assay IC50=11.7 µM 24-h Lung 2285300 None CCTHHHHHHHHHHHHTTTTHHHHC
1043 1319823, 2285300 1992 AIGKFLHSAKKFGKAFVGEIMNS Magainin A 23 Linear L None Amidation Beta-alanine Antibacterial African clawed frog Xenopus laevis skin NCI-H678 Lung Cancer MTT/MTS assay IC50=6.23 µM 24-h Lung 2285300 None CCTHHHHHHHHHHHHTTTTHHHHC
1044 1319823, 2285300 1992 AIGKFLHSAKKFGKAFVGEIMNS Magainin A 23 Linear L None Amidation Beta-alanine Antibacterial African clawed frog Xenopus laevis skin NCI-H735 Lung Cancer MTT/MTS assay IC50=10.4 µM 24-h Lung 2285300 None CCTHHHHHHHHHHHHTTTTHHHHC
1045 1319823, 2285300 1992 AIGKFLHSAKKFGKAFVGEIMNS Magainin A 23 Linear L None Amidation Beta-alanine Antibacterial African clawed frog Xenopus laevis skin NCI-H841 Lung Cancer MTT/MTS assay IC50=9.7 µM 24-h Lung 2285300 None CCTHHHHHHHHHHHHTTTTHHHHC
1046 1319823, 2285300 1992 AIGKFLHSAKKFGKAFVGEIMNS Magainin A 23 Linear L None Amidation Beta-alanine Antibacterial African clawed frog Xenopus laevis skin NCI-H889 Lung Cancer MTT/MTS assay IC50=6.56 µM 24-h Lung 2285300 None CCTHHHHHHHHHHHHTTTTHHHHC
1356 1708887, 2285300 1990 AIGKFLHSAKKFGKAFVGEIMNS Magainin A 23 Linear L None Amidation Beta-alanine Antibacterial Xenopus laevis U-937 Lymphoma Cancer Trypan blue assay IC50=16 µg/ml 72-h Blood 2285300 None CCTHHHHHHHHHHHHTTTTHHHHC
1362 1708887, 2285300 1990 AIGKFLHSAKKFGKAFVGEIMNS Magainin A 23 Linear L None Amidation Beta-alanine Antibacterial Xenopus laevis 8402 Leukemia Cancer Trypan blue assay IC50=18 µg/ml 72-h Blood 2285300 None CCTHHHHHHHHHHHHTTTTHHHHC
1368 1708887, 2285300 1990 AIGKFLHSAKKFGKAFVGEIMNS Magainin A 23 Linear L None Amidation Beta-alanine Antibacterial Xenopus laevis SSKT-1 Hematopoietic Cancer Trypan blue assay IC50=23 µg/ml 72-h Blood 2285300 None CCTHHHHHHHHHHHHTTTTHHHHC
1374 1708887, 2285300 1990 AIGKFLHSAKKFGKAFVGEIMNS Magainin A 23 Linear L None Amidation Beta-alanine Antibacterial Xenopus laevis Daudi Lung Cancer Trypan blue assay IC50=30 µg/ml 72-h Blood 2285300 None CCTHHHHHHHHHHHHTTTTHHHHC
1380 1708887, 2285300 1990 AIGKFLHSAKKFGKAFVGEIMNS Magainin A 23 Linear L None Amidation Beta-alanine Antibacterial Xenopus laevis MLA Leukemia Cancer Trypan blue assay IC50=34 µg/ml 72-h Blood 2285300 None CCTHHHHHHHHHHHHTTTTHHHHC
1386 1708887, 2285300 1990 AIGKFLHSAKKFGKAFVGEIMNS Magainin A 23 Linear L None Amidation Beta-alanine Antibacterial Xenopus laevis Raji Lymphoma Cancer Trypan blue assay IC50=20 µg/ml 72-h Blood 2285300 None CCTHHHHHHHHHHHHTTTTHHHHC
1392 1708887, 2285300 1990 AIGKFLHSAKKFGKAFVGEIMNS Magainin A 23 Linear L None Amidation Beta-alanine Antibacterial Xenopus laevis K-562 Leukemia Cancer Trypan blue assay IC50=40 µg/ml 72-h Blood 2285300 None CCTHHHHHHHHHHHHTTTTHHHHC
1398 1708887, 2285300 1990 AIGKFLHSAKKFGKAFVGEIMNS Magainin A 23 Linear L None Amidation Beta-alanine Antibacterial Xenopus laevis CHP-100 Ewing sarcoma Trypan blue assay IC50=45 µg/ml 72-h Blood 2285300 None CCTHHHHHHHHHHHHTTTTHHHHC
1404 1708887, 2285300 1990 AIGKFLHSAKKFGKAFVGEIMNS Magainin A 23 Linear L None Amidation Beta-alanine Antibacterial Xenopus laevis MCF-7 Breast Cancer Trypan blue assay IC50=49 µg/ml 72-h Breast 2285300 None CCTHHHHHHHHHHHHTTTTHHHHC
1410 1708887, 2285300 1990 AIGKFLHSAKKFGKAFVGEIMNS Magainin A 23 Linear L None Amidation Beta-alanine Antibacterial Xenopus laevis PC-3 Prostate Cancer Trypan blue assay IC50=53 µg/ml 72-h Prostate 2285300 None CCTHHHHHHHHHHHHTTTTHHHHC
1047 1319823, 2285300 1992 GIGKFLHSAKKFAKAFVAEIMNS Magainin G 23 Linear L None Amidation Beta-alanine Antibacterial African clawed frog Xenopus laevis skin NCI-H182 Lung Cancer MTT/MTS assay IC50=12.5 µM 24-h Lung 2285300 None CTHHHHHHHHHHHTTTTTTTTSCC
1048 1319823, 2285300 1992 GIGKFLHSAKKFAKAFVAEIMNS Magainin G 23 Linear L None Amidation Beta-alanine Antibacterial African clawed frog Xenopus laevis skin NCI-H526 Lung Cancer MTT/MTS assay IC50=10.5 µM 24-h Lung 2285300 None CTHHHHHHHHHHHTTTTTTTTSCC
1049 1319823, 2285300 1992 GIGKFLHSAKKFAKAFVAEIMNS Magainin G 23 Linear L None Amidation Beta-alanine Antibacterial African clawed frog Xenopus laevis skin NCI-H678 Lung Cancer MTT/MTS assay IC50=4.44 µM 24-h Lung 2285300 None CTHHHHHHHHHHHTTTTTTTTSCC
1050 1319823, 2285300 1992 GIGKFLHSAKKFAKAFVAEIMNS Magainin G 23 Linear L None Amidation Beta-alanine Antibacterial African clawed frog Xenopus laevis skin NCI-H735 Lung Cancer MTT/MTS assay IC50=7.23 µM 24-h Lung 2285300 None CTHHHHHHHHHHHTTTTTTTTSCC
1051 1319823, 2285300 1992 GIGKFLHSAKKFAKAFVAEIMNS Magainin G 23 Linear L None Amidation Beta-alanine Antibacterial African clawed frog Xenopus laevis skin NCI-H841 Lung Cancer MTT/MTS assay IC50=11.7 µM 24-h Lung 2285300 None CTHHHHHHHHHHHTTTTTTTTSCC
1052 1319823, 2285300 1992 GIGKFLHSAKKFAKAFVAEIMNS Magainin G 23 Linear L None Amidation Beta-alanine Antibacterial African clawed frog Xenopus laevis skin NCI-H889 Lung Cancer MTT/MTS assay IC50=6.57 µM 24-h Lung 2285300 None CTHHHHHHHHHHHTTTTTTTTSCC
1355 1708887, 2285300 1990 GIGKFLHSAKKFAKAFVAEIMNS Magainin G 23 Linear L None Amidation Beta-alanine Antibacterial Xenopus laevis U-937 Lymphoma Cancer Trypan blue assay IC50=19 µg/ml 72-h Blood 2285300 None CTHHHHHHHHHHHTTTTTTTTSCC
1361 1708887, 2285300 1990 GIGKFLHSAKKFAKAFVAEIMNS Magainin G 23 Linear L None Amidation Beta-alanine Antibacterial Xenopus laevis 8402 Leukemia Cancer Trypan blue assay IC50=16 µg/ml 72-h Blood 2285300 None CTHHHHHHHHHHHTTTTTTTTSCC
1367 1708887, 2285300 1990 GIGKFLHSAKKFAKAFVAEIMNS Magainin G 23 Linear L None Amidation Beta-alanine Antibacterial Xenopus laevis SSKT-1 Hematopoietic Cancer Trypan blue assay IC50=29 µg/ml 72-h Blood 2285300 None CTHHHHHHHHHHHTTTTTTTTSCC
1373 1708887, 2285300 1990 GIGKFLHSAKKFAKAFVAEIMNS Magainin G 23 Linear L None Amidation Beta-alanine Antibacterial Xenopus laevis Daudi Renal Cancer Trypan blue assay IC50=38 µg/ml 72-h Blood 2285300 None CTHHHHHHHHHHHTTTTTTTTSCC
1379 1708887, 2285300 1990 GIGKFLHSAKKFAKAFVAEIMNS Magainin G 23 Linear L None Amidation Beta-alanine Antibacterial Xenopus laevis MLA Leukemia Cancer Trypan blue assay IC50=33 µg/ml 72-h Blood 2285300 None CTHHHHHHHHHHHTTTTTTTTSCC
1385 1708887, 2285300 1990 GIGKFLHSAKKFAKAFVAEIMNS Magainin G 23 Linear L None Amidation Beta-alanine Antibacterial Xenopus laevis Raji Lymphoma Cancer Trypan blue assay IC50=25 µg/ml 72-h Blood 2285300 None CTHHHHHHHHHHHTTTTTTTTSCC
1391 1708887, 2285300 1990 GIGKFLHSAKKFAKAFVAEIMNS Magainin G 23 Linear L None Amidation Beta-alanine Antibacterial Xenopus laevis K-562 Leukemia Cancer Trypan blue assay IC50=37 µg/ml 72-h Blood 2285300 None CTHHHHHHHHHHHTTTTTTTTSCC
1397 1708887, 2285300 1990 GIGKFLHSAKKFAKAFVAEIMNS Magainin G 23 Linear L None Amidation Beta-alanine Antibacterial Xenopus laevis CHP-100 Ewing sarcoma Trypan blue assay IC50=39 µg/ml 72-h Blood 2285300 None CTHHHHHHHHHHHTTTTTTTTSCC
1403 1708887, 2285300 1990 GIGKFLHSAKKFAKAFVAEIMNS Magainin G 23 Linear L None Amidation Beta-alanine Antibacterial Xenopus laevis MCF-7 Breast Cancer Trypan blue assay IC50=42 µg/ml 72-h Breast 2285300 None CTHHHHHHHHHHHTTTTTTTTSCC
1409 1708887, 2285300 1990 GIGKFLHSAKKFAKAFVAEIMNS Magainin G 23 Linear L None Amidation Beta-alanine Antibacterial Xenopus laevis PC-3 Prostate Cancer Trypan blue assay IC50=47 µg/ml 72-h Prostate 2285300 None CTHHHHHHHHHHHTTTTTTTTSCC
1053 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A CCRF-CEM Leukemia Cancer MTT/MTS assay IC50=14.7 µg/ml 48-h Blood None None CCCCCCCHHHHHHHHHHHHHC
1054 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A HL-60 Leukemia Cancer MTT/MTS assay IC50=11.3 µg/ml 48-h Blood None None CCCCCCCHHHHHHHHHHHHHC
1055 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A K-562 Leukemia Cancer MTT/MTS assay IC50=8.2 µg/ml 48-h Blood None None CCCCCCCHHHHHHHHHHHHHC
1056 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A MOLT-4 Leukemia Cancer MTT/MTS assay IC50=17 µg/ml 48-h Blood None None CCCCCCCHHHHHHHHHHHHHC
1057 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A RPMI-8226 Leukemia Cancer MTT/MTS assay IC50=10.5 µg/ml 48-h Blood None None CCCCCCCHHHHHHHHHHHHHC
1058 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A SR Leukemia Cancer MTT/MTS assay IC50=20.2 µg/ml 48-h Blood None None CCCCCCCHHHHHHHHHHHHHC
1059 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A MCF-7 Breast Cancer MTT/MTS assay IC50=15.1 µg/ml 48-h Breast None None CCCCCCCHHHHHHHHHHHHHC
1060 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A NCI/ADR-RES Breast Cancer MTT/MTS assay IC50=11.5 µg/ml 48-h Breast None None CCCCCCCHHHHHHHHHHHHHC
1061 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A MDA-MB-231 Breast Cancer MTT/MTS assay IC50=11.3 µg/ml 48-h Breast None None CCCCCCCHHHHHHHHHHHHHC
1062 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A HS578T Breast Cancer MTT/MTS assay IC50=11.7 µg/ml 48-h Breast None None CCCCCCCHHHHHHHHHHHHHC
1063 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A MDA-MB-435 Breast Cancer MTT/MTS assay IC50=11.3 µg/ml 48-h Breast None None CCCCCCCHHHHHHHHHHHHHC
1064 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A MDA-N Breast Cancer MTT/MTS assay IC50=10.6 µg/ml 48-h Breast None None CCCCCCCHHHHHHHHHHHHHC
1065 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A BT-549 Breast Cancer MTT/MTS assay IC50=12.9 µg/ml 48-h Breast None None CCCCCCCHHHHHHHHHHHHHC
1066 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A T-47D Breast Cancer MTT/MTS assay IC50=23.9 µg/ml 48-h Breast None None CCCCCCCHHHHHHHHHHHHHC
1067 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A A-549 Lung Cancer MTT/MTS assay IC50=11.7 µg/ml 48-h Lung None None CCCCCCCHHHHHHHHHHHHHC
1068 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A EKVX Lung Cancer MTT/MTS assay IC50=12.1 µg/ml 48-h Lung None None CCCCCCCHHHHHHHHHHHHHC
1069 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A HOP-62 Lung Cancer MTT/MTS assay IC50=12.6 µg/ml 48-h Lung None None CCCCCCCHHHHHHHHHHHHHC
1070 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A HOP-92 Lung Cancer MTT/MTS assay IC50=7.2 µg/ml 48-h Lung None None CCCCCCCHHHHHHHHHHHHHC
1071 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A NCI-H226 Lung Cancer MTT/MTS assay IC50=13.3 µg/ml 48-h Lung None None CCCCCCCHHHHHHHHHHHHHC
1072 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A NCI-H23 Lung Cancer MTT/MTS assay IC50=10.8 µg/ml 48-h Lung None None CCCCCCCHHHHHHHHHHHHHC
1073 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A NCI-H322M Lung Cancer MTT/MTS assay IC50=10.7 µg/ml 48-h Lung None None CCCCCCCHHHHHHHHHHHHHC
1074 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A NCI-H460 Lung Cancer MTT/MTS assay IC50=12.1 µg/ml 48-h Lung None None CCCCCCCHHHHHHHHHHHHHC
1075 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A NCI-H522 Lung Cancer MTT/MTS assay IC50=11.2 µg/ml 48-h Lung None None CCCCCCCHHHHHHHHHHHHHC
1076 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A SF-268 Brain Tumor MTT/MTS assay IC50=12.4 µg/ml 48-h Brain None None CCCCCCCHHHHHHHHHHHHHC
1077 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A SF-295 Brain Tumor MTT/MTS assay IC50=12.9 µg/ml 48-h Brain None None CCCCCCCHHHHHHHHHHHHHC
1078 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A SF-539 Brain Tumor MTT/MTS assay IC50=9.5 µg/ml 48-h Brain None None CCCCCCCHHHHHHHHHHHHHC
1079 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A SNB-19 Brain Tumor MTT/MTS assay IC50=13.8 µg/ml 48-h Brain None None CCCCCCCHHHHHHHHHHHHHC
1080 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A SNB-75 Brain Tumor MTT/MTS assay IC50=15.5 µg/ml 48-h Brain None None CCCCCCCHHHHHHHHHHHHHC
1081 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A U-251 Brain Tumor MTT/MTS assay IC50=10.6 µg/ml 48-h Brain None None CCCCCCCHHHHHHHHHHHHHC
1082 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A LOXIMVI Skin Cancer MTT/MTS assay IC50=9.5 µg/ml 48-h Skin None None CCCCCCCHHHHHHHHHHHHHC
1083 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A MALME-3M Skin Cancer MTT/MTS assay IC50=10.9 µg/ml 48-h Skin None None CCCCCCCHHHHHHHHHHHHHC
1084 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A M14 Skin Cancer MTT/MTS assay IC50=15.1 µg/ml 48-h Skin None None CCCCCCCHHHHHHHHHHHHHC
1085 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A SK-MEL-2 Skin Cancer MTT/MTS assay IC50=11.1 µg/ml 48-h Skin None None CCCCCCCHHHHHHHHHHHHHC
1086 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A SK-MEL-5 Skin Cancer MTT/MTS assay IC50=8.9 µg/ml 48-h Skin None None CCCCCCCHHHHHHHHHHHHHC
1087 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A UACC-257 Skin Cancer MTT/MTS assay IC50=12.5 µg/ml 48-h Skin None None CCCCCCCHHHHHHHHHHHHHC
1088 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A UACC-62 Skin Cancer MTT/MTS assay IC50=10.6 µg/ml 48-h Skin None None CCCCCCCHHHHHHHHHHHHHC
1089 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A 786-0 Renal Cancer MTT/MTS assay IC50=12.2 µg/ml 48-h Renal None None CCCCCCCHHHHHHHHHHHHHC
1090 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A A-498 Renal Cancer MTT/MTS assay IC50=10 µg/ml 48-h Renal None None CCCCCCCHHHHHHHHHHHHHC
1091 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A ACHN Renal Cancer MTT/MTS assay IC50=12 µg/ml 48-h Renal None None CCCCCCCHHHHHHHHHHHHHC
1092 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A CAKI-1 Renal Cancer MTT/MTS assay IC50=14.1 µg/ml 48-h Renal None None CCCCCCCHHHHHHHHHHHHHC
1093 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A RFX393 Renal Cancer MTT/MTS assay IC50=11 µg/ml 48-h Renal None None CCCCCCCHHHHHHHHHHHHHC
1094 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A SN-12C Renal Cancer MTT/MTS assay IC50=11.4 µg/ml 48-h Renal None None CCCCCCCHHHHHHHHHHHHHC
1095 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A TK-10 Renal Cancer MTT/MTS assay IC50=13.1 µg/ml 48-h Renal None None CCCCCCCHHHHHHHHHHHHHC
1096 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A UO-31 Renal Cancer MTT/MTS assay IC50=10.6 µg/ml 48-h Renal None None CCCCCCCHHHHHHHHHHHHHC
1097 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A IGROV1 Ovarian Cancer MTT/MTS assay IC50=9 µg/ml 48-h Ovary None None CCCCCCCHHHHHHHHHHHHHC
1098 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A OVRCAR-3 Ovarian Cancer MTT/MTS assay IC50=15.2 µg/ml 48-h Ovary None None CCCCCCCHHHHHHHHHHHHHC
1099 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A OVRCAR-4 Ovarian Cancer MTT/MTS assay IC50=17.6 µg/ml 48-h Ovary None None CCCCCCCHHHHHHHHHHHHHC
1100 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A OVRCAR-5 Ovarian Cancer MTT/MTS assay IC50=13.8 µg/ml 48-h Ovary None None CCCCCCCHHHHHHHHHHHHHC
1101 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A OVRCAR-8 Ovarian Cancer MTT/MTS assay IC50=13 µg/ml 48-h Ovary None None CCCCCCCHHHHHHHHHHHHHC
1102 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial Histone H2A SK-OV-3 Ovarian Cancer MTT/MTS assay IC50=12.6 µg/ml 48-h Ovary None None CCCCCCCHHHHHHHHHHHHHC
1103 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A COLO-205 Colon Cancer MTT/MTS assay IC50=11.2 µg/ml 48-h Colon None None CCCCCCCHHHHHHHHHHHHHC
1104 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A HCT-116 Colon Cancer MTT/MTS assay IC50=14.6 µg/ml 48-h Colon None None CCCCCCCHHHHHHHHHHHHHC
1105 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A HCT-15 Colon Cancer MTT/MTS assay IC50=13.2 µg/ml 48-h Colon None None CCCCCCCHHHHHHHHHHHHHC
1106 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A HT-29 Colon Cancer MTT/MTS assay IC50=17.6 µg/ml 48-h Colon None None CCCCCCCHHHHHHHHHHHHHC
1107 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A KM12 Colon Cancer MTT/MTS assay IC50=12 µg/ml 48-h Colon None None CCCCCCCHHHHHHHHHHHHHC
1108 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A SW-620 Colon Cancer MTT/MTS assay IC50=12.7 µg/ml 48-h Colon None None CCCCCCCHHHHHHHHHHHHHC
1109 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A PC-3 Prostate Cancer MTT/MTS assay IC50=12 µg/ml 48-h Prostate None None CCCCCCCHHHHHHHHHHHHHC
1110 18617323 2008 RAGLQFPVGRLLRRLLRRLLR Buforin IIb 21 Linear L None Free Free Antibacterial histone H2A DU-145 Prostate Cancer MTT/MTS assay IC50=15.3 µg/ml 48-h Prostate None None CCCCCCCHHHHHHHHHHHHHC
1111 16572423 2008 FKCRRWQWRMKKLGA Lactoferricin B 15 Linear L None Amidation Free Antibacterial Temporins family Kelly Brain Tumor MTT/MTS assay IC50=15.5 µM 48-h Brain None None CCSCSSHHHHHTTCC
1112 16572423 2008 FKCRRWQWRMKKLGA Lactoferricin B 15 Linear L None Amidation Free Antimicrobial Temporins family IMR-32 Brain Tumor MTT/MTS assay IC50=29 µM 48-h Brain None None CCSCSSHHHHHTTCC
1113 16572423 2008 FKCRRWQWRMKKLGA Lactoferricin B 15 Linear L None Amidation Free Antimicrobial Temporins family SK-N-DZ Brain Tumor MTT/MTS assay IC50=37 µM 48-h Brain None None CCSCSSHHHHHTTCC
1114 16572423 2008 FKCRRWQWRMKKLGA Lactoferricin B 15 Linear L None Amidation Free Antimicrobial Temporins family SHEP-12 Brain Tumor MTT/MTS assay IC50=45 µM 48-h Brain None None CCSCSSHHHHHTTCC
1115 16572423 2008 FKCRRWQWRMKKLGA Lactoferricin B 15 Linear L None Amidation Free Antimicrobial Temporins family SH-SY-5Y2 Brain Tumor MTT/MTS assay IC50=60 µM 48-h Brain None None CCSCSSHHHHHTTCC
1116 8319212 1993 GIGKFLHSAKKFGKAFVGEIMNS Magainin 2 23 Linear L None Amidation Free Antibacterial African clawed frog Xenopus laevis skin A-549 Lung Cancer MTT/MTS assay IC50=110 µM 48-h Lung None None CCSSTHHHHTTTGGGTTTTTTTC
1306 16476519 2006 GIGKFLHSAKKFGKAFVGEIMNS Magainin 2 23 Linear L None Amidation Free Antimicrobial African clawed frog Xenopus laevis skin RT4(G1) Bladder Cancer LDH leakage assay IC50=32.3 µM 48-h Bladder None None CCSSTHHHHTTTGGGTTTTTTTC
1307 16476519 2006 GIGKFLHSAKKFGKAFVGEIMNS Magainin 2 23 Linear L None Amidation Free Antimicrobial African clawed frog Xenopus laevis skin 647V(G2) Bladder Cancer LDH leakage assay IC50=54.1 µM 48-h Bladder None None CCSSTHHHHTTTGGGTTTTTTTC
1308 16476519 2006 GIGKFLHSAKKFGKAFVGEIMNS Magainin 2 23 Linear L None Amidation Free Antimicrobial African clawed frog Xenopus laevis skin 486P(G4) Bladder Cancer LDH leakage assay IC50=28.6 µM 48-h Bladder None None CCSSTHHHHTTTGGGTTTTTTTC
1309 16476519 2006 GIGKFLHSAKKFGKAFVGEIMNS Magainin 2 23 Linear L None Amidation Free Antimicrobial African clawed frog Xenopus laevis skin RT4(G1) Bladder Cancer WST-1 assay IC50=484 µM 48-h Bladder None None CCSSTHHHHTTTGGGTTTTTTTC
1310 16476519 2006 GIGKFLHSAKKFGKAFVGEIMNS Magainin 2 23 Linear L None Amidation Free Antimicrobial African clawed frog Xenopus laevis skin 647V(G2) Bladder Cancer WST-1 assay IC50=52.4 µM 48-h Bladder None None CCSSTHHHHTTTGGGTTTTTTTC
1311 16476519 2006 GIGKFLHSAKKFGKAFVGEIMNS Magainin 2 23 Linear L None Amidation Free Antimicrobial African clawed frog Xenopus laevis skin 486P(G4) Bladder Cancer WST-1 assay IC50=57.8 µM 48-h Bladder None None CCSSTHHHHTTTGGGTTTTTTTC
1312 16476519 2006 GIGKFLHSAKKFGKAFVGEIMNS Magainin 2 23 Linear L None Amidation Free Antimicrobial African clawed frog Xenopus laevis skin RT4(G1) Bladder Cancer Cell Viability assay IC50=135.3 µM 48-h Bladder None None CCSSTHHHHTTTGGGTTTTTTTC
1313 16476519 2006 GIGKFLHSAKKFGKAFVGEIMNS Magainin 2 23 Linear L None Amidation Free Antimicrobial African clawed frog Xenopus laevis skin 647V(G2) Bladder Cancer Cell Viability assay IC50=31 µM 48-h Bladder None None CCSSTHHHHTTTGGGTTTTTTTC
1314 16476519 2006 GIGKFLHSAKKFGKAFVGEIMNS Magainin 2 23 Linear L None Amidation Free Antimicrobial African clawed frog Xenopus laevis skin 486P(G4) Bladder Cancer Cell Viability assay IC50=59.4 µM 48-h Bladder None None CCSSTHHHHTTTGGGTTTTTTTC
1359 1708887, 2285300 1990 GIGKFLHSAKKFGKAFVGEIMNS Magainin 2 23 Linear L None Amidation Free Antibacterial Xenopus laevis U-937 Lymphoma Cancer Trypan blue assay IC50 >150 µg/ml 72-h Blood 2285300 None CCSSTHHHHTTTGGGTTTTTTTC
1365 1708887, 2285300 1990 GIGKFLHSAKKFGKAFVGEIMNS Magainin 2 23 Linear L None Amidation Free Antibacterial Xenopus laevis 8402 Leukemia Cancer Trypan blue assay IC50 >150 µg/ml 72-h Blood 2285300 None CCSSTHHHHTTTGGGTTTTTTTC
1371 1708887, 2285300 1990 GIGKFLHSAKKFGKAFVGEIMNS Magainin 2 23 Linear L None Amidation Free Antibacterial Xenopus laevis SSKT-1 Hematopoietic Cancer Trypan blue assay IC50 >150 µg/ml 72-h Blood 2285300 None CCSSTHHHHTTTGGGTTTTTTTC
1377 1708887, 2285300 1990 GIGKFLHSAKKFGKAFVGEIMNS Magainin 2 23 Linear L None Amidation Free Antibacterial Xenopus laevis Daudi Colon Cancer Trypan blue assay IC50 >150 µg/ml 72-h Blood 2285300 None CCSSTHHHHTTTGGGTTTTTTTC
1383 1708887, 2285300 1990 GIGKFLHSAKKFGKAFVGEIMNS Magainin 2 23 Linear L None Amidation Free Antibacterial Xenopus laevis MLA Leukemia Cancer Trypan blue assay IC50 >150 µg/ml 72-h Blood 2285300 None CCSSTHHHHTTTGGGTTTTTTTC
1389 1708887, 2285300 1990 GIGKFLHSAKKFGKAFVGEIMNS Magainin 2 23 Linear L None Amidation Free Antibacterial Xenopus laevis Raji Lymphoma Cancer Trypan blue assay IC50 >150 µg/ml 72-h Blood 2285300 None CCSSTHHHHTTTGGGTTTTTTTC
1395 1708887, 2285300 1990 GIGKFLHSAKKFGKAFVGEIMNS Magainin 2 23 Linear L None Amidation Free Antibacterial Xenopus laevis K-562 Leukemia Cancer Trypan blue assay IC50 >150 µg/ml 72-h Blood 2285300 None CCSSTHHHHTTTGGGTTTTTTTC
1401 1708887, 2285300 1990 GIGKFLHSAKKFGKAFVGEIMNS Magainin 2 23 Linear L None Amidation Free Antibacterial Xenopus laevis CHP-100 Ewing sarcoma Trypan blue assay IC50 >200 µg/ml 72-h Blood 2285300 None CCSSTHHHHTTTGGGTTTTTTTC
1407 1708887, 2285300 1990 GIGKFLHSAKKFGKAFVGEIMNS Magainin 2 23 Linear L None Amidation Free Antibacterial Xenopus laevis MCF-7 Breast Cancer Trypan blue assay IC50 >200 µg/ml 72-h Breast 2285300 None CCSSTHHHHTTTGGGTTTTTTTC
1413 1708887, 2285300 1990 GIGKFLHSAKKFGKAFVGEIMNS Magainin 2 23 Linear L None Amidation Free Antibacterial Xenopus laevis PC-3 Prostate Cancer Trypan blue assay IC50 >200 µg/ml 72-h Prostate 2285300 None CCSSTHHHHTTTGGGTTTTTTTC
1435 21955251 2011 GIGKFLHSAKKFGKAFVGEIMNS Magainin 2 23 Linear L None Free Free Antimicrobial Xenopus laevis HeLa Pancreatic Cancer WST-1 assay IC50 = >60 µM Not Available Pancreatic None None CCSSTHHHHTTTGGGTTTTTTTC
1117 8319212 1993 GIGKFLKKAKKFAKAFVKIINN MSI-136 22 Linear L None Amidation Free Antibacterial African clawed frog Xenopus laevis skin A-549 Lung Cancer MTT/MTS assay IC50=10 µM 48-h Lung None None CTHHHHHHHTTTHHHHHHHHCC
1118 8319212 1993 gigkflkkakkfakafvkiinn MSI-238 22 Linear D None Amidation Free Antibacterial African clawed frog Xenopus laevis skin A-549 Lung Cancer MTT/MTS assay IC50=6 µM 48-h Lung None None CTHHHHHHHTHHHHHHHHHTCC
1119 12005420 2001 KWKLFKKIPKFLHSAKKF CA-MA-P 18 Linear L None Amidation Free Antibacterial Ceropin A MDA-MB-361 Breast Cancer MTT/MTS assay IC50=20 µM 48-h Breast None None CCGGGGTSCCHHHHHTTC
1141 12005420 2001 KWKLFKKIPKFLHSAKKF CA-MA-P 18 Linear L None Amidation Free Antibacterial Ceropin A Jurkat Blood Cancer MTT/MTS assay IC50=20 µM 48-h Blood None None CCGGGGTSCCHHHHHTTC
1163 12005420 2001 KWKLFKKIPKFLHSAKKF CA-MA-P 18 Linear L None Amidation Free Antibacterial Ceropin A K-562 Leukemia Cancer MTT/MTS assay IC50=25 µM 48-h Blood None None CCGGGGTSCCHHHHHTTC
1187 10675500 2000 KWKLFKKIPKFLHSAKKF CA-MA2 18 Linear L None Amidation Free Antibacterial Ceropin-Magainin hybrid peptides K-562 Leukemia Cancer MTT/MTS assay IC50=35.1 µM 72-h Blood None None CCGGGGTSCCHHHHHTTC
1191 10675500 2000 KWKLFKKIPKFLHSAKKF CA-MA2 18 Linear L None Amidation Free Antibacterial Ceropin-Magainin hybrid peptides A-549 Lung Cancer MTT/MTS assay IC50=25 µM 72-h Lung None None CCGGGGTSCCHHHHHTTC
1195 10675500 2000 KWKLFKKIPKFLHSAKKF CA-MA2 18 Linear L None Amidation Free Antibacterial Ceropin-Magainin hybrid peptides Jurkat Blood Cancer MTT/MTS assay IC50=20 µM 72-h Blood None None CCGGGGTSCCHHHHHTTC
1199 10675500 2000 KWKLFKKIPKFLHSAKKF CA-MA2 18 Linear L None Amidation Free Antibacterial Ceropin-Magainin hybrid peptides MDA-MB-361 Breast Cancer MTT/MTS assay IC50=28 µM 72-h Breast None None CCGGGGTSCCHHHHHTTC
1120 12005420 2001 KWKFKKIPKFLHLAKKF P18 17 Linear L None Amidation Free Antibacterial Ceropin A MDA-MB-361 Breast Cancer MTT/MTS assay IC50=8 µM 48-h Breast None None CCCCSSTTTTCSCCCCC
1142 12005420 2001 KWKFKKIPKFLHLAKKF P18 17 Linear L None Amidation Free Antibacterial Ceropin A Jurkat Blood Cancer MTT/MTS assay IC50=4 µM 48-h Blood None None CCCCSSTTTTCSCCCCC
1164 12005420 2001 KWKFKKIPKFLHLAKKF P18 17 Linear L None Amidation Free Antibacterial Ceropin A K-562 Leukemia Cancer MTT/MTS assay IC50=3.5 µM 48-h Blood None None CCCCSSTTTTCSCCCCC
1121 12005420 2001 KWKLFKKILKFLHLAKKF [L9]-P18 18 Linear L None Amidation Free Antibacterial Ceropin A MDA-MB-361 Breast Cancer MTT/MTS assay IC50=3 µM 48-h Breast None None CCTTHHHHHHHHTTTTCC
1143 12005420 2001 KWKLFKKILKFLHLAKKF [L9]-P18 18 Linear L None Amidation Free Antibacterial Ceropin A Jurkat Blood Cancer MTT/MTS assay IC50=9 µM 48-h Blood None None CCTTHHHHHHHHTTTTCC
1165 12005420 2001 KWKLFKKILKFLHLAKKF [L9]-P18 18 Linear L None Amidation Free Antibacterial Ceropin A K-562 Leukemia Cancer MTT/MTS assay IC50=3 µM 48-h Blood None None CCTTHHHHHHHHTTTTCC
1122 12005420 2001 KWKLFKKISKFLHLAKKF [S9]-P18 18 Linear L None Amidation Free Antibacterial Ceropin A MDA-MB-361 Breast Cancer MTT/MTS assay IC50=4 µM 48-h Breast None None CCTTHHHHHHHHTTTTTC
1144 12005420 2001 KWKLFKKISKFLHLAKKF [S9]-P18 18 Linear L None Amidation Free Antibacterial Ceropin A Jurkat Blood Cancer MTT/MTS assay IC50=7 µM 48-h Blood None None CCTTHHHHHHHHTTTTTC
1166 12005420 2001 KWKLFKKISKFLHLAKKF [S9]-P18 18 Linear L None Amidation Free Antibacterial Ceropin A K-562 Leukemia Cancer MTT/MTS assay IC50=3 µM 48-h Blood None None CCTTHHHHHHHHTTTTTC
1123 12005420 2001 WKLFKKIPKFLHLAKKF N-1 17 Linear L None Amidation Free Antibacterial Ceropin A MDA-MB-361 Breast Cancer MTT/MTS assay IC50=9.5 µM 48-h Breast None None CCSCCCCHHHHTSSSCC
1145 12005420 2001 WKLFKKIPKFLHLAKKF N-1 17 Linear L None Amidation Free Antibacterial Ceropin A Jurkat Blood Cancer MTT/MTS assay IC50=12 µM 48-h Blood None None CCSCCCCHHHHTSSSCC
1167 12005420 2001 WKLFKKIPKFLHLAKKF N-1 17 Linear L None Amidation Free Antibacterial Ceropin A K-562 Leukemia Cancer MTT/MTS assay IC50=6 µM 48-h Blood None None CCSCCCCHHHHTSSSCC
1124 12005420 2001 FKLFKKIPKFLHLAKKF N-2 17 Linear L None Amidation Free Antibacterial Ceropin A MDA-MB-361 Breast Cancer MTT/MTS assay IC50=11 µM 48-h Breast None None CCCCCCCHHHHTTSCCC
1146 12005420 2001 FKLFKKIPKFLHLAKKF N-2 17 Linear L None Amidation Free Antibacterial Ceropin A Jurkat Blood Cancer MTT/MTS assay IC50=11 µM 48-h Blood None None CCCCCCCHHHHTTSCCC
1168 12005420 2001 FKLFKKIPKFLHLAKKF N-2 17 Linear L None Amidation Free Antibacterial Ceropin A K-562 Leukemia Cancer MTT/MTS assay IC50=7 µM 48-h Blood None None CCCCCCCHHHHTTSCCC
1125 12005420 2001 KWFKKIPKFLHLAKKF N-3 16 Linear L None Amidation Free Antibacterial Ceropin A MDA-MB-361 Breast Cancer MTT/MTS assay IC50=17 µM 48-h Breast None None CCCCCSSHHHHTSSCC
1147 12005420 2001 KWFKKIPKFLHLAKKF N-3 16 Linear L None Amidation Free Antibacterial Ceropin A Jurkat Blood Cancer MTT/MTS assay IC50=17 µM 48-h Blood None None CCCCCSSHHHHTSSCC
1169 12005420 2001 KWFKKIPKFLHLAKKF N-3 16 Linear L None Amidation Free Antibacterial Ceropin A K-562 Leukemia Cancer MTT/MTS assay IC50=11 µM 48-h Blood None None CCCCCSSHHHHTSSCC
1126 12005420 2001 WFKKIPKFLHLAKKF N-4 15 Linear L None Amidation Free Antibacterial Ceropin A MDA-MB-361 Breast Cancer MTT/MTS assay IC50=32 µM 48-h Breast None None CCCCCTTGGGSSSCC
1148 12005420 2001 WFKKIPKFLHLAKKF N-4 15 Linear L None Amidation Free Antibacterial Ceropin A Jurkat Blood Cancer MTT/MTS assay IC50=23 µM 48-h Blood None None CCCCCTTGGGSSSCC
1170 12005420 2001 WFKKIPKFLHLAKKF N-4 15 Linear L None Amidation Free Antibacterial Ceropin A K-562 Leukemia Cancer MTT/MTS assay IC50=24 µM 48-h Blood None None CCCCCTTGGGSSSCC
1127 12005420 2001 WKKIPKFLHLAKKF N-5 14 Linear L None Amidation Free Antibacterial Ceropin A MDA-MB-361 Breast Cancer MTT/MTS assay IC50=100. <µM 48-h Breast None None CCSCSCHHHHTTCC
1149 12005420 2001 WKKIPKFLHLAKKF N-5 14 Linear L None Amidation Free Antibacterial Ceropin A Jurkat Blood Cancer MTT/MTS assay IC50=100.0 <µM 48-h Blood None None CCSCSCHHHHTTCC
1171 12005420 2001 WKKIPKFLHLAKKF N-5 14 Linear L None Amidation Free Antibacterial Ceropin A K-562 Leukemia Cancer MTT/MTS assay IC50=100.0 <µM 48-h Blood None None CCSCSCHHHHTTCC
1128 12005420 2001 WFKKIPKFLHLLKKF N-3L 15 Linear L None Amidation Free Antibacterial Ceropin A MDA-MB-361 Breast Cancer MTT/MTS assay IC50=5 µM 48-h Breast None None CTTCCHHHHTTTCCC
1151 12005420 2001 WFKKIPKFLHLLKKF N-4L 15 Linear L None Amidation Free Antibacterial Ceropin A Jurkat Blood Cancer MTT/MTS assay IC50=6 µM 48-h Blood None None CTTCCHHHHTTTCCC
1173 12005420 2001 WFKKIPKFLHLLKKF N-4L 15 Linear L None Amidation Free Antibacterial Ceropin A K-562 Leukemia Cancer MTT/MTS assay IC50=3 µM 48-h Blood None None CTTCCHHHHTTTCCC
1129 12005420 2001 WKKIPKFLHLLKKF N-4L 14 Linear L None Amidation Free Antibacterial Ceropin A MDA-MB-361 Breast Cancer MTT/MTS assay IC50=5 µM 48-h Breast None None CCSSCCHHHHGGGC
1130 12005420 2001 WKKIPKFLHLLKKF N-5L 14 Linear L None Amidation Free Antibacterial Ceropin A MDA-MB-361 Breast Cancer MTT/MTS assay IC50=17 µM 48-h Breast None None CCSSCCHHHHGGGC
1152 12005420 2001 WKKIPKFLHLLKKF N-5L 14 Linear L None Amidation Free Antibacterial Ceropin A Jurkat Blood Cancer MTT/MTS assay IC50=14 µM 48-h Blood None None CCSSCCHHHHGGGC
1174 12005420 2001 WKKIPKFLHLLKKF N-5L 14 Linear L None Amidation Free Antibacterial Ceropin A K-562 Leukemia Cancer MTT/MTS assay IC50=10 µM 48-h Blood None None CCSSCCHHHHGGGC
1131 12005420 2001 KWKLFKKIPFLHLAKKF C-1 17 Linear L None Amidation Free Antibacterial Ceropin A MDA-MB-361 Breast Cancer MTT/MTS assay IC50=26 µM 48-h Breast None None CCCCSSSCCCCSSCCCC
1153 12005420 2001 KWKLFKKIPFLHLAKKF C-1 17 Linear L None Amidation Free Antibacterial Ceropin A Jurkat Blood Cancer MTT/MTS assay IC50=32 µM 48-h Blood None None CCCCSSSCCCCSSCCCC
1175 12005420 2001 KWKLFKKIPFLHLAKKF C-1 17 Linear L None Amidation Free Antibacterial Ceropin A K-562 Leukemia Cancer MTT/MTS assay IC50=31 µM 48-h Blood None None CCCCSSSCCCCSSCCCC
1132 12005420 2001 KWKLFKKIPKFLHLAKK C-2 17 Linear L None Amidation Free Antibacterial Ceropin A MDA-MB-361 Breast Cancer MTT/MTS assay IC50=38 µM 48-h Breast None None CCCSSSCCTTTTCSSCC
1154 12005420 2001 KWKLFKKIPKFLHLAKK C-2 17 Linear L None Amidation Free Antibacterial Ceropin A Jurkat Blood Cancer MTT/MTS assay IC50=26 µM 48-h Blood None None CCCSSSCCTTTTCSSCC
1176 12005420 2001 KWKLFKKIPKFLHLAKK C-2 17 Linear L None Amidation Free Antibacterial Ceropin A K-562 Leukemia Cancer MTT/MTS assay IC50=23 µM 48-h Blood None None CCCSSSCCTTTTCSSCC
1133 12005420 2001 KWKLFKKIPLHLAKKF C-3 16 Linear L None Amidation Free Antibacterial Ceropin A MDA-MB-361 Breast Cancer MTT/MTS assay IC50=79 µM 48-h Breast None None CCCCCCCCSSTTSCCC
1155 12005420 2001 KWKLFKKIPLHLAKKF C-3 16 Linear L None Amidation Free Antibacterial Ceropin A Jurkat Blood Cancer MTT/MTS assay IC50=74 µM 48-h Blood None None CCCCCCCCSSTTSCCC
1177 12005420 2001 KWKLFKKIPLHLAKKF C-3 16 Linear L None Amidation Free Antibacterial Ceropin A K-562 Leukemia Cancer MTT/MTS assay IC50=62 µM 48-h Blood None None CCCCCCCCSSTTSCCC
1134 12005420 2001 KWKLFKKIPKFLHLAK C-4 16 Linear L None Amidation Free Antibacterial Ceropin A MDA-MB-361 Breast Cancer MTT/MTS assay IC50=54 µM 48-h Breast None None CCSCCCCTTCTTCSCC
1156 12005420 2001 KWKLFKKIPKFLHLAK C-4 16 Linear L None Amidation Free Antibacterial Ceropin A Jurkat Blood Cancer MTT/MTS assay IC50=31 µM 48-h Blood None None CCSCCCCTTCTTCSCC
1178 12005420 2001 KWKLFKKIPKFLHLAK C-4 16 Linear L None Amidation Free Antibacterial Ceropin A K-562 Leukemia Cancer MTT/MTS assay IC50=25 µM 48-h Blood None None CCSCCCCTTCTTCSCC
1135 12005420 2001 KWKLFKKIPHLAKKF C-5 15 Linear L None Amidation Free Antibacterial Ceropin A MDA-MB-361 Breast Cancer MTT/MTS assay IC50=100 µM 48-h Breast None None CCCCCCCSSCCSSCC
1157 12005420 2001 KWKLFKKIPHLAKKF C-5 15 Linear L None Amidation Free Antibacterial Ceropin A Jurkat Blood Cancer MTT/MTS assay IC50=81 µM 48-h Blood None None CCCCCCCSSCCSSCC
1179 12005420 2001 KWKLFKKIPHLAKKF C-5 15 Linear L None Amidation Free Antibacterial Ceropin A K-562 Leukemia Cancer MTT/MTS assay IC50=67 µM 48-h Blood None None CCCCCCCSSCCSSCC
1136 12005420 2001 KWKLFKKIPKFLHLA C-6 15 Linear L None Amidation Free Antibacterial Ceropin A MDA-MB-361 Breast Cancer MTT/MTS assay IC50=47 µM 48-h Breast None None CCSSCSSGGGTSCCC
1158 12005420 2001 KWKLFKKIPKFLHLA C-6 15 Linear L None Amidation Free Antibacterial Ceropin A Jurkat Blood Cancer MTT/MTS assay IC50=21 µM 48-h Blood None None CCSSCSSGGGTSCCC
1180 12005420 2001 KWKLFKKIPKFLHLA C-6 15 Linear L None Amidation Free Antibacterial Ceropin A K-562 Leukemia Cancer MTT/MTS assay IC50=27 µM 48-h Blood None None CCSSCSSGGGTSCCC
1137 12005420 2001 KWKLFKKIPLAKKF C-7 14 Linear L None Amidation Free Antibacterial Ceropin A MDA-MB-361 Breast Cancer MTT/MTS assay IC50=100. <µM 48-h Breast None None CCCSCCCCCGGGCC
1159 12005420 2001 KWKLFKKIPLAKKF C-7 14 Linear L None Amidation Free Antibacterial Ceropin A Jurkat Blood Cancer MTT/MTS assay IC50=100.0 <µM 48-h Blood None None CCCSCCCCCGGGCC
1181 12005420 2001 KWKLFKKIPLAKKF C-7 14 Linear L None Amidation Free Antibacterial Ceropin A K-562 Leukemia Cancer MTT/MTS assay IC50=100.0 <µM 48-h Blood None None CCCSCCCCCGGGCC
1138 12005420 2001 KWKLFKKIPKFLHL C-8 14 Linear L None Amidation Free Antibacterial Ceropin A MDA-MB-361 Breast Cancer MTT/MTS assay IC50=83 µM 48-h Breast None None CCSCCCSGGGTTCC
1160 12005420 2001 KWKLFKKIPKFLHL C-8 14 Linear L None Amidation Free Antibacterial Ceropin A Jurkat Blood Cancer MTT/MTS assay IC50=54 µM 48-h Blood None None CCSCCCSGGGTTCC
1182 12005420 2001 KWKLFKKIPKFLHL C-8 14 Linear L None Amidation Free Antibacterial Ceropin A K-562 Leukemia Cancer MTT/MTS assay IC50=30 µM 48-h Blood None None CCSCCCSGGGTTCC
1139 12005420 2001 KWKLFKKIPLKKF C-9 13 Linear L None Amidation Free Antibacterial Ceropin A MDA-MB-361 Breast Cancer MTT/MTS assay IC50=100. <µM 48-h Breast None None CCCCCTTSGGGCC
1161 12005420 2001 KWKLFKKIPLKKF C-9 13 Linear L None Amidation Free Antibacterial Ceropin A Jurkat Blood Cancer MTT/MTS assay IC50=100.0 <µM 48-h Blood None None CCCCCTTSGGGCC
1183 12005420 2001 KWKLFKKIPLKKF C-9 13 Linear L None Amidation Free Antibacterial Ceropin A K-562 Leukemia Cancer MTT/MTS assay IC50=100.0 <µM 48-h Blood None None CCCCCTTSGGGCC
1140 12005420 2001 KWKLFKKIPKFLH C-10 13 Linear L None Amidation Free Antibacterial Ceropin A MDA-MB-361 Breast Cancer MTT/MTS assay IC50=100. <µM 48-h Breast None None CCTTCCCTTCCCC
1162 12005420 2001 KWKLFKKIPKFLH C-10 13 Linear L None Amidation Free Antibacterial Ceropin A Jurkat Blood Cancer MTT/MTS assay IC50=100.0 <µM 48-h Blood None None CCTTCCCTTCCCC
1184 12005420 2001 KWKLFKKIPKFLH C-10 13 Linear L None Amidation Free Antibacterial Ceropin A K-562 Leukemia Cancer MTT/MTS assay IC50=100.0 <µM 48-h Blood None None CCTTCCCTTCCCC
1150 12005420 2001 KWFKKIPKFLHLLKKF N-3L 16 Linear L None Amidation Free Antibacterial Ceropin A Jurkat Blood Cancer MTT/MTS assay IC50=4 µM 48-h Blood None None CCTTSSCTHHHHTTCC
1172 12005420 2001 KWFKKIPKFLHLLKKF N-3L 16 Linear L None Amidation Free Antibacterial Ceropin A K-562 Leukemia Cancer MTT/MTS assay IC50=4.2 µM 48-h Blood None None CCTTSSCTHHHHTTCC
1185 10675500 2000 KWKLFKKIGIGKFLHSAKKF CA-MA 20 Linear L None Amidation Free Antibacterial Ceropin-Magainin hybrid peptides K-562 Leukemia Cancer MTT/MTS assay IC50=65 µM 72-h Blood None None CCGGGGGTTSTTTTTGGGTC
1189 10675500 2000 KWKLFKKIGIGKFLHSAKKF CA-MA 20 Linear L None Amidation Free Antibacterial Ceropin-Magainin hybrid peptides A-549 Lung Cancer MTT/MTS assay IC50=60 µM 72-h Lung None None CCGGGGGTTSTTTTTGGGTC
1193 10675500 2000 KWKLFKKIGIGKFLHSAKKF CA-MA 20 Linear L None Amidation Free Antibacterial Ceropin-Magainin hybrid peptides Jurkat Blood Cancer MTT/MTS assay IC50=30 µM 72-h Blood None None CCGGGGGTTSTTTTTGGGTC
1197 10675500 2000 KWKLFKKIGIGKFLHSAKKF CA-MA 20 Linear L None Amidation Free Antibacterial Ceropin-Magainin hybrid peptides MDA-MB-361 Breast Cancer MTT/MTS assay IC50=44 µM 72-h Breast None None CCGGGGGTTSTTTTTGGGTC
1201 9352466 1997 KWKLFKKIGIGKFLHSAKKF CA-MA 20 Linear L None Amidation Free Antibacterial Ceropin A-Magainin 2 NCI-H69 Lung Cancer MTT/MTS assay IC50=15.8 µM 72-h Lung None None CCGGGGGTTSTTTTTGGGTC
1211 9352466 1997 KWKLFKKIGIGKFLHSAKKF CA-MA 20 Linear L None Amidation Free Antibacterial Ceropin A-Magainin 2 NCI-H128 Lung Cancer MTT/MTS assay IC50=16.1 µM 72-h Lung None None CCGGGGGTTSTTTTTGGGTC
1221 9352466 1997 KWKLFKKIGIGKFLHSAKKF CA-MA 20 Linear L None Amidation Free Antibacterial Ceropin A-Magainin 2 NCI-H146 Lung Cancer MTT/MTS assay IC50=15.8 µM 72-h Lung None None CCGGGGGTTSTTTTTGGGTC
3350 None 2004 KWKLFKKIGIGKFLHSAKKF CA-MA 20 Linear L None Amidation Free Antimicrobial and Anticancer, antibacterial, antifungal Ceropin-Melittin hybrid Calu-6 Lung Cancer MTT/MTS assay ~90% survival rate at 10 µM NA Lung None US_6800727_B2 CCGGGGGTTSTTTTTGGGTC
3351 None 2004 KWKLFKKIGIGKFLHSAKKF CA-MA 20 Linear L None Amidation Free Antimicrobial and Anticancer, antibacterial, antifungal Ceropin-Melittin hybrid Calu-6 Lung Cancer MTT/MTS assay <20% survival rate at 100 µM NA Lung None US_6800727_B2 CCGGGGGTTSTTTTTGGGTC
3352 None 2004 KWKLFKKIGIGKFLHSAKKF CA-MA 20 Linear L None Amidation Free Antimicrobial and Anticancer, antibacterial, antifungal Ceropin-Melittin hybrid Jurkat Blood Cancer MTT/MTS assay 100% survival rate at 10 µM NA Blood None US_6800727_B2 CCGGGGGTTSTTTTTGGGTC
3353 None 2004 KWKLFKKIGIGKFLHSAKKF CA-MA 20 Linear L None Amidation Free Antimicrobial and Anticancer, antibacterial, antifungal Ceropin-Melittin hybrid Jurkat Blood Cancer MTT/MTS assay 0% survival rate at 100 µM NA Blood None US_6800727_B2 CCGGGGGTTSTTTTTGGGTC
3354 None 2004 KWKLFKKIGIGKFLHSAKKF CA-MA 20 Linear L None Amidation Free Antimicrobial and Anticancer, antibacterial, antifungal Ceropin-Melittin hybrid SNU-601 Gastric Cancer MTT/MTS assay ~80% survival rate at 10 µM NA Stomach None US_6800727_B2 CCGGGGGTTSTTTTTGGGTC
3355 None 2004 KWKLFKKIGIGKFLHSAKKF CA-MA 20 Linear L None Amidation Free Antimicrobial and Anticancer, antibacterial, antifungal Ceropin-Melittin hybrid SNU-601 Gastric Cancer MTT/MTS assay 10% survival rate at 100 µM NA Stomach None US_6800727_B2 CCGGGGGTTSTTTTTGGGTC
1186 10675500 2000 KWKLFKKIKFLHSAKKF CA-MA1 17 Linear L None Amidation Free Antibacterial Ceropin-Magainin hybrid peptides K-562 Leukemia Cancer MTT/MTS assay IC50=85.3 µM 72-h Blood None None CCCTHHHHHHHHHTTCC
1190 10675500 2000 KWKLFKKIKFLHSAKKF CA-MA1 17 Linear L None Amidation Free Antibacterial Ceropin-Magainin hybrid peptides A-549 Lung Cancer MTT/MTS assay IC50=100 µM 72-h Lung None None CCCTHHHHHHHHHTTCC
1194 10675500 2000 KWKLFKKIKFLHSAKKF CA-MA1 17 Linear L None Amidation Free Antibacterial Ceropin-Magainin hybrid peptides Jurkat Blood Cancer MTT/MTS assay IC50=65 µM 72-h Blood None None CCCTHHHHHHHHHTTCC
1198 10675500 2000 KWKLFKKIKFLHSAKKF CA-MA1 17 Linear L None Amidation Free Antibacterial Ceropin-Magainin hybrid peptides MDA-MB-361 Breast Cancer MTT/MTS assay IC50=100 µM 72-h Breast None None CCCTHHHHHHHHHTTCC
1188 10675500 2000 KWKLFKKIGPGKFLHSAKKF CA-MA3 20 Linear L None Amidation Free Antibacterial Ceropin-Magainin hybrid peptides K-562 Leukemia Cancer MTT/MTS assay IC50=>100 µM 72-h Blood None None CCCSSSCCSSSCCCCSCCCC
1192 10675500 2000 KWKLFKKIGPGKFLHSAKKF CA-MA3 20 Linear L None Amidation Free Antibacterial Ceropin-Magainin hybrid peptides A-549 Lung Cancer MTT/MTS assay IC50=>100 µM 72-h Lung None None CCCSSSCCSSSCCCCSCCCC
1196 10675500 2000 KWKLFKKIGPGKFLHSAKKF CA-MA3 20 Linear L None Amidation Free Antibacterial Ceropin-Magainin hybrid peptides Jurkat Blood Cancer MTT/MTS assay IC50=75 µM 72-h Blood None None CCCSSSCCSSSCCCCSCCCC
1200 10675500 2000 KWKLFKKIGPGKFLHSAKKF CA-MA3 20 Linear L None Amidation Free Antibacterial Ceropin-Magainin hybrid peptides MDA-MB-361 Breast Cancer MTT/MTS assay IC50=>100 µM 72-h Breast None None CCCSSSCCSSSCCCCSCCCC
1202 9352466 1997 KWKLFKKIGIGAVLKVLTTG CA-ME 20 Linear L None Amidation Free Antibacterial Ceropin A-Magainin 2 NCI-H69 Lung Cancer MTT/MTS assay IC50=32.2 µM 72-h Lung None None CCCCCCCCSSSSCCCCGGGC
1212 9352466 1997 KWKLFKKIGIGAVLKVLTTG CA-ME 20 Linear L None Amidation Free Antibacterial Ceropin A-Magainin 2 NCI-H128 Lung Cancer MTT/MTS assay IC50=28.6 µM 72-h Lung None None CCCCCCCCSSSSCCCCGGGC
1222 9352466 1997 KWKLFKKIGIGAVLKVLTTG CA-ME 20 Linear L None Amidation Free Antibacterial Ceropin A-Magainin 2 NCI-H146 Lung Cancer MTT/MTS assay IC50=28.6 µM 72-h Lung None None CCCCCCCCSSSSCCCCGGGC
1203 9352466 1997 KWKLFKKIGIGAVLKVLKKG P1 20 Linear L None Amidation Free Antibacterial Ceropin A-Magainin 2 NCI-H69 Lung Cancer MTT/MTS assay IC50=3.4 µM 72-h Lung None None CCCCCCCCSSGGGHHHHHCC
1213 9352466 1997 KWKLFKKIGIGAVLKVLKKG P1 20 Linear L None Amidation Free Antibacterial Ceropin A-Magainin 2 NCI-H128 Lung Cancer MTT/MTS assay IC50=3.5 µM 72-h Lung None None CCCCCCCCSSGGGHHHHHCC
1223 9352466 1997 KWKLFKKIGIGAVLKVLKKG P1 20 Linear L None Amidation Free Antibacterial Ceropin A-Magainin 2 NCI-H146 Lung Cancer MTT/MTS assay IC50=4.5 µM 72-h Lung None None CCCCCCCCSSGGGHHHHHCC
1204 9352466 1997 KWKLFKKIGIGKFLHSATTF P2 20 Linear L None Amidation Free Antibacterial Ceropin A-Magainin 2 NCI-H69 Lung Cancer MTT/MTS assay IC50=36.2 µM 72-h Lung None None CCCCSCCEECSSSEECCCCC
1214 9352466 1997 KWKLFKKIGIGKFLHSATTF P2 20 Linear L None Amidation Free Antibacterial Ceropin A-Magainin 2 NCI-H128 Lung Cancer MTT/MTS assay IC50=37.9 µM 72-h Lung None None CCCCSCCEECSSSEECCCCC
1224 9352466 1997 KWKLFKKIGIGKFLHSATTF P2 20 Linear L None Amidation Free Antibacterial Ceropin A-Magainin 2 NCI-H146 Lung Cancer MTT/MTS assay IC50=47.7 µM 72-h Lung None None CCCCSCCEECSSSEECCCCC
1205 9352466 1997 KWKLFKKIGIGAFLHSAKKF P3 20 Linear L None Amidation Free Antibacterial Ceropin A-Magainin 2 NCI-H69 Lung Cancer MTT/MTS assay IC50=9.3 µM 72-h Lung None None CCSSCSSCCSTTTTTCCCCC
1215 9352466 1997 KWKLFKKIGIGAFLHSAKKF P3 20 Linear L None Amidation Free Antibacterial Ceropin A-Magainin 2 NCI-H128 Lung Cancer MTT/MTS assay IC50=9.3 µM 72-h Lung None None CCSSCSSCCSTTTTTCCCCC
1225 9352466 1997 KWKLFKKIGIGAFLHSAKKF P3 20 Linear L None Amidation Free Antibacterial Ceropin A-Magainin 2 NCI-H146 Lung Cancer MTT/MTS assay IC50=10.9 µM 72-h Lung None None CCSSCSSCCSTTTTTCCCCC
1206 9352466 1997 KWKLFKKIGIGKFLHLAKKF P4 20 Linear L None Amidation Free Antibacterial Ceropin A-Magainin 2 NCI-H69 Lung Cancer MTT/MTS assay IC50=1.9 µM 72-h Lung None None CCCSSSCCSSTHHHHHTSCC
1216 9352466 1997 KWKLFKKIGIGKFLHLAKKF P4 20 Linear L None Amidation Free Antibacterial Ceropin A-Magainin 2 NCI-H128 Lung Cancer MTT/MTS assay IC50=1.3 µM 72-h Lung None None CCCSSSCCSSTHHHHHTSCC
1226 9352466 1997 KWKLFKKIGIGKFLHLAKKF P4 20 Linear L None Amidation Free Antibacterial Ceropin A-Magainin 2 NCI-H146 Lung Cancer MTT/MTS assay IC50=2.8 µM 72-h Lung None None CCCSSSCCSSTHHHHHTSCC
1207 9352466 1997 KWKLFKKIGIGAFLHLAKKF P5 20 Linear L None Amidation Free Antibacterial Ceropin A-Magainin 2 NCI-H69 Lung Cancer MTT/MTS assay IC50=2.9 µM 72-h Lung None None CCCCCCCCSSTTHHHHHSCC
1217 9352466 1997 KWKLFKKIGIGAFLHLAKKF P5 20 Linear L None Amidation Free Antibacterial Ceropin A-Magainin 2 NCI-H128 Lung Cancer MTT/MTS assay IC50=2.9 µM 72-h Lung None None CCCCCCCCSSTTHHHHHSCC
1227 9352466 1997 KWKLFKKIGIGAFLHLAKKF P5 20 Linear L None Amidation Free Antibacterial Ceropin A-Magainin 2 NCI-H146 Lung Cancer MTT/MTS assay IC50=3.2 µM 72-h Lung None None CCCCCCCCSSTTHHHHHSCC
1208 9352466 1997 KWKLFKKIGIGKFKLAKKF P6 19 Linear L None Amidation Free Antibacterial Ceropin A-Magainin 2 NCI-H69 Lung Cancer MTT/MTS assay IC50=1.7 µM 72-h Lung None None CCCSSCCCSHHHHBCCCCC
1218 9352466 1997 KWKLFKKIGIGKFKLAKKF P6 19 Linear L None Amidation Free Antibacterial Ceropin A-Magainin 2 NCI-H128 Lung Cancer MTT/MTS assay IC50=2 µM 72-h Lung None None CCCSSCCCSHHHHBCCCCC
1228 9352466 1997 KWKLFKKIGIGKFKLAKKF P6 19 Linear L None Amidation Free Antibacterial Ceropin A-Magainin 2 NCI-H146 Lung Cancer MTT/MTS assay IC50=3.1 µM 72-h Lung None None CCCSSCCCSHHHHBCCCCC
1209 9352466 1997 KWKLFAKIGIGKFLHLAKKF P7 20 Linear L None Amidation Free Antibacterial Ceropin A-Magainin 2 NCI-H69 Lung Cancer MTT/MTS assay IC50=3.1 µM 72-h Lung None None CCCCCCCCCCHHHHHTTSCC
1219 9352466 1997 KWKLFAKIGIGKFLHLAKKF P7 20 Linear L None Amidation Free Antibacterial Ceropin A-Magainin 2 NCI-H128 Lung Cancer MTT/MTS assay IC50=2.4 µM 72-h Lung None None CCCCCCCCCCHHHHHTTSCC
1229 9352466 1997 KWKLFAKIGIGKFLHLAKKF P7 20 Linear L None Amidation Free Antibacterial Ceropin A-Magainin 2 NCI-H146 Lung Cancer MTT/MTS assay IC50=2.4 µM 72-h Lung None None CCCCCCCCCCHHHHHTTSCC
1210 9352466 1997 KWKKFLKIGIGKFLHLAKKF P8 20 Linear L None Amidation Free Antibacterial Ceropin A-Magainin 2 NCI-H69 Lung Cancer MTT/MTS assay IC50=2.6 µM 72-h Lung None None CCGGGGCCTHHHHHHHHTTC
1220 9352466 1997 KWKKFLKIGIGKFLHLAKKF P8 20 Linear L None Amidation Free Antibacterial Ceropin A-Magainin 2 NCI-H128 Lung Cancer MTT/MTS assay IC50=2.3 µM 72-h Lung None None CCGGGGCCTHHHHHHHHTTC
1230 9352466 1997 KWKKFLKIGIGKFLHLAKKF P8 20 Linear L None Amidation Free Antibacterial Ceropin A-Magainin 2 NCI-H146 Lung Cancer MTT/MTS assay IC50=1.8 µM 72-h Lung None None CCGGGGCCTHHHHHHHHTTC
1231 7849420 1994 KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL Cecropin B 35 Linear L None Amidation Free Antibacterial Hyalophora Cecropia(silkmoth) K-562 Leukemia Cancer MTT assay IC50=15.5 µM 96-h Blood None None CCSSSSCCHHHHHHHTTSHHHHSSCCCTTCCSSCC
1232 7849420 1994 KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL Cecropin B 35 Linear L None Amidation Free Antibacterial Hyalophora Cecropia(silkmoth) BTS-30 Breast Cancer MTT assay IC50=24.8 µM 96-h Breast None None CCSSSSCCHHHHHHHTTSHHHHSSCCCTTCCSSCC
1233 7849420 1994 KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL Cecropin B 35 Linear L None Amidation Free Antibacterial Hyalophora Cecropia(silkmoth) HRT-18 Colon Cancer MTT assay IC50=25.5 µM 96-h Colon None None CCSSSSCCHHHHHHHTTSHHHHSSCCCTTCCSSCC
1234 7849420 1994 KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL Cecropin B 35 Linear L None Amidation Free Antibacterial Hyalophora Cecropia(silkmoth) DLD-1 Colon Cancer MTT assay IC50=>100 µM 96-h Colon None None CCSSSSCCHHHHHHHTTSHHHHSSCCCTTCCSSCC
1243 7849420 1994 KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL Cecropin B 35 Linear L None Amidation Free Antibacterial Hyalophora Cecropia(silkmoth) WEHI-3B Leukemia Cancer MTT assay IC50=4.4 µM 96-h Blood None None CCSSSSCCHHHHHHHTTSHHHHSSCCCTTCCSSCC
1244 7849420 1994 KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL Cecropin B 35 Linear L None Amidation Free Antibacterial Hyalophora Cecropia(silkmoth) A-2780 Ovarian Cancer MTT assay IC50=30.6 µM 96-h Ovary None None CCSSSSCCHHHHHHHTTSHHHHSSCCCTTCCSSCC
1245 7849420 1994 KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL Cecropin B 35 Linear L None Amidation Free Antibacterial Hyalophora Cecropia(silkmoth) HCLO Colon Cancer MTT assay IC50=33.5 µM 96-h Colon None None CCSSSSCCHHHHHHHTTSHHHHSSCCCTTCCSSCC
1246 7849420 1994 KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL Cecropin B 35 Linear L None Amidation Free Antibacterial Hyalophora Cecropia(silkmoth) CHO-KI Ovarian Cancer MTT assay IC50=32 µM 96-h Ovary None None CCSSSSCCHHHHHHHTTSHHHHSSCCCTTCCSSCC
1247 7849420 1994 KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL Cecropin B 35 Linear L None Amidation Free Antibacterial Hyalophora Cecropia(silkmoth) MAC15A Colon Cancer MTT assay IC50=37 µM 96-h Colon None None CCSSSSCCHHHHHHHTTSHHHHSSCCCTTCCSSCC
1248 7849420 1994 KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL Cecropin B 35 Linear L None Amidation Free Antibacterial Hyalophora Cecropia(silkmoth) MCF-7 Breast Cancer MTT assay IC50=42.5 µM 96-h Breast None None CCSSSSCCHHHHHHHTTSHHHHSSCCCTTCCSSCC
1249 7849420 1994 KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL Cecropin B 35 Linear L None Amidation Free Antibacterial Hyalophora Cecropia(silkmoth) HT-29 Colon Cancer MTT assay IC50=>100 µM 96-h Colon None None CCSSSSCCHHHHHHHTTSHHHHSSCCCTTCCSSCC
1250 7849420 1994 KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL Cecropin B 35 Linear L None Amidation Free Antibacterial Hyalophora Cecropia(silkmoth) A-2780R Ovarian Cancer MTT assay IC50=34.5 96-h Ovary None None CCSSSSCCHHHHHHHTTSHHHHSSCCCTTCCSSCC
1251 7849420 1994 KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL Cecropin B 35 Linear L None Amidation Free Antibacterial Hyalophora Cecropia(silkmoth) MCF-7R Breast Cancer MTT assay IC50=24.5 96-h Breast None None CCSSSSCCHHHHHHHTTSHHHHSSCCCTTCCSSCC
4601 15496597 2004 KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL CB 36 Linear L None Free Free Antibacterial Synthetic Ags Gastric Cancer Not Available Not Available Not Available Stomach None None CCSSTTCCTHHHHHHHHSSGGGSSSCCSSSCTTTC
1235 7849420 1994 SWLSKTAKKLENSAKKRISEGIAIAIQGGPR Cecropin P1 31 Linear L None Free Free Antibacterial Small Intestine of Pig K-562 Leukemia Cancer MTT assay IC50=93 µM 96-h Blood None None CCTHHHHTTTHHHHHHHSSTTCCCCCCSSCC
1236 7849420 1994 SWLSKTAKKLENSAKKRISEGIAIAIQGGPR Cecropin P1 31 Linear L None Free Free Antibacterial Small Intestine of Pig BTS-30 Breast Cancer MTT assay IC50=>100 µM 96-h Breast None None CCTHHHHTTTHHHHHHHSSTTCCCCCCSSCC
1237 7849420 1994 SWLSKTAKKLENSAKKRISEGIAIAIQGGPR Cecropin P1 31 Linear L None Free Free Antibacterial Small Intestine of Pig HRT-18 Colon Cancer MTT assay IC50=>100 µM 96-h Colon None None CCTHHHHTTTHHHHHHHSSTTCCCCCCSSCC
1238 7849420 1994 SWLSKTAKKLENSAKKRISEGIAIAIQGGPR Cecropin P1 31 Linear L None Free Free Antibacterial Small Intestine of Pig DLD-1 Colon Cancer MTT assay IC50=>100 µM 96-h Colon None None CCTHHHHTTTHHHHHHHSSTTCCCCCCSSCC
1239 7849420 1994 MPRWRLFRRIDRVGKQIKQGILRAGPAIALVGDARAVG Shiva-1 38 Linear L None Free Free Antibacterial Magainin K-562 Leukemia Cancer MTT assay IC50=28.7 µM 96-h Blood None None CCCCHHHHSSCSTTTTGGGCCTTSTTCSCSSCCTTTTC
1240 7849420 1994 MPRWRLFRRIDRVGKQIKQGILRAGPAIALVGDARAVG Shiva-1 38 Linear L None Free Free Antibacterial Magainin BTS-30 Breast Cancer MTT assay IC50=56 µM 96-h Breast None None CCCCHHHHSSCSTTTTGGGCCTTSTTCSCSSCCTTTTC
1241 7849420 1994 MPRWRLFRRIDRVGKQIKQGILRAGPAIALVGDARAVG Shiva-1 38 Linear L None Free Free Antibacterial Magainin HRT-18 Colon Cancer MTT assay IC50=49.3 µM 96-h Colon None None CCCCHHHHSSCSTTTTGGGCCTTSTTCSCSSCCTTTTC
1242 7849420 1994 MPRWRLFRRIDRVGKQIKQGILRAGPAIALVGDARAVG Shiva-1 38 Linear L None Free Free Antibacterial Magainin DLD-1 Colon Cancer MTT assay IC50=>100 µM 96-h Colon None None CCCCHHHHSSCSTTTTGGGCCTTSTTCSCSSCCTTTTC
1252 10951191 2000 GLFDIIKKIAESF Aurein1.2 13 Linear L None Amidation Free Antimicrobial Southern bell frog Breast tumor cellline Breast Cancer Not Available LC50 = 10 µM Not Available Breast National Cancer Institute, Washington, DC, USA. None CCHHHHHHHHHHC
1253 10951191 2000 GLFDIIKKIAESF Aurein1.2 13 Linear L None Amidation Free Antimicrobial Southern bell frog Leukemia tumor cellline Leukemia Cancer Not Available LC50=10-100 µM Not Available Blood National Cancer Institute, Washington, DC, USA. None CCHHHHHHHHHHC
1254 10951191 2000 GLFDIIKKIAESF Aurein1.2 13 Linear L None Amidation Free Antimicrobial Southern bell frog Lung tumor cellline Lung Cancer Not Available LC50 = 10 µM Not Available Lung National Cancer Institute, Washington, DC, USA. None CCHHHHHHHHHHC
1255 10951191 2000 GLFDIIKKIAESF Aurein1.2 13 Linear L None Amidation Free Antimicrobial Southern bell frog Colon tumor cellline Colon Cancer Not Available LC50 = 10 µM Not Available Colon National Cancer Institute, Washington, DC, USA. None CCHHHHHHHHHHC
1256 10951191 2000 GLFDIIKKIAESF Aurein1.2 13 Linear L None Amidation Free Antimicrobial Southern bell frog Brain tumor cellline Brain Tumor Not Available LC50 = 10 µM Not Available Brain National Cancer Institute, Washington, DC, USA. None CCHHHHHHHHHHC
1257 10951191 2000 GLFDIIKKIAESF Aurein1.2 13 Linear L None Amidation Free Antimicrobial Southern bell frog Skin tumor cellline Skin Cancer Not Available LC50 = 10 µM Not Available Skin National Cancer Institute, Washington, DC, USA. None CCHHHHHHHHHHC
1258 10951191 2000 GLFDIIKKIAESF Aurein1.2 13 Linear L None Amidation Free Antimicrobial Southern bell frog Ovary tumor cellline Ovarian Cancer Not Available LC50 = 10 µM Not Available Ovary National Cancer Institute, Washington, DC, USA. None CCHHHHHHHHHHC
1259 10951191 2000 GLFDIIKKIAESF Aurein1.2 13 Linear L None Amidation Free Antimicrobial Southern bell frog Renal tumor cellline Renal Cancer Not Available LC50 = 10 µM Not Available Renal National Cancer Institute, Washington, DC, USA. None CCHHHHHHHHHHC
1260 10951191 2000 GLFDIIKKIAESF Aurein1.2 13 Linear L None Amidation Free Antimicrobial Southern bell frog Prostate tumor cellline Prostate Cancer Not Available LC50 = 10 µM Not Available Prostate National Cancer Institute, Washington, DC, USA. None CCHHHHHHHHHHC
1261 10951191 2000 GLFDIVKKVVGAFGSL Aurein2.5 16 Linear L None Amidation Free Antimicrobial Southern bell frog Breast tumor cellline Breast Cancer Not Available LC50 = 10 µM Not Available Breast National Cancer Institute, Washington, DC, USA. None CHHHHHTTTTTGGGCC
1262 10951191 2000 GLFDIVKKVVGAFGSL Aurein2.5 16 Linear L None Amidation Free Antimicrobial Southern bell frog Leukemia tumor cellline Leukemia Cancer Not Available LC50=10-100 µM Not Available Blood National Cancer Institute, Washington, DC, USA. None CHHHHHTTTTTGGGCC
1263 10951191 2000 GLFDIVKKVVGAFGSL Aurein2.5 16 Linear L None Amidation Free Antimicrobial Southern bell frog Lung tumor cellline Lung Cancer Not Available LC50 = 10 µM Not Available Lung National Cancer Institute, Washington, DC, USA. None CHHHHHTTTTTGGGCC
1264 10951191 2000 GLFDIVKKVVGAFGSL Aurein2.5 16 Linear L None Amidation Free Antimicrobial Southern bell frog Colon tumor cellline Colon Cancer Not Available LC50=10-100 µM Not Available Colon National Cancer Institute, Washington, DC, USA. None CHHHHHTTTTTGGGCC
1265 10951191 2000 GLFDIVKKVVGAFGSL Aurein2.5 16 Linear L None Amidation Free Antimicrobial Southern bell frog Brain tumor cellline Brain Tumor Not Available LC50 = 10 µM Not Available Brain National Cancer Institute, Washington, DC, USA. None CHHHHHTTTTTGGGCC
1266 10951191 2000 GLFDIVKKVVGAFGSL Aurein2.5 16 Linear L None Amidation Free Antimicrobial Southern bell frog Skin tumor cellline Skin Cancer Not Available LC50 = 10 µM Not Available Skin National Cancer Institute, Washington, DC, USA. None CHHHHHTTTTTGGGCC
1267 10951191 2000 GLFDIVKKVVGAFGSL Aurein2.5 16 Linear L None Amidation Free Antimicrobial Southern bell frog Ovary tumor cellline Ovarian Cancer Not Available LC50 = 10 µM Not Available Ovary National Cancer Institute, Washington, DC, USA. None CHHHHHTTTTTGGGCC
1268 10951191 2000 GLFDIVKKVVGAFGSL Aurein2.5 16 Linear L None Amidation Free Antimicrobial Southern bell frog Renal tumor cellline Renal Cancer Not Available LC50 = 10 µM Not Available Renal National Cancer Institute, Washington, DC, USA. None CHHHHHTTTTTGGGCC
1269 10951191 2000 GLFDIVKKVVGAFGSL Aurein2.5 16 Linear L None Amidation Free Antimicrobial Southern bell frog Prostate tumor cellline Prostate Cancer Not Available LC50 = 10 µM Not Available Prostate National Cancer Institute, Washington, DC, USA. None CHHHHHTTTTTGGGCC
1270 10951191 2000 GLFDIAKKVIGVIGSL Aurein2.6 16 Linear L None Amidation Free Antimicrobial Southern bell frog Breast tumor cellline Breast Cancer Not Available LC50 = 10 µM Not Available Breast National Cancer Institute, Washington, DC, USA. None CCSCHHHHHHSCSSCC
1271 10951191 2000 GLFDIAKKVIGVIGSL Aurein2.6 16 Linear L None Amidation Free Antimicrobial Southern bell frog Leukemia tumor cellline Leukemia Cancer Not Available LC50=10-100 µM Not Available Blood National Cancer Institute, Washington, DC, USA. None CCSCHHHHHHSCSSCC
1272 10951191 2000 GLFDIAKKVIGVIGSL Aurein2.6 16 Linear L None Amidation Free Antimicrobial Southern bell frog Lung tumor cellline Lung Cancer Not Available LC50 = 10 µM Not Available Lung National Cancer Institute, Washington, DC, USA. None CCSCHHHHHHSCSSCC
1273 10951191 2000 GLFDIAKKVIGVIGSL Aurein2.6 16 Linear L None Amidation Free Antimicrobial Southern bell frog Colon tumor cellline Colon Cancer Not Available LC50=10-100 µM Not Available Colon National Cancer Institute, Washington, DC, USA. None CCSCHHHHHHSCSSCC
1274 10951191 2000 GLFDIAKKVIGVIGSL Aurein2.6 16 Linear L None Amidation Free Antimicrobial Southern bell frog Brain tumor cellline Brain Tumor Not Available LC50 = 10 µM Not Available Brain National Cancer Institute, Washington, DC, USA. None CCSCHHHHHHSCSSCC
1275 10951191 2000 GLFDIAKKVIGVIGSL Aurein2.6 16 Linear L None Amidation Free Antimicrobial Southern bell frog Skin tumor cellline Skin Cancer Not Available LC50 = 10 µM Not Available Skin National Cancer Institute, Washington, DC, USA. None CCSCHHHHHHSCSSCC
1276 10951191 2000 GLFDIAKKVIGVIGSL Aurein2.6 16 Linear L None Amidation Free Antimicrobial Southern bell frog Ovary tumor cellline Ovarian Cancer Not Available LC50 = 10 µM Not Available Ovary National Cancer Institute, Washington, DC, USA. None CCSCHHHHHHSCSSCC
1277 10951191 2000 GLFDIAKKVIGVIGSL Aurein2.6 16 Linear L None Amidation Free Antimicrobial Southern bell frog Renal tumor cellline Renal Cancer Not Available LC50 = 10 µM Not Available Renal National Cancer Institute, Washington, DC, USA. None CCSCHHHHHHSCSSCC
1278 10951191 2000 GLFDIAKKVIGVIGSL Aurein2.6 16 Linear L None Amidation Free Antimicrobial Southern bell frog Prostate tumor cellline Prostate Cancer Not Available LC50 = 10 µM Not Available Prostate National Cancer Institute, Washington, DC, USA. None CCSCHHHHHHSCSSCC
1279 10951191 2000 GLFDIVKKIAGHIAGSI Aurein 3.1 17 Linear L None Amidation Free Antimicrobial Southern bell frog Breast tumor cellline Breast Cancer Not Available LC50=10-100 µM Not Available Breast National Cancer Institute, Washington, DC, USA. None CCHHHHTTTTTCCCSCC
1280 10951191 2000 GLFDIVKKIAGHIAGSI Aurein 3.1 17 Linear L None Amidation Free Antimicrobial Southern bell frog Leukemia tumor cellline Leukemia Cancer Not Available LC50 = 10 µM Not Available Blood National Cancer Institute, Washington, DC, USA. None CCHHHHTTTTTCCCSCC
1281 10951191 2000 GLFDIVKKIAGHIAGSI Aurein 3.1 17 Linear L None Amidation Free Antimicrobial Southern bell frog Lung tumor cellline Lung Cancer Not Available LC50 = 10 µM Not Available Lung National Cancer Institute, Washington, DC, USA. None CCHHHHTTTTTCCCSCC
1282 10951191 2000 GLFDIVKKIAGHIAGSI Aurein 3.1 17 Linear L None Amidation Free Antimicrobial Southern bell frog Colon tumor cellline Colon Cancer Not Available LC50 = 10 µM Not Available Colon National Cancer Institute, Washington, DC, USA. None CCHHHHTTTTTCCCSCC
1283 10951191 2000 GLFDIVKKIAGHIAGSI Aurein 3.1 17 Linear L None Amidation Free Antimicrobial Southern bell frog Brain tumor cellline Brain Tumor Not Available LC50=10-100 µM Not Available Brain National Cancer Institute, Washington, DC, USA. None CCHHHHTTTTTCCCSCC
1284 10951191 2000 GLFDIVKKIAGHIAGSI Aurein 3.1 17 Linear L None Amidation Free Antimicrobial Southern bell frog Skin tumor cellline Skin Cancer Not Available LC50=10-100 µM Not Available Skin National Cancer Institute, Washington, DC, USA. None CCHHHHTTTTTCCCSCC
1285 10951191 2000 GLFDIVKKIAGHIAGSI Aurein 3.1 17 Linear L None Amidation Free Antimicrobial Southern bell frog Ovary tumor cellline Ovarian Cancer Not Available LC50=10-100 µM Not Available Ovary National Cancer Institute, Washington, DC, USA. None CCHHHHTTTTTCCCSCC
1286 10951191 2000 GLFDIVKKIAGHIAGSI Aurein 3.1 17 Linear L None Amidation Free Antimicrobial Southern bell frog Renal tumor cellline Renal Cancer Not Available LC50=10-100 µM Not Available Renal National Cancer Institute, Washington, DC, USA. None CCHHHHTTTTTCCCSCC
1287 10951191 2000 GLFDIVKKIAGHIAGSI Aurein 3.1 17 Linear L None Amidation Free Antimicrobial Southern bell frog Prostate tumor cellline Prostate Cancer Not Available LC50 = 10 µM Not Available Prostate National Cancer Institute, Washington, DC, USA. None CCHHHHTTTTTCCCSCC
1288 10951191 2000 GLFDIVKKIAGHIASSI Aurein 3.2 17 Linear L None Amidation Free Antimicrobial Southern bell frog Breast tumor cellline Breast Cancer Not Available LC50 = 10 µM Not Available Breast National Cancer Institute, Washington, DC, USA. None CHHHHHHHHHHHTTSCC
1289 10951191 2000 GLFDIVKKIAGHIASSI Aurein 3.2 17 Linear L None Amidation Free Antimicrobial Southern bell frog Leukemia tumor cellline Leukemia Cancer Not Available LC50 = 10 µM Not Available Blood National Cancer Institute, Washington, DC, USA. None CHHHHHHHHHHHTTSCC
1290 10951191 2000 GLFDIVKKIAGHIASSI Aurein 3.2 17 Linear L None Amidation Free Antimicrobial Southern bell frog Lung tumor cellline Lung Cancer Not Available LC50 = 10 µM Not Available Lung National Cancer Institute, Washington, DC, USA. None CHHHHHHHHHHHTTSCC
1291 10951191 2000 GLFDIVKKIAGHIASSI Aurein 3.2 17 Linear L None Amidation Free Antimicrobial Southern bell frog Colon tumor cellline Colon Cancer Not Available LC50=10-100 µM Not Available Colon National Cancer Institute, Washington, DC, USA. None CHHHHHHHHHHHTTSCC
1292 10951191 2000 GLFDIVKKIAGHIASSI Aurein 3.2 17 Linear L None Amidation Free Antimicrobial Southern bell frog Brain tumor cellline Brain Tumor Not Available LC50 = 10 µM Not Available Brain National Cancer Institute, Washington, DC, USA. None CHHHHHHHHHHHTTSCC
1293 10951191 2000 GLFDIVKKIAGHIASSI Aurein 3.2 17 Linear L None Amidation Free Antimicrobial Southern bell frog Skin tumor cellline Skin Cancer Not Available LC50 = 10 µM Not Available Skin National Cancer Institute, Washington, DC, USA. None CHHHHHHHHHHHTTSCC
1294 10951191 2000 GLFDIVKKIAGHIASSI Aurein 3.2 17 Linear L None Amidation Free Antimicrobial Southern bell frog Ovary tumor cellline Ovarian Cancer Not Available LC50 = 10 µM Not Available Ovary National Cancer Institute, Washington, DC, USA. None CHHHHHHHHHHHTTSCC
1295 10951191 2000 GLFDIVKKIAGHIASSI Aurein 3.2 17 Linear L None Amidation Free Antimicrobial Southern bell frog Renal tumor cellline Renal Cancer Not Available LC50 = 10 µM Not Available Renal National Cancer Institute, Washington, DC, USA. None CHHHHHHHHHHHTTSCC
1296 10951191 2000 GLFDIVKKIAGHIASSI Aurein 3.2 17 Linear L None Amidation Free Antimicrobial Southern bell frog Prostate tumor cellline Prostate Cancer Not Available LC50 = 10 µM Not Available Prostate National Cancer Institute, Washington, DC, USA. None CHHHHHHHHHHHTTSCC
1297 10951191 2000 GLFDIVKKIAGHIVSSI Aurein 3.3 17 Linear L None Amidation Free Antimicrobial Southern bell frog Breast tumor cellline Breast Cancer Not Available LC50 = 10 µM Not Available Breast National Cancer Institute, Washington, DC, USA. None CGGGGGSTTTTSCCSCC
1298 10951191 2000 GLFDIVKKIAGHIVSSI Aurein 3.3 17 Linear L None Amidation Free Antimicrobial Southern bell frog Leukemia tumor cellline Leukemia Cancer Not Available LC50=10-100 µM Not Available Blood National Cancer Institute, Washington, DC, USA. None CGGGGGSTTTTSCCSCC
1299 10951191 2000 GLFDIVKKIAGHIVSSI Aurein 3.3 17 Linear L None Amidation Free Antimicrobial Southern bell frog Lung tumor cellline Lung Cancer Not Available LC50 = 10 µM Not Available Lung National Cancer Institute, Washington, DC, USA. None CGGGGGSTTTTSCCSCC
1300 10951191 2000 GLFDIVKKIAGHIVSSI Aurein 3.3 17 Linear L None Amidation Free Antimicrobial Southern bell frog Colon tumor cellline Colon Cancer Not Available LC50 = 10 µM Not Available Colon National Cancer Institute, Washington, DC, USA. None CGGGGGSTTTTSCCSCC
1301 10951191 2000 GLFDIVKKIAGHIVSSI Aurein 3.3 17 Linear L None Amidation Free Antimicrobial Southern bell frog Brain tumor cellline Brain Tumor Not Available LC50 = 10 µM Not Available Brain National Cancer Institute, Washington, DC, USA. None CGGGGGSTTTTSCCSCC
1302 10951191 2000 GLFDIVKKIAGHIVSSI Aurein 3.3 17 Linear L None Amidation Free Antimicrobial Southern bell frog Skin tumor cellline Skin Cancer Not Available LC50 = 10 µM Not Available Skin National Cancer Institute, Washington, DC, USA. None CGGGGGSTTTTSCCSCC
1303 10951191 2000 GLFDIVKKIAGHIVSSI Aurein 3.3 17 Linear L None Amidation Free Antimicrobial Southern bell frog Ovary tumor cellline Ovarian Cancer Not Available LC50 = 10 µM Not Available Ovary National Cancer Institute, Washington, DC, USA. None CGGGGGSTTTTSCCSCC
1304 10951191 2000 GLFDIVKKIAGHIVSSI Aurein 3.3 17 Linear L None Amidation Free Antimicrobial Southern bell frog Renal tumor cellline Renal Cancer Not Available LC50 = 10 µM Not Available Renal National Cancer Institute, Washington, DC, USA. None CGGGGGSTTTTSCCSCC
1305 10951191 2000 GLFDIVKKIAGHIVSSI Aurein 3.3 17 Linear L None Amidation Free Antimicrobial Southern bell frog Prostate tumor cellline Prostate Cancer Not Available LC50 = 10 µM Not Available Prostate National Cancer Institute, Washington, DC, USA. None CGGGGGSTTTTSCCSCC
1317 18315881 2008 KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK Cecropin A 37 Linear L None Amidation Free Antimicrobial Hyalophora Cecropia(silkmoth) 486P Bladder Cancer WST-1 assay IC50=251.47 µg/ml 48-h Bladder None None CCCCCSCCCGGGHHHHTHHHHHTTTTSCCCSSSSSCC
1318 18315881 2008 KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK Cecropin A 37 Linear L None Amidation Free Antimicrobial Hyalophora Cecropia(silkmoth) RT4 Bladder Cancer WST-1 assay IC50=231.26 µg/ml 48-h Bladder None None CCCCCSCCCGGGHHHHTHHHHHTTTTSCCCSSSSSCC
1319 18315881 2008 KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK Cecropin A 37 Linear L None Amidation Free Antimicrobial Hyalophora Cecropia(silkmoth) 647V Bladder Cancer WST-1 assay IC50=185.39 µg/ml 48-h Bladder None None CCCCCSCCCGGGHHHHTHHHHHTTTTSCCCSSSSSCC
1320 18315881 2008 KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK Cecropin A 37 Linear L None Amidation Free Antimicrobial Hyalophora Cecropia(silkmoth) J82 Bladder Cancer WST-1 assay IC50=212.07 µg/ml 48-h Bladder None None CCCCCSCCCGGGHHHHTHHHHHTTTTSCCCSSSSSCC
1329 18315881 2008 KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK Cecropin A 37 Linear L None Amidation Free Antimicrobial Hyalophora Cecropia(silkmoth) 486P Bladder Cancer Cell Viability assay IC50=69.2 µg/ml 48-h Bladder None None CCCCCSCCCGGGHHHHTHHHHHTTTTSCCCSSSSSCC
1330 18315881 2008 KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK Cecropin A 37 Linear L None Amidation Free Antimicrobial Hyalophora Cecropia(silkmoth) RT4 Bladder Cancer Cell Viability assay IC50=96.22 µg/ml 48-h Bladder None None CCCCCSCCCGGGHHHHTHHHHHTTTTSCCCSSSSSCC
1331 18315881 2008 KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK Cecropin A 37 Linear L None Amidation Free Antimicrobial Hyalophora Cecropia(silkmoth) 647V Bladder Cancer Cell Viability assay IC50=28.74 µg/ml 48-h Bladder None None CCCCCSCCCGGGHHHHTHHHHHTTTTSCCCSSSSSCC
1332 18315881 2008 KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK Cecropin A 37 Linear L None Amidation Free Antimicrobial Hyalophora Cecropia(silkmoth) J82 Bladder Cancer Cell Viability assay IC50=99.01 µg/ml 48-h Bladder None None CCCCCSCCCGGGHHHHTHHHHHTTTTSCCCSSSSSCC
1341 18315881 2008 KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK Cecropin A 37 Linear L None Amidation Free Antimicrobial Hyalophora Cecropia(silkmoth) 486P Bladder Cancer LDH leakage assay IC50=373.3/ µg/ml 48-h Bladder None None CCCCCSCCCGGGHHHHTHHHHHTTTTSCCCSSSSSCC
1342 18315881 2008 KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK Cecropin A 37 Linear L None Amidation Free Antimicrobial Hyalophora Cecropia(silkmoth) RT4 Bladder Cancer LDH leakage assay IC50=289.3 µg/ml 48-h Bladder None None CCCCCSCCCGGGHHHHTHHHHHTTTTSCCCSSSSSCC
1343 18315881 2008 KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK Cecropin A 37 Linear L None Amidation Free Antimicrobial Hyalophora Cecropia(silkmoth) 647V Bladder Cancer LDH leakage assay IC50=200.7 µg/ml 48-h Bladder None None CCCCCSCCCGGGHHHHTHHHHHTTTTSCCCSSSSSCC
1344 18315881 2008 KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK Cecropin A 37 Linear L None Amidation Free Antimicrobial Hyalophora Cecropia(silkmoth) J82 Bladder Cancer LDH leakage assay IC50=319.2 µg/ml 48-h Bladder None None CCCCCSCCCGGGHHHHTHHHHHTTTTSCCCSSSSSCC
5007 24661024 2014 KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK Cecropin A 37 Linear L None Free Free Antimicrobial Isolated from the giant silk moth Hyalophora cecropia SCC12 Skin Cancer MTT/MTS assay IC50=1 µM 48-h Skin None None CCSCCCCCGGGCCHHHHHHTTSGGGGCCSCSSSSSCC
5008 24661024 2014 KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK Cecropin A 37 Linear L None Free Free Antimicrobial Isolated from the giant silk moth Hyalophora cecropia SCC25 Skin Cancer MTT/MTS assay IC50=2.2 µM 48-h Skin None None CCSCCCCCGGGCCHHHHHHTTSGGGGCCSCSSSSSCC
5009 24661024 2014 KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK Cecropin A 37 Linear L None Free Free Antimicrobial Isolated from the giant silk moth Hyalophora cecropia SCC25 Skin Cancer Cell Viability assay 0.6 ± 0.6% cell growth inhibition at 10 µM 48-h Skin None None CCSCCCCCGGGCCHHHHHHTTSGGGGCCSCSSSSSCC
5010 24661024 2014 KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK Cecropin A 37 Linear L None Free Free Antimicrobial Isolated from the giant silk moth Hyalophora cecropia SCC25 Skin Cancer Cell Viability assay 107.0 ± 5.0% cell growth inhibition at 1 µM 24-h Skin None None CCSCCCCCGGGCCHHHHHHTTSGGGGCCSCSSSSSCC
1323 18315881 2008 KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL Cecropin B 35 Linear L None Amidation Free Antimicrobial Chinese oak silk moth 486P Bladder Cancer WST-1 assay IC50=161.76 µg/ml 48-h Bladder None None CCCSCCCGGGTGGGGTSSSCTTSSSCCSTTCSSCC
1324 18315881 2008 KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL Cecropin B 35 Linear L None Amidation Free Antimicrobial Chinese oak silk moth RT4 Bladder Cancer WST-1 assay IC50=184.81 µg/ml 48-h Bladder None None CCCSCCCGGGTGGGGTSSSCTTSSSCCSTTCSSCC
1325 18315881 2008 KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL Cecropin B 35 Linear L None Amidation Free Antimicrobial Chinese oak silk moth 647V Bladder Cancer WST-1 assay IC50=115.12 µg/ml 48-h Bladder None None CCCSCCCGGGTGGGGTSSSCTTSSSCCSTTCSSCC
1326 18315881 2008 KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL Cecropin B 35 Linear L None Amidation Free Antimicrobial Chinese oak silk moth J82 Bladder Cancer WST-1 assay IC50=97.93 µg/ml 48-h Bladder None None CCCSCCCGGGTGGGGTSSSCTTSSSCCSTTCSSCC
1335 18315881 2008 KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL Cecropin B 35 Linear L None Amidation Free Antimicrobial Chinese oak silk moth 486P Bladder Cancer Cell Viability assay IC50=87.47 µg/ml 48-h Bladder None None CCCSCCCGGGTGGGGTSSSCTTSSSCCSTTCSSCC
1336 18315881 2008 KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL Cecropin B 35 Linear L None Amidation Free Antimicrobial Chinese oak silk moth RT4 Bladder Cancer Cell Viability assay IC50=92.9 µg/ml 48-h Bladder None None CCCSCCCGGGTGGGGTSSSCTTSSSCCSTTCSSCC
1337 18315881 2008 KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL Cecropin B 35 Linear L None Amidation Free Antimicrobial Chinese oak silk moth 647V Bladder Cancer Cell Viability assay IC50=61.86 µg/ml 48-h Bladder None None CCCSCCCGGGTGGGGTSSSCTTSSSCCSTTCSSCC
1338 18315881 2008 KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL Cecropin B 35 Linear L None Amidation Free Antimicrobial Chinese oak silk moth J82 Bladder Cancer Cell Viability assay IC50=77.51 µg/ml 48-h Bladder None None CCCSCCCGGGTGGGGTSSSCTTSSSCCSTTCSSCC
1347 18315881 2008 KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL Cecropin B 35 Linear L None Amidation Free Antimicrobial Chinese oak silk moth 486P Bladder Cancer LDH leakage assay IC50=232.4 µg/ml 48-h Bladder None None CCCSCCCGGGTGGGGTSSSCTTSSSCCSTTCSSCC
1348 18315881 2008 KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL Cecropin B 35 Linear L None Amidation Free Antimicrobial Chinese oak silk moth RT4 Bladder Cancer LDH leakage assay IC50=240.4 µg/ml 48-h Bladder None None CCCSCCCGGGTGGGGTSSSCTTSSSCCSTTCSSCC
1349 18315881 2008 KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL Cecropin B 35 Linear L None Amidation Free Antimicrobial Chinese oak silk moth 647V Bladder Cancer LDH leakage assay IC50=181.1 µg/ml 48-h Bladder None None CCCSCCCGGGTGGGGTSSSCTTSSSCCSTTCSSCC
1351 18315881 2008 KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL Cecropin B 35 Linear L None Amidation Free Antimicrobial Chinese oak silk moth J82 Bladder Cancer LDH leakage assay Cytotoxicity=196.3 µg/ml 48-h Bladder None None CCCSCCCGGGTGGGGTSSSCTTSSSCCSTTCSSCC
1350 18931881 2008 ETFSDLWKLL PNC-28 10 Linear L None Free Free Anticancer Antennapedia MiaPaCa.2 Pancreatic Cancer MTT/MTS assay Cytotoxicity=80% µMo/ml 48-h Pancreatic None None CHHHHHHHHC
1352 18425992 2008 FKCRRWQWRMKKLGAPSITCVR pep1 22 Linear L None Free Free Antimicrobial Bovine lactoferrin (Lf-B) HL-60 Prostate Cancer MTT/MTS assay IC50=77 µM 24-h Blood None None CCSCCCHHHHHTSSCSSHHHHC
1353 18425992 2008 RKAFRWAWRMLKKAAPSITCVR mPep1 22 Linear L None Free Free Antimicrobial Bovine lactoferrin (Lf-B) HL-60 Skin Cancer MTT/MTS assay IC50=8 µM 24-h Blood None None CTTHHHHHHHHTTTSSCCCCCC
1354 1708887, 2285300 1990 GIGKFLHAAKKFAKAFVAEIMNS Magainin B 23 Linear L None Amidation Free Antibacterial Xenopus laevis U-937 Lymphoma Cancer Trypan blue assay IC50=17 µg/ml 72-h Blood 2285300 None CCCTHHHHHHHHTTCSTTTGGGC
1360 1708887, 2285300 1990 GIGKFLHAAKKFAKAFVAEIMNS Magainin B 23 Linear L None Amidation Free Antibacterial Xenopus laevis 8402 Leukemia Cancer Trypan blue assay IC50=12 µg/ml 72-h Blood 2285300 None CCCTHHHHHHHHTTCSTTTGGGC
1366 1708887, 2285300 1990 GIGKFLHAAKKFAKAFVAEIMNS Magainin B 23 Linear L None Amidation Free Antibacterial Xenopus laevis SSKT-1 Hematopoietic Cancer Trypan blue assay IC50=27 µg/ml 72-h Blood 2285300 None CCCTHHHHHHHHTTCSTTTGGGC
1372 1708887, 2285300 1990 GIGKFLHAAKKFAKAFVAEIMNS Magainin B 23 Linear L None Amidation Free Antibacterial Xenopus laevis Daudi Ovarian Cancer Trypan blue assay IC50=28 µg/ml 72-h Blood 2285300 None CCCTHHHHHHHHTTCSTTTGGGC
1378 1708887, 2285300 1990 GIGKFLHAAKKFAKAFVAEIMNS Magainin B 23 Linear L None Amidation Free Antibacterial Xenopus laevis MLA Leukemia Cancer Trypan blue assay IC50=30 µg/ml 72-h Blood 2285300 None CCCTHHHHHHHHTTCSTTTGGGC
1384 1708887, 2285300 1990 GIGKFLHAAKKFAKAFVAEIMNS Magainin B 23 Linear L None Amidation Free Antibacterial Xenopus laevis Raji Lymphoma Cancer Trypan blue assay IC50=23 µg/ml 72-h Blood 2285300 None CCCTHHHHHHHHTTCSTTTGGGC
1390 1708887, 2285300 1990 GIGKFLHAAKKFAKAFVAEIMNS Magainin B 23 Linear L None Amidation Free Antibacterial Xenopus laevis K-562 Leukemia Cancer Trypan blue assay IC50=32 µg/ml 72-h Blood 2285300 None CCCTHHHHHHHHTTCSTTTGGGC
1396 1708887, 2285300 1990 GIGKFLHAAKKFAKAFVAEIMNS Magainin B 23 Linear L None Amidation Free Antibacterial Xenopus laevis CHP-100 Ewing sarcoma Trypan blue assay IC50=32 µg/ml 72-h Blood 2285300 None CCCTHHHHHHHHTTCSTTTGGGC
1402 1708887, 2285300 1990 GIGKFLHAAKKFAKAFVAEIMNS Magainin B 23 Linear L None Amidation Free Antibacterial Xenopus laevis MCF-7 Breast Cancer Trypan blue assay IC50=37 µg/ml 72-h Breast 2285300 None CCCTHHHHHHHHTTCSTTTGGGC
1408 1708887, 2285300 1990 GIGKFLHAAKKFAKAFVAEIMNS Magainin B 23 Linear L None Amidation Free Antibacterial Xenopus laevis PC-3 Prostate Cancer Trypan blue assay IC50=41 µg/ml 72-h Prostate 2285300 None CCCTHHHHHHHHTTCSTTTGGGC
1909 None 2005 GIGKFLHAAKKFAKAFVAEIMNS Magainin2wisc 23 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =22 µg/ml 24-h Breast None US_06875744_B2 CCCTHHHHHHHHTTCSTTTGGGC
2061 None 2005 GIGKFLHAAKKFAKAFVAEIMNS Magainin2wisc 23 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =60 µg/ml 24-h Colon None US_06875744_B2 CCCTHHHHHHHHTTCSTTTGGGC
2213 None 2005 GIGKFLHAAKKFAKAFVAEIMNS Magainin2wisc 23 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =130 µg/ml 24-h Skin None US_06875744_B2 CCCTHHHHHHHHTTCSTTTGGGC
2365 None 2005 GIGKFLHAAKKFAKAFVAEIMNS Magainin2wisc 23 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =130 µg/ml 24-h Skin None US_06875744_B2 CCCTHHHHHHHHTTCSTTTGGGC
2518 None 2005 GIGKFLHAAKKFAKAFVAEIMNS Magainin2wisc 23 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =60 µg/ml 24-h Lung None US_06875744_B2 CCCTHHHHHHHHTTCSTTTGGGC
2661 None 2005 GIGKFLHAAKKFAKAFVAEIMNS Magainin2wisc 23 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =45 µg/ml 24-h Prostate None US_06875744_B2 CCCTHHHHHHHHTTCSTTTGGGC
2804 None 2005 GIGKFLHAAKKFAKAFVAEIMNS Magainin2wisc 23 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =125 µg/ml 24-h Cervix None US_06875744_B2 CCCTHHHHHHHHTTCSTTTGGGC
1357 1708887, 2285300 1990 ALSKALSKALSKALSKALSKALSK Z44 24 Linear L None Amidation Free Antibacterial Xenopus laevis U-937 Lymphoma Cancer Trypan blue assay IC50=97 µg/ml 72-h Blood 2285300 None CHHHHHHHHHHHHHHHHHHHHHCC
1358 1708887, 2285300 1990 ALSKALSKALSKALSKALSKALSK Z24 24 Linear L None Amidation Free Antibacterial Xenopus laevis U-937 Lymphoma Cancer Trypan blue assay IC50=123 µg/ml 72-h Blood 2285300 None CHHHHHHHHHHHHHHHHHHHHHCC
1363 1708887, 2285300 1990 ALSKALSKALSKALSKALSKALSK Z44 24 Linear L None Amidation Free Antibacterial Xenopus laevis 8402 Leukemia Cancer Trypan blue assay IC50=60 µg/ml 72-h Blood 2285300 None CHHHHHHHHHHHHHHHHHHHHHCC
1364 1708887, 2285300 1990 ALSKALSKALSKALSKALSKALSK Z24 24 Linear L None Amidation Free Antibacterial Xenopus laevis 8402 Leukemia Cancer Trypan blue assay IC50=83 µg/ml 72-h Blood 2285300 None CHHHHHHHHHHHHHHHHHHHHHCC
1369 1708887, 2285300 1990 ALSKALSKALSKALSKALSKALSK Z44 24 Linear L None Amidation Free Antibacterial Xenopus laevis SSKT-1 Hematopoietic Cancer Trypan blue assay IC50=107 µg/ml 72-h Blood 2285300 None CHHHHHHHHHHHHHHHHHHHHHCC
1370 1708887, 2285300 1990 ALSKALSKALSKALSKALSKALSK Z24 24 Linear L None Amidation Free Antibacterial Xenopus laevis SSKT-1 Hematopoietic Cancer Trypan blue assay IC50=109 µg/ml 72-h Blood 2285300 None CHHHHHHHHHHHHHHHHHHHHHCC
1375 1708887, 2285300 1990 ALSKALSKALSKALSKALSKALSK Z44 24 Linear L None Amidation Free Antibacterial Xenopus laevis Daudi Brain Tumor Trypan blue assay IC50=115 µg/ml 72-h Blood 2285300 None CHHHHHHHHHHHHHHHHHHHHHCC
1376 1708887, 2285300 1990 ALSKALSKALSKALSKALSKALSK Z24 24 Linear L None Amidation Free Antibacterial Xenopus laevis Daudi Leukemia Cancer Trypan blue assay IC50=143 µg/ml 72-h Blood 2285300 None CHHHHHHHHHHHHHHHHHHHHHCC
1381 1708887, 2285300 1990 ALSKALSKALSKALSKALSKALSK Z44 24 Linear L None Amidation Free Antibacterial Xenopus laevis MLA Leukemia Cancer Trypan blue assay IC50=80 µg/ml 72-h Blood 2285300 None CHHHHHHHHHHHHHHHHHHHHHCC
1382 1708887, 2285300 1990 ALSKALSKALSKALSKALSKALSK Z24 24 Linear L None Amidation Free Antibacterial Xenopus laevis MLA Leukemia Cancer Trypan blue assay IC50=102 µg/ml 72-h Blood 2285300 None CHHHHHHHHHHHHHHHHHHHHHCC
1387 1708887, 2285300 1990 ALSKALSKALSKALSKALSKALSK Z44 24 Linear L None Amidation Free Antibacterial Xenopus laevis Raji Lymphoma Cancer Trypan blue assay IC50=64 µg/ml 72-h Blood 2285300 None CHHHHHHHHHHHHHHHHHHHHHCC
1388 1708887, 2285300 1990 ALSKALSKALSKALSKALSKALSK Z24 24 Linear L None Amidation Free Antibacterial Xenopus laevis Raji Lymphoma Cancer Trypan blue assay IC50=72 µg/ml 72-h Blood 2285300 None CHHHHHHHHHHHHHHHHHHHHHCC
1393 1708887, 2285300 1990 ALSKALSKALSKALSKALSKALSK Z44 24 Linear L None Amidation Free Antibacterial Xenopus laevis K-562 Leukemia Cancer Trypan blue assay IC50=98 µg/ml 72-h Blood 2285300 None CHHHHHHHHHHHHHHHHHHHHHCC
1394 1708887, 2285300 1990 ALSKALSKALSKALSKALSKALSK Z24 24 Linear L None Amidation Free Antibacterial Xenopus laevis K-562 Leukemia Cancer Trypan blue assay IC50=112 µg/ml 72-h Blood 2285300 None CHHHHHHHHHHHHHHHHHHHHHCC
1399 1708887, 2285300 1990 ALSKALSKALSKALSKALSKALSK Z44 24 Linear L None Amidation Free Antibacterial Xenopus laevis CHP-100 Ewing sarcoma Trypan blue assay Not Available 72-h Blood 2285300 None CHHHHHHHHHHHHHHHHHHHHHCC
1400 1708887, 2285300 1990 ALSKALSKALSKALSKALSKALSK Z24 24 Linear L None Amidation Free Antibacterial Xenopus laevis CHP-100 Ewing sarcoma Trypan blue assay Not Available 72-h Blood 2285300 None CHHHHHHHHHHHHHHHHHHHHHCC
1405 1708887, 2285300 1990 ALSKALSKALSKALSKALSKALSK Z44 24 Linear L None Amidation Free Antibacterial Xenopus laevis MCF-7 Breast Cancer Trypan blue assay Not Available 72-h Breast 2285300 None CHHHHHHHHHHHHHHHHHHHHHCC
1406 1708887, 2285300 1990 ALSKALSKALSKALSKALSKALSK Z24 24 Linear L None Amidation Free Antibacterial Xenopus laevis MCF-7 Breast Cancer Trypan blue assay Not Available 72-h Breast 2285300 None CHHHHHHHHHHHHHHHHHHHHHCC
1411 1708887, 2285300 1990 ALSKALSKALSKALSKALSKALSK Z44 24 Linear L None Amidation Free Antibacterial Xenopus laevis PC-3 Prostate Cancer Trypan blue assay Not Available 72-h Prostate 2285300 None CHHHHHHHHHHHHHHHHHHHHHCC
1412 1708887, 2285300 1990 ALSKALSKALSKALSKALSKALSK Z24 24 Linear L None Amidation Free Antibacterial Xenopus laevis PC-3 Prostate Cancer Trypan blue assay Not Available 72-h Prostate 2285300 None CHHHHHHHHHHHHHHHHHHHHHCC
1420 8573171, 21403917 1996 TRSSRAGLQFPVGRVHRLLRK Buforin2 21 Linear L None Amidation Free Antimicrobial Bufo Bufo Gargarizans U-937 Lymphoma Cancer MTT/MTS assay 5% Cytotoxicity at 0.5 µg/ml 6-h Blood 21403917 None CCCCSSSSSSTTCCCCCGGGC
4592 21403917 2011 TRSSRAGLQFPVGRVHRLLRK Buforin 2 21 Linear L None Free Free Antimicrobial Bufo Bufo Gargarizans U-937 Lymphoma Cancer MTT/MTS assay IC50 =90-95 µg/ml Not Available Blood None None CCCCSSSSSSSSTTTCCTTTC
1421 10455241, 21403917 2009 GLFDVIKKVASVIGGL Citropin1.1 16 Linear L None Amidation Free Antibacterial Australian blue mountains tree frog, Litoria citropa U-937 Lymphoma Cancer MTT/MTS assay 60% Cytotoxicity at 0.5 µg/ml 6-h Blood 21403917 None CHHHHHHHHHTTTSCC
1422 10504394, 21403917 2009 GLFDVIKKVASVIGGL Citropin1.1 16 Linear L None Amidation Free Antibacterial Australian blue mountains tree frog, Litoria citropa U-937 Lymphoma Cancer MTT/MTS assay 60% Cytotoxicity at 0.5 µg/ml 6-h Blood 21403917 None CHHHHHHHHHTTTSCC
4030 12631273, 9266696 2003 GLFDVIKKVASVIGGL Citropin 1.1 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Leukemia tumor cellline Leukemia Cancer Sulforhodamine B assay IC50= 5 M Not Available Blood 9266696 None CHHHHHHHHHTTTSCC
4031 12631273, 9266696 2003 GLFDVIKKVASVIGGL Citropin 1.1 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Lung tumor cellline Lung Cancer Sulforhodamine B assay IC50= 5 M Not Available Lung 9266696 None CHHHHHHHHHTTTSCC
4032 12631273, 9266696 2003 GLFDVIKKVASVIGGL Citropin 1.1 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Colon tumor cellline Colon Cancer Sulforhodamine B assay IC50= 5 M Not Available Colon 9266696 None CHHHHHHHHHTTTSCC
4033 12631273, 9266696 2003 GLFDVIKKVASVIGGL Citropin 1.1 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Brain tumor cellline Brain Tumor Sulforhodamine B assay IC50= 5 M Not Available Brain 9266696 None CHHHHHHHHHTTTSCC
4034 12631273, 9266696 2003 GLFDVIKKVASVIGGL Citropin 1.1 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Skin tumor cellline Skin Cancer Sulforhodamine B assay IC50= 5 M Not Available Skin 9266696 None CHHHHHHHHHTTTSCC
4035 12631273, 9266696 2003 GLFDVIKKVASVIGGL Citropin 1.1 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Ovary tumor cellline Ovarian Cancer Sulforhodamine B assay IC50= 5 M Not Available Ovary 9266696 None CHHHHHHHHHTTTSCC
4036 12631273, 9266696 2003 GLFDVIKKVASVIGGL Citropin 1.1 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Liver tumor celline Liver Cancer Sulforhodamine B assay IC50= 5 M Not Available Liver 9266696 None CHHHHHHHHHTTTSCC
4037 12631273, 9266696 2003 GLFDVIKKVASVIGGL Citropin 1.1 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Prostate tumor cellline Prostate Cancer Sulforhodamine B assay IC50= 5 M Not Available Prostate 9266696 None CHHHHHHHHHTTTSCC
4038 12631273, 9266696 2003 GLFDVIKKVASVIGGL Citropin 1.1 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Breast tumor cellline Breast Cancer Sulforhodamine B assay IC50= 5 M Not Available Breast 9266696 None CHHHHHHHHHTTTSCC
4039 12631273, 9266696 2003 glfdvikkvasviggl Citropin 1.1D 16 Linear D None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Leukemia tumor cellline Leukemia Cancer Sulforhodamine B assay IC50= 5 M Not Available Blood 9266696 None CHHHHHHHHHHGGGTC
4040 12631273, 9266696 2003 glfdvikkvasviggl Citropin 1.1D 16 Linear D None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Lung tumor cellline Lung Cancer Sulforhodamine B assay IC50= 5 M Not Available Lung 9266696 None CHHHHHHHHHHGGGTC
4041 12631273, 9266696 2003 glfdvikkvasviggl Citropin 1.1D 16 Linear D None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Colon tumor cellline Colon Cancer Sulforhodamine B assay IC50= 5 M Not Available Colon 9266696 None CHHHHHHHHHHGGGTC
4042 12631273, 9266696 2003 glfdvikkvasviggl Citropin 1.1D 16 Linear D None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Brain tumor cellline Brain Tumor Sulforhodamine B assay IC50= 5 M Not Available Brain 9266696 None CHHHHHHHHHHGGGTC
4043 12631273, 9266696 2003 glfdvikkvasviggl Citropin 1.1D 16 Linear D None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Skin tumor cellline Skin Cancer Sulforhodamine B assay IC50= 5 M Not Available Skin 9266696 None CHHHHHHHHHHGGGTC
4044 12631273, 9266696 2003 glfdvikkvasviggl Citropin 1.1D 16 Linear D None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Ovary tumor cellline Ovarian Cancer Sulforhodamine B assay IC50= 5 M Not Available Ovary 9266696 None CHHHHHHHHHHGGGTC
4045 12631273, 9266696 2003 glfdvikkvasviggl Citropin 1.1D 16 Linear D None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Liver tumor celline Liver Cancer Sulforhodamine B assay IC50= 5 M Not Available Liver 9266696 None CHHHHHHHHHHGGGTC
4046 12631273, 9266696 2003 glfdvikkvasviggl Citropin 1.1D 16 Linear D None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Prostate tumor cellline Prostate Cancer Sulforhodamine B assay IC50= 5 M Not Available Prostate 9266696 None CHHHHHHHHHHGGGTC
4047 12631273, 9266696 2003 glfdvikkvasviggl Citropin 1.1D 16 Linear D None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Breast tumor cellline Breast Cancer Sulforhodamine B assay IC50= 5 M Not Available Breast 9266696 None CHHHHHHHHHHGGGTC
4593 21403917 2011 GLFDVIKKVASVIGGL Citropin 1.1 16 Linear L None Amidation Free Antimicrobial Australian blue mountains tree frog, Litoria citropa U-938 Lymphoma Cancer MTT/MTS assay IC50 =40 µg/ml Not Available Blood None None CHHHHHHHHHTTTSCC
1423 16512752, 21403917 2006 AKRHHGYKRKFH Demegen P-113 12 Linear L None Amidation Free Antimicrobial Amphibian skin peptide U-937 Lymphoma Cancer MTT/MTS assay 15% Cytotoxicity at 0.5 µg/ml 6-h Blood 21403917 None CCTTTTCCCSCC
4594 21403917 2011 AKRHHGYKRKFH Demegen P-113 12 Linear L None Amidation Free Antimicrobial Canaida albicans U-939 Lymphoma Cancer MTT/MTS assay IC50 =85-90 µg/ml Not Available Blood None None CCTTTTCCCSCC
1424 14508884, 21403917 2003 ILRWPWWPWRRK OmigaNAn MBI-226 12 Linear L None Amidation Free Antimicrobial Helical peptide with a predominance of one or more amino acids tryptophane-rich U-937 Lymphoma Cancer MTT/MTS assay 27% Cytotoxicity at 0.5 µg/ml 6-h Blood 21403917 None CCCSCCSTTSCC
4595 21403917 2011 ILRWPWWPWRRK Omiganan MBI-226 12 Linear L None Amidation Free Antimicrobial Bovine neutrophils U-937 Lymphoma Cancer MTT/MTS assay IC50 =80-85 µg/ml Not Available Blood None None CCCSCCSTTSCC
1425 7768152, 21403917 1994 GIGKFLKKAKKFGKAFVKILKK PexigaNAn MSI-78 22 Linear L None Amidation Free Antimicrobial Helical peptide with a predominance of one or more amino acids tryptophane-rich U-937 Lymphoma Cancer MTT/MTS assay 75% Cytotoxicity at 0.5 µg/ml 6-h Blood 21403917 None CHHHHHHHHTTTHHHHTTTCCC
1794 None 2005 GIGKFLKKAKKFGKAFVKILKK MSI-78 AM 22 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =31 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHTTTHHHHTTTCCC
1946 None 2005 GIGKFLKKAKKFGKAFVKILKK MSI-78 AM 22 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =34 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHTTTHHHHTTTCCC
2098 None 2005 GIGKFLKKAKKFGKAFVKILKK MSI-78 AM 22 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =140 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTHHHHTTTCCC
2250 None 2005 GIGKFLKKAKKFGKAFVKILKK MSI-78 AM 22 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =140 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTHHHHTTTCCC
2402 None 2005 GIGKFLKKAKKFGKAFVKILKK MSI-78 AM 22 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =150 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHTTTHHHHTTTCCC
2545 None 2005 GIGKFLKKAKKFGKAFVKILKK MSI-78 AM 22 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =66 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHTTTHHHHTTTCCC
2688 None 2005 GIGKFLKKAKKFGKAFVKILKK MSI-78 AM 22 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay Not Available 24-h Cervix None US_06875744_B2 CHHHHHHHHTTTHHHHTTTCCC
4596 21403917 2011 GIGKFLKKAKKFGKAFVKILKK Pexiganan MSI-78 18 Linear L None Amidation Free Antimicrobial Analog of Magainin U-941 Lymphoma Cancer MTT/MTS assay IC50 =20-30 µg/ml Not Available Blood None None CHHHHHHHHTTTHHHHTTTCCC
5001 24587350 2014 GIGKFLKKAKKFGKAFVKILKK Pexiganan 22 Linear L None Amidation Free Antimicrobial Analog of magainin 2 MCF-7 Breast Cancer MTT/MTS assay LC50= 8 at 100 µM 72-h Breast None None CHHHHHHHHTTTHHHHTTTCCC
5003 24587350 2014 GIGKFLKKAKKFGKAFVKILKK Pexiganan 22 Linear L None Amidation Free Antimicrobial Analog of magainin 2 LNCaP Prostate cancer MTT/MTS assay LC50= 6 at 100 µM 72-h Prostate None None CHHHHHHHHTTTHHHHTTTCCC
5005 24587350 2014 GIGKFLKKAKKFGKAFVKILKK Pexiganan 22 Linear L None Amidation Free Antimicrobial Analog of magainin 2 OVRCAR-3 Ovarian Cancer MTT/MTS assay LC50= 13 at 100 µM 72-h Ovary None None CHHHHHHHHTTTHHHHTTTCCC
1426 8335113, 21403917 1993 RGGRLCYCRRRFCVCVGR Protegrin 1 18 Linear L None Amidation Free Antimicrobial Alpha helical peptide without cysteines U-937 Lymphoma Cancer MTT/MTS assay 61% Cytotoxicity at 0.5 µg/ml 6-h Blood 21403917 None CCSEEEEEETTEEEEEEC
4597 21403917 2011 RGGRLCYCRRRFCVCVGR Protegrin 1 18 Linear L None Amidation Free Antimicrobial alpha helical peptide without cysteines U-942 Lymphoma Cancer MTT/MTS assay IC50 =30-40 µg/ml Not Available Blood None None CCSEEEEEETTEEEEEEC
1427 9022710 1996 FLPLIGRVLSGIL Temporin A 13 Linear L None Amidation Free Antimicrobial Frog Rana temporaria U-937 Lymphoma Cancer MTT/MTS assay 15% Cytotoxicity at 0.5 µg/ml 6-h Blood 21403917 None CCTTTTTHHHHCC
4598 21403917 2011 FLPLIGRVLSGIL Temporin A 13 Linear L None Amidation Free Antimicrobial Frog Rana temporaria U-943 Lymphoma Cancer MTT/MTS assay IC50 =80-90 µg/ml Not Available Blood None None CCTTTTTHHHHCC
1428 16269280 2005 KILRGVCKKIMRTFLRRISKDILTGKK NK-2 27 Linear L None Amidation Free Antibacterial NK-lysin NB LA-N-1 Colorectal Cancer PI-uptake assay LD50=1-4 µM Not Available Colon 23893605 None CCCTTHHHHHHHHHHHHHHHHHHHHHC
1429 16269280 2005 KILRGVCKKIMRTFLRRISKDILTGKK NK-2 27 Linear L None Amidation Free Antibacterial NK-lysin SH-SY5Y Brain Tumor PI-uptake assay LD50=1-4 µM Not Available Brain 23893605 None CCCTTHHHHHHHHHHHHHHHHHHHHHC
1430 16269280 2005 KILRGVCKKIMRTFLRRISKDILTGKK NK-2 27 Linear L None Amidation Free Antibacterial NK-lysin U-937 Lymphoma Cancer PI-uptake assay LD50=30 µM Not Available Blood 23893605 None CCCTTHHHHHHHHHHHHHHHHHHHHHC
1431 16269280 2005 KILRGVCKKIMRTFLRRISKDILTGKK NK-2 27 Linear L None Amidation Free Antibacterial NK-lysin SW-480 Leukemia Cancer PI-uptake assay LD50=1-4 µM Not Available Blood 23893605 None CCCTTHHHHHHHHHHHHHHHHHHHHHC
3317 23893605 2013 KILRGVCKKIMRTFLRRISKDILTGKK NK-2 27 Linear L None Amidation Free Antimicrobial Synthetic peptide E42/02 Skin Cancer MTT/MTS assay IC50 = ~70 µM 30-Min Skin None None CCCTTHHHHHHHHHHHHHHHHHHHHHC
3318 23893605 2013 KILRGVCKKIMRTFLRRISKDILTGKK NK-2 27 Linear L None Amidation Free Antimicrobial Synthetic peptide E42/02 Skin Cancer MTT/MTS assay IC50 = ~50 µM 2-h Skin None None CCCTTHHHHHHHHHHHHHHHHHHHHHC
3319 23893605 2013 KILRGVCKKIMRTFLRRISKDILTGKK NK-2 27 Linear L None Amidation Free Antimicrobial Synthetic peptide E42/02 Skin Cancer MTT/MTS assay IC50 = ~50 µM 4-h Skin None None CCCTTHHHHHHHHHHHHHHHHHHHHHC
3320 23893605 2013 KILRGVCKKIMRTFLRRISKDILTGKK NK-2 27 Linear L None Amidation Free Antimicrobial Synthetic peptide E42/02 Skin Cancer MTT/MTS assay IC50 = ~40 µM 24-h Skin None None CCCTTHHHHHHHHHHHHHHHHHHHHHC
3789 23893605 2013 KILRGVCKKIMRTFLRRISKDILTGKK NK-2 27 Linear L None Amidation Free Anticancer Residue of 39-65 of porcine NK-lysine E42/02 Skin Cancer MTT/MTS assay IC50= 4.3±0.3 µM 4-h Skin None None CCCTTHHHHHHHHHHHHHHHHHHHHHC
3792 23893605 2013 KILRGVCKKIMRTFLRRISKDILTGKK NK-2 27 Linear L None Amidation Free Anticancer Residue of 39-65 of porcine NK-lysine E42/02 Skin Cancer MTT/MTS assay IC50= 70 µM (approx) 30-Min Skin None None CCCTTHHHHHHHHHHHHHHHHHHHHHC
3798 23893605 2013 KILRGVCKKIMRTFLRRISKDILTGKK NK-2 27 Linear L None Amidation Free Anticancer Residue of 39-65 of porcine NK-lysine E42/02 Skin Cancer MTT/MTS assay IC50= 50 µM (approx) 2-h Skin None None CCCTTHHHHHHHHHHHHHHHHHHHHHC
3804 23893605 2013 KILRGVCKKIMRTFLRRISKDILTGKK NK-2 27 Linear L None Amidation Free Anticancer Residue of 39-65 of porcine NK-lysine E42/02 Skin Cancer MTT/MTS assay IC50= 50 µM (approx) 4-h Skin None None CCCTTHHHHHHHHHHHHHHHHHHHHHC
3810 23893605 2013 KILRGVCKKIMRTFLRRISKDILTGKK NK-2 27 Linear L None Amidation Free Anticancer Residue of 39-65 of porcine NK-lysine E42/02 Skin Cancer MTT/MTS assay IC50= 40 µM (approx) 24-h Skin None None CCCTTHHHHHHHHHHHHHHHHHHHHHC
1432 21955251 2011 GIIKKIIIKKI Cationic Amphiphilic 11 Cyclic L None Free Free Antimicrobial AMP HeLa Cervical Cancer WST-1 assay IC50 = 160 µM Not Available Cervix None None CCCSSCCCCCC
1436 21955251 2011 GIIKKIIIKKI Cationic Amphiphilic 11 Cyclic L None Free Free Antimicrobial AMP HL-60 Pancreatic Cancer WST-1 assay IC50 = >500 µM Not Available Pancreatic None None CCCSSCCCCCC
1433 21955251 2011 GIIKKIIIKKIIIKKI Cationic Amphiphilic 16 Cyclic L None Free Free Antimicrobial AMP HeLa Cervical Cancer WST-1 assay IC50 = 15 µM Not Available Cervix None None CCSSTTSTTTCCCCCC
1437 21955251 2011 GIIKKIIIKKIIIKKI Cationic Amphiphilic 16 Cyclic L None Free Free Antimicrobial AMP HL-60 Pancreatic Cancer WST-1 assay IC50 = 25 µM Not Available Pancreatic None None CCSSTTSTTTCCCCCC
1434 21955251 2011 GIIKKIIIKKIIIKKIIIKKI Cationic Amphiphilic 21 Cyclic L None Free Free Antimicrobial AMP HeLa Pancreatic Cancer WST-1 assay IC50 = 4 µM Not Available Pancreatic None None CCCTTTSTTSCCTTTSCTTCC
1438 21955251 2011 GIIKKIIIKKIIIKKIIIKKI Cationic Amphiphilic 21 Cyclic L None Free Free Antimicrobial AMP HL-60 Pancreatic Cancer WST-1 assay IC50 = 10 µM Not Available Pancreatic None None CCCTTTSTTSCCTTTSCTTCC
1445 21252288 2011 KWKSFAKTFKSAKKTVAHTALKAISS L6A/L17A 26 Linear L None Free Free Anticancer PeptideV13K A-549 Lung Cancer MTT/MTS assay IC50=>83.6 µMo/L 36-h Lung None None CCTTHHHHHHHHHHHHTTTTSGGGGC
1455 21252288 2011 KWKSFAKTFKSAKKTVAHTALKAISS L6A/L17A 26 Linear L None Free Free Anticancer PeptideV13K A-375 Skin Cancer MTT/MTS assay IC50=>83.6 µMo/L 36-h Skin None None CCTTHHHHHHHHHHHHTTTTSGGGGC
1465 21252288 2011 KWKSFAKTFKSAKKTVAHTALKAISS L6A/L17A 26 Linear L None Free Free Anticancer PeptideV13K MCF-7 Breast Cancer MTT/MTS assay IC50=>83.6 µMo/L 36-h Breast None None CCTTHHHHHHHHHHHHTTTTSGGGGC
1475 21252288 2011 KWKSFAKTFKSAKKTVAHTALKAISS L6A/L17A 26 Linear L None Free Free Anticancer PeptideV13K SW-1116 Colorectal Cancer MTT/MTS assay IC50=>83.6 µMo/L 36-h Colon None None CCTTHHHHHHHHHHHHTTTTSGGGGC
1485 21252288 2011 KWKSFAKTFKSAKKTVAHTALKAISS L6A/L17A 26 Linear L None Free Free Anticancer PeptideV13K RD Rhabdomyosarcoma Cancer MTT/MTS assay IC50=>83.6 µMo/L 36-h Muscle None None CCTTHHHHHHHHHHHHTTTTSGGGGC
1495 21252288 2011 KWKSFAKTFKSAKKTVAHTALKAISS L6A/L17A 26 Linear L None Free Free Anticancer PeptideV13K H-1299 Lung Cancer MTT/MTS assay IC50=>83.6 µMo/L 36-h Lung None None CCTTHHHHHHHHHHHHTTTTSGGGGC
1505 21252288 2011 KWKSFAKTFKSAKKTVAHTALKAISS L6A/L17A 26 Linear L None Free Free Anticancer PeptideV13K B-16 Skin Cancer MTT/MTS assay IC50=>83.6 µMo/L 36-h Skin None None CCTTHHHHHHHHHHHHTTTTSGGGGC
1515 21252288 2011 KWKSFAKTFKSAKKTVAHTALKAISS L6A/L17A 26 Linear L None Free Free Anticancer PeptideV13K HeLa Cervical Cancer MTT/MTS assay IC50=>83.6 µMo/L 36-h Cervix None None CCTTHHHHHHHHHHHHTTTTSGGGGC
1446 21252288 2011 KWKSFLKTFKSAKKTVAHTAAKAISS L17A/L21A 26 Linear L None Free Free Anticancer PeptideV13K A-549 Lung Cancer MTT/MTS assay IC50=>83.6 µMo/L 36-h Lung None None CCTTTTTHHHHHTTTHHHHHHHHHCC
1448 21252288 2011 KWKSFLKTFKSAKKTVAHTAAKAISS L21A 26 Linear L None Free Free Anticancer PeptideV13K A-549 Lung Cancer MTT/MTS assay IC50=71 µMo/L 36-h Lung None None CCTTTTTHHHHHTTTHHHHHHHHHCC
1456 21252288 2011 KWKSFLKTFKSAKKTVAHTAAKAISS L17A/L21A 26 Linear L None Free Free Anticancer PeptideV13K A-375 Skin Cancer MTT/MTS assay IC50=>83.6 µMo/L 36-h Skin None None CCTTTTTHHHHHTTTHHHHHHHHHCC
1458 21252288 2011 KWKSFLKTFKSAKKTVAHTAAKAISS L21A 26 Linear L None Free Free Anticancer PeptideV13K A-375 Skin Cancer MTT/MTS assay IC50=59.8 µMo/L 36-h Skin None None CCTTTTTHHHHHTTTHHHHHHHHHCC
1466 21252288 2011 KWKSFLKTFKSAKKTVAHTAAKAISS L17A/L21A 26 Linear L None Free Free Anticancer PeptideV13K MCF-7 Breast Cancer MTT/MTS assay IC50=>83.6 µMo/L 36-h Breast None None CCTTTTTHHHHHTTTHHHHHHHHHCC
1468 21252288 2011 KWKSFLKTFKSAKKTVAHTAAKAISS L21A 26 Linear L None Free Free Anticancer PeptideV13K MCF-7 Breast Cancer MTT/MTS assay IC50=70.8 µMo/L 36-h Breast None None CCTTTTTHHHHHTTTHHHHHHHHHCC
1476 21252288 2011 KWKSFLKTFKSAKKTVAHTAAKAISS L17A/L21A 26 Linear L None Free Free Anticancer PeptideV13K SW-1116 Colorectal Cancer MTT/MTS assay IC50=>83.6 µMo/L 36-h Colon None None CCTTTTTHHHHHTTTHHHHHHHHHCC
1478 21252288 2011 KWKSFLKTFKSAKKTVAHTAAKAISS L21A 26 Linear L None Free Free Anticancer PeptideV13K SW-1116 Colorectal Cancer MTT/MTS assay IC50=>83.6 µMo/L 36-h Colon None None CCTTTTTHHHHHTTTHHHHHHHHHCC
1486 21252288 2011 KWKSFLKTFKSAKKTVAHTAAKAISS L17A/L21A 26 Linear L None Free Free Anticancer PeptideV13K RD Rhabdomyosarcoma Cancer MTT/MTS assay IC50=>83.6 µMo/L 36-h Muscle None None CCTTTTTHHHHHTTTHHHHHHHHHCC
1488 21252288 2011 KWKSFLKTFKSAKKTVAHTAAKAISS L21A 26 Linear L None Free Free Anticancer PeptideV13K RD Rhabdomyosarcoma Cancer MTT/MTS assay IC50=>83.6 µMo/L 36-h Muscle None None CCTTTTTHHHHHTTTHHHHHHHHHCC
1496 21252288 2011 KWKSFLKTFKSAKKTVAHTAAKAISS L17A/L21A 26 Linear L None Free Free Anticancer PeptideV13K H-1299 Lung Cancer MTT/MTS assay IC50=37.7 µMo/L 36-h Lung None None CCTTTTTHHHHHTTTHHHHHHHHHCC
1498 21252288 2011 KWKSFLKTFKSAKKTVAHTAAKAISS L21A 26 Linear L None Free Free Anticancer PeptideV13K H-1299 Lung Cancer MTT/MTS assay IC50=15.6 µMo/L 36-h Lung None None CCTTTTTHHHHHTTTHHHHHHHHHCC
1506 21252288 2011 KWKSFLKTFKSAKKTVAHTAAKAISS L17A/L21A 26 Linear L None Free Free Anticancer PeptideV13K B-16 Skin Cancer MTT/MTS assay IC50=>83.6 µMo/L 36-h Skin None None CCTTTTTHHHHHTTTHHHHHHHHHCC
1508 21252288 2011 KWKSFLKTFKSAKKTVAHTAAKAISS L21A 26 Linear L None Free Free Anticancer PeptideV13K B-16 Skin Cancer MTT/MTS assay IC50=63.5 µMo/L 36-h Skin None None CCTTTTTHHHHHTTTHHHHHHHHHCC
1516 21252288 2011 KWKSFLKTFKSAKKTVAHTAAKAISS L17A/L21A 26 Linear L None Free Free Anticancer PeptideV13K HeLa Cervical Cancer MTT/MTS assay IC50=>83.6 µMo/L 36-h Cervix None None CCTTTTTHHHHHTTTHHHHHHHHHCC
1518 21252288 2011 KWKSFLKTFKSAKKTVAHTAAKAISS L21A 26 Linear L None Free Free Anticancer PeptideV13K HeLa Cervical Cancer MTT/MTS assay IC50=64.7 µMo/L 36-h Cervix None None CCTTTTTHHHHHTTTHHHHHHHHHCC
1447 21252288 2011 KWKSFLKTFKSAKKTVAHTALKAISS L17A 26 Linear L None Free Free Anticancer PeptideV13K A-549 Lung Cancer MTT/MTS assay IC50=>83.6 µMo/L 36-h Lung None None CCTTTHHHHHHHTTSHHHHHHHHHTC
1457 21252288 2011 KWKSFLKTFKSAKKTVAHTALKAISS L17A 26 Linear L None Free Free Anticancer PeptideV13K A-375 Skin Cancer MTT/MTS assay IC50=>83.6 µMo/L 36-h Skin None None CCTTTHHHHHHHTTSHHHHHHHHHTC
1467 21252288 2011 KWKSFLKTFKSAKKTVAHTALKAISS L17A 26 Linear L None Free Free Anticancer PeptideV13K MCF-7 Breast Cancer MTT/MTS assay IC50=>83.6 µMo/L 36-h Breast None None CCTTTHHHHHHHTTSHHHHHHHHHTC
1477 21252288 2011 KWKSFLKTFKSAKKTVAHTALKAISS L17A 26 Linear L None Free Free Anticancer PeptideV13K SW-1116 Colorectal Cancer MTT/MTS assay IC50=>83.6 µMo/L 36-h Colon None None CCTTTHHHHHHHTTSHHHHHHHHHTC
1487 21252288 2011 KWKSFLKTFKSAKKTVAHTALKAISS L17A 26 Linear L None Free Free Anticancer PeptideV13K RD Rhabdomyosarcoma Cancer MTT/MTS assay IC50=>83.6 µMo/L 36-h Muscle None None CCTTTHHHHHHHTTSHHHHHHHHHTC
1497 21252288 2011 KWKSFLKTFKSAKKTVAHTALKAISS L17A 26 Linear L None Free Free Anticancer PeptideV13K H-1299 Lung Cancer MTT/MTS assay IC50=16.4 µMo/L 36-h Lung None None CCTTTHHHHHHHTTSHHHHHHHHHTC
1507 21252288 2011 KWKSFLKTFKSAKKTVAHTALKAISS L17A 26 Linear L None Free Free Anticancer PeptideV13K B-16 Skin Cancer MTT/MTS assay IC50=>83.6 µMo/L 36-h Skin None None CCTTTHHHHHHHTTSHHHHHHHHHTC
1517 21252288 2011 KWKSFLKTFKSAKKTVAHTALKAISS L17A 26 Linear L None Free Free Anticancer PeptideV13K HeLa Cervical Cancer MTT/MTS assay IC50=>83.6 µMo/L 36-h Cervix None None CCTTTHHHHHHHTTSHHHHHHHHHTC
1449 21252288 2011 KWKSFAKTFKSAKKTVLHTALKAISS L6A 26 Linear L None Free Free Anticancer PeptideV13K A-549 Lung Cancer MTT/MTS assay IC50=53 µMo/L 36-h Lung None None CCGGGHHHHHHHHHHHHHHHHHHHCC
1459 21252288 2011 KWKSFAKTFKSAKKTVLHTALKAISS L6A 26 Linear L None Free Free Anticancer PeptideV13K A-375 Skin Cancer MTT/MTS assay IC50=58.7 µMo/L 36-h Skin None None CCGGGHHHHHHHHHHHHHHHHHHHCC
1469 21252288 2011 KWKSFAKTFKSAKKTVLHTALKAISS L6A 26 Linear L None Free Free Anticancer PeptideV13K MCF-7 Breast Cancer MTT/MTS assay IC50=62.3 µMo/L 36-h Breast None None CCGGGHHHHHHHHHHHHHHHHHHHCC
1479 21252288 2011 KWKSFAKTFKSAKKTVLHTALKAISS L6A 26 Linear L None Free Free Anticancer PeptideV13K SW-1116 Colorectal Cancer MTT/MTS assay IC50=>83.6 µMo/L 36-h Colon None None CCGGGHHHHHHHHHHHHHHHHHHHCC
1489 21252288 2011 KWKSFAKTFKSAKKTVLHTALKAISS L6A 26 Linear L None Free Free Anticancer PeptideV13K RD Rhabdomyosarcoma Cancer MTT/MTS assay IC50=>83.6 µMo/L 36-h Muscle None None CCGGGHHHHHHHHHHHHHHHHHHHCC
1499 21252288 2011 KWKSFAKTFKSAKKTVLHTALKAISS L6A 26 Linear L None Free Free Anticancer PeptideV13K H-1299 Lung Cancer MTT/MTS assay IC50=14 µMo/L 36-h Lung None None CCGGGHHHHHHHHHHHHHHHHHHHCC
1509 21252288 2011 KWKSFAKTFKSAKKTVLHTALKAISS L6A 26 Linear L None Free Free Anticancer PeptideV13K B-16 Skin Cancer MTT/MTS assay IC50=62.5 µMo/L 36-h Skin None None CCGGGHHHHHHHHHHHHHHHHHHHCC
1519 21252288 2011 KWKSFAKTFKSAKKTVLHTALKAISS L6A 26 Linear L None Free Free Anticancer PeptideV13K HeLa Cervical Cancer MTT/MTS assay IC50=58.6 µMo/L 36-h Cervix None None CCGGGHHHHHHHHHHHHHHHHHHHCC
1450 21252288 2011 KWKSFLKTFKSAKKTVLHTALKAISS P 26 Linear L None Free Free Anticancer PeptideV13K A-549 Lung Cancer MTT/MTS assay IC50=33 µMo/L 36-h Lung None None CCSTHHHHTTTSTTCTHHHHTTTTCC
1460 21252288 2011 KWKSFLKTFKSAKKTVLHTALKAISS P 26 Linear L None Free Free Anticancer PeptideV13K A-375 Skin Cancer MTT/MTS assay IC50=17.8 µMo/L 36-h Skin None None CCSTHHHHTTTSTTCTHHHHTTTTCC
1470 21252288 2011 KWKSFLKTFKSAKKTVLHTALKAISS P 26 Linear L None Free Free Anticancer PeptideV13K MCF-7 Breast Cancer MTT/MTS assay IC50=15.8 µMo/L 36-h Breast None None CCSTHHHHTTTSTTCTHHHHTTTTCC
1480 21252288 2011 KWKSFLKTFKSAKKTVLHTALKAISS P 26 Linear L None Free Free Anticancer PeptideV13K SW-1116 Colorectal Cancer MTT/MTS assay IC50=11.1 µMo/L 36-h Colon None None CCSTHHHHTTTSTTCTHHHHTTTTCC
1490 21252288 2011 KWKSFLKTFKSAKKTVLHTALKAISS P 26 Linear L None Free Free Anticancer PeptideV13K RD Rhabdomyosarcoma Cancer MTT/MTS assay IC50=25.2 µMo/L 36-h Muscle None None CCSTHHHHTTTSTTCTHHHHTTTTCC
1500 21252288 2011 KWKSFLKTFKSAKKTVLHTALKAISS P 26 Linear L None Free Free Anticancer PeptideV13K H-1299 Lung Cancer MTT/MTS assay IC50=4.7 µMo/L 36-h Lung None None CCSTHHHHTTTSTTCTHHHHTTTTCC
1510 21252288 2011 KWKSFLKTFKSAKKTVLHTALKAISS P 26 Linear L None Free Free Anticancer PeptideV13K B-16 Skin Cancer MTT/MTS assay IC50=11.5 µMo/L 36-h Skin None None CCSTHHHHTTTSTTCTHHHHTTTTCC
1520 21252288 2011 KWKSFLKTFKSAKKTVLHTALKAISS P 26 Linear L None Free Free Anticancer PeptideV13K HeLa Cervical Cancer MTT/MTS assay IC50=10.4 µMo/L 36-h Cervix None None CCSTHHHHTTTSTTCTHHHHTTTTCC
1451 21252288 2011 KWKSFLKTFKSLKKTVLHTALKAISS A12L 26 Linear L None Free Free Anticancer PeptideV13K A-549 Lung Cancer MTT/MTS assay IC50=11.1 µMo/L 36-h Lung None None CCTTTTTIIIIITHHHHHHHHHHHCC
1461 21252288 2011 KWKSFLKTFKSLKKTVLHTALKAISS A12L 26 Linear L None Free Free Anticancer PeptideV13K A-375 Skin Cancer MTT/MTS assay IC50=4.3 µMo/L 36-h Skin None None CCTTTTTIIIIITHHHHHHHHHHHCC
1471 21252288 2011 KWKSFLKTFKSLKKTVLHTALKAISS A12L 26 Linear L None Free Free Anticancer PeptideV13K MCF-7 Breast Cancer MTT/MTS assay IC50=5 µMo/L 36-h Breast None None CCTTTTTIIIIITHHHHHHHHHHHCC
1481 21252288 2011 KWKSFLKTFKSLKKTVLHTALKAISS A12L 26 Linear L None Free Free Anticancer PeptideV13K SW-1116 Colorectal Cancer MTT/MTS assay IC50=6.4 µMo/L 36-h Colon None None CCTTTTTIIIIITHHHHHHHHHHHCC
1491 21252288 2011 KWKSFLKTFKSLKKTVLHTALKAISS A12L 26 Linear L None Free Free Anticancer PeptideV13K RD Rhabdomyosarcoma Cancer MTT/MTS assay IC50=7.5 µMo/L 36-h Muscle None None CCTTTTTIIIIITHHHHHHHHHHHCC
1501 21252288 2011 KWKSFLKTFKSLKKTVLHTALKAISS A12L 26 Linear L None Free Free Anticancer PeptideV13K H-1299 Lung Cancer MTT/MTS assay IC50=4.4 µMo/L 36-h Lung None None CCTTTTTIIIIITHHHHHHHHHHHCC
1511 21252288 2011 KWKSFLKTFKSLKKTVLHTALKAISS A12L 26 Linear L None Free Free Anticancer PeptideV13K B-16 Skin Cancer MTT/MTS assay IC50=5.2 µMo/L 36-h Skin None None CCTTTTTIIIIITHHHHHHHHHHHCC
1521 21252288 2011 KWKSFLKTFKSLKKTVLHTALKAISS A12L 26 Linear L None Free Free Anticancer PeptideV13K HeLa Cervical Cancer MTT/MTS assay IC50=3.8 µMo/L 36-h Cervix None None CCTTTTTIIIIITHHHHHHHHHHHCC
1452 21252288 2011 KWKSFLKTFKSAKKTVLHTLLKAISS A20L 26 Linear L None Free Free Anticancer PeptideV13K A-549 Lung Cancer MTT/MTS assay IC50=8.7 µMo/L 36-h Lung None None CCHHHHHHHHTTSTTHHHHHHHHHCC
1462 21252288 2011 KWKSFLKTFKSAKKTVLHTLLKAISS A20L 26 Linear L None Free Free Anticancer PeptideV13K A-375 Skin Cancer MTT/MTS assay IC50=6.5 µMo/L 36-h Skin None None CCHHHHHHHHTTSTTHHHHHHHHHCC
1472 21252288 2011 KWKSFLKTFKSAKKTVLHTLLKAISS A20L 26 Linear L None Free Free Anticancer PeptideV13K MCF-7 Breast Cancer MTT/MTS assay IC50=5.1 µMo/L 36-h Breast None None CCHHHHHHHHTTSTTHHHHHHHHHCC
1482 21252288 2011 KWKSFLKTFKSAKKTVLHTLLKAISS A20L 26 Linear L None Free Free Anticancer PeptideV13K SW-1116 Colorectal Cancer MTT/MTS assay IC50=5 µMo/L 36-h Colon None None CCHHHHHHHHTTSTTHHHHHHHHHCC
1492 21252288 2011 KWKSFLKTFKSAKKTVLHTLLKAISS A20L 26 Linear L None Free Free Anticancer PeptideV13K RD Rhabdomyosarcoma Cancer MTT/MTS assay IC50=9.8 µMo/L 36-h Muscle None None CCHHHHHHHHTTSTTHHHHHHHHHCC
1502 21252288 2011 KWKSFLKTFKSAKKTVLHTLLKAISS A20L 26 Linear L None Free Free Anticancer PeptideV13K H-1299 Lung Cancer MTT/MTS assay IC50=2.9 µMo/L 36-h Lung None None CCHHHHHHHHTTSTTHHHHHHHHHCC
1512 21252288 2011 KWKSFLKTFKSAKKTVLHTLLKAISS A20L 26 Linear L None Free Free Anticancer PeptideV13K B-16 Skin Cancer MTT/MTS assay IC50=7.8 µMo/L 36-h Skin None None CCHHHHHHHHTTSTTHHHHHHHHHCC
1522 21252288 2011 KWKSFLKTFKSAKKTVLHTLLKAISS A20L 26 Linear L None Free Free Anticancer PeptideV13K HeLa Cervical Cancer MTT/MTS assay IC50=4.3 µMo/L 36-h Cervix None None CCHHHHHHHHTTSTTHHHHHHHHHCC
1453 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-549 Lung Cancer MTT/MTS assay IC50=9.7 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1463 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-375 Skin Cancer MTT/MTS assay IC50=8.7 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1473 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K MCF-7 Breast Cancer MTT/MTS assay IC50=6.2 µMo/L 36-h Breast None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1483 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K SW-1116 Colorectal Cancer MTT/MTS assay IC50=4.3 µMo/L 36-h Colon None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1493 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K RD Rhabdomyosarcoma Cancer MTT/MTS assay IC50=6.4 µMo/L 36-h Muscle None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1503 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K H-1299 Lung Cancer MTT/MTS assay IC50=4.1 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1513 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K B-16 Skin Cancer MTT/MTS assay IC50=4.4 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1523 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K HeLa Cervical Cancer MTT/MTS assay IC50=2 µMo/L 36-h Cervix None None CCHHHHHTHHHHTTTHHHHHHHHHTC
3755 22837667 2012 KWKSFLKTFKSLKKTVLHTLLKAISS Peptide P 26 Linear L None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.71±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHGGGTHHHHHHHHHTC
3756 22837667 2012 KWKSFLkTFKSLKKTVLHTLLKAISS Peptide K7D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.29±0.03 µMol/L 1-h Cervix None None CCGGGGTTHHHHTTTHHHHHHHHHTC
3757 22837667 2012 KWKSFLKTFKSLKkTVLHTLLKAISS Peptide K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.52±0.05 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGGHHHHHHHHHCC
3758 22837667 2012 KWKSFLKTFKSLKKTVLHTLLkAISS Peptide K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.39±0.02 µMol/L 1-h Cervix None None CCTTHHHHHHHHHHHHHHHHHHHHTC
3759 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.06±0.01 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3760 22837667 2012 KWKSFLKTFKSLKkTVLHTLLkAISS Peptide K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.40±0.09 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGTHHHHHHHHHCC
3761 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.45±0.19 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3762 22837667 2012 KWKSFLkTFkSLKkTVLHTLLkAISS Peptide K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.79±0.23 µMol/L 1-h Cervix None None CCGGGHHHHHHHHTTTTHHHHTTTCC
3763 22837667 2012 KWkSFLkTFkSLKkTVLHTLLkAISS Peptide K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 20.41±0.64 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3764 22837667 2012 kWkSFLkTFkSLKkTVLHTLLkAISS Peptide K1D/K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 18.07±0.48 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3765 22837667 2012 KWKSFlKTFKSLKKTVLHTLLKAISS Peptide L6D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.23±0.10 µMol/L 1-h Cervix None None CCGGGHHHHHHGGGGHHHHHHHHHCC
3766 22837667 2012 KWKSFLKTFKSlKKTVLHTLLKAISS Peptide L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.63±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHHTTTHHHHHHHHHTC
3767 22837667 2012 KWKSFLKTFKSLKKTVLHTlLKAISS Peptide L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.33±0.06 µMol/L 1-h Cervix None None CCGGGHHHHHTTTHHHHHHHHTTTCC
3768 22837667 2012 KWKSFlKTFKSlKKTVLHTLLKAISS Peptide L6D/L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.01±0.08 µMol/L 1-h Cervix None None CCTHHHHHHHHHHHHHHHHTGGGTCC
3769 22837667 2012 KWKSFLKTFKSlKKTVLHTlLKAISS Peptide L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.14±0.06 µMol/L 1-h Cervix None None CCTTHHHHHHHTTHHHHHHHHTTTCC
3770 22837667 2012 KWKSFlKTFKSlKKTVLHTlLKAISS Peptide L6D/L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 7.80±0.26 µMol/L 1-h Cervix None None CCSGGGHHHHHGGGTHHHHHHHHHTC
3771 22837667 2012 KWKSFlKTFKSlKKTVlHTlLKAISS Peptide L6D/L12D/L17D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 9.69±0.38 µMol/L 1-h Cervix None None CCTHHHHIIIIITHHHHHHHHTTTCC
3772 22837667 2012 KWKSFlKTFKSlKKTVlHTllKAISS Peptide L6D/L12D/L17D/L20D/L21D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 12.88±0.15 µMol/L 1-h Cervix None None CCGGGHHHHHHTTHHHHHHHHTTTCC
1454 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKLISS A12L/A20L/A23L 26 Linear L None Free Free Anticancer PeptideV13K A-549 Lung Cancer MTT/MTS assay IC50=9.2 µMo/L 36-h Lung None None CCTTTTTTTTTHHHHHHHHHHHHHCC
1464 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKLISS A12L/A20L/A23L 26 Linear L None Free Free Anticancer PeptideV13K A-375 Skin Cancer MTT/MTS assay IC50=7.2 µMo/L 36-h Skin None None CCTTTTTTTTTHHHHHHHHHHHHHCC
1474 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKLISS A12L/A20L/A23L 26 Linear L None Free Free Anticancer PeptideV13K MCF-7 Breast Cancer MTT/MTS assay IC50=5.7 µMo/L 36-h Breast None None CCTTTTTTTTTHHHHHHHHHHHHHCC
1484 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKLISS A12L/A20L/A23L 26 Linear L None Free Free Anticancer PeptideV13K SW-1116 Colorectal Cancer MTT/MTS assay IC50=3.5 µMo/L 36-h Colon None None CCTTTTTTTTTHHHHHHHHHHHHHCC
1494 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKLISS A12L/A20L/A23L 26 Linear L None Free Free Anticancer PeptideV13K RD Rhabdomyosarcoma Cancer MTT/MTS assay IC50=5.5 µMo/L 36-h Muscle None None CCTTTTTTTTTHHHHHHHHHHHHHCC
1504 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKLISS A12L/A20L/A23L 26 Linear L None Free Free Anticancer PeptideV13K H-1299 Lung Cancer MTT/MTS assay IC50=2.7 µMo/L 36-h Lung None None CCTTTTTTTTTHHHHHHHHHHHHHCC
1514 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKLISS A12L/A20L/A23L 26 Linear L None Free Free Anticancer PeptideV13K B-16 Skin Cancer MTT/MTS assay IC50=4.6 µMo/L 36-h Skin None None CCTTTTTTTTTHHHHHHHHHHHHHCC
1524 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKLISS A12L/A20L/A23L 26 Linear L None Free Free Anticancer PeptideV13K HeLa Cervical Cancer MTT/MTS assay IC50=2.2 µMo/L 36-h Cervix None None CCTTTTTTTTTHHHHHHHHHHHHHCC
1525 16637646 2006 LLGDFFRKSKEK LL-37(1-12) 12 Linear L None Free Free Antibacterial LL-37,a series of peptide fragments KBv Tumor MTT/MTS assay Not Available 24-h Not Available None None CCHHHHHCSSCC
1531 16637646 2006 LLGDFFRKSKEK LL-37(1-12) 12 Linear L None Free Free Antibacterial LL-37,a series of peptide fragments KB Oral Cancer MTT/MTS assay Not Available 24-h Not Available None None CCHHHHHCSSCC
1537 16637646 2006 LLGDFFRKSKEK LL-37(1-12) 12 Linear L None Free Free Antibacterial LL-37,a series of peptide fragments HBMEC Prostate Cancer MTT/MTS assay Not Available 24-h Not Available None None CCHHHHHCSSCC
1526 16637646 2006 IGKEFKRIVQRIKDFLRNLVPRTES LL-37(13-37) 25 Linear L None Free Free Antibacterial LL-37,a series of peptide fragments KBv Tumor MTT/MTS assay LC50=39 µM 24-h Not Available None None CCTHHHHHHHHHTTTTTTTSCCCCC
1532 16637646 2006 IGKEFKRIVQRIKDFLRNLVPRTES LL-37(13-37) 25 Linear L None Free Free Antibacterial LL-37,a series of peptide fragments KB Oral Cancer MTT/MTS assay LC50=40 µM 24-h Not Available None None CCTHHHHHHHHHTTTTTTTSCCCCC
1538 16637646 2006 IGKEFKRIVQRIKDFLRNLVPRTES LL-37(13-37) 25 Linear L None Free Free Antibacterial LL-37,a series of peptide fragments HBMEC Prostate Cancer MTT/MTS assay LC50=38 µM 24-h Not Available None None CCTHHHHHHHHHTTTTTTTSCCCCC
1527 16637646 2006 FKRIVQRIKDFLRNLV LL-37(17-32)b 16 Linear L None Free Free Antibacterial LL-37,a series of peptide fragments KBv Tumor MTT/MTS assay LC50=30 µM 24-h Not Available None None CGGGHHHHHHHGGGTC
1530 16637646 2006 FKRiVQRiKDFlRNLV dLL-37(17-32)c 16 Linear Mix None Free Free Antibacterial LL-37,a series of peptide fragments KBv Tumor MTT/MTS assay Not Available 24-h Not Available None None CGGGHHHHHHHGGGCC
1533 16637646 2006 FKRIVQRIKDFLRNLV LL-37(17-32)b 16 Linear L None Free Free Antibacterial LL-37,a series of peptide fragments KB Oral Cancer MTT/MTS assay LC50=30 µM 24-h Not Available None None CGGGHHHHHHHGGGTC
1536 16637646 2006 FKRIVQRIKDFLRNLV dLL-37(17-32)c 16 Linear L None Free Free Antibacterial LL-37,a series of peptide fragments KB Oral Cancer MTT/MTS assay Not Available 24-h Not Available None None CGGGHHHHHHHGGGTC
1539 16637646 2006 FKRIVQRIKDFLRNLV LL-37(17-32)b 16 Linear L None Free Free Antibacterial LL-37,a series of peptide fragments HBMEC Prostate Cancer MTT/MTS assay LC50=25 µM 24-h Not Available None None CGGGHHHHHHHGGGTC
1542 16637646 2006 FKRIVQRIKDFLRNLV dLL-37(17-32)c 16 Linear L None Free Free Antibacterial LL-37,a series of peptide fragments HBMEC Prostate Cancer MTT/MTS assay Not Available 24-h Not Available None None CGGGHHHHHHHGGGTC
1528 16637646 2006 FKRIVQRIKDFLR LL-37(17-29) 13 Linear L None Free Free Antibacterial LL-37,a series of peptide fragments KBv Tumor MTT/MTS assay LC50=60 µM 24-h Not Available None None CHHHHHHHHHHHC
1534 16637646 2006 FKRIVQRIKDFLR LL-37(17-29) 13 Linear L None Free Free Antibacterial LL-37,a series of peptide fragments KB Oral Cancer MTT/MTS assay LC50=57 µM 24-h Not Available None None CHHHHHHHHHHHC
1540 16637646 2006 FKRIVQRIKDFLR LL-37(17-29) 13 Linear L None Free Free Antibacterial LL-37,a series of peptide fragments HBMEC Prostate Cancer MTT/MTS assay LC50=55 µM 24-h Not Available None None CHHHHHHHHHHHC
1529 16637646 2006 LLGDFKRIVQRIKDF LL-37(1-4,17-27) 15 Linear L None Free Free Antibacterial LL-37,a series of peptide fragments KBv Tumor MTT/MTS assay Not Available 24-h Not Available None None CCCHHHHHHHTTSCC
1535 16637646 2006 LLGDFKRIVQRIKDF LL-37(1-4,17-27) 15 Linear L None Free Free Antibacterial LL-37,a series of peptide fragments KB Oral Cancer MTT/MTS assay Not Available 24-h Not Available None None CCCHHHHHHHTTSCC
1541 16637646 2006 LLGDFKRIVQRIKDF LL-37(1-4,17-27) 15 Linear L None Free Free Antibacterial LL-37,a series of peptide fragments HBMEC Prostate Cancer MTT/MTS assay Not Available 24-h Not Available None None CCCHHHHHHHTTSCC
1543 22073006 2011 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin 33 Linear L None Free Free Antibacterial Red Sea Mosessole HT-1080 Fibrosarcoma MTT/MTS assay IC50=15.74 µg/ml 3-h Not Available None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
1544 22073006 2011 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin 33 Linear L None Free Free Antibacterial Red Sea Mosessole HT-1080 Fibrosarcoma MTT/MTS assay IC50=15.40 µg/ml 6-h Not Available None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
1545 22073006 2011 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin 33 Linear L None Free Free Antibacterial Red Sea Mosessole HT-1080 Fibrosarcoma MTT/MTS assay IC50=14.51 µg/ml 12-h Fibrous connective tissue  None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
1546 22073006 2011 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin 33 Linear L None Free Free Antibacterial Red Sea Mosessole HT-1080 Fibrosarcoma MTT/MTS assay IC50=14.52 µg/ml 24-h Fibrous connective tissue  None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
2996 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 62 % Cytotoxicity at 50 mg/L 3-h Cervix None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
2997 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 44 % Cytotoxicity at 25 mg/L 3-h Cervix None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
2998 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 4 % Cytotoxicity at 12.5 mg/L 3-h Cervix None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
2999 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 75 % Cytotoxicity at 50 mg/L 6-h Cervix None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3000 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 70 % Cytotoxicity at 25 mg/L 6-h Cervix None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3001 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 4 % Cytotoxicity at 3.125 mg/L 6-h Cervix None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3002 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 78 % Cytotoxicity at 50 mg/L 12-h Cervix None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3003 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 68 % Cytotoxicity at 25 mg/L 12-h Cervix None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3004 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 4 % Cytotoxicity at 12.5 mg/L 12-h Cervix None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3005 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 5 % Cytotoxicity at 6.25 mg/L 12-h Cervix None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3006 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 10 % Cytotoxicity at 3.125 mg/L 12-h Cervix None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3007 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 90 % Cytotoxicity at 50 mg/L 24-h Cervix None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3008 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 80 % Cytotoxicity at 25 mg/L 24-h Cervix None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3009 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 15 % Cytotoxicity at 12.5 mg/L 24-h Cervix None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3010 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 12 % Cytotoxicity at 6.25 mg/L 24-h Cervix None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3011 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 5 % Cytotoxicity at 3.125 mg/L 24-h Cervix None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3012 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 88 % Cytotoxicity at 50 mg/L 3-h Fibrous connective tissue  None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3013 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 82 % Cytotoxicity at 25 mg/L 3-h Fibrous connective tissue  None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3014 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 40 % Cytotoxicity at 12.5 mg/L 3-h Fibrous connective tissue  None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3015 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 35 % Cytotoxicity at 6.25 mg/L 3-h Fibrous connective tissue  None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3016 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 35 % Cytotoxicity at 3.125 mg/L 3-h Fibrous connective tissue  None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3017 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 90 % Cytotoxicity at 50 mg/L 6-h Fibrous connective tissue  None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3018 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 90 % Cytotoxicity at 25 mg/L 6-h Fibrous connective tissue  None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3019 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 30 % Cytotoxicity at 12.5 mg/L 6-h Fibrous connective tissue  None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3020 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 30 % Cytotoxicity at 6.25 mg/L 6-h Fibrous connective tissue  None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3021 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 30 % Cytotoxicity at 3.125 mg/L 6-h Fibrous connective tissue  None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3022 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 97 % Cytotoxicity at 50 mg/L 12-h Fibrous connective tissue  None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3023 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 95 % Cytotoxicity at 25 mg/L 12-h Fibrous connective tissue  None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3024 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 39 % Cytotoxicity at 12.5 mg/L 12-h Fibrous connective tissue  None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3025 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 28 % Cytotoxicity at 6.25 mg/L 12-h Fibrous connective tissue  None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3026 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 38 % Cytotoxicity at 3.125 mg/L 12-h Fibrous connective tissue  None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3027 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 90 % Cytotoxicity at 50 mg/L 24-h Fibrous connective tissue  None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3028 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 90 % Cytotoxicity at 25 mg/L 24-h Fibrous connective tissue  None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3029 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 15 % Cytotoxicity at 12.5 mg/L 24-h Fibrous connective tissue  None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3030 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 5 % Cytotoxicity at 6.25 mg/L 24-h Fibrous connective tissue  None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
3031 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Pardaxin-1 33 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 10 % Cytotoxicity at 3.125 mg/L 24-h Fibrous connective tissue  None None CCSSSHHHHTTTTTHHHHHHHHHHHTTTTTTCC
1547 18656352 2008 KAQIRAMECNIL A5 12 Linear L None Free Free Anticancer Cyclin B (285-296) HCT-116 Colon Cancer MTT/MTS assay Not Available 24-h Colon None None CCCCCSCSSCCC
1548 18656352 2008 RKKRRQRRR Tat 9 Linear L None Free Free Anticancer HIV-Tat (49-57) HCT-116 Colon Cancer MTT/MTS assay ~10% Cytotoxicity at 100 µM 24-h Colon None None CGGGTSCCC
1549 18656352 2008 KAQIRAMECNILGRKKRRQRRR Tat-a5 22 Linear L None Free Free Anticancer HIV-Tat (49-57) HCT-116 Colon Cancer MTT/MTS assay ~80% Cytotoxicity at 100 µM 24-h Colon None None CCCCCCCSSSTTCGGGGGCCCC
1604 12366526 2002 PEWFKCRRWQWRMKKLGA L1 18 Cyclic L None Free Free Antimicrobial Lactoferrin Meth A Skin Cancer MTT/MTS assay IC50=>404 µM 4-h Skin None None CCCSSCCCTTCCCSSSCC
1619 12366526 2002 PEWFKCRRWQWRMKKLGA L1 18 Cyclic L None Free Free Antimicrobial Lactoferrin MT-1 Breast Cancer MTT/MTS assay IC50=>404 µM 4-h Breast None None CCCSSCCCTTCCCSSSCC
1634 12366526 2002 PEWFKCRRWQWRMKKLGA L1 18 Cyclic L None Free Free Antimicrobial Lactoferrin HT-29 Colon Cancer MTT/MTS assay IC50=>404 µM 4-h Colon None None CCCSSCCCTTCCCSSSCC
1605 12366526 2002 PAWFKARRWAWRMKKLAA L2 18 Cyclic L None Free Free Antimicrobial Lactoferrin Meth A Skin Cancer MTT/MTS assay IC50=144 µM 4-h Skin None None CCCCTTHHHHTTTTSSCC
1620 12366526 2002 PAWFKARRWAWRMKKLAA L2 18 Cyclic L None Free Free Antimicrobial Lactoferrin MT-1 Breast Cancer MTT/MTS assay IC50=>254 µM 4-h Breast None None CCCCTTHHHHTTTTSSCC
1635 12366526 2002 PAWFKARRWAWRMKKLAA L2 18 Cyclic L None Free Free Antimicrobial Lactoferrin HT-29 Colon Cancer MTT/MTS assay IC50=>440 µM 4-h Colon None None CCCCTTHHHHTTTTSSCC
1606 12366526 2002 PAWRKAFRWAWRMKKLAA L3 18 Cyclic L None Free Free Antimicrobial Lactoferrin Meth A Skin Cancer MTT/MTS assay IC50=32 µM 4-h Skin None None CCSCSSSSSCTTSCCSCC
1621 12366526 2002 PAWRKAFRWAWRMKKLAA L3 18 Cyclic L None Free Free Antimicrobial Lactoferrin MT-1 Breast Cancer MTT/MTS assay IC50=18 µM 4-h Breast None None CCSCSSSSSCTTSCCSCC
1636 12366526 2002 PAWRKAFRWAWRMKKLAA L3 18 Cyclic L None Free Free Antimicrobial Lactoferrin HT-29 Colon Cancer MTT/MTS assay IC50=141 µM 4-h Colon None None CCSCSSSSSCTTSCCSCC
1607 12366526 2002 PAWFKARRWAWRMLKKAA L4 18 Cyclic L None Free Free Antimicrobial Lactoferrin Meth A Skin Cancer MTT/MTS assay IC50=31 µM 4-h Skin None None CCCCGGGGGGGGTTTTCC
1622 12366526 2002 PAWFKARRWAWRMLKKAA L4 18 Cyclic L None Free Free Antimicrobial Lactoferrin MT-1 Breast Cancer MTT/MTS assay IC50=16 µM 4-h Breast None None CCCCGGGGGGGGTTTTCC
1637 12366526 2002 PAWFKARRWAWRMLKKAA L4 18 Cyclic L None Free Free Antimicrobial Lactoferrin HT-29 Colon Cancer MTT/MTS assay IC50=57 µM 4-h Colon None None CCCCGGGGGGGGTTTTCC
1608 12366526 2002 PAWRKAFRWAWRMLKKAA L5 18 Cyclic L None Free Free Antimicrobial Lactoferrin Meth A Skin Cancer MTT/MTS assay IC50=6.6 µM 4-h Skin None None CCSCBCSTTCCCBCCSCC
1623 12366526 2002 PAWRKAFRWAWRMLKKAA L5 18 Cyclic L None Free Free Antimicrobial Lactoferrin MT-1 Breast Cancer MTT/MTS assay IC50=8 µM 4-h Breast None None CCSCBCSTTCCCBCCSCC
1638 12366526 2002 PAWRKAFRWAWRMLKKAA L5 18 Cyclic L None Free Free Antimicrobial Lactoferrin HT-29 Colon Cancer MTT/MTS assay IC50=14 µM 4-h Colon None None CCSCBCSTTCCCBCCSCC
1609 12366526 2002 PAWRKAFRWAARMLKKAA L6 18 Cyclic L None Free Free Antimicrobial Lactoferrin Meth A Skin Cancer MTT/MTS assay IC50=11 µM 4-h Skin None None CCCTTTCGGGGTTTSSCC
1624 12366526 2002 PAWRKAFRWAARMLKKAA L6 18 Cyclic L None Free Free Antimicrobial Lactoferrin MT-1 Breast Cancer MTT/MTS assay IC50=12 µM 4-h Breast None None CCCTTTCGGGGTTTSSCC
1639 12366526 2002 PAWRKAFRWAARMLKKAA L6 18 Cyclic L None Free Free Antimicrobial Lactoferrin HT-29 Colon Cancer MTT/MTS assay IC50=15 µM 4-h Colon None None CCCTTTCGGGGTTTSSCC
1610 12366526 2002 PAWRKAFRAAWRMLKKAA L7 18 Cyclic L None Free Free Antimicrobial Lactoferrin Meth A Skin Cancer MTT/MTS assay IC50=16 µM 4-h Skin None None CCTTGGGTCCSSGGGGCC
1625 12366526 2002 PAWRKAFRAAWRMLKKAA L7 18 Cyclic L None Free Free Antimicrobial Lactoferrin MT-1 Breast Cancer MTT/MTS assay IC50=11 µM 4-h Breast None None CCTTGGGTCCSSGGGGCC
1640 12366526 2002 PAWRKAFRAAWRMLKKAA L7 18 Cyclic L None Free Free Antimicrobial Lactoferrin HT-29 Colon Cancer MTT/MTS assay IC50=16 µM 4-h Colon None None CCTTGGGTCCSSGGGGCC
1611 12366526 2002 PAWAKAFRAAARMKLKAA L8 18 Cyclic L None Free Free Antimicrobial Lactoferrin Meth A Skin Cancer MTT/MTS assay IC50=110 µM 4-h Skin None None CTTCSSCSSGGGTTTSCC
1626 12366526 2002 PAWAKAFRAAARMKLKAA L8 18 Cyclic L None Free Free Antimicrobial Lactoferrin MT-1 Breast Cancer MTT/MTS assay IC50=87 µM 4-h Breast None None CTTCSSCSSGGGTTTSCC
1641 12366526 2002 PAWAKAFRAAARMKLKAA L8 18 Cyclic L None Free Free Antimicrobial Lactoferrin HT-29 Colon Cancer MTT/MTS assay IC50=180 µM 4-h Colon None None CTTCSSCSSGGGTTTSCC
1612 12366526 2002 PAWRKAARWAWRMLKKAA L9 18 Cyclic L None Free Free Antimicrobial Lactoferrin Meth A Skin Cancer MTT/MTS assay IC50=35 µM 4-h Skin None None CCSSSCCSSCTTCSSSCC
1627 12366526 2002 PAWRKAARWAWRMLKKAA L9 18 Cyclic L None Free Free Antimicrobial Lactoferrin MT-1 Breast Cancer MTT/MTS assay IC50=32 µM 4-h Breast None None CCSSSCCSSCTTCSSSCC
1642 12366526 2002 PAWRKAARWAWRMLKKAA L9 18 Cyclic L None Free Free Antimicrobial Lactoferrin HT-29 Colon Cancer MTT/MTS assay IC50=52 µM 4-h Colon None None CCSSSCCSSCTTCSSSCC
1613 12366526 2002 PAARKAFRWAWRMLKKAA L10 18 Cyclic L None Free Free Antimicrobial Lactoferrin Meth A Skin Cancer MTT/MTS assay IC50=24 µM 4-h Skin None None CCGGGCCCCBTTTTBCCC
1628 12366526 2002 PAARKAFRWAWRMLKKAA L10 18 Cyclic L None Free Free Antimicrobial Lactoferrin MT-1 Breast Cancer MTT/MTS assay IC50=20 µM 4-h Breast None None CCGGGCCCCBTTTTBCCC
1643 12366526 2002 PAARKAFRWAWRMLKKAA L10 18 Cyclic L None Free Free Antimicrobial Lactoferrin HT-29 Colon Cancer MTT/MTS assay IC50=35 µM 4-h Colon None None CCGGGCCCCBTTTTBCCC
1614 12366526 2002 PAARKAARWAWRMLKKGA L11 18 Cyclic L None Free Free Antimicrobial Lactoferrin Meth A Skin Cancer MTT/MTS assay IC50=116 µM 4-h Skin None None CCGGGHHHHTTTGGGCCC
1629 12366526 2002 PAARKAARWAWRMLKKGA L11 18 Cyclic L None Free Free Antimicrobial Lactoferrin MT-1 Breast Cancer MTT/MTS assay IC50=75 µM 4-h Breast None None CCGGGHHHHTTTGGGCCC
1644 12366526 2002 PAARKAARWAWRMLKKGA L11 18 Cyclic L None Free Free Antimicrobial Lactoferrin HT-29 Colon Cancer MTT/MTS assay IC50=248 µM 4-h Colon None None CCGGGHHHHTTTGGGCCC
1615 12366526 2002 PAWRKAFRWAKRMLKKAA L12 18 Cyclic L None Free Free Antimicrobial Lactoferrin Meth A Skin Cancer MTT/MTS assay IC50=7.9 µM 4-h Skin None None CCSSSSCCCTTSGGGSCC
1630 12366526 2002 PAWRKAFRWAKRMLKKAA L12 18 Cyclic L None Free Free Antimicrobial Lactoferrin MT-1 Breast Cancer MTT/MTS assay IC50=10 µM 4-h Breast None None CCSSSSCCCTTSGGGSCC
1645 12366526 2002 PAWRKAFRWAKRMLKKAA L12 18 Cyclic L None Free Free Antimicrobial Lactoferrin HT-29 Colon Cancer MTT/MTS assay IC50=25 µM 4-h Colon None None CCSSSSCCCTTSGGGSCC
1616 12366526 2002 PAWRKAFRKAWRMLKKAA L13 18 Cyclic L None Free Free Antimicrobial Lactoferrin Meth A Skin Cancer MTT/MTS assay IC50=14 µM 4-h Skin None None CCTTTCTTCCTTSCCCCC
1631 12366526 2002 PAWRKAFRKAWRMLKKAA L13 18 Cyclic L None Free Free Antimicrobial Lactoferrin MT-1 Breast Cancer MTT/MTS assay IC50=12 µM 4-h Breast None None CCTTTCTTCCTTSCCCCC
1646 12366526 2002 PAWRKAFRKAWRMLKKAA L13 18 Cyclic L None Free Free Antimicrobial Lactoferrin HT-29 Colon Cancer MTT/MTS assay IC50=29 µM 4-h Colon None None CCTTTCTTCCTTSCCCCC
1617 12366526 2002 PAWRKARRWAWRMKKLAA L14 18 Cyclic L None Free Free Antimicrobial Lactoferrin Meth A Skin Cancer MTT/MTS assay IC50=125 µM 4-h Skin None None CCGGGSTTSSCCCCCSCC
1632 12366526 2002 PAWRKARRWAWRMKKLAA L14 18 Cyclic L None Free Free Antimicrobial Lactoferrin MT-1 Breast Cancer MTT/MTS assay IC50=141 µM 4-h Breast None None CCGGGSTTSSCCCCCSCC
1647 12366526 2002 PAWRKARRWAWRMKKLAA L14 18 Cyclic L None Free Free Antimicrobial Lactoferrin HT-29 Colon Cancer MTT/MTS assay IC50=423 µM 4-h Colon None None CCGGGSTTSSCCCCCSCC
1618 12366526 2002 PAWRKARRWARRMKKLAA L15 18 Cyclic L None Free Free Antimicrobial Lactoferrin Meth A Skin Cancer MTT/MTS assay IC50=87 µM 4-h Skin None None CCCSCCSGGGGCSSSCCC
1633 12366526 2002 PAWRKARRWARRMKKLAA L15 18 Cyclic L None Free Free Antimicrobial Lactoferrin MT-1 Breast Cancer MTT/MTS assay IC50=92 µM 4-h Breast None None CCCSCCSGGGGCSSSCCC
1648 12366526 2002 PAWRKARRWARRMKKLAA L15 18 Cyclic L None Free Free Antimicrobial Lactoferrin HT-29 Colon Cancer MTT/MTS assay IC50=178 µM 4-h Colon None None CCCSCCSGGGGCSSSCCC
1649 11835991 2001 GIGTKILGGVKTALKGALKELASTYAN maximin1 27 Linear L None Amidation Free Antimicrobial Bombina maxima C8166 Leukemia Cancer MTT/MTS assay IC50=15.3 µg/ml 48-h Blood None None CCSSTTSCTHHHHHHHHSTTGGGCTTC
1653 11835991 2001 GIGTKILGGVKTALKGALKELASTYAN maximin1 27 Linear L None Amidation Free Antimicrobial Bombina maxima MOLT-4 Leukemia Cancer MTT/MTS assay IC50=24.3 µg/ml 48-h Blood None None CCSSTTSCTHHHHHHHHSTTGGGCTTC
1657 11835991 2001 GIGTKILGGVKTALKGALKELASTYAN maximin1 27 Linear L None Amidation Free Antimicrobial Bombina maxima BIU-87 Bladder Cancer MTT/MTS assay IC50=20.5 µg/ml 48-h Bladder None None CCSSTTSCTHHHHHHHHSTTGGGCTTC
1661 11835991 2001 GIGTKILGGVKTALKGALKELASTYAN maximin1 27 Linear L None Amidation Free Antimicrobial Bombina maxima T-24 Bladder Cancer MTT/MTS assay IC50 =35.4 µg/ml 48-h Bladder None None CCSSTTSCTHHHHHHHHSTTGGGCTTC
4401 11835991, 18957441 2002 GIGTKILGGVKTALKGALKELASTYAN Maximin 1 27 Not Available L None Free Free Anticancer Bombina maxima Not Available Not Available Not Available Not Available Not Available Not Available 18957441 None CCCTTCCCTHHHHHHHHCCCGGGGTCC
1650 11835991 2001 GIGGKILSGLKTALKGAAKELASTYLH maximin3 27 Linear L None Free Free Antimicrobial Bombina maxima C8166 Leukemia Cancer MTT/MTS assay IC50=11.4 µg/ml 48-h Blood None None CTTSSCCSTHHHHHHHHCCGGGGGGTC
1654 11835991 2001 GIGGKILSGLKTALKGAAKELASTYLH maximin3 27 Linear L None Free Free Antimicrobial Bombina maxima MOLT-4 Leukemia Cancer MTT/MTS assay IC50 =25.2 µg/ml 48-h Blood None None CTTSSCCSTHHHHHHHHCCGGGGGGTC
1658 11835991 2001 GIGGKILSGLKTALKGAAKELASTYLH maximin3 27 Linear L None Free Free Antimicrobial Bombina maxima BIU-87 Bladder Cancer MTT/MTS assay IC50=28 µg/ml 48-h Bladder None None CTTSSCCSTHHHHHHHHCCGGGGGGTC
1662 11835991 2001 GIGGKILSGLKTALKGAAKELASTYLH maximin3 27 Linear L None Free Free Antimicrobial Bombina maxima T-24 Bladder Cancer MTT/MTS assay IC50 =18 µg/ml 48-h Bladder None None CTTSSCCSTHHHHHHHHCCGGGGGGTC
4399 11835991, 18957441 2002 GIGGKILSGLKTALKGAAKELASTYLH Maximin 3 27 Not Available L None Free Free Antibacterial Bombina maxima Not Available Not Available Not Available Not Available Not Available Not Available 18957441 None CTTSSCCSTHHHHHHHHCCGGGGGGTC
1651 11835991 2001 GIGVLLSAGKAALKGLAKVLAEKYAN maximin4 26 Linear L None Amidation Free Antimicrobial Bombina maxima C8166 Leukemia Cancer MTT/MTS assay IC50=24.2 µg/ml 48-h Blood None None CTTCCSSSCGGGHHHHHHHTGGGTCC
1655 11835991 2001 GIGVLLSAGKAALKGLAKVLAEKYAN maximin4 26 Linear L None Amidation Free Antimicrobial Bombina maxima MOLT-4 Leukemia Cancer MTT/MTS assay IC50 =53.4 µg/ml 48-h Blood None None CTTCCSSSCGGGHHHHHHHTGGGTCC
1659 11835991 2001 GIGVLLSAGKAALKGLAKVLAEKYAN maximin4 26 Linear L None Amidation Free Antimicrobial Bombina maxima BIU-87 Bladder Cancer MTT/MTS assay IC50 =>50 µg/ml 48-h Bladder None None CTTCCSSSCGGGHHHHHHHTGGGTCC
1663 11835991 2001 GIGVLLSAGKAALKGLAKVLAEKYAN maximin4 26 Linear L None Amidation Free Antimicrobial Bombina maxima T-24 Bladder Cancer MTT/MTS assay IC50=>50 µg/ml 48-h Bladder None None CTTCCSSSCGGGHHHHHHHTGGGTCC
1652 11835991 2001 SIGAKILGGVKTFFKGALKELASTYLQ maximin5 27 Linear L None Free Free Antimicrobial Bombina maxima C8166 Leukemia Cancer MTT/MTS assay IC50=34.4 µg/ml 48-h Blood None None CCGGGCCCGGGGSGGGTSCCGGGGTTC
1656 11835991 2001 SIGAKILGGVKTFFKGALKELASTYLQ maximin5 27 Linear L None Free Free Antimicrobial Bombina maxima MOLT-4 Leukemia Cancer MTT/MTS assay IC50 >50 µg/ml 48-h Blood None None CCGGGCCCGGGGSGGGTSCCGGGGTTC
1660 11835991 2001 SIGAKILGGVKTFFKGALKELASTYLQ maximin5 27 Linear L None Free Free Antimicrobial Bombina maxima BIU-87 Bladder Cancer MTT/MTS assay IC50 =>50 µg/ml 48-h Bladder None None CCGGGCCCGGGGSGGGTSCCGGGGTTC
1664 11835991 2001 SIGAKILGGVKTFFKGALKELASTYLQ maximin5 27 Linear L None Free Free Antimicrobial Bombina maxima T-24 Bladder Cancer MTT/MTS assay IC50=>50 µg/ml 48-h Bladder None None CCGGGCCCGGGGSGGGTSCCGGGGTTC
1665 15796184 2005 LRVRLASHLRKLRKRLLRDADDLQKRLAVY Apo E 30 Linear L None Free Free Antibacterial Apoprotein E PANC-1 Pancreatic Cancer MTT/MTS assay 55 % Cytotoxity at 40 µg/ml 4-h Pancreatic None None CTTHHHHHHTTSCSSCSSCCTHHHHTTTCC
1666 15796184 2005 LRVRLASHLRKLRKRLLRDADDLQKRLAVY Apo E 30 Linear L None Free Free Antibacterial Apoprotein E Paca-2 Pancreatic Cancer MTT/MTS assay 55 % Cytotoxity at 40 µg/ml 4-h Pancreatic None None CTTHHHHHHTTSCSSCSSCCTHHHHTTTCC
1667 15796184 2005 LRVRLASHLRKLRKRLLRDADDLQKRLAVY Apo E 30 Linear L None Free Free Antibacterial Apoprotein E MKN-1 Gastric Cancer MTT/MTS assay 60 % Cytotoxity at 40 µg/ml 4-h Stomach None None CTTHHHHHHTTSCSSCSSCCTHHHHTTTCC
1668 15796184 2005 LRVRLASHLRKLRKRLLRDADDLQKRLAVY Apo E 30 Linear L None Free Free Antibacterial Apoprotein E MKN-7 Gastric Cancer MTT/MTS assay 35 % Cytotoxity at 40 µg/ml 4-h Stomach None None CTTHHHHHHTTSCSSCSSCCTHHHHTTTCC
1669 15796184 2005 LRVRLASHLRKLRKRLLRDADDLQKRLAVY Apo E 30 Linear L None Free Free Antibacterial Apoprotein E COLO-201 Colon Cancer MTT/MTS assay 65 % Cytotoxity at 40 µg/ml 4-h Colon None None CTTHHHHHHTTSCSSCSSCCTHHHHTTTCC
1670 22641352 2012 LLRHVVKILEKYL Temporin-La 13 Linear L None Free Free Anticancer Temporins family SW-1116 Colorectal Cancer MTT/MTS assay 57.62 Inhibition ratio at 50 µg/ml 24-h Colon None None CHHHHGGGTTTTC
1674 22641352 2012 LLRHVVKILEKYL Temporin-La 13 Linear L None Free Free Anticancer Temporins family SMMC-7721 Liver Cancer MTT/MTS assay 52.77 Inhibition ratio at 50 µg/ml 24-h Liver None None CHHHHGGGTTTTC
1678 22641352 2012 LLRHVVKILEKYL Temporin-La 13 Linear L None Free Free Anticancer Temporins family HeLa Cervical Cancer MTT/MTS assay 52.32 Inhibition ratio at 50 µg/ml 24-h Cervix None None CHHHHGGGTTTTC
1682 22641352 2012 LLRHVVKILEKYL Temporin-La 13 Linear L None Free Free Anticancer Temporins family HepG-2 Liver Cancer MTT/MTS assay 50.90 Inhibition ratio at 50 µg/ml 24-h Liver None None CHHHHGGGTTTTC
1686 22641352 2012 LLRHVVKILEKYL Temporin-La 13 Linear L None Free Free Anticancer Temporins family BGC-823 Gastric Cancer MTT/MTS assay 48.19 Inhibition ratio at 50 µg/ml 24-h Stomach None None CHHHHGGGTTTTC
1690 22641352 2012 LLRHVVKILEKYL Temporin-La 13 Linear L None Free Free Anticancer Temporins family A-549 Lung Cancer MTT/MTS assay 45.62 Inhibition ratio at 50 µg/ml 24-h Lung None None CHHHHGGGTTTTC
1694 22641352 2012 LLRHVVKILEKYL Temporin-La 13 Linear L None Free Free Anticancer Temporins family HL7702 Liver Cancer MTT/MTS assay 37.22 Inhibition ratio at 50 µg/ml 24-h Liver None None CHHHHGGGTTTTC
1698 22641352 2012 LLRHVVKILEKYL Temporin-La 13 Linear L None Free Free Anticancer Temporins family HEK-293T Renal Cancer MTT/MTS assay 30.82 Inhibition ratio at 50 µg/ml 24-h Renal None None CHHHHGGGTTTTC
1702 22641352 2012 LLRHVVKILEKYL Temporin-La 13 Linear L None Free Free Anticancer Temporins family MEC Breast Cancer MTT/MTS assay 24.15Inhibition ratio at 50 µg/ml 24-h Breast None None CHHHHGGGTTTTC
1671 22641352 2012 LLRHVVKILSKYL Temporin-Las 13 Linear L None Free Free Anticancer Temporins family SW-1116 Colorectal Cancer MTT/MTS assay 62.73 Inhibition ratio at 50 µg/ml 24-h Colon None None CGGGHHHHTTTCC
1675 22641352 2012 LLRHVVKILSKYL Temporin-Las 13 Linear L None Free Free Anticancer Temporins family SMMC-7721 Liver Cancer MTT/MTS assay 59.37 Inhibition ratio at 50 µg/ml 24-h Liver None None CGGGHHHHTTTCC
1679 22641352 2012 LLRHVVKILSKYL Temporin-Las 13 Linear L None Free Free Anticancer Temporins family HeLa Cervical Cancer MTT/MTS assay 56.81 Inhibition ratio at 50 µg/ml 24-h Cervix None None CGGGHHHHTTTCC
1683 22641352 2012 LLRHVVKILSKYL Temporin-Las 13 Linear L None Free Free Anticancer Temporins family HepG-2 Liver Cancer MTT/MTS assay 55.98 Inhibition ratio at 50 µg/ml 24-h Liver None None CGGGHHHHTTTCC
1687 22641352 2012 LLRHVVKILSKYL Temporin-Las 13 Linear L None Free Free Anticancer Temporins family BGC-823 Gastric Cancer MTT/MTS assay 50.85 Inhibition ratio at 50 µg/ml 24-h Stomach None None CGGGHHHHTTTCC
1691 22641352 2012 LLRHVVKILSKYL Temporin-Las 13 Linear L None Free Free Anticancer Temporins family A-549 Lung Cancer MTT/MTS assay 50.64 Inhibition ratio at 50 µg/ml 24-h Lung None None CGGGHHHHTTTCC
1695 22641352 2012 LLRHVVKILSKYL Temporin-Las 13 Linear L None Free Free Anticancer Temporins family HL7702 Liver Cancer MTT/MTS assay 37.00 Inhibition ratio at 50 µg/ml 24-h Liver None None CGGGHHHHTTTCC
1699 22641352 2012 LLRHVVKILSKYL Temporin-Las 13 Linear L None Free Free Anticancer Temporins family HEK-293T Renal Cancer MTT/MTS assay 30.90 Inhibition ratio at 50 µg/ml 24-h Renal None None CGGGHHHHTTTCC
1703 22641352 2012 LLRHVVKILSKYL Temporin-Las 13 Linear L None Free Free Anticancer Temporins family MEC Breast Cancer MTT/MTS assay 27.99 Inhibition ratio at 50 µg/ml 24-h Breast None None CGGGHHHHTTTCC
1672 22641352 2012 RGDLLRHVVKILEKYL RGD-La 16 Linear L None Free Free Anticancer Arg-Gly-Asp(RGD) tripeptide ana temporins SW-1116 Colorectal Cancer MTT/MTS assay 72.69 Inhibition ratio at 50 µg/ml 24-h Colon None None CCCCGGGTTHHHHTTC
1676 22641352 2012 RGDLLRHVVKILEKYL RGD-La 16 Linear L None Free Free Anticancer Arg-Gly-Asp(RGD) tripeptide ana temporins SMMC-7721 Liver Cancer MTT/MTS assay 70.39 Inhibition ratio at 50 µg/ml 24-h Liver None None CCCCGGGTTHHHHTTC
1680 22641352 2012 RGDLLRHVVKILEKYL RGD-La 16 Linear L None Free Free Anticancer Arg-Gly-Asp(RGD) tripeptide ana temporins HeLa Cervical Cancer MTT/MTS assay 73.09 Inhibition ratio at 50 µg/ml 24-h Cervix None None CCCCGGGTTHHHHTTC
1684 22641352 2012 RGDLLRHVVKILEKYL RGD-La 16 Linear L None Free Free Anticancer Arg-Gly-Asp(RGD) tripeptide aNot Available temporins HepG-2 Liver Cancer MTT/MTS assay 60.22 Inhibition ratio at 50 µg/ml 24-h Liver None None CCCCGGGTTHHHHTTC
1688 22641352 2012 RGDLLRHVVKILEKYL RGD-La 16 Linear L None Free Free Anticancer Arg-Gly-Asp(RGD) tripeptide ana temporins BGC-823 Gastric Cancer MTT/MTS assay 62.49 Inhibition ratio at 50 µg/ml 24-h Stomach None None CCCCGGGTTHHHHTTC
1692 22641352 2012 RGDLLRHVVKILEKYL RGD-La 16 Linear L None Free Free Anticancer Arg-Gly-Asp(RGD) tripeptide ana temporins A-549 Lung Cancer MTT/MTS assay 47.26Inhibition ratio at 50 µg/ml 24-h Lung None None CCCCGGGTTHHHHTTC
1696 22641352 2012 RGDLLRHVVKILEKYL RGD-La 16 Linear L None Free Free Anticancer Arg-Gly-Asp(RGD) tripeptide ana temporins HL7702 Liver Cancer MTT/MTS assay 36.25 Inhibition ratio at 50 µg/ml 24-h Liver None None CCCCGGGTTHHHHTTC
1700 22641352 2012 RGDLLRHVVKILEKYL RGD-La 16 Linear L None Free Free Anticancer Arg-Gly-Asp(RGD) tripeptide ana temporins HEK-293T Renal Cancer MTT/MTS assay 27.86 Inhibition ratio at 50 µg/ml 24-h Renal None None CCCCGGGTTHHHHTTC
1704 22641352 2012 RGDLLRHVVKILEKYL RGD-La 16 Linear L None Free Free Anticancer Arg-Gly-Asp(RGD) tripeptide ana temporins MEC Breast Cancer MTT/MTS assay 19.76 Inhibition ratio at 50 µg/ml 24-h Breast None None CCCCGGGTTHHHHTTC
1673 22641352 2012 RGDLLRHVVKILSKYL RGD-Las 16 Linear L None Free Free Anticancer Arg-Gly-Asp(RGD) tripeptide ana temporins SW-1116 Colorectal Cancer MTT/MTS assay 81.465 Inhibition ratio at 50 µg/ml 24-h Colon None None CCCCHHHHTTTSSSCC
1677 22641352 2012 RGDLLRHVVKILSKYL RGD-Las 16 Linear L None Free Free Anticancer Arg-Gly-Asp(RGD) tripeptide ana temporins SMMC-7721 Liver Cancer MTT/MTS assay 86.175 Inhibition ratio at 50 µg/ml 24-h Liver None None CCCCHHHHTTTSSSCC
1681 22641352 2012 RGDLLRHVVKILSKYL RGD-Las 16 Linear L None Free Free Anticancer Arg-Gly-Asp(RGD) tripeptide ana temporins HeLa Cervical Cancer MTT/MTS assay 78.045 Inhibition ratio at 50 µg/ml 24-h Cervix None None CCCCHHHHTTTSSSCC
1685 22641352 2012 RGDLLRHVVKILSKYL RGD-Las 16 Linear L None Free Free Anticancer Arg-Gly-Asp(RGD) tripeptide aNot Available temporins HepG-2 Liver Cancer MTT/MTS assay 73.07 Inhibition ratio at 50 µg/ml 24-h Liver None None CCCCHHHHTTTSSSCC
1689 22641352 2012 RGDLLRHVVKILSKYL RGD-Las 16 Linear L None Free Free Anticancer Arg-Gly-Asp(RGD) tripeptide ana temporins BGC-823 Gastric Cancer MTT/MTS assay 73.705 Inhibition ratio at 50 µg/ml 24-h Stomach None None CCCCHHHHTTTSSSCC
1693 22641352 2012 RGDLLRHVVKILSKYL RGD-Las 16 Linear L None Free Free Anticancer Arg-Gly-Asp(RGD) tripeptide ana temporins A-549 Lung Cancer MTT/MTS assay 52.50 Inhibition ratio at 50 µg/ml 24-h Lung None None CCCCHHHHTTTSSSCC
1697 22641352 2012 RGDLLRHVVKILSKYL RGD-Las 16 Linear L None Free Free Anticancer Arg-Gly-Asp(RGD) tripeptide ana temporins HL7702 Liver Cancer MTT/MTS assay 38.13 Inhibition ratio at 50 µg/ml 24-h Liver None None CCCCHHHHTTTSSSCC
1701 22641352 2012 RGDLLRHVVKILSKYL RGD-Las 16 Linear L None Free Free Anticancer Arg-Gly-Asp(RGD) tripeptide ana temporins HEK-293T Renal Cancer MTT/MTS assay 32.52 Inhibition ratio at 50 µg/ml 24-h Renal None None CCCCHHHHTTTSSSCC
1705 22641352 2012 RGDLLRHVVKILSKYL RGD-Las 16 Linear L None Free Free Anticancer Arg-Gly-Asp(RGD) tripeptide ana temporins MEC Breast Cancer MTT/MTS assay 29.33 Inhibition ratio at 50 µg/ml 24-h Breast None None CCCCHHHHTTTSSSCC
1706 9614066 1998 ALWKNMLKGIGKLAGQAALGAVKTLVGA DRS B3 28 Linear L None Free Free Antimicrobial Dermaseptins B MCF-7 Breast Cancer Thymidine Incorporation assay Cytotoxicity =12 µM 6-h Breast None None CHHHHHHHHHHHHHHHHHCCHHHHHHTC
1707 9614066 1998 ALWKDILKNVGKAAGKAVLNTVTDMVNQ DRS B4 28 Linear L None Amidation Free Antimicrobial Dermaseptins B MCF-7 Breast Cancer Thymidine Incorporation assay Cytotoxicity =15 µM 6-h Breast None None CCCSSSHHHHTTCGGGGSSCSTTTTTTC
1708 9614066 1998 ALWKTMLKKLGTMALHAGKAALGAAADTISQGTQ DRS S1 35 Linear L None Free Free Antimicrobial Dermaseptins B MCF-7 Breast Cancer Thymidine Incorporation assay Not Available 6-h Breast None None CHHHHTGGGCGGGGTTTCCSSBTTBCGGGTSSCC
1709 11691780 2001 KLAKLAKKLAKLAK DP1 14 Linear L None Free Free Antimicrobial Protein transduction domain MCA205 Renal Cancer MTT/MTS assay LC50 =< 50 µM 168-h Renal None None CTHHHHHHHHHHCC
1710 None 2011 FLGWLFKWAKK Gaegurin peptides SEQID NO: 1 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa SK-MEL-2 Skin Cancer MTT/MTS assay IC50 = 27.39 mM 24-h Skin 14739294 US_008076284_B2 CHHHHTTTCCC
1711 None 2011 FLGWLFKWAKK Gaegurin peptides SEQID NO: 1 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa A-549 Lung Cancer MTT/MTS assay IC50 = 25.2 mM 24-h Lung 14739294 US_008076284_B2 CHHHHTTTCCC
1712 None 2011 FLGWLFKWAKK Gaegurin peptides SEQID NO: 1 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa SK-OV-3 Ovarian Cancer MTT/MTS assay IC50 = 24.76 mM 24-h Ovary 14739294 US_008076284_B2 CHHHHTTTCCC
1713 None 2011 FLGWLFKWAKK Gaegurin peptides SEQID NO: 1 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa MKN-45 Gastric Cancer MTT/MTS assay IC50 = 26.7 mM 24-h Stomach 14739294 US_008076284_B2 CHHHHTTTCCC
1714 None 2011 FLGWLFKWAKK Gaegurin peptides SEQID NO: 1 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa PC-3 Prostate Cancer MTT/MTS assay IC50 = 47.69 mM 24-h Prostate 14739294 US_008076284_B2 CHHHHTTTCCC
1715 None 2011 FLGWLFKWAKK Gaegurin peptides SEQID NO: 1 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa A-498 Renal Cancer MTT/MTS assay IC50 = 41.21 mM 24-h Renal 14739294 US_008076284_B2 CHHHHTTTCCC
1734 None 2011 FLGWLFKWAKK Gaegurin peptides SEQID NO: 1 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa HCTl-16 Colon Cancer MTT/MTS assay IC50 = 27 mM 24-h Colon 14739294 US_008076284_B2 CHHHHTTTCCC
1738 None 2011 FLGWLFKWAKK Gaegurin peptides SEQID NO: 1 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa NCI-H630 Colon Cancer MTT/MTS assay Not Available 24-h Colon 14739294 US_008076284_B2 CHHHHTTTCCC
1742 None 2011 FLGWLFKWAKK Gaegurin peptides SEQID NO: 1 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa A-498 Renal Cancer MTT/MTS assay IC50 = 41.21 mM 24-h Renal 14739294 WO_2007133033_A1 CHHHHTTTCCC
1743 None 2011 FLGWLFKWAKK Gaegurin peptides SEQID NO: 1 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa A-549 Lung Cancer MTT/MTS assay IC50 = 25.2 mM 24-h Lung 14739294 WO_2007133033_A1 CHHHHTTTCCC
1744 None 2011 FLGWLFKWAKK Gaegurin peptides SEQID NO: 1 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa MKN-45 Gastric Cancer MTT/MTS assay IC50 = 26.7 mM 24-h Stomach 14739294 WO_2007133033_A1 CHHHHTTTCCC
1745 None 2011 FLGWLFKWAKK Gaegurin peptides SEQID NO: 1 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa NCI-H630 Colon Cancer MTT/MTS assay Not Available 24-h Colon 14739294 WO_2007133033_A1 CHHHHTTTCCC
1746 None 2011 FLGWLFKWAKK Gaegurin peptides SEQID NO: 1 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa PC-3 Prostate Cancer MTT/MTS assay IC50 = 47.69 mM 24-h Prostate 14739294 WO_2007133033_A1 CHHHHTTTCCC
1747 None 2011 FLGWLFKWAKK Gaegurin peptides SEQID NO: 1 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa SK-MEL-2 Skin Cancer MTT/MTS assay IC50 = 27.39 mM 24-h Skin 14739294 WO_2007133033_A1 CHHHHTTTCCC
1748 None 2011 FLGWLFKWAKK Gaegurin peptides SEQID NO: 1 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa SK-OV-3 Ovarian Cancer MTT/MTS assay IC50 = 24.76 mM 24-h Ovary 14739294 WO_2007133033_A1 CHHHHTTTCCC
3240 22644847 2012 FLGWLFKWAKK GA-K3 11 Linear L None Amidation Free Antimicrobial Undecapeptide analogues derived from Brevinin-1EMa A-498 Renal Cancer MTT/MTS assay IC50 =41.21 µM 72-h Renal None None CCHHHHTTCCC
3241 22644847 2012 FLGWLFKWAKK GA-K3 11 Linear L None Amidation Free Antimicrobial Undecapeptide analogues derived from Brevinin-1EMa A-549 Lung Cancer MTT/MTS assay IC50 =25.20 µM 72-h Lung None None CCHHHHTTCCC
3242 22644847 2012 FLGWLFKWAKK GA-K3 11 Linear L None Amidation Free Antimicrobial Undecapeptide analogues derived from Brevinin-1EMa HCT-116 Colon Cancer MTT/MTS assay IC50 =27.00 µM 72-h Colon None None CCHHHHTTCCC
3243 22644847 2012 FLGWLFKWAKK GA-K3 11 Linear L None Amidation Free Antimicrobial Undecapeptide analogues derived from Brevinin-1EMa MKN-45 Gastric Cancer MTT/MTS assay IC50 =26.70 µM 72-h Stomach None None CCHHHHTTCCC
3244 22644847 2012 FLGWLFKWAKK GA-K3 11 Linear L None Amidation Free Antimicrobial Undecapeptide analogues derived from Brevinin-1EMa PC-3 Prostate Cancer MTT/MTS assay IC50 =47.69 µM 72-h Prostate None None CCHHHHTTCCC
3245 22644847 2012 FLGWLFKWAKK GA-K3 11 Linear L None Amidation Free Antimicrobial Undecapeptide analogues derived from Brevinin-1EMa SK-MEL-2 Skin Cancer MTT/MTS assay IC50 =27.39 µM 72-h Skin None None CCHHHHTTCCC
3246 22644847 2012 FLGWLFKWAKK GA-K3 11 Linear L None Amidation Free Antimicrobial Undecapeptide analogues derived from Brevinin-1EMa SK-OV-3 Ovarian Cancer MTT/MTS assay IC50 72-h Ovary None None CCHHHHTTCCC
3741 22644847 2012 FLGWLFKWAKK GA-K3 11 Linear L None Free Free Anticancer and Antimicrobial Brevinin-1EMa A-498 Renal Cancer MTT/MTS assay IC50= 41.21 µM 72-h Renal None None CHHHHTTTCCC
3742 22644847 2012 FLGWLFKWAKK GA-K3 11 Linear L None Free Free Anticancer and Antimicrobial Brevinin-1EMa A-549 Lung Cancer MTT/MTS assay IC50= 25.20 µM 72-h Lung None None CHHHHTTTCCC
3743 22644847 2012 FLGWLFKWAKK GA-K3 11 Linear L None Free Free Anticancer and Antimicrobial Brevinin-1EMa HCT-116 Colon Cancer MTT/MTS assay IC50= 27.00 µM 72-h Colon None None CHHHHTTTCCC
3744 22644847 2012 FLGWLFKWAKK GA-K3 11 Linear L None Free Free Anticancer and Antimicrobial Brevinin-1EMa MKN-45 Gastric Cancer MTT/MTS assay IC50= 26.70 µM 72-h Stomach None None CHHHHTTTCCC
3745 22644847 2012 FLGWLFKWAKK GA-K3 11 Linear L None Free Free Anticancer and Antimicrobial Brevinin-1EMa PC-3 Prostate Cancer MTT/MTS assay IC50= 47.69 µM 72-h Prostate None None CHHHHTTTCCC
3746 22644847 2012 FLGWLFKWAKK GA-K3 11 Linear L None Free Free Anticancer and Antimicrobial Brevinin-1EMa SK-MEL-2 Skin Cancer MTT/MTS assay IC50= 27.39 µM 72-h Skin None None CHHHHTTTCCC
1716 None 2011 FLKWLFKWAKK Gaegurin peptides SEQID NO: 2 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa SK-MEL-2 Skin Cancer MTT/MTS assay IC50 = 22.25 mM 24-h Skin 14739294 US_008076284_B2 CHHHHHHHHCC
1717 None 2011 FLKWLFKWAKK Gaegurin peptides SEQID NO: 2 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa A-549 Lung Cancer MTT/MTS assay IC50 = 14.53 mM 24-h Lung 14739294 US_008076284_B2 CHHHHHHHHCC
1718 None 2011 FLKWLFKWAKK Gaegurin peptides SEQID NO: 2 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa SK-OV-3 Ovarian Cancer MTT/MTS assay IC50 = 12.55 mM 24-h Ovary 14739294 US_008076284_B2 CHHHHHHHHCC
1719 None 2011 FLKWLFKWAKK Gaegurin peptides SEQID NO: 2 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa MKN-45 Gastric Cancer MTT/MTS assay IC50 = 22.51 mM 24-h Stomach 14739294 US_008076284_B2 CHHHHHHHHCC
1720 None 2011 FLKWLFKWAKK Gaegurin peptides SEQID NO: 2 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa PC-3 Prostate Cancer MTT/MTS assay IC50 = 29.1 mM 24-h Prostate 14739294 US_008076284_B2 CHHHHHHHHCC
1721 None 2011 FLKWLFKWAKK Gaegurin peptides SEQID NO: 2 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa A-498 Renal Cancer MTT/MTS assay IC50 = 21.48 mM 24-h Renal 14739294 US_008076284_B2 CHHHHHHHHCC
1735 None 2011 FLKWLFKWAKK Gaegurin peptides SEQID NO: 2 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa HCTl-16 Colon Cancer MTT/MTS assay IC50 = 14.8 mM 24-h Colon 14739294 US_008076284_B2 CHHHHHHHHCC
1739 None 2011 FLKWLFKWAKK Gaegurin peptides SEQID NO: 2 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa NCI-H630 Colon Cancer MTT/MTS assay Not Available 24-h Colon 14739294 US_008076284_B2 CHHHHHHHHCC
1749 None 2011 FLKWLFKWAKK Gaegurin peptides SEQID NO: 2 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa A-498 Renal Cancer MTT/MTS assay IC50 = 21.48 mM 24-h Renal 14739294 WO_2007133033_A1 CHHHHHHHHCC
1750 None 2011 FLKWLFKWAKK Gaegurin peptides SEQID NO: 2 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa A-549 Lung Cancer MTT/MTS assay IC50 = 14.53 mM 24-h Lung 14739294 WO_2007133033_A1 CHHHHHHHHCC
1751 None 2011 FLKWLFKWAKK Gaegurin peptides SEQID NO: 2 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa HCTl-16 Colon Cancer MTT/MTS assay IC50 = 14.8 mM 24-h Colon 14739294 WO_2007133033_A1 CHHHHHHHHCC
1752 None 2011 FLKWLFKWAKK Gaegurin peptides SEQID NO: 2 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa MKN-45 Gastric Cancer MTT/MTS assay IC50 = 22.51 mM 24-h Stomach 14739294 WO_2007133033_A1 CHHHHHHHHCC
1753 None 2011 FLKWLFKWAKK Gaegurin peptides SEQID NO: 2 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa NCI-H630 Colon Cancer MTT/MTS assay Not Available 24-h Colon 14739294 WO_2007133033_A1 CHHHHHHHHCC
1754 None 2011 FLKWLFKWAKK Gaegurin peptides SEQID NO: 2 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa PC-3 Prostate Cancer MTT/MTS assay IC50 = 29.1 mM 24-h Prostate 14739294 WO_2007133033_A1 CHHHHHHHHCC
1755 None 2011 FLKWLFKWAKK Gaegurin peptides SEQID NO: 2 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa SK-MEL-2 Skin Cancer MTT/MTS assay IC50 = 22.25 mM 24-h Skin 14739294 WO_2007133033_A1 CHHHHHHHHCC
1756 None 2011 FLKWLFKWAKK Gaegurin peptides SEQID NO: 2 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa SK-OV-3 Ovarian Cancer MTT/MTS assay IC50 = 12.55 mM 24-h Ovary 14739294 WO_2007133033_A1 CHHHHHHHHCC
3247 22644847 2012 FLKWLFKWAKK GA-K4 11 Linear L None Amidation Free Antimicrobial Undecapeptide analogues derived from Brevinin-1EMa A-498 Renal Cancer MTT/MTS assay IC50 =21.48 µM 72-h Renal None None CHHHHGGGSCC
3248 22644847 2012 FLKWLFKWAKK GA-K4 11 Linear L None Amidation Free Antimicrobial Undecapeptide analogues derived from Brevinin-1EMa A-549 Lung Cancer MTT/MTS assay IC50 =14.53 µM 72-h Lung None None CHHHHGGGSCC
3249 22644847 2012 FLKWLFKWAKK GA-K4 11 Linear L None Amidation Free Antimicrobial Undecapeptide analogues derived from Brevinin-1EMa HCT-116 Colon Cancer MTT/MTS assay IC50 =14.80 µM 72-h Colon None None CHHHHGGGSCC
3250 22644847 2012 FLKWLFKWAKK GA-K4 11 Linear L None Amidation Free Antimicrobial Undecapeptide analogues derived from Brevinin-1EMa MKN-45 Gastric Cancer MTT/MTS assay IC50 =22.51 µM 72-h Stomach None None CHHHHGGGSCC
3251 22644847 2012 FLKWLFKWAKK GA-K4 11 Linear L None Amidation Free Antimicrobial Undecapeptide analogues derived from Brevinin-1EMa PC-3 Prostate Cancer MTT/MTS assay IC50 =29.10 µM 72-h Prostate None None CHHHHGGGSCC
3252 22644847 2012 FLKWLFKWAKK GA-K4 11 Linear L None Amidation Free Antimicrobial Undecapeptide analogues derived from Brevinin-1EMa SK-MEL-2 Skin Cancer MTT/MTS assay IC50 =22.25 µM 72-h Skin None None CHHHHGGGSCC
3253 22644847 2012 FLKWLFKWAKK GA-K4 11 Linear L None Amidation Free Antimicrobial Undecapeptide analogues derived from Brevinin-1EMa SK-OV-3 Ovarian Cancer MTT/MTS assay IC50 =12.55 µM 72-h Ovary None None CHHHHGGGSCC
3747 22644847 2012 FLKWLFKWAKK GA-K3 11 Linear L None Free Free Anticancer and Antimicrobial Brevinin-1EMa SK-OV-3 Ovarian Cancer MTT/MTS assay IC50= 24.76 µM 72-h Ovary None None CHHHHHHHHCC
3748 22644847 2012 FLKWLFKWAKK GA-K4 11 Linear L None Free Free Anticancer and Antimicrobial Brevinin-1EMa A-498 Renal Cancer MTT/MTS assay IC50= 21.48 µM 72-h Renal None None CHHHHHHHHCC
3749 22644847 2012 FLKWLFKWAKK GA-K4 11 Linear L None Free Free Anticancer and Antimicrobial Brevinin-1EMa A-549 Lung Cancer MTT/MTS assay IC50= 14.53 µM 72-h Lung None None CHHHHHHHHCC
3750 22644847 2012 FLKWLFKWAKK GA-K4 11 Linear L None Free Free Anticancer and Antimicrobial Brevinin-1EMa HCT-116 Colon Cancer MTT/MTS assay IC50= 14.8 µM 72-h Colon None None CHHHHHHHHCC
3751 22644847 2012 FLKWLFKWAKK GA-K4 11 Linear L None Free Free Anticancer and Antimicrobial Brevinin-1EMa MKN-45 Gastric Cancer MTT/MTS assay IC50= 22.51 µM 72-h Stomach None None CHHHHHHHHCC
3752 22644847 2012 FLKWLFKWAKK GA-K4 11 Linear L None Free Free Anticancer and Antimicrobial Brevinin-1EMa PC-3 Prostate Cancer MTT/MTS assay IC50= 29.10 µM 72-h Prostate None None CHHHHHHHHCC
3753 22644847 2012 FLKWLFKWAKK GA-K4 11 Linear L None Free Free Anticancer and Antimicrobial Brevinin-1EMa SK-MEL-2 Skin Cancer MTT/MTS assay IC50= 22.25 µM 72-h Skin None None CHHHHHHHHCC
3754 22644847 2012 FLKWLFKWAKK GA-K4 11 Linear L None Free Free Anticancer and Antimicrobial Brevinin-1EMa SK-OV-3 Ovarian Cancer MTT/MTS assay IC50= 12.55 µM 72-h Ovary None None CHHHHHHHHCC
1722 None 2011 FLGWLFKWAWK Gaegurin peptides SEQID NO: 3 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa SK-MEL-2 Skin Cancer MTT/MTS assay IC50 = 13.97 mM 24-h Skin 14739294 US_008076284_B2 CCCSSSCCCCC
1723 None 2011 FLGWLFKWAWK Gaegurin peptides SEQID NO: 3 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa A-549 Lung Cancer MTT/MTS assay IC50 = 20.36 mM 24-h Lung 14739294 US_008076284_B2 CCCSSSCCCCC
1724 None 2011 FLGWLFKWAWK Gaegurin peptides SEQID NO: 3 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa SK-OV-3 Ovarian Cancer MTT/MTS assay IC50 = 22.06 mM 24-h Ovary 14739294 US_008076284_B2 CCCSSSCCCCC
1725 None 2011 FLGWLFKWAWK Gaegurin peptides SEQID NO: 3 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa MKN-45 Gastric Cancer MTT/MTS assay IC50 = 24.31 mM 24-h Stomach 14739294 US_008076284_B2 CCCSSSCCCCC
1726 None 2011 FLGWLFKWAWK Gaegurin peptides SEQID NO: 3 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa PC-3 Prostate Cancer MTT/MTS assay IC50 = 46.51 mM 24-h Prostate 14739294 US_008076284_B2 CCCSSSCCCCC
1727 None 2011 FLGWLFKWAWK Gaegurin peptides SEQID NO: 3 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa A-498 Renal Cancer MTT/MTS assay Not Available 24-h Renal 14739294 US_008076284_B2 CCCSSSCCCCC
1736 None 2011 FLGWLFKWAWK Gaegurin peptides SEQID NO: 3 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa HCTl-16 Colon Cancer MTT/MTS assay IC50 = 24.63 mM 24-h Colon 14739294 US_008076284_B2 CCCSSSCCCCC
1740 None 2011 FLGWLFKWAWK Gaegurin peptides SEQID NO: 3 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa NCI-H630 Colon Cancer MTT/MTS assay IC50 = 48 mM 24-h Colon 14739294 US_008076284_B2 CCCSSSCCCCC
1757 None 2011 FLGWLFKWAWK Gaegurin peptides SEQID NO: 3 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa A-498 Renal Cancer MTT/MTS assay Not Available 24-h Renal 14739294 WO_2007133033_A1 CCCSSSCCCCC
1758 None 2011 FLGWLFKWAWK Gaegurin peptides SEQID NO: 3 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa A-549 Lung Cancer MTT/MTS assay IC50 = 20.36 mM 24-h Lung 14739294 WO_2007133033_A1 CCCSSSCCCCC
1759 None 2011 FLGWLFKWAWK Gaegurin peptides SEQID NO: 3 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa HCTl-16 Colon Cancer MTT/MTS assay IC50 = 24.63 mM 24-h Colon 14739294 WO_2007133033_A1 CCCSSSCCCCC
1760 None 2011 FLGWLFKWAWK Gaegurin peptides SEQID NO: 3 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa MKN-45 Gastric Cancer MTT/MTS assay IC50 = 22.31 mM 24-h Stomach 14739294 WO_2007133033_A1 CCCSSSCCCCC
1761 None 2011 FLGWLFKWAWK Gaegurin peptides SEQID NO: 3 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa NCI-H630 Colon Cancer MTT/MTS assay IC50 = 48 mM 24-h Colon 14739294 WO_2007133033_A1 CCCSSSCCCCC
1762 None 2011 FLGWLFKWAWK Gaegurin peptides SEQID NO: 3 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa PC-3 Prostate Cancer MTT/MTS assay IC50 = 46.51 mM 24-h Prostate 14739294 WO_2007133033_A1 CCCSSSCCCCC
1763 None 2011 FLGWLFKWAWK Gaegurin peptides SEQID NO: 3 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa SK-MEL-2 Skin Cancer MTT/MTS assay IC50 = 13.97 mM 24-h Skin 14739294 WO_2007133033_A1 CCCSSSCCCCC
1764 None 2011 FLGWLFKWAWK Gaegurin peptides SEQID NO: 3 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa SK-OV-3 Ovarian Cancer MTT/MTS assay IC50 = 22.06 mM 24-h Ovary 14739294 WO_2007133033_A1 CCCSSSCCCCC
3226 22644847 2012 FLGWLFKWAWK GA-W3 11 Linear L None Amidation Free Antimicrobial Undecapeptide analogues derived from Brevinin-1EMa A-498 Renal Cancer MTT/MTS assay IC50 =22.88 µM 72-h Renal None None CCCSSSCCCCC
3227 22644847 2012 FLGWLFKWAWK GA-W3 11 Linear L None Amidation Free Antimicrobial Undecapeptide analogues derived from Brevinin-1EMa A-549 Lung Cancer MTT/MTS assay IC50 =20.36 µM 72-h Lung None None CCCSSSCCCCC
3228 22644847 2012 FLGWLFKWAWK GA-W3 11 Linear L None Amidation Free Antimicrobial Undecapeptide analogues derived from Brevinin-1EMa HCT-116 Colon Cancer MTT/MTS assay IC50 =24.63 µM 72-h Colon None None CCCSSSCCCCC
3229 22644847 2012 FLGWLFKWAWK GA-W3 11 Linear L None Amidation Free Antimicrobial Undecapeptide analogues derived from Brevinin-1EMa MKN-45 Gastric Cancer MTT/MTS assay IC50 =24.31 µM 72-h Stomach None None CCCSSSCCCCC
3230 22644847 2012 FLGWLFKWAWK GA-W3 11 Linear L None Amidation Free Antimicrobial Undecapeptide analogues derived from Brevinin-1EMa PC-3 Prostate Cancer MTT/MTS assay IC50 =46.51 µM 72-h Prostate None None CCCSSSCCCCC
3231 22644847 2012 FLGWLFKWAWK GA-W3 11 Linear L None Amidation Free Antimicrobial Undecapeptide analogues derived from Brevinin-1EMa SK-MEL-2 Skin Cancer MTT/MTS assay IC50 =13.97 µM 72-h Skin None None CCCSSSCCCCC
3232 22644847 2012 FLGWLFKWAWK GA-W3 11 Linear L None Amidation Free Antimicrobial Undecapeptide analogues derived from Brevinin-1EMa SK-OV-3 Ovarian Cancer MTT/MTS assay IC50 =22.06 µM 72-h Ovary None None CCCSSSCCCCC
3727 22644847 2012 FLGWLFKWAWK GA-W3 11 Linear L None Free Free Anticancer and Antimicrobial Brevinin-1EMa A-498 Renal Cancer MTT/MTS assay IC50= 22.88 µM 72-h Renal None None CCCSSSCCCCC
3728 22644847 2012 FLGWLFKWAWK GA-W3 11 Linear L None Free Free Anticancer and Antimicrobial Brevinin-1EMa A-549 Lung Cancer MTT/MTS assay IC50= 20.36 µM 72-h Lung None None CCCSSSCCCCC
3729 22644847 2012 FLGWLFKWAWK GA-W3 11 Linear L None Free Free Anticancer and Antimicrobial Brevinin-1EMa HCT-116 Colon Cancer MTT/MTS assay IC50= 24.63 µM 72-h Colon None None CCCSSSCCCCC
3730 22644847 2012 FLGWLFKWAWK GA-W3 11 Linear L None Free Free Anticancer and Antimicrobial Brevinin-1EMa MKN-45 Gastric Cancer MTT/MTS assay IC50= 24.31 µM 72-h Stomach None None CCCSSSCCCCC
3731 22644847 2012 FLGWLFKWAWK GA-W3 11 Linear L None Free Free Anticancer and Antimicrobial Brevinin-1EMa PC-3 Prostate Cancer MTT/MTS assay IC50= 46.51 µM 72-h Prostate None None CCCSSSCCCCC
3732 22644847 2012 FLGWLFKWAWK GA-W3 11 Linear L None Free Free Anticancer and Antimicrobial Brevinin-1EMa SK-MEL-2 Skin Cancer MTT/MTS assay IC50= 13.97 µM 72-h Skin None None CCCSSSCCCCC
3733 22644847 2012 FLGWLFKWAWK GA-W3 11 Linear L None Free Free Anticancer and Antimicrobial Brevinin-1EMa SK-OV-3 Ovarian Cancer MTT/MTS assay IC50= 22.06 µM 72-h Ovary None None CCCSSSCCCCC
1728 None 2011 FLWWLFKWAWK Gaegurin peptides SEQID NO: 4 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa SK-MEL-2 Skin Cancer MTT/MTS assay IC50 = 13.16 mM 24-h Skin 14739294 US_008076284_B2 CHHHHCCSSCC
1729 None 2011 FLWWLFKWAWK Gaegurin peptides SEQID NO: 4 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa A-549 Lung Cancer MTT/MTS assay IC50 = 14.8 mM 24-h Lung 14739294 US_008076284_B2 CHHHHCCSSCC
1730 None 2011 FLWWLFKWAWK Gaegurin peptides SEQID NO: 4 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa SK-OV-3 Ovarian Cancer MTT/MTS assay IC50 = 14.58 mM 24-h Ovary 14739294 US_008076284_B2 CHHHHCCSSCC
1731 None 2011 FLWWLFKWAWK Gaegurin peptides SEQID NO: 4 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa MKN-45 Gastric Cancer MTT/MTS assay IC50 = 13.77 mM 24-h Stomach 14739294 US_008076284_B2 CHHHHCCSSCC
1732 None 2011 FLWWLFKWAWK Gaegurin peptides SEQID NO: 4 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa PC-3 Prostate Cancer MTT/MTS assay IC50 = 24.32 mM 24-h Prostate 14739294 US_008076284_B2 CHHHHCCSSCC
1733 None 2011 FLWWLFKWAWK Gaegurin peptides SEQID NO: 4 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa A-498 Renal Cancer MTT/MTS assay Not Available 24-h Renal 14739294 US_008076284_B2 CHHHHCCSSCC
1737 None 2011 FLWWLFKWAWK Gaegurin peptides SEQID NO: 4 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa HCTl-16 Colon Cancer MTT/MTS assay IC50 = 14.8 mM 24-h Colon 14739294 US_008076284_B2 CHHHHCCSSCC
1741 None 2011 FLWWLFKWAWK Gaegurin peptides SEQID NO: 4 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa NCI-H630 Colon Cancer MTT/MTS assay IC50 = 57 mM 24-h Colon 14739294 US_008076284_B2 CHHHHCCSSCC
1765 None 2011 FLWWLFKWAWK Gaegurin peptides SEQID NO: 4 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa A-498 Renal Cancer MTT/MTS assay Not Available 24-h Renal 14739294 WO_2007133033_A1 CHHHHCCSSCC
1766 None 2011 FLWWLFKWAWK Gaegurin peptides SEQID NO: 4 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa A-549 Lung Cancer MTT/MTS assay IC50 = 15.88 mM 24-h Lung 14739294 WO_2007133033_A1 CHHHHCCSSCC
1767 None 2011 FLWWLFKWAWK Gaegurin peptides SEQID NO: 4 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa HCTl-16 Colon Cancer MTT/MTS assay IC50 = 14.8 mM 24-h Colon 14739294 WO_2007133033_A1 CHHHHCCSSCC
1768 None 2011 FLWWLFKWAWK Gaegurin peptides SEQID NO: 4 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa MKN-45 Gastric Cancer MTT/MTS assay IC50 = 13.77 mM 24-h Stomach 14739294 WO_2007133033_A1 CHHHHCCSSCC
1769 None 2011 FLWWLFKWAWK Gaegurin peptides SEQID NO: 4 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa NCI-H630 Colon Cancer MTT/MTS assay IC50 = 57 mM 24-h Colon 14739294 WO_2007133033_A1 CHHHHCCSSCC
1770 None 2011 FLWWLFKWAWK Gaegurin peptides SEQID NO: 4 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa PC-3 Prostate Cancer MTT/MTS assay IC50 = 24.32 mM 24-h Prostate 14739294 WO_2007133033_A1 CHHHHCCSSCC
1771 None 2011 FLWWLFKWAWK Gaegurin peptides SEQID NO: 4 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa SK-MEL-2 Skin Cancer MTT/MTS assay IC50 = 13.16 mM 24-h Skin 14739294 WO_2007133033_A1 CHHHHCCSSCC
1772 None 2011 FLWWLFKWAWK Gaegurin peptides SEQID NO: 4 11 Linear L None Free Free Antimicrobial Korean frog Rana rugosa SK-OV-3 Ovarian Cancer MTT/MTS assay IC50 = 14.58 mM 24-h Ovary 14739294 WO_2007133033_A1 CHHHHCCSSCC
3233 22644847 2012 FLWWLFKWAWK GA-W4 11 Linear L None Amidation Free Antimicrobial Undecapeptide analogues derived from Brevinin-1EMa A-498 Renal Cancer MTT/MTS assay IC50 =22.59 µM 72-h Renal None None CHHHHCSSSCC
3234 22644847 2012 FLWWLFKWAWK GA-W4 11 Linear L None Amidation Free Antimicrobial Undecapeptide analogues derived from Brevinin-1EMa A-549 Lung Cancer MTT/MTS assay IC50 =15.88 µM 72-h Lung None None CHHHHCSSSCC
3235 22644847 2012 FLWWLFKWAWK GA-W4 11 Linear L None Amidation Free Antimicrobial Undecapeptide analogues derived from Brevinin-1EMa HCT-116 Colon Cancer MTT/MTS assay IC50 =14.80 µM 72-h Colon None None CHHHHCSSSCC
3236 22644847 2012 FLWWLFKWAWK GA-W4 11 Linear L None Amidation Free Antimicrobial Undecapeptide analogues derived from Brevinin-1EMa MKN-45 Gastric Cancer MTT/MTS assay IC50 =13.77 µM 72-h Stomach None None CHHHHCSSSCC
3237 22644847 2012 FLWWLFKWAWK GA-W4 11 Linear L None Amidation Free Antimicrobial Undecapeptide analogues derived from Brevinin-1EMa PC-3 Prostate Cancer MTT/MTS assay IC50 =24.32 µM 72-h Prostate None None CHHHHCSSSCC
3238 22644847 2012 FLWWLFKWAWK GA-W4 11 Linear L None Amidation Free Antimicrobial Undecapeptide analogues derived from Brevinin-1EMa SK-MEL-2 Skin Cancer MTT/MTS assay IC50 =13.16 µM 72-h Skin None None CHHHHCSSSCC
3239 22644847 2012 FLWWLFKWAWK GA-W4 11 Linear L None Amidation Free Antimicrobial Undecapeptide analogues derived from Brevinin-1EMa SK-OV-3 Ovarian Cancer MTT/MTS assay IC50 =14.58 µM 72-h Ovary None None CHHHHCSSSCC
3734 22644847 2012 FLWWLFKWAWK GA-W4 11 Linear L None Free Free Anticancer and Antimicrobial Brevinin-1EMa A-498 Renal Cancer MTT/MTS assay IC50= 22.59 µM 72-h Renal None None CHHHHCCSSCC
3735 22644847 2012 FLWWLFKWAWK GA-W4 11 Linear L None Free Free Anticancer and Antimicrobial Brevinin-1EMa A-549 Lung Cancer MTT/MTS assay IC50= 15.88 µM 72-h Lung None None CHHHHCCSSCC
3736 22644847 2012 FLWWLFKWAWK GA-W4 11 Linear L None Free Free Anticancer and Antimicrobial Brevinin-1EMa HCT-116 Colon Cancer MTT/MTS assay IC50= 14.80 µM 72-h Colon None None CHHHHCCSSCC
3737 22644847 2012 FLWWLFKWAWK GA-W4 11 Linear L None Free Free Anticancer and Antimicrobial Brevinin-1EMa MKN-45 Gastric Cancer MTT/MTS assay IC50= 13.77 µM 72-h Stomach None None CHHHHCCSSCC
3738 22644847 2012 FLWWLFKWAWK GA-W4 11 Linear L None Free Free Anticancer and Antimicrobial Brevinin-1EMa PC-3 Prostate Cancer MTT/MTS assay IC50= 24.32 µM 72-h Prostate None None CHHHHCCSSCC
3739 22644847 2012 FLWWLFKWAWK GA-W4 11 Linear L None Free Free Anticancer and Antimicrobial Brevinin-1EMa SK-MEL-2 Skin Cancer MTT/MTS assay IC50= 13.16 µM 72-h Skin None None CHHHHCCSSCC
3740 22644847 2012 FLWWLFKWAWK GA-W4 11 Linear L None Free Free Anticancer and Antimicrobial Brevinin-1EMa SK-OV-3 Ovarian Cancer MTT/MTS assay IC50= 14.58 µM 72-h Ovary None None CHHHHCCSSCC
1773 None 2005 FALALKALKKALKKLKKALKKAL Hecate Ac 23 Linear L None Free Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =54 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHGGGTTTHHHHHGGGTC
1774 None 2005 FALALKALKKALKKLKKALKKAL Hecate AM 23 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =23 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHTTHHHHHHTTTC
1789 None 2005 FALALKALKKALkkLKKALKKAL HECATE 2DAc 23 Linear Mix None Free Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =14 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHSSCGGGGTCTTTC
1925 None 2005 FALALKALKKALKKLKKALKKAL Hecate AC 23 Linear L None Free Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =6 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHGGGTTTHHHHHGGGTC
1926 None 2005 FALALKALKKALKKLKKALKKAL Hecate AM 23 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =46 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHHTTHHHHHHTTTC
1941 None 2005 FALALKALKKALkkLKKALKKAL HECATE 2DAc 23 Linear Mix None Free Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =57 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHSSCGGGGTCTTTC
2077 None 2005 FALALKALKKALKKLKKALKKAL Hecate AC 23 Linear L None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =72 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHGGGTTTHHHHHGGGTC
2078 None 2005 FALALKALKKALKKLKKALKKAL Hecate AM 23 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =128 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHTTHHHHHHTTTC
2093 None 2005 FALALKALKKALkkLKKALKKAL HECATE 2DAc 23 Linear Mix None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =150 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHSSCGGGGTCTTTC
2229 None 2005 FALALKALKKALKKLKKALKKAL Hecate AC 23 Linear L None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =72 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHGGGTTTHHHHHGGGTC
2230 None 2005 FALALKALKKALKKLKKALKKAL Hecate AM 23 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =128 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHTTHHHHHHTTTC
2245 None 2005 FALALKALKKALkkLKKALKKAL HECATE 2DAc 23 Linear Mix None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =150 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHSSCGGGGTCTTTC
2381 None 2005 FALALKALKKALKKLKKALKKAL Hecate AC 23 Linear L None Free Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =44 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHGGGTTTHHHHHGGGTC
2382 None 2005 FALALKALKKALKKLKKALKKAL Hecate AM 23 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =140 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHHTTHHHHHHTTTC
2397 None 2005 FALALKALKKALkkLKKALKKAL HECATE 2DAc 23 Linear Mix None Free Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =150 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHSSCGGGGTCTTTC
2524 None 2005 FALALKALKKALKKLKKALKKAL Hecate AC 23 Linear L None Free Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =61 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHGGGTTTHHHHHGGGTC
2525 None 2005 FALALKALKKALKKLKKALKKAL Hecate AM 23 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =44 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHHTTHHHHHHTTTC
2540 None 2005 FALALKALKKALkkLKKALKKAL HECATE 2DAc 23 Linear Mix None Free Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =64 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHSSCGGGGTCTTTC
2667 None 2005 FALALKALKKALKKLKKALKKAL Hecate AC 23 Linear L None Free Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =95 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHGGGTTTHHHHHGGGTC
2668 None 2005 FALALKALKKALKKLKKALKKAL Hecate AM 23 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =50 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHHTTHHHHHHTTTC
2683 None 2005 FALALKALKKALkkLKKALKKAL HECATE 2DAc 23 Linear Mix None Free Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay Not Available 24-h Cervix None US_06875744_B2 CHHHHHHHHHSSCGGGGTCTTTC
1775 None 2005 MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG SB-37 AC 38 Linear L None Free Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =175 µg/ml 24-h Breast None US_06875744_B2 CCCCCTTHHHHTTCCSTTTSCSSSSSTTSSCTTCTTCC
1776 None 2005 MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG SB-37 AM 38 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =540 µg/ml 24-h Breast None US_06875744_B2 CCCCCGGGGTTTGGGSSCSSSSCCSSSSCCCCCCSCCC
1927 None 2005 MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG SB-37 AC 38 Linear L None Free Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =82 µg/ml 24-h Colon None US_06875744_B2 CCCCCTTHHHHTTCCSTTTSCSSSSSTTSSCTTCTTCC
1928 None 2005 MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG SB-37 AM 38 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CCCCCGGGGTTTGGGSSCSSSSCCSSSSCCCCCCSCCC
2079 None 2005 MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG SB-37 AC 38 Linear L None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =120 µg/ml 24-h Skin None US_06875744_B2 CCCCCTTHHHHTTCCSTTTSCSSSSSTTSSCTTCTTCC
2080 None 2005 MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG SB-37 AM 38 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CCCCCGGGGTTTGGGSSCSSSSCCSSSSCCCCCCSCCC
2231 None 2005 MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG SB-37 AC 38 Linear L None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =120 µg/ml 24-h Skin None US_06875744_B2 CCCCCTTHHHHTTCCSTTTSCSSSSSTTSSCTTCTTCC
2232 None 2005 MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG SB-37 AM 38 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CCCCCGGGGTTTGGGSSCSSSSCCSSSSCCCCCCSCCC
2383 None 2005 MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG SB-37 AC 38 Linear L None Free Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =220 µg/ml 24-h Lung None US_06875744_B2 CCCCCTTHHHHTTCCSTTTSCSSSSSTTSSCTTCTTCC
2384 None 2005 MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG SB-37 AM 38 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =720 µg/ml 24-h Lung None US_06875744_B2 CCCCCGGGGTTTGGGSSCSSSSCCSSSSCCCCCCSCCC
2526 None 2005 MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG SB-37 AC 38 Linear L None Free Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay Not Available 24-h Prostate None US_06875744_B2 CCCCCTTHHHHTTCCSTTTSCSSSSSTTSSCTTCTTCC
2527 None 2005 MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG SB-37 AM 38 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =630 µg/ml 24-h Prostate None US_06875744_B2 CCCCCGGGGTTTGGGSSCSSSSCCSSSSCCCCCCSCCC
2669 None 2005 MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG SB-37 AC 38 Linear L None Free Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =150 µg/ml 24-h Cervix None US_06875744_B2 CCCCCTTHHHHTTCCSTTTSCSSSSSTTSSCTTCTTCC
2670 None 2005 MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG SB-37 AM 38 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Cervix None US_06875744_B2 CCCCCGGGGTTTGGGSSCSSSSCCSSSSCCCCCCSCCC
1777 None 2005 FAKKLAKKLKKLAKKLAKLALAL SHIVA 10 AC 23 Linear L None Free Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHHHHHHTTTTTTC
1929 None 2005 FAKKLAKKLKKLAKKLAKLALAL SHIVA 10 AC 23 Linear L None Free Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay Not Available 24-h Colon None US_06875744_B2 CHHHHHHHHHHHHHHHTTTTTTC
2081 None 2005 FAKKLAKKLKKLAKKLAKLALAL SHIVA 10 AC 23 Linear L None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay Not Available 24-h Skin None US_06875744_B2 CHHHHHHHHHHHHHHHTTTTTTC
2233 None 2005 FAKKLAKKLKKLAKKLAKLALAL SHIVA 10 AC 23 Linear L None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay Not Available 24-h Skin None US_06875744_B2 CHHHHHHHHHHHHHHHTTTTTTC
2385 None 2005 FAKKLAKKLKKLAKKLAKLALAL SHIVA 10 AC 23 Linear L None Free Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHHHHHHHTTTTTTC
2528 None 2005 FAKKLAKKLKKLAKKLAKLALAL SHIVA 10 AC 23 Linear L None Free Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =83 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHHHHHHHTTTTTTC
2671 None 2005 FAKKLAKKLKKLAKKLAKLALAL SHIVA 10 AC 23 Linear L None Free Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHHHHHHHTTTTTTC
1778 None 2005 FALAAKALKKLAKKLKKLAKKAL FLAK01 AM 23 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =62 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHHHHHHHHHTTTC
1930 None 2005 FALAAKALKKLAKKLKKLAKKAL FLAK01 AM 23 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =5 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHHHHHHHHHHTTTC
2082 None 2005 FALAAKALKKLAKKLKKLAKKAL FLAK01 AM 23 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =27 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHHHHHHHHTTTC
2234 None 2005 FALAAKALKKLAKKLKKLAKKAL FLAK01 AM 23 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =27 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHHHHHHHHTTTC
2386 None 2005 FALAAKALKKLAKKLKKLAKKAL FLAK01 AM 23 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =64 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHHHHHHHHHHTTTC
2529 None 2005 FALAAKALKKLAKKLKKLAKKAL FLAK01 AM 23 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =41 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHHHHHHHHHHTTTC
2672 None 2005 FALAAKALKKLAKKLKKLAKKAL FLAK01 AM 23 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =82 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHHHHHHHHHHTTTC
1779 None 2005 FALALKALKKLLKKLKKLAKKAL FLAK03 AM 23 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =26 µg/ml 24-h Breast None US_06875744_B2 CHHHHTTHHHHHHHHHHHHHHHC
1931 None 2005 FALALKALKKLLKKLKKLAKKAL FLAK03 AM 23 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =38 µg/ml 24-h Colon None US_06875744_B2 CHHHHTTHHHHHHHHHHHHHHHC
2083 None 2005 FALALKALKKLLKKLKKLAKKAL FLAK03 AM 23 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =85 µg/ml 24-h Skin None US_06875744_B2 CHHHHTTHHHHHHHHHHHHHHHC
2235 None 2005 FALALKALKKLLKKLKKLAKKAL FLAK03 AM 23 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =85 µg/ml 24-h Skin None US_06875744_B2 CHHHHTTHHHHHHHHHHHHHHHC
2387 None 2005 FALALKALKKLLKKLKKLAKKAL FLAK03 AM 23 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =72 µg/ml 24-h Lung None US_06875744_B2 CHHHHTTHHHHHHHHHHHHHHHC
2530 None 2005 FALALKALKKLLKKLKKLAKKAL FLAK03 AM 23 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =38 µg/ml 24-h Prostate None US_06875744_B2 CHHHHTTHHHHHHHHHHHHHHHC
2673 None 2005 FALALKALKKLLKKLKKLAKKAL FLAK03 AM 23 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =145 µg/ml 24-h Cervix None US_06875744_B2 CHHHHTTHHHHHHHHHHHHHHHC
1780 None 2005 FALALKALKKLAKKLKKLAKKAL FLAK04 AM 23 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =10 µg/ml 24-h Breast None US_06875744_B2 CHHHHHTTHHHHHHHHHHGGGTC
1932 None 2005 FALALKALKKLAKKLKKLAKKAL FLAK04 AM 23 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =12 µg/ml 24-h Colon None US_06875744_B2 CHHHHHTTHHHHHHHHHHGGGTC
2075 None 2005 FALALKALKKLAKKLKKLAKKAL FLAK04 AM V 23 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay Not Available 24-h Colon None US_06875744_B2 CHHHHHTTHHHHHHHHHHGGGTC
2084 None 2005 FALALKALKKLAKKLKKLAKKAL FLAK04 AM 23 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =36 µg/ml 24-h Skin None US_06875744_B2 CHHHHHTTHHHHHHHHHHGGGTC
2227 None 2005 FALALKALKKLAKKLKKLAKKAL FLAK04 AM V 23 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay Not Available 24-h Skin None US_06875744_B2 CHHHHHTTHHHHHHHHHHGGGTC
2236 None 2005 FALALKALKKLAKKLKKLAKKAL FLAK04 AM 23 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =36 µg/ml 24-h Skin None US_06875744_B2 CHHHHHTTHHHHHHHHHHGGGTC
2388 None 2005 FALALKALKKLAKKLKKLAKKAL FLAK04 AM 23 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =37 µg/ml 24-h Lung None US_06875744_B2 CHHHHHTTHHHHHHHHHHGGGTC
2531 None 2005 FALALKALKKLAKKLKKLAKKAL FLAK04 AM 23 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =12 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHTTHHHHHHHHHHGGGTC
2674 None 2005 FALALKALKKLAKKLKKLAKKAL FLAK04 AM 23 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =20 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHTTHHHHHHHHHHGGGTC
1781 None 2005 FALAKLAKKAKAKLKKALKAL FLAK05 AM 21 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =74 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHHTHHHHTTCC
1933 None 2005 FALAKLAKKAKAKLKKALKAL FLAK05 AM 21 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =8 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHHHTHHHHTTCC
2085 None 2005 FALAKLAKKAKAKLKKALKAL FLAK05 AM 21 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =94 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHTHHHHTTCC
2237 None 2005 FALAKLAKKAKAKLKKALKAL FLAK05 AM 21 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =94 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHTHHHHTTCC
2389 None 2005 FALAKLAKKAKAKLKKALKAL FLAK05 AM 21 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =84 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHHHTHHHHTTCC
2532 None 2005 FALAKLAKKAKAKLKKALKAL FLAK05 AM 21 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =125 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHHHTHHHHTTCC
2675 None 2005 FALAKLAKKAKAKLKKALKAL FLAK05 AM 21 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =150 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHHHTHHHHTTCC
1782 None 2005 FALALKALKKLKKALKKAL FLAK06 AM 19 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =14 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHHHHHTTTC
1783 None 2005 FALALKALKKLKKALKKAL FLAK06 AC 19 Linear L None Free Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =65 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHHHHHTTTC
1934 None 2005 FALALKALKKLKKALKKAL FLAK06 AM 19 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =26 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHHHHHHTTTC
1935 None 2005 FALALKALKKLKKALKKAL FLAK06 AC 19 Linear L None Free Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =59 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHHHHHHTTTC
2086 None 2005 FALALKALKKLKKALKKAL FLAK06 AM 19 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =44 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHHHHTTTC
2087 None 2005 FALALKALKKLKKALKKAL FLAK06 AC 19 Linear L None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =93 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHHHHTTTC
2238 None 2005 FALALKALKKLKKALKKAL FLAK06 AM 19 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =44 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHHHHTTTC
2239 None 2005 FALALKALKKLKKALKKAL FLAK06 AC 19 Linear L None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =93 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHHHHTTTC
2390 None 2005 FALALKALKKLKKALKKAL FLAK06 AM 19 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =16 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHHHHHHTTTC
2391 None 2005 FALALKALKKLKKALKKAL FLAK06 AC 19 Linear L None Free Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =54 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHHHHHHTTTC
2533 None 2005 FALALKALKKLKKALKKAL FLAK06 AM 19 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =8 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHHHHHHTTTC
2534 None 2005 FALALKALKKLKKALKKAL FLAK06 AC 19 Linear L None Free Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =16 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHHHHHHTTTC
2676 None 2005 FALALKALKKLKKALKKAL FLAK06 AM 19 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =25 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHHHHHHTTTC
2677 None 2005 FALALKALKKLKKALKKAL FLAK06 AC 19 Linear L None Free Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =80 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHHHHHHTTTC
1784 None 2005 FAKKLAKKLKKLAKLALAL FLAK06 R-AC 19 Linear L None Free Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =140 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHHHHHHTTC
1936 None 2005 FAKKLAKKLKKLAKLALAL FLAK06 R-AC 19 Linear L None Free Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =210 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHHHHHHHTTC
2088 None 2005 FAKKLAKKLKKLAKLALAL FLAK06 AM 19 Linear L None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =300 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHHHHHTTC
2240 None 2005 FAKKLAKKLKKLAKLALAL FLAK06 R-AC 19 Linear L None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =300 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHHHHHTTC
2392 None 2005 FAKKLAKKLKKLAKLALAL FLAK06 AM 19 Linear L None Free Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =170 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHHHHHHHTTC
2535 None 2005 FAKKLAKKLKKLAKLALAL FLAK06 R-AC 19 Linear L None Free Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =280 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHHHHHHHTTC
2678 None 2005 FAKKLAKKLKKLAKLALAL FLAK06 R-AC 19 Linear L None Free Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =260 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHHHHHHHTTC
1785 None 2005 VALALKALKKALKKLKKALKKAL KAL V 23 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =72 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHGGGGHHHHHHHGGGTC
1921 None 2005 VALALKALKKALKKLKKALKKAL Hecate AM V 23 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =340 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHGGGGHHHHHHHGGGTC
1922 None 2005 VALALKALKKALKKLKKALKKAL Hecate AC V 23 Linear L None Free Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =160 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHHHHHHHHHHHHC
1937 None 2005 VALALKALKKALKKLKKALKKAL KAL V 23 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =62 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHGGGGHHHHHHHGGGTC
2073 None 2005 VALALKALKKALKKLKKALKKAL Hecate AM V 23 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay Not Available 24-h Colon None US_06875744_B2 CHHHHHHGGGGHHHHHHHGGGTC
2074 None 2005 VALALKALKKALKKLKKALKKAL Hecate AC V 23 Linear L None Free Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay Not Available 24-h Colon None US_06875744_B2 CHHHHHHHHHHHHHHHHHHHHHC
2089 None 2005 VALALKALKKALKKLKKALKKAL KAL V 23 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =140 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHGGGGHHHHHHHGGGTC
2225 None 2005 VALALKALKKALKKLKKALKKAL Hecate AM V 23 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay Not Available 24-h Skin None US_06875744_B2 CHHHHHHGGGGHHHHHHHGGGTC
2226 None 2005 VALALKALKKALKKLKKALKKAL Hecate AC V 23 Linear L None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay Not Available 24-h Skin None US_06875744_B2 CHHHHHHHHHHHHHHHHHHHHHC
2241 None 2005 VALALKALKKALKKLKKALKKAL KAL V 23 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =140 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHGGGGHHHHHHHGGGTC
2377 None 2005 VALALKALKKALKKLKKALKKAL Hecate AM V 23 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay Not Available 24-h Skin None US_06875744_B2 CHHHHHHGGGGHHHHHHHGGGTC
2378 None 2005 VALALKALKKALKKLKKALKKAL Hecate AC V 23 Linear L None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay Not Available 24-h Skin None US_06875744_B2 CHHHHHHHHHHHHHHHHHHHHHC
2393 None 2005 VALALKALKKALKKLKKALKKAL KAL V 23 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =125 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHGGGGHHHHHHHGGGTC
2536 None 2005 VALALKALKKALKKLKKALKKAL KAL V 23 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =65 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHGGGGHHHHHHHGGGTC
2679 None 2005 VALALKALKKALKKLKKALKKAL KAL V 23 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =190 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHGGGGHHHHHHHGGGTC
1786 None 2005 FALALKKALKALKKAL FLAK 17 AM 16 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =21 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHHTTTC
1938 None 2005 FALALKKALKALKKAL FLAK 17 AM 16 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =35 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHHHTTTC
2090 None 2005 FALALKKALKALKKAL FLAK 17 AM 16 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =53 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHTTTC
2242 None 2005 FALALKKALKALKKAL FLAK 17 AM 16 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =53 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHTTTC
2394 None 2005 FALALKKALKALKKAL FLAK 17 AM 16 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =24 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHHHTTTC
2537 None 2005 FALALKKALKALKKAL FLAK 17 AM 16 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =9 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHHHTTTC
2680 None 2005 FALALKKALKALKKAL FLAK 17 AM 16 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =62 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHHHTTTC
1787 None 2005 FAKKLAKLAKKLAKLAL FLAK 26 AM 17 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =9 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHTTTTTCCC
1811 None 2005 FAKKLAKLAKKLAKLAL FLAK 26 Ac 17 Linear L None Free Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =105 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHGGGGGGTCC
1939 None 2005 FAKKLAKLAKKLAKLAL FLAK 26 AM 17 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =14 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHTTTTTCCC
1963 None 2005 FAKKLAKLAKKLAKLAL FLAK 26 Ac 17 Linear L None Free Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =100 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHGGGGGGTCC
2091 None 2005 FAKKLAKLAKKLAKLAL FLAK 26 AM 17 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =7 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTTTCCC
2115 None 2005 FAKKLAKLAKKLAKLAL FLAK 26 Ac 17 Linear L None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =140 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHGGGGGGTCC
2243 None 2005 FAKKLAKLAKKLAKLAL FLAK 26 AM 17 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =7 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTTTCCC
2267 None 2005 FAKKLAKLAKKLAKLAL FLAK 26 Ac 17 Linear L None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =140 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHGGGGGGTCC
2395 None 2005 FAKKLAKLAKKLAKLAL FLAK 26 AM 17 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =16 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHTTTTTCCC
2419 None 2005 FAKKLAKLAKKLAKLAL FLAK 26 Ac 17 Linear L None Free Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =127 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHGGGGGGTCC
2538 None 2005 FAKKLAKLAKKLAKLAL FLAK 26 AM 17 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =5 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHTTTTTCCC
2562 None 2005 FAKKLAKLAKKLAKLAL FLAK 26 Ac 17 Linear L None Free Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =66 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHGGGGGGTCC
2681 None 2005 FAKKLAKLAKKLAKLAL FLAK 26 AM 17 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =27 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHTTTTTCCC
2705 None 2005 FAKKLAKLAKKLAKLAL FLAK 26 Ac 17 Linear L None Free Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =170 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHGGGGGGTCC
1788 None 2005 FAKKLAKLAKKLAKLALAL FLAK 25 AM 19 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =9 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHHHHHTTTC
1915 None 2005 FAKKLAKLAKKLAKLALAL FLAK 17 CV 19 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =23 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHHHHHTTTC
1940 None 2005 FAKKLAKLAKKLAKLALAL FLAK 25 AM 19 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =30 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHHHHHHTTTC
2067 None 2005 FAKKLAKLAKKLAKLALAL FLAK 17 CV 19 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay Not Available 24-h Colon None US_06875744_B2 CHHHHHHHHHHHHHHTTTC
2070 None 2005 FAKKLAKLAKKLAKLALAL FLAK 25 AM V 19 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay Not Available 24-h Colon None US_06875744_B2 CHHHHHHHHHHHHHHTTTC
2092 None 2005 FAKKLAKLAKKLAKLALAL FLAK 25 AM 19 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =56 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHHHHTTTC
2244 None 2005 FAKKLAKLAKKLAKLALAL FLAK 25 AM 19 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =56 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHHHHTTTC
2396 None 2005 FAKKLAKLAKKLAKLALAL FLAK 25 AM 19 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =57 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHHHHHHTTTC
2539 None 2005 FAKKLAKLAKKLAKLALAL FLAK 25 AM 19 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =19 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHHHHHHTTTC
2682 None 2005 FAKKLAKLAKKLAKLALAL FLAK 25 AM 19 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay Not Available 24-h Cervix None US_06875744_B2 CHHHHHHHHHHHHHHTTTC
1791 None 2005 FAKKLAKLAKKALAL FLAK44 AM 15 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =130 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHHSCC
1943 None 2005 FAKKLAKLAKKALAL FLAK44 AM 15 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =435 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHHHSCC
2095 None 2005 FAKKLAKLAKKALAL FLAK44 AM 15 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =510 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHSCC
2247 None 2005 FAKKLAKLAKKALAL FLAK44 AM 15 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =510 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHSCC
2399 None 2005 FAKKLAKLAKKALAL FLAK44 AM 15 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =420 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHHHSCC
2542 None 2005 FAKKLAKLAKKALAL FLAK44 AM 15 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =310 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHHHSCC
2685 None 2005 FAKKLAKLAKKALAL FLAK44 AM 15 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =620 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHHHSCC
1792 None 2005 FALAKKALKKAKKAL FLAK62 AM 15 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =760 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHTTCC
1944 None 2005 FALAKKALKKAKKAL FLAK62 AM 15 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHHTTCC
2096 None 2005 FALAKKALKKAKKAL FLAK62 AM 15 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHTTCC
2248 None 2005 FALAKKALKKAKKAL FLAK62 AM 15 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHTTCC
2400 None 2005 FALAKKALKKAKKAL FLAK62 AM 15 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHHTTCC
2543 None 2005 FALAKKALKKAKKAL FLAK62 AM 15 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =435 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHHTTCC
2686 None 2005 FALAKKALKKAKKAL FLAK62 AM 15 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHHTTCC
1793 None 2005 FAKKLAKKLKKLAKLALAK FLAK 06R-AM 19 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =98 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHHHHHHTCC
1945 None 2005 FAKKLAKKLKKLAKLALAK FLAK 06R-AM 19 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =120 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHHHHHHHTCC
2097 None 2005 FAKKLAKKLKKLAKLALAK FLAK 06R-AM 19 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =290 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHHHHHTCC
2249 None 2005 FAKKLAKKLKKLAKLALAK FLAK 06R-AM 19 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =290 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHHHHHTCC
2401 None 2005 FAKKLAKKLKKLAKLALAK FLAK 06R-AM 19 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =245 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHHHHHHHTCC
2544 None 2005 FAKKLAKKLKKLAKLALAK FLAK 06R-AM 19 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =140 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHHHHHHHTCC
2687 None 2005 FAKKLAKKLKKLAKLALAK FLAK 06R-AM 19 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =185 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHHHHHHHTCC
1795 None 2005 FAKLLAKLAKKLL FLAK50 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =9 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHTTTC
1947 None 2005 FAKLLAKLAKKLL FLAK50 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =9 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHTTTC
2099 None 2005 FAKLLAKLAKKLL FLAK50 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =7 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2251 None 2005 FAKLLAKLAKKLL FLAK50 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =7 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2403 None 2005 FAKLLAKLAKKLL FLAK50 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =6 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHTTTC
2546 None 2005 FAKLLAKLAKKLL FLAK50 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =12 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHTTTC
2689 None 2005 FAKLLAKLAKKLL FLAK50 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =15 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHTTTC
1796 None 2005 FAKKLAKLALKLAKL FLAK51 15 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =140 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHHHCC
1948 None 2005 FAKKLAKLALKLAKL FLAK51 15 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =32 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHHHHCC
2100 None 2005 FAKKLAKLALKLAKL FLAK51 15 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =47 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHHCC
2252 None 2005 FAKKLAKLALKLAKL FLAK51 15 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =47 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHHCC
2404 None 2005 FAKKLAKLALKLAKL FLAK51 15 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =72 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHHHHCC
2547 None 2005 FAKKLAKLALKLAKL FLAK51 15 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =45 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHHHHCC
2690 None 2005 FAKKLAKLALKLAKL FLAK51 15 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =22 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHHHHCC
1797 None 2005 FAKKLAKKLAKLAL FLAK57 14 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =260 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHTTTCC
1949 None 2005 FAKKLAKKLAKLAL FLAK57 14 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =180 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHTTTCC
2101 None 2005 FAKKLAKKLAKLAL FLAK57 14 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =160 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTCC
2253 None 2005 FAKKLAKKLAKLAL FLAK57 14 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =160 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTCC
2405 None 2005 FAKKLAKKLAKLAL FLAK57 14 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =330 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHTTTCC
2548 None 2005 FAKKLAKKLAKLAL FLAK57 14 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =170 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHTTTCC
2691 None 2005 FAKKLAKKLAKLAL FLAK57 14 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =160 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHTTTCC
1798 None 2005 FAKKLKKLAKLAKKL FLAK71 15 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =300 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHHTTC
1950 None 2005 FAKKLKKLAKLAKKL FLAK71 15 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =160 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHHHTTC
2102 None 2005 FAKKLKKLAKLAKKL FLAK71 15 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =150 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHTTC
2254 None 2005 FAKKLKKLAKLAKKL FLAK71 15 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =150 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHTTC
2406 None 2005 FAKKLKKLAKLAKKL FLAK71 15 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =290 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHHHTTC
2549 None 2005 FAKKLKKLAKLAKKL FLAK71 15 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =280 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHHHTTC
2692 None 2005 FAKKLKKLAKLAKKL FLAK71 15 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =280 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHHHTTC
1799 None 2005 FAKKALKALKKL FLAK77 12 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =575 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHTTCC
1951 None 2005 FAKKALKALKKL FLAK77 12 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHTTCC
2103 None 2005 FAKKALKALKKL FLAK77 12 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =700 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHTTCC
2255 None 2005 FAKKALKALKKL FLAK77 12 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =700 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHTTCC
2407 None 2005 FAKKALKALKKL FLAK77 12 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHTTCC
2550 None 2005 FAKKALKALKKL FLAK77 12 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHTTCC
2693 None 2005 FAKKALKALKKL FLAK77 12 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHTTCC
1800 None 2005 VAKLLAKLAKKLL FLAK50V 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =23 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHTTTC
1952 None 2005 VAKLLAKLAKKLL FLAK50V 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =47 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHTTTC
2104 None 2005 VAKLLAKLAKKLL FLAK50V 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =43 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2256 None 2005 VAKLLAKLAKKLL FLAK50V 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =43 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2408 None 2005 VAKLLAKLAKKLL FLAK50V 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =17 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHTTTC
2551 None 2005 VAKLLAKLAKKLL FLAK50V 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =32 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHTTTC
2694 None 2005 VAKLLAKLAKKLL FLAK50V 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =44 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHTTTC
1801 None 2005 FAKLLAKLAKKL FLAK50F 12 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =40 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHTTC
1953 None 2005 FAKLLAKLAKKL FLAK50F 12 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =100 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHTTC
2105 None 2005 FAKLLAKLAKKL FLAK50F 12 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =115 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTC
2257 None 2005 FAKLLAKLAKKL FLAK50F 12 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =115 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTC
2409 None 2005 FAKLLAKLAKKL FLAK50F 12 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =140 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHTTC
2552 None 2005 FAKLLAKLAKKL FLAK50F 12 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =77 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHTTC
2695 None 2005 FAKLLAKLAKKL FLAK50F 12 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay Not Available 24-h Cervix None US_06875744_B2 CHHHHHHHHTTC
1802 None 2005 VAKKLAKLAKKLAKLAL FLAK26V AM 17 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =32 µg/ml 24-h Breast None US_06875744_B2 CHHHHTTTTHHHHTTTC
1954 None 2005 VAKKLAKLAKKLAKLAL FLAK26V AM 17 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =46 µg/ml 24-h Colon None US_06875744_B2 CHHHHTTTTHHHHTTTC
2106 None 2005 VAKKLAKLAKKLAKLAL FLAK26V AM 17 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =40 µg/ml 24-h Skin None US_06875744_B2 CHHHHTTTTHHHHTTTC
2258 None 2005 VAKKLAKLAKKLAKLAL FLAK26V AM 17 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =40 µg/ml 24-h Skin None US_06875744_B2 CHHHHTTTTHHHHTTTC
2410 None 2005 VAKKLAKLAKKLAKLAL FLAK26V AM 17 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =7 µg/ml 24-h Lung None US_06875744_B2 CHHHHTTTTHHHHTTTC
2553 None 2005 VAKKLAKLAKKLAKLAL FLAK26V AM 17 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =54 µg/ml 24-h Prostate None US_06875744_B2 CHHHHTTTTHHHHTTTC
2696 None 2005 VAKKLAKLAKKLAKLAL FLAK26V AM 17 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =33 µg/ml 24-h Cervix None US_06875744_B2 CHHHHTTTTHHHHTTTC
1803 None 2005 KWKLFKKIGAVLKVL CAME-15 15 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =45 µg/ml 24-h Breast None US_06875744_B2 CCSSHHHHHHHHHHC
1955 None 2005 KWKLFKKIGAVLKVL CAME-15 15 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay Not Available 24-h Colon None US_06875744_B2 CCSSHHHHHHHHHHC
2107 None 2005 KWKLFKKIGAVLKVL CAME-15 15 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =40 µg/ml 24-h Skin None US_06875744_B2 CCSSHHHHHHHHHHC
2259 None 2005 KWKLFKKIGAVLKVL CAME-15 15 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =40 µg/ml 24-h Skin None US_06875744_B2 CCSSHHHHHHHHHHC
2411 None 2005 KWKLFKKIGAVLKVL CAME-15 15 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =65 µg/ml 24-h Lung None US_06875744_B2 CCSSHHHHHHHHHHC
2554 None 2005 KWKLFKKIGAVLKVL CAME-15 15 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =40 µg/ml 24-h Prostate None US_06875744_B2 CCSSHHHHHHHHHHC
2697 None 2005 KWKLFKKIGAVLKVL CAME-15 15 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =30 µg/ml 24-h Cervix None US_06875744_B2 CCSSHHHHHHHHHHC
2878 20212453 2010 KWKLFKKIGAVLKVL Camel 15 Linear L None Free Free Antimicrobial Ceropin-Melittin hybrid B16-F10 Skin Cancer MTT/MTS assay LC50 = 1.75 µM 24-h Skin None None CCSSHHHHHHHHHHC
2879 20212453 2010 KWKLFKKIGAVLKVL Camel 15 Linear L None Free Free Antimicrobial Ceropin-Melittin hybrid RENCA Renal Cancer MTT/MTS assay LC50 = 1.3 µM 24-h Renal None None CCSSHHHHHHHHHHC
2880 20212453 2010 KWKLFKKIGAVLKVL Camel 15 Linear L None Free Free Antimicrobial Ceropin-Melittin hybrid 4T1 Breast Cancer MTT/MTS assay LC50 = 6.2 µM 24-h Breast None None CCSSHHHHHHHHHHC
2881 20212453 2010 KWKLFKKIGAVLKVL Camel 15 Linear L None Free Free Antimicrobial Ceropin-Melittin hybrid WM1158 Skin Cancer MTT/MTS assay LC50 = 4.1 µM 24-h Skin None None CCSSHHHHHHHHHHC
1804 None 2005 FAKLLAKLAKKAL FLAK50C 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =60 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHTTTC
1956 None 2005 FAKLLAKLAKKAL FLAK50C 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay Not Available 24-h Colon None US_06875744_B2 CHHHHHHHHTTTC
2108 None 2005 FAKLLAKLAKKAL FLAK50C 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =90 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2260 None 2005 FAKLLAKLAKKAL FLAK50C 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =90 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2412 None 2005 FAKLLAKLAKKAL FLAK50C 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =80 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHTTTC
2555 None 2005 FAKLLAKLAKKAL FLAK50C 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =90 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHTTTC
2698 None 2005 FAKLLAKLAKKAL FLAK50C 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =190 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHTTTC
1805 None 2005 FAKLLAKALKKLL FLAK50D 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =16 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHTTTC
1957 None 2005 FAKLLAKALKKLL FLAK50D 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =14 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHTTTC
2109 None 2005 FAKLLAKALKKLL FLAK50D 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =16 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2261 None 2005 FAKLLAKALKKLL FLAK50D 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =16 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2413 None 2005 FAKLLAKALKKLL FLAK50D 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =7 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHTTTC
2556 None 2005 FAKLLAKALKKLL FLAK50D 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =47 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHTTTC
2699 None 2005 FAKLLAKALKKLL FLAK50D 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =15 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHTTTC
1806 None 2005 FAKLLKLAAKKLL FLAK 50E 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =500 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHHC
1958 None 2005 FAKLLKLAAKKLL FLAK 50E 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =215 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHHHC
2110 None 2005 FAKLLKLAAKKLL FLAK 50E 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =205 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHC
2262 None 2005 FAKLLKLAAKKLL FLAK 50E 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =205 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHC
2414 None 2005 FAKLLKLAAKKLL FLAK 50E 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =370 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHHHC
2557 None 2005 FAKLLKLAAKKLL FLAK 50E 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =435 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHHHC
2700 None 2005 FAKLLKLAAKKLL FLAK 50E 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =300 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHHHC
1807 None 2005 FAKLLAKKLL FLAK80 10 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Breast None US_06875744_B2 CHHHHTTTCC
1959 None 2005 FAKLLAKKLL FLAK80 10 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =740 µg/ml 24-h Colon None US_06875744_B2 CHHHHTTTCC
2111 None 2005 FAKLLAKKLL FLAK80 10 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =740 µg/ml 24-h Skin None US_06875744_B2 CHHHHTTTCC
2263 None 2005 FAKLLAKKLL FLAK80 10 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =740 µg/ml 24-h Skin None US_06875744_B2 CHHHHTTTCC
2415 None 2005 FAKLLAKKLL FLAK80 10 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CHHHHTTTCC
2558 None 2005 FAKLLAKKLL FLAK80 10 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHTTTCC
2701 None 2005 FAKLLAKKLL FLAK80 10 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =830 µg/ml 24-h Cervix None US_06875744_B2 CHHHHTTTCC
1808 None 2005 FAKKLAKALL FLAK81 10 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHC
1960 None 2005 FAKKLAKALL FLAK81 10 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHC
2112 None 2005 FAKKLAKALL FLAK81 10 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHC
2264 None 2005 FAKKLAKALL FLAK81 10 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHC
2416 None 2005 FAKKLAKALL FLAK81 10 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHC
2559 None 2005 FAKKLAKALL FLAK81 10 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHC
2702 None 2005 FAKKLAKALL FLAK81 10 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHC
1809 None 2005 FAKKLAKKLL FLAK82 10 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =31 µg/ml 24-h Breast None US_06875744_B2 CHHHHGGGTC
1961 None 2005 FAKKLAKKLL FLAK82 10 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =42 µg/ml 24-h Colon None US_06875744_B2 CHHHHGGGTC
2113 None 2005 FAKKLAKKLL FLAK82 10 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =155 µg/ml 24-h Skin None US_06875744_B2 CHHHHGGGTC
2265 None 2005 FAKKLAKKLL FLAK82 10 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =155 µg/ml 24-h Skin None US_06875744_B2 CHHHHGGGTC
2417 None 2005 FAKKLAKKLL FLAK82 10 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =180 µg/ml 24-h Lung None US_06875744_B2 CHHHHGGGTC
2560 None 2005 FAKKLAKKLL FLAK82 10 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =81 µg/ml 24-h Prostate None US_06875744_B2 CHHHHGGGTC
2703 None 2005 FAKKLAKKLL FLAK82 10 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay Not Available 24-h Cervix None US_06875744_B2 CHHHHGGGTC
1810 None 2005 FAKLAKKLL FLAK83M 9 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Breast None US_06875744_B2 CHHHHTTTC
1962 None 2005 FAKLAKKLL FLAK83M 9 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CHHHHTTTC
2114 None 2005 FAKLAKKLL FLAK83M 9 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHTTTC
2266 None 2005 FAKLAKKLL FLAK83M 9 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHTTTC
2418 None 2005 FAKLAKKLL FLAK83M 9 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CHHHHTTTC
2561 None 2005 FAKLAKKLL FLAK83M 9 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHTTTC
2704 None 2005 FAKLAKKLL FLAK83M 9 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Cervix None US_06875744_B2 CHHHHTTTC
1812 None 2005 ILPWKWPWWPWRR Indolicidin 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =64 µg/ml 24-h Breast None US_06875744_B2 CCCSCCSSCCCCC
1827 None 2005 ILPWKWPWWPWRR Indolocidin-ac 13 Linear L None Free Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =12 µg/ml 24-h Breast None US_06875744_B2 CCCSCCSSCCCCC
1964 None 2005 ILPWKWPWWPWRR Indolicidin 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =345 µg/ml 24-h Colon None US_06875744_B2 CCCSCCSSCCCCC
1979 None 2005 ILPWKWPWWPWRR Indolocidin-ac 13 Linear L None Free Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =30 µg/ml 24-h Colon None US_06875744_B2 CCCSCCSSCCCCC
2116 None 2005 ILPWKWPWWPWRR Indolicidin 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =200 µg/ml 24-h Skin None US_06875744_B2 CCCSCCSSCCCCC
2131 None 2005 ILPWKWPWWPWRR Indolocidin-ac 13 Linear L None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =180 µg/ml 24-h Skin None US_06875744_B2 CCCSCCSSCCCCC
2268 None 2005 ILPWKWPWWPWRR Indolicidin 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =200 µg/ml 24-h Skin None US_06875744_B2 CCCSCCSSCCCCC
2283 None 2005 ILPWKWPWWPWRR Indolocidin-ac 13 Linear L None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =180 µg/ml 24-h Skin None US_06875744_B2 CCCSCCSSCCCCC
2420 None 2005 ILPWKWPWWPWRR Indolicidin 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =270 µg/ml 24-h Lung None US_06875744_B2 CCCSCCSSCCCCC
2435 None 2005 ILPWKWPWWPWRR Indolocidin-ac 13 Linear L None Free Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =64 µg/ml 24-h Lung None US_06875744_B2 CCCSCCSSCCCCC
2563 None 2005 ILPWKWPWWPWRR Indolicidin 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =290 µg/ml 24-h Prostate None US_06875744_B2 CCCSCCSSCCCCC
2578 None 2005 ILPWKWPWWPWRR Indolocidin-ac 13 Linear L None Free Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =31 µg/ml 24-h Prostate None US_06875744_B2 CCCSCCSSCCCCC
2706 None 2005 ILPWKWPWWPWRR Indolicidin 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =345 µg/ml 24-h Cervix None US_06875744_B2 CCCSCCSSCCCCC
2721 None 2005 ILPWKWPWWPWRR Indolocidin-ac 13 Linear L None Free Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =20 µg/ml 24-h Cervix None US_06875744_B2 CCCSCCSSCCCCC
1813 None 2005 FAKALKALLKALKAL FLAK 17 C 15 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =80 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHHTTC
2117 None 2005 FAKALKALLKALKAL FLAK 17 C 15 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =35 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHTTC
2269 None 2005 FAKALKALLKALKAL FLAK 17 C 15 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =35 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHTTC
2421 None 2005 FAKALKALLKALKAL FLAK 17 C 15 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =30 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHHHTTC
2564 None 2005 FAKALKALLKALKAL FLAK 17 C 15 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =46 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHHHTTC
2707 None 2005 FAKALKALLKALKAL FLAK 17 C 15 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =30 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHHHTTC
1814 None 2005 FAKLLAKLAKAKL FLAK 50H 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =475 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHTSSCC
1966 None 2005 FAKLLAKLAKAKL FLAK 50H 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =345 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHTSSCC
2118 None 2005 FAKLLAKLAKAKL FLAK 50H 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =250 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHTSSCC
2270 None 2005 FAKLLAKLAKAKL FLAK 50H 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =250 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHTSSCC
2422 None 2005 FAKLLAKLAKAKL FLAK 50H 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =450 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHTSSCC
2565 None 2005 FAKLLAKLAKAKL FLAK 50H 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =470 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHTSSCC
2708 None 2005 FAKLLAKLAKAKL FLAK 50H 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =210 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHTSSCC
1815 None 2005 FAKLLAKLAKLKL FLAK 50G 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =90 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHTCCC
1967 None 2005 FAKLLAKLAKLKL FLAK 50G 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =145 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHTCCC
2119 None 2005 FAKLLAKLAKLKL FLAK 50G 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =200 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTCCC
2271 None 2005 FAKLLAKLAKLKL FLAK 50G 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =200 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTCCC
2423 None 2005 FAKLLAKLAKLKL FLAK 50G 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =130 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHTCCC
2566 None 2005 FAKLLAKLAKLKL FLAK 50G 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =170 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHTCCC
2709 None 2005 FAKLLAKLAKLKL FLAK 50G 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =140 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHTCCC
1816 None 2005 FAKKLAKKLKKLAKKLAKKWKL SHIVA DERIV P69 + KWKL 22 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =44 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHGGGHHHHHTTTCC
1818 None 2005 FAKKLAKKLKKLAKKLAKKWKL SHIVA 10 PEPTIDE 71 + KWKL 22 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =93 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHGGGHHHHHTTTCC
1968 None 2005 FAKKLAKKLKKLAKKLAKKWKL SHIVA DERIV P69 + KWKL 22 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =11 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHGGGHHHHHTTTCC
1970 None 2005 FAKKLAKKLKKLAKKLAKKWKL SHIVA 10 PEPTIDE 71 + KWKL 22 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =82 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHGGGHHHHHTTTCC
2120 None 2005 FAKKLAKKLKKLAKKLAKKWKL SHIVA DERIV P69 + KWKL 22 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =94 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHGGGHHHHHTTTCC
2122 None 2005 FAKKLAKKLKKLAKKLAKKWKL SHIVA 10 PEPTIDE 71 + KWKL 22 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =290 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHGGGHHHHHTTTCC
2272 None 2005 FAKKLAKKLKKLAKKLAKKWKL SHIVA DERIV P69 + KWKL 22 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =94 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHGGGHHHHHTTTCC
2274 None 2005 FAKKLAKKLKKLAKKLAKKWKL SHIVA 10 PEPTIDE 71 + KWKL 22 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =290 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHGGGHHHHHTTTCC
2424 None 2005 FAKKLAKKLKKLAKKLAKKWKL SHIVA DERIV P69 + KWKL 22 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =63 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHGGGHHHHHTTTCC
2426 None 2005 FAKKLAKKLKKLAKKLAKKWKL SHIVA 10 PEPTIDE 71 + KWKL 22 Linear L None Free Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =160 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHHHHHHHTTTSCC
2567 None 2005 FAKKLAKKLKKLAKKLAKKWKL SHIVA DERIV P69 + KWKL 22 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =82 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHGGGHHHHHTTTCC
2569 None 2005 FAKKLAKKLKKLAKKLAKKWKL SHIVA 10 PEPTIDE 71 + KWKL 22 Linear L None Free Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =63 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHHHHHHHTTTSCC
2710 None 2005 FAKKLAKKLKKLAKKLAKKWKL SHIVA DERIV P69 + KWKL 22 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =28 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHGGGHHHHHTTTCC
2712 None 2005 FAKKLAKKLKKLAKKLAKKWKL SHIVA 10 PEPTIDE 71 + KWKL 22 Linear L None Free Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =240 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHHHHHHHTTTSCC
1817 None 2005 FAKKLAKKLKKLAKKLAK Shiva 10(1-18 AC) 18 Linear L None Free Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =190 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHHHHHHTC
1969 None 2005 FAKKLAKKLKKLAKKLAK Shiva 10(1-18 AC) 18 Linear L None Free Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =250 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHHHHHHHTC
2121 None 2005 FAKKLAKKLKKLAKKLAK Shiva 10(1-18 AC) 18 Linear L None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =445 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHHHHHTC
2273 None 2005 FAKKLAKKLKKLAKKLAK Shiva 10(1-18 AC) 18 Linear L None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =445 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHHHHHTC
2425 None 2005 FAKKLAKKLKKLAKKLAK Shiva 10(1-18 AC) 18 Linear L None Free Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =320 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHHHHHHHTC
2568 None 2005 FAKKLAKKLKKLAKKLAK Shiva 10(1-18 AC) 18 Linear L None Free Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =270 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHHHHHHHTC
2711 None 2005 FAKKLAKKLKKLAKKLAK Shiva 10(1-18 AC) 18 Linear L None Free Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =570 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHHHHHHHTC
1819 None 2005 KWKLFKKKTKLFKKFAKKLAKKL CA (1-7) Shiva10 (1-16) 23 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =150 µg/ml 24-h Breast None US_06875744_B2 CCSCSTTHHHHHHHHHHHHTTTC
1826 None 2005 KWKLFKKKTKLFKKFAKKLAKKL CA(1-7) Shiva10(1-16)-COOH 23 Linear L None Free Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =63 µg/ml 24-h Breast None US_06875744_B2 CCCSSTTTTTCCTTTCHHHHTTC
1971 None 2005 KWKLFKKKTKLFKKFAKKLAKKL CA(1-7) Shiva10(1-16) 23 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =70 µg/ml 24-h Colon None US_06875744_B2 CCSCSTTHHHHHHHHHHHHTTTC
1978 None 2005 KWKLFKKKTKLFKKFAKKLAKKL CA(1-7) Shiva10(1-16)-COOH 23 Linear L None Free Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =13 µg/ml 24-h Colon None US_06875744_B2 CCCSSTTTTTCCTTTCHHHHTTC
2123 None 2005 KWKLFKKKTKLFKKFAKKLAKKL CA(1-7)Shiva10(1-16) 23 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =360 µg/ml 24-h Skin None US_06875744_B2 CCSCSTTHHHHHHHHHHHHTTTC
2130 None 2005 KWKLFKKKTKLFKKFAKKLAKKL CA(1-7) Shiva10(1-16)-COOH 23 Linear L None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =12 µg/ml 24-h Skin None US_06875744_B2 CCCSSTTTTTCCTTTCHHHHTTC
2275 None 2005 KWKLFKKKTKLFKKFAKKLAKKL CA(1-7)Shiva10(1-16) 23 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =360 µg/ml 24-h Skin None US_06875744_B2 CCSCSTTHHHHHHHHHHHHTTTC
2282 None 2005 KWKLFKKKTKLFKKFAKKLAKKL CA(1-7) Shiva10(1-16)-COOH 23 Linear L None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =12 µg/ml 24-h Skin None US_06875744_B2 CCCSSTTTTTCCTTTCHHHHTTC
2427 None 2005 KWKLFKKKTKLFKKFAKKLAKKL CA(1-7)Shiva10(1-16) 23 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =115 µg/ml 24-h Lung None US_06875744_B2 CCSCSTTHHHHHHHHHHHHTTTC
2434 None 2005 KWKLFKKKTKLFKKFAKKLAKKL CA(1-7) Shiva10(1-16) 23 Linear L None Free Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =22 µg/ml 24-h Lung None US_06875744_B2 CCCSSTTTTTCCTTTCHHHHTTC
2570 None 2005 KWKLFKKKTKLFKKFAKKLAKKL CA(1-7)Shiva10(1-16) 23 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =97 µg/ml 24-h Prostate None US_06875744_B2 CCSCSTTHHHHHHHHHHHHTTTC
2577 None 2005 KWKLFKKKTKLFKKFAKKLAKKL CA(1-7) Shiva10(1-16)-COOH 23 Linear L None Free Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =170 µg/ml 24-h Prostate None US_06875744_B2 CCCSSTTTTTCCTTTCHHHHTTC
2713 None 2005 KWKLFKKKTKLFKKFAKKLAKKL CA(1-7) Shiva10(1-16) 23 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =270 µg/ml 24-h Cervix None US_06875744_B2 CCSCSTTHHHHHHHHHHHHTTTC
2720 None 2005 KWKLFKKKTKLFKKFAKKLAKKL CA(1-7) Shiva10(1-16)-COOH 23 Linear L None Free Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =19 µg/ml 24-h Cervix None US_06875744_B2 CCCSSTTTTTCCTTTCHHHHTTC
1820 None 2005 FAKKLAKKLAKAL FLAK 54 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =465 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHTTTC
1972 None 2005 FAKKLAKKLAKAL FLAK 54 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =340 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHTTTC
2124 None 2005 FAKKLAKKLAKAL FLAK 54 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =460 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2276 None 2005 FAKKLAKKLAKAL FLAK 54 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =460 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2428 None 2005 FAKKLAKKLAKAL FLAK 54 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =670 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHTTTC
2571 None 2005 FAKKLAKKLAKAL FLAK 54 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =660 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHTTTC
2714 None 2005 FAKKLAKKLAKAL FLAK 54 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =260 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHTTTC
1821 None 2005 FAKKLAKKLAKLL FLAK 56 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =42 µg/ml 24-h Breast None US_06875744_B2 CHHHHGGGTTTTC
1973 None 2005 FAKKLAKKLAKLL FLAK 56 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =17 µg/ml 24-h Colon None US_06875744_B2 CHHHHGGGTTTTC
2125 None 2005 FAKKLAKKLAKLL FLAK 56 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =24 µg/ml 24-h Skin None US_06875744_B2 CHHHHGGGTTTTC
2277 None 2005 FAKKLAKKLAKLL FLAK 56 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =24 µg/ml 24-h Skin None US_06875744_B2 CHHHHGGGTTTTC
2429 None 2005 FAKKLAKKLAKLL FLAK 56 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =80 µg/ml 24-h Lung None US_06875744_B2 CHHHHGGGTTTTC
2572 None 2005 FAKKLAKKLAKLL FLAK 56 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =54 µg/ml 24-h Prostate None US_06875744_B2 CHHHHGGGTTTTC
2715 None 2005 FAKKLAKKLAKLL FLAK 56 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =74 µg/ml 24-h Cervix None US_06875744_B2 CHHHHGGGTTTTC
1822 None 2005 FAKKLAKKLAKAAL FLAK 58 14 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =970 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHGGGTC
1974 None 2005 FAKKLAKKLAKAAL FLAK 58 14 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =400 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHGGGTC
2126 None 2005 FAKKLAKKLAKAAL FLAK 58 14 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =750 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHGGGTC
2278 None 2005 FAKKLAKKLAKAAL FLAK 58 14 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =750 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHGGGTC
2430 None 2005 FAKKLAKKLAKAAL FLAK 58 14 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =860 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHGGGTC
2573 None 2005 FAKKLAKKLAKAAL FLAK 58 14 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =675 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHGGGTC
2716 None 2005 FAKKLAKKLAKAAL FLAK 58 14 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =380 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHGGGTC
1823 None 2005 FAKKLAKKAKLAKKL FLAK 72 15 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHTCCCC
1975 None 2005 FAKKLAKKAKLAKKL FLAK 72 15 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHTCCCC
2127 None 2005 FAKKLAKKAKLAKKL FLAK 72 15 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =125 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHTCCCC
2279 None 2005 FAKKLAKKAKLAKKL FLAK 72 15 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =125 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHTCCCC
2431 None 2005 FAKKLAKKAKLAKKL FLAK 72 15 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHTCCCC
2574 None 2005 FAKKLAKKAKLAKKL FLAK 72 15 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHTCCCC
2717 None 2005 FAKKLAKKAKLAKKL FLAK 72 15 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHTCCCC
1824 None 2005 FAKKLKKLAKKL FLAK 75 12 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =540 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHTTTC
1976 None 2005 FAKKLKKLAKKL FLAK 75 12 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHTTTC
2128 None 2005 FAKKLKKLAKKL FLAK 75 12 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =830 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHTTTC
2280 None 2005 FAKKLKKLAKKL FLAK 75 12 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =830 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHTTTC
2432 None 2005 FAKKLKKLAKKL FLAK 75 12 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHTTTC
2575 None 2005 FAKKLKKLAKKL FLAK 75 12 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHTTTC
2718 None 2005 FAKKLKKLAKKL FLAK 75 12 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHTTTC
1825 None 2005 KTKLFKKFAKKLAKKLKKLAKKL SHIVA 10 (1-16) Ac 23 Linear L None Free Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =29 µg/ml 24-h Breast None US_06875744_B2 CCTTHHHHHHHHHHHHHHHTTTC
1977 None 2005 KTKLFKKFAKKLAKKLKKLAKKL SHIVA 10 (1-16) Ac 23 Linear L None Free Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =35 µg0/ml 24-h Colon None US_06875744_B2 CCTTHHHHHHHHHHHHHHHTTTC
2129 None 2005 KTKLFKKFAKKLAKKLKKLAKKL SHIVA 10 (1-16) Ac 23 Linear L None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =76 µg/ml 24-h Skin None US_06875744_B2 CCTTHHHHHHHHHHHHHHHTTTC
2281 None 2005 KTKLFKKFAKKLAKKLKKLAKKL SHIVA 10 (1-16) Ac 23 Linear L None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =76 µg/ml 24-h Skin None US_06875744_B2 CCTTHHHHHHHHHHHHHHHTTTC
2433 None 2005 KTKLFKKFAKKLAKKLKKLAKKL SHIVA 10 (1-16) 23 Linear L None Free Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =64 µg/ml 24-h Lung None US_06875744_B2 CCTTHHHHHHHHHHHHHHHTTTC
2576 None 2005 KTKLFKKFAKKLAKKLKKLAKKL SHIVA 10 (1-16) Ac 23 Linear L None Free Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =28 µg/ml 24-h Prostate None US_06875744_B2 CCTTHHHHHHHHHHHHHHHTTTC
2719 None 2005 KTKLFKKFAKKLAKKLKKLAKKL SHIVA 10 (1-16) Ac 23 Linear L None Free Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =97 µg/ml 24-h Cervix None US_06875744_B2 CCTTHHHHHHHHHHHHHHHTTTC
1828 None 2005 FAKALAKLAKKLL FLAK50B 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =23 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHHC
1980 None 2005 FAKALAKLAKKLL FLAK50B 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =51 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHHHC
2132 None 2005 FAKALAKLAKKLL FLAK50B 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =46 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHC
2284 None 2005 FAKALAKLAKKLL FLAK50B 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =46 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHC
2436 None 2005 FAKALAKLAKKLL FLAK50B 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =25 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHHHC
2579 None 2005 FAKALAKLAKKLL FLAK50B 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =83 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHHHC
2722 None 2005 FAKALAKLAKKLL FLAK50B 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =670 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHHHC
1829 None 2005 FAKLLALALKLKL FLAK50I 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =65 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHCCC
1981 None 2005 FAKLLALALKLKL FLAK50I 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay Not Available 24-h Colon None US_06875744_B2 CHHHHHHHHHCCC
2133 None 2005 FAKLLALALKLKL FLAK50I 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =11 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHCCC
2285 None 2005 FAKLLALALKLKL FLAK50I 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =11 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHCCC
2438 None 2005 FAKLLALALKLKL FLAK50I 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay Not Available 24-h Lung None US_06875744_B2 CHHHHHHHHHCCC
2581 None 2005 FAKLLALALKLKL FLAK50I 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay Not Available 24-h Prostate None US_06875744_B2 CHHHHHHHHHCCC
2724 None 2005 FAKLLALALKLKL FLAK50I 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHCCC
1830 None 2005 FAKLLAKLAKAKA FLAK50K 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHCC
1982 None 2005 FAKLLAKLAKAKA FLAK50K 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHHCC
2134 None 2005 FAKLLAKLAKAKA FLAK50K 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =820 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHCC
2286 None 2005 FAKLLAKLAKAKA FLAK50K 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =820 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHCC
2439 None 2005 FAKLLAKLAKAKA FLAK50K 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHHCC
2582 None 2005 FAKLLAKLAKAKA FLAK50K 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHHCC
2725 None 2005 FAKLLAKLAKAKA FLAK50K 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHHCC
1831 None 2005 FAKLLAKLAKAKG FLAK50L 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHCC
1983 None 2005 FAKLLAKLAKAKG FLAK50L 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHHCC
2135 None 2005 FAKLLAKLAKAKG FLAK50L 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHCC
2287 None 2005 FAKLLAKLAKAKG FLAK50L 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHCC
2440 None 2005 FAKLLAKLAKAKG FLAK50L 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHHCC
2583 None 2005 FAKLLAKLAKAKG FLAK50L 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHHCC
2726 None 2005 FAKLLAKLAKAKG FLAK50L 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHHCC
1832 None 2005 FAKKLAKKLKKLAKKLAKLALALKALALKAL Shiva-11 31 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =96 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHC
1984 None 2005 FAKKLAKKLKKLAKKLAKLALALKALALKAL Shiva-11 31 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =125 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHC
2136 None 2005 FAKKLAKKLKKLAKKLAKLALALKALALKAL Shiva-11 31 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =94 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHC
2288 None 2005 FAKKLAKKLKKLAKKLAKLALALKALALKAL Shiva-11 31 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =94 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHC
2441 None 2005 FAKKLAKKLKKLAKKLAKLALALKALALKAL Shiva-11 31 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =53 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHC
2584 None 2005 FAKKLAKKLKKLAKKLAKLALALKALALKAL Shiva-11 31 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =52 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHC
2727 None 2005 FAKKLAKKLKKLAKKLAKLALALKALALKAL Shiva-11 31 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =175 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHC
1833 None 2005 FAKKLAKKLKKLAKKLIGAVLKV SHIVA 11[(1-16)ME(2-9]-COOH 23 Linear L None Free Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =95 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHHHHHHHHHTSCC
1985 None 2005 FAKKLAKKLKKLAKKLIGAVLKV SHIVA 11[(1-16)ME(2-9]-COOH 23 Linear L None Free Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =120 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHHHHHHHHHHTSCC
2137 None 2005 FAKKLAKKLKKLAKKLIGAVLKV SHIVA 11[(1-16)ME(2-9]-COOH 23 Linear L None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =94 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHHHHHHHHTSCC
2289 None 2005 FAKKLAKKLKKLAKKLIGAVLKV SHIVA 11[(1-16)ME(2-9]-COOH 23 Linear L None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =94 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHHHHHHHHTSCC
2442 None 2005 FAKKLAKKLKKLAKKLIGAVLKV SHIVA 11[(1-16)ME(2-9]-COOH 23 Linear L None Free Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =54 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHHHHHHHHHHTSCC
2585 None 2005 FAKKLAKKLKKLAKKLIGAVLKV SHIVA 11[(1-16)ME(2-9]-COOH 23 Linear L None Free Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =28 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHHHHHHHHHHTSCC
2728 None 2005 FAKKLAKKLKKLAKKLIGAVLKV SHIVA 11[(1-16)ME(2-9]-COOH 23 Linear L None Free Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =180 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHHHHHHHHHHTSCC
1834 None 2005 FAKLLAKALKLKL FLAK 50N 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =250 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHTTSCC
1986 None 2005 FAKLLAKALKLKL FLAK 50N 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =170 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHTTSCC
2138 None 2005 FAKLLAKALKLKL FLAK 50N 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =160 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHTTSCC
2290 None 2005 FAKLLAKALKLKL FLAK 50N 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =160 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHTTSCC
2443 None 2005 FAKLLAKALKLKL FLAK 50N 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =340 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHTTSCC
2586 None 2005 FAKLLAKALKLKL FLAK 50N 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =730 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHTTSCC
2729 None 2005 FAKLLAKALKLKL FLAK 50N 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =170 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHTTSCC
1835 None 2005 FAKLLAKALKKAL FLAK 50O 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =60 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHTTTC
1987 None 2005 FAKLLAKALKKAL FLAK 50O 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =57 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHTTTC
2139 None 2005 FAKLLAKALKKAL FLAK 50O 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =60 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2291 None 2005 FAKLLAKALKKAL FLAK 50O 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =60 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2444 None 2005 FAKLLAKALKKAL FLAK 50O 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =27 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHTTTC
2587 None 2005 FAKLLAKALKKAL FLAK 50O 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =66 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHTTTC
2730 None 2005 FAKLLAKALKKAL FLAK 50O 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =43 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHTTTC
1836 None 2005 FAKLLAKALKKL FLAK 50P 12 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =46 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHGGGC
1988 None 2005 FAKLLAKALKKL FLAK 50P 12 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =90 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHGGGC
2140 None 2005 FAKLLAKALKKL FLAK 50P 12 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =75 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHGGGC
2292 None 2005 FAKLLAKALKKL FLAK 50P 12 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =75 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHGGGC
2445 None 2005 FAKLLAKALKKL FLAK 50P 12 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =150 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHGGGC
2588 None 2005 FAKLLAKALKKL FLAK 50P 12 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =330 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHGGGC
2731 None 2005 FAKLLAKALKKL FLAK 50P 12 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =70 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHGGGC
1837 None 2005 KWKLFKKALKKLKKALKKAL CA(1-& HECATE(11/23) 20 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =11 µg/ml 24-h Breast None US_06875744_B2 CCTTHHHHHHHHHHHHTTTC
1989 None 2005 KWKLFKKALKKLKKALKKAL CA(1-& HECATE(11/23) 20 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =54 µg/ml 24-h Colon None US_06875744_B2 CCTTHHHHHHHHHHHHTTTC
2141 None 2005 KWKLFKKALKKLKKALKKAL CA(1-& HECATE(11/23) 20 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =100 µg/ml 24-h Skin None US_06875744_B2 CCTTHHHHHHHHHHHHTTTC
2293 None 2005 KWKLFKKALKKLKKALKKAL CA(1-& HECATE(11/23) 20 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =100 µg/ml 24-h Skin None US_06875744_B2 CCTTHHHHHHHHHHHHTTTC
2446 None 2005 KWKLFKKALKKLKKALKKAL CA(1-& HECATE(11/23) 20 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =52 µg/ml 24-h Lung None US_06875744_B2 CCTTHHHHHHHHHHHHTTTC
2589 None 2005 KWKLFKKALKKLKKALKKAL CA(1-& HECATE(11/23) 20 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =18 µg/ml 24-h Prostate None US_06875744_B2 CCTTHHHHHHHHHHHHTTTC
2732 None 2005 KWKLFKKALKKLKKALKKAL CA(1-& HECATE(11/23) 20 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =130 µg/ml 24-h Cervix None US_06875744_B2 CCTTHHHHHHHHHHHHTTTC
1838 None 2005 KIAKVALAKLGIGAVLKVLTTGL PYL-ME 23 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =635 µg/ml 24-h Breast None US_06875744_B2 CCGGGTCGGGGGGSCHHHHHCCC
1990 None 2005 KIAKVALAKLGIGAVLKVLTTGL PYL-ME 23 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CCGGGTCGGGGGGSCHHHHHCCC
2142 None 2005 KIAKVALAKLGIGAVLKVLTTGL PYL-ME 23 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay Not Available 24-h Skin None US_06875744_B2 CCGGGTCGGGGGGSCHHHHHCCC
2294 None 2005 KIAKVALAKLGIGAVLKVLTTGL PYL-ME 23 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay Not Available 24-h Skin None US_06875744_B2 CCGGGTCGGGGGGSCHHHHHCCC
2447 None 2005 KIAKVALAKLGIGAVLKVLTTGL PYL-ME 23 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CCGGGTCGGGGGGSCHHHHHCCC
2590 None 2005 KIAKVALAKLGIGAVLKVLTTGL PYL-ME 23 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay Not Available 24-h Prostate None US_06875744_B2 CCGGGTCGGGGGGSCHHHHHCCC
2733 None 2005 KIAKVALAKLGIGAVLKVLTTGL PYL-ME 23 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CCGGGTCGGGGGGSCHHHHHCCC
1839 None 2005 FAKKLAKLAKKL FLAG26-D1 12 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =620 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHTTC
1991 None 2005 FAKKLAKLAKKL FLAG26-D1 12 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =570 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHTTC
2143 None 2005 FAKKLAKLAKKL FLAG26-D1 12 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =690 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTC
2295 None 2005 FAKKLAKLAKKL FLAG26-D1 12 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =690 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTC
2448 None 2005 FAKKLAKLAKKL FLAG26-D1 12 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =920 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHTTC
2591 None 2005 FAKKLAKLAKKL FLAG26-D1 12 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHTTC
2734 None 2005 FAKKLAKLAKKL FLAG26-D1 12 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =700 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHTTC
1840 None 2005 MPKEKVFLKIEKMGRNIRN VISHNU3 19 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Breast None US_06875744_B2 CCCCSCSCCCSSSSCCCCC
1992 None 2005 MPKEKVFLKIEKMGRNIRN VISHNU3 19 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CCCCSCSCCCSSSSCCCCC
2144 None 2005 MPKEKVFLKIEKMGRNIRN VISHNU3 19 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CCCCSCSCCCSSSSCCCCC
2296 None 2005 MPKEKVFLKIEKMGRNIRN VISHNU3 19 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CCCCSCSCCCSSSSCCCCC
2449 None 2005 MPKEKVFLKIEKMGRNIRN VISHNU3 19 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CCCCSCSCCCSSSSCCCCC
2592 None 2005 MPKEKVFLKIEKMGRNIRN VISHNU3 19 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CCCCSCSCCCSSSSCCCCC
2735 None 2005 MPKEKVFLKIEKMGRNIRN VISHNU3 19 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CCCCSCSCCCSSSSCCCCC
1841 None 2005 GIGAVLKVLTTGLPALISWIKRKRQQ MELITTIIN 26 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =9 µg/ml 24-h Breast None US_06875744_B2 CCTTHHHHSSSSCTTHHHHHHHHHCC
1993 None 2005 GIGAVLKVLTTGLPALISWIKRKRQQ MELITTIIN 26 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =23 µg/ml 24-h Colon None US_06875744_B2 CCTTHHHHSSSSCTTHHHHHHHHHCC
2145 None 2005 GIGAVLKVLTTGLPALISWIKRKRQQ MELITTIIN 26 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =18 µg/ml 24-h Skin None US_06875744_B2 CCTTHHHHSSSSCTTHHHHHHHHHCC
2297 None 2005 GIGAVLKVLTTGLPALISWIKRKRQQ MELITTIIN 26 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =18 µg/ml 24-h Skin None US_06875744_B2 CCTTHHHHSSSSCTTHHHHHHHHHCC
2450 None 2005 GIGAVLKVLTTGLPALISWIKRKRQQ MELITTIIN 26 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =25 µg/ml 24-h Lung None US_06875744_B2 CCTTHHHHSSSSCTTHHHHHHHHHCC
2593 None 2005 GIGAVLKVLTTGLPALISWIKRKRQQ MELITTIIN 26 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =13 µg/ml 24-h Prostate None US_06875744_B2 CCTTHHHHSSSSCTTHHHHHHHHHCC
2736 None 2005 GIGAVLKVLTTGLPALISWIKRKRQQ MELITTIIN 26 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =35 µg/ml 24-h Cervix None US_06875744_B2 CCTTHHHHSSSSCTTHHHHHHHHHCC
3337 23893605 2013 GIGAVLKVLTTGLPALISWIKRKRQQ Melittin 26 Linear L None Amidation Free Antimicrobial Synthetic peptide E42/02 Skin Cancer MTT/MTS assay IC50 =3.2 ± 0.1 µM 30-Min Skin None None CCTTHHHHSSSSCTTHHHHHHHHHCC
3338 23893605 2013 GIGAVLKVLTTGLPALISWIKRKRQQ Melittin 26 Linear L None Amidation Free Antimicrobial Synthetic peptide E42/02 Skin Cancer MTT/MTS assay IC50 =2.1 ± 0.1 µM 2-h Skin None None CCTTHHHHSSSSCTTHHHHHHHHHCC
3339 23893605 2013 GIGAVLKVLTTGLPALISWIKRKRQQ Melittin 26 Linear L None Amidation Free Antimicrobial Synthetic peptide E42/02 Skin Cancer MTT/MTS assay IC50 =1.8 ± 0.1 µM 4-h Skin None None CCTTHHHHSSSSCTTHHHHHHHHHCC
3340 23893605 2013 GIGAVLKVLTTGLPALISWIKRKRQQ Melittin 26 Linear L None Amidation Free Antimicrobial Synthetic peptide E42/02 Skin Cancer MTT/MTS assay IC50 =1.4 ± 0.1 µM 24-h Skin None None CCTTHHHHSSSSCTTHHHHHHHHHCC
3791 23893605 2013 GIGAVLKVLTTGLPALISWIKRKRQQ Melittin 26 Linear L None Amidation Free Anticancer Natural component of bee venom E42/02 Skin Cancer MTT/MTS assay IC50= 1.4±0.1 µM 4-h Skin None None CCTTHHHHSSSSCTTHHHHHHHHHCC
3797 23893605 2013 GIGAVLKVLTTGLPALISWIKRKRQQ Melittin 26 Linear L None Amidation Free Anticancer Natural component of bee venom E42/02 Skin Cancer MTT/MTS assay IC50= 3.2±0.1 µM 30-Min Skin None None CCTTHHHHSSSSCTTHHHHHHHHHCC
3803 23893605 2013 GIGAVLKVLTTGLPALISWIKRKRQQ Melittin 26 Linear L None Amidation Free Anticancer Natural component of bee venom E42/02 Skin Cancer MTT/MTS assay IC50= 2.1±0.1 µM 2-h Skin None None CCTTHHHHSSSSCTTHHHHHHHHHCC
3809 23893605 2013 GIGAVLKVLTTGLPALISWIKRKRQQ Melittin 26 Linear L None Amidation Free Anticancer Natural component of bee venom E42/02 Skin Cancer MTT/MTS assay IC50= 1.8±0.1 µM 4-h Skin None None CCTTHHHHSSSSCTTHHHHHHHHHCC
3815 23893605 2013 GIGAVLKVLTTGLPALISWIKRKRQQ Melittin 26 Linear L None Amidation Free Anticancer Natural component of bee venom E42/02 Skin Cancer MTT/MTS assay IC50= 1.4±0.1 µM 24-h Skin None None CCTTHHHHSSSSCTTHHHHHHHHHCC
5011 24661024 2014 GIGAVLKVLTTGLPALISWIKRKRQQ Melittin 26 Linear L None Free Free Antimicrobial Main component of honey bee venom SCC25 Skin Cancer Cell Viability assay 102.9 ± 4.1% cell growth inhibition at 1 µM 24-h Skin None None CCTTHHHHSSSSCTTHHHHHHHHHCC
1842 None 2005 FAKKLAKLAKKLAKAL FLAK26-D2 16 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHGGGGGCC
1994 None 2005 FAKKLAKLAKKLAKAL FLAK26-D2 16 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHGGGGGCC
2146 None 2005 FAKKLAKLAKKLAKAL FLAK26-D2 16 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHGGGGGCC
2298 None 2005 FAKKLAKLAKKLAKAL FLAK26-D2 16 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHGGGGGCC
2451 None 2005 FAKKLAKLAKKLAKAL FLAK26-D2 16 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHGGGGGCC
2594 None 2005 FAKKLAKLAKKLAKAL FLAK26-D2 16 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHGGGGGCC
2737 None 2005 FAKKLAKLAKKLAKAL FLAK26-D2 16 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHGGGGGCC
1843 None 2005 FAKKLLAKALKL FLAG26-D3 12 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =180 µg/ml 24-h Breast None US_06875744_B2 CHHHHTHHHHTC
1995 None 2005 FAKKLLAKALKL FLAG26-D3 12 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =325 µg/ml 24-h Colon None US_06875744_B2 CHHHHTHHHHTC
2147 None 2005 FAKKLLAKALKL FLAG26-D3 12 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =400 µg/ml 24-h Skin None US_06875744_B2 CHHHHTHHHHTC
2299 None 2005 FAKKLLAKALKL FLAG26-D3 12 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =400 µg/ml 24-h Skin None US_06875744_B2 CHHHHTHHHHTC
2452 None 2005 FAKKLLAKALKL FLAG26-D3 12 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =95 µg/ml 24-h Lung None US_06875744_B2 CHHHHTHHHHTC
2595 None 2005 FAKKLLAKALKL FLAG26-D3 12 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHTHHHHTC
2738 None 2005 FAKKLLAKALKL FLAG26-D3 12 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =540 µg/ml 24-h Cervix None US_06875744_B2 CHHHHTHHHHTC
1844 None 2005 FAKFLAKFLKKAL FLAK50 Q1 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =35 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHTTTC
1996 None 2005 FAKFLAKFLKKAL FLAK50 Q1 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =27 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHTTTC
2148 None 2005 FAKFLAKFLKKAL FLAK50 Q1 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =26 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2300 None 2005 FAKFLAKFLKKAL FLAK50 Q1 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =26 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2453 None 2005 FAKFLAKFLKKAL FLAK50 Q1 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =8 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHTTTC
2596 None 2005 FAKFLAKFLKKAL FLAK50 Q1 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =11 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHTTTC
2739 None 2005 FAKFLAKFLKKAL FLAK50 Q1 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =7 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHTTTC
1845 None 2005 FAKLLFKALKKAL FLAK50 Q2 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =500 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHTTTC
1997 None 2005 FAKLLFKALKKAL FLAK50 Q2 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =800 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHTTTC
2149 None 2005 FAKLLFKALKKAL FLAK50 Q2 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =445 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2301 None 2005 FAKLLFKALKKAL FLAK50 Q2 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =445 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2454 None 2005 FAKLLFKALKKAL FLAK50 Q2 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =470 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHTTTC
2597 None 2005 FAKLLFKALKKAL FLAK50 Q2 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =640 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHTTTC
2740 None 2005 FAKLLFKALKKAL FLAK50 Q2 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =660 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHTTTC
1846 None 2005 FAKLLAKFLKKAL FLAK50 Q3 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =150 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHTTTC
1998 None 2005 FAKLLAKFLKKAL FLAK50 Q3 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =180 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHTTTC
2150 None 2005 FAKLLAKFLKKAL FLAK50 Q3 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =115 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2302 None 2005 FAKLLAKFLKKAL FLAK50 Q3 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =115 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2455 None 2005 FAKLLAKFLKKAL FLAK50 Q3 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =50 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHTTTC
2598 None 2005 FAKLLAKFLKKAL FLAK50 Q3 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =240 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHTTTC
2741 None 2005 FAKLLAKFLKKAL FLAK50 Q3 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =190 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHTTTC
1847 None 2005 FAKLLAKAFKKAL FLAK50 Q4 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =730 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHHC
1999 None 2005 FAKLLAKAFKKAL FLAK50 Q4 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHHHC
2151 None 2005 FAKLLAKAFKKAL FLAK50 Q4 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHC
2303 None 2005 FAKLLAKAFKKAL FLAK50 Q4 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHC
2456 None 2005 FAKLLAKAFKKAL FLAK50 Q4 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHHHC
2599 None 2005 FAKLLAKAFKKAL FLAK50 Q4 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHHHC
2742 None 2005 FAKLLAKAFKKAL FLAK50 Q4 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHHHC
1848 None 2005 FAKLFAKAFKKAL FLAK50 Q5 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHHC
2000 None 2005 FAKLFAKAFKKAL FLAK50 Q5 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHHHC
2152 None 2005 FAKLFAKAFKKAL FLAK50 Q5 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHC
2304 None 2005 FAKLFAKAFKKAL FLAK50 Q5 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHC
2457 None 2005 FAKLFAKAFKKAL FLAK50 Q5 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHHHC
2600 None 2005 FAKLFAKAFKKAL FLAK50 Q5 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHHHC
2743 None 2005 FAKLFAKAFKKAL FLAK50 Q5 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHHHC
1849 None 2005 FAKLLAKALKKFL FLAK50 Q6 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =70 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHTTTC
2001 None 2005 FAKLLAKALKKFL FLAK50 Q6 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =115 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHTTTC
2153 None 2005 FAKLLAKALKKFL FLAK50 Q6 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =135 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2305 None 2005 FAKLLAKALKKFL FLAK50 Q6 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =135 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2458 None 2005 FAKLLAKALKKFL FLAK50 Q6 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =74 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHTTTC
2601 None 2005 FAKLLAKALKKFL FLAK50 Q6 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =330 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHTTTC
2744 None 2005 FAKLLAKALKKFL FLAK50 Q6 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =87 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHTTTC
1850 None 2005 FAKLLAKALKKFAL FLAK50 Q7 14 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =54 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHTTSCC
2002 None 2005 FAKLLAKALKKFAL FLAK50 Q7 14 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =46 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHTTSCC
2154 None 2005 FAKLLAKALKKFAL FLAK50 Q7 14 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =36 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTSCC
2306 None 2005 FAKLLAKALKKFAL FLAK50 Q7 14 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =36 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTSCC
2459 None 2005 FAKLLAKALKKFAL FLAK50 Q7 14 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =33 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHTTSCC
2602 None 2005 FAKLLAKALKKFAL FLAK50 Q7 14 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =140 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHTTSCC
2745 None 2005 FAKLLAKALKKFAL FLAK50 Q7 14 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =30 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHTTSCC
1851 None 2005 FAKLLAKLAKKFAL FLAK50 Q8 14 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =730 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHSSCC
2003 None 2005 FAKLLAKLAKKFAL FLAK50 Q8 14 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =630 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHSSCC
2155 None 2005 FAKLLAKLAKKFAL FLAK50 Q8 14 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =660 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHSSCC
2307 None 2005 FAKLLAKLAKKFAL FLAK50 Q8 14 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =660 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHSSCC
2460 None 2005 FAKLLAKLAKKFAL FLAK50 Q8 14 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =620 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHSSCC
2603 None 2005 FAKLLAKLAKKFAL FLAK50 Q8 14 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHSSCC
2746 None 2005 FAKLLAKLAKKFAL FLAK50 Q8 14 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =810 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHSSCC
1852 None 2005 FAKLFAKLAKKFAL FLAK50 Q9 14 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =400 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHTTTTC
2004 None 2005 FAKLFAKLAKKFAL FLAK50 Q9 14 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =800 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHTTTTC
2156 None 2005 FAKLFAKLAKKFAL FLAK50 Q9 14 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =670 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTTC
2308 None 2005 FAKLFAKLAKKFAL FLAK50 Q9 14 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =670 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTTC
2461 None 2005 FAKLFAKLAKKFAL FLAK50 Q9 14 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =460 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHTTTTC
2604 None 2005 FAKLFAKLAKKFAL FLAK50 Q9 14 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHTTTTC
2747 None 2005 FAKLFAKLAKKFAL FLAK50 Q9 14 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =830 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHTTTTC
1853 None 2005 FKLAFKLAKKAFL FLAK50 Q10 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =360 µg/ml 24-h Breast None US_06875744_B2 CCTTHHHHHHHTC
2005 None 2005 FKLAFKLAKKAFL FLAK50 Q10 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =570 µg/ml 24-h Colon None US_06875744_B2 CCTTHHHHHHHTC
2157 None 2005 FKLAFKLAKKAFL FLAK50 Q10 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =700 µg/ml 24-h Skin None US_06875744_B2 CCTTHHHHHHHTC
2309 None 2005 FKLAFKLAKKAFL FLAK50 Q10 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =700 µg/ml 24-h Skin None US_06875744_B2 CCTTHHHHHHHTC
2462 None 2005 FKLAFKLAKKAFL FLAK50 Q10 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =830 µg/ml 24-h Lung None US_06875744_B2 CCTTHHHHHHHTC
2605 None 2005 FKLAFKLAKKAFL FLAK50 Q10 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =800 µg/ml 24-h Prostate None US_06875744_B2 CCTTHHHHHHHTC
2748 None 2005 FKLAFKLAKKAFL FLAK50 Q10 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =780 µg/ml 24-h Cervix None US_06875744_B2 CCTTHHHHHHHTC
1854 None 2005 FAKLLAKLAK FLAK50 T1 10 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =615 µg/ml 24-h Breast None US_06875744_B2 CHHHHTTTCC
2006 None 2005 FAKLLAKLAK FLAK50 T1 10 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CHHHHTTTCC
2158 None 2005 FAKLLAKLAK FLAK50 T1 10 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =635 µg/ml 24-h Skin None US_06875744_B2 CHHHHTTTCC
2310 None 2005 FAKLLAKLAK FLAK50 T1 10 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =635 µg/ml 24-h Skin None US_06875744_B2 CHHHHTTTCC
2463 None 2005 FAKLLAKLAK FLAK50 T1 10 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CHHHHTTTCC
2606 None 2005 FAKLLAKLAK FLAK50 T1 10 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHTTTCC
2749 None 2005 FAKLLAKLAK FLAK50 T1 10 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =940 µg/ml 24-h Cervix None US_06875744_B2 CHHHHTTTCC
1855 None 2005 FAKLLAKLAKKVL FLAK50 T2 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =18 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHTTTC
2007 None 2005 FAKLLAKLAKKVL FLAK50 T2 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =9 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHTTTC
2159 None 2005 FAKLLAKLAKKVL FLAK50 T2 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =10 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2311 None 2005 FAKLLAKLAKKVL FLAK50 T2 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =10 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2464 None 2005 FAKLLAKLAKKVL FLAK50 T2 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =30 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHTTTC
2607 None 2005 FAKLLAKLAKKVL FLAK50 T2 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =10 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHTTTC
2750 None 2005 FAKLLAKLAKKVL FLAK50 T2 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =14 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHTTTC
1856 None 2005 FAKLLAKLAKKIL FLAK50 T3 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =90 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHTTTC
2008 None 2005 FAKLLAKLAKKIL FLAK50 T3 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =125 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHTTTC
2160 None 2005 FAKLLAKLAKKIL FLAK50 T3 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =220 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2312 None 2005 FAKLLAKLAKKIL FLAK50 T3 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =220 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2465 None 2005 FAKLLAKLAKKIL FLAK50 T3 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =76 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHTTTC
2608 None 2005 FAKLLAKLAKKIL FLAK50 T3 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =145 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHTTTC
2751 None 2005 FAKLLAKLAKKIL FLAK50 T3 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =220 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHTTTC
1857 None 2005 FAKLLAKLAKKEL FLAK50 T4 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHTTTCC
2009 None 2005 FAKLLAKLAKKEL FLAK50 T4 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHTTTCC
2161 None 2005 FAKLLAKLAKKEL FLAK50 T4 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHTTTCC
2313 None 2005 FAKLLAKLAKKEL FLAK50 T4 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHTTTCC
2466 None 2005 FAKLLAKLAKKEL FLAK50 T4 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHTTTCC
2609 None 2005 FAKLLAKLAKKEL FLAK50 T4 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHTTTCC
2752 None 2005 FAKLLAKLAKKEL FLAK50 T4 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHTTTCC
1858 None 2005 FAKLLAKLAKKSL FLAK50 T5 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =440 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHTTC
2010 None 2005 FAKLLAKLAKKSL FLAK50 T5 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =400 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHTTC
2162 None 2005 FAKLLAKLAKKSL FLAK50 T5 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =535 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHTTC
2314 None 2005 FAKLLAKLAKKSL FLAK50 T5 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =535 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHTTC
2467 None 2005 FAKLLAKLAKKSL FLAK50 T5 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =770 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHTTC
2610 None 2005 FAKLLAKLAKKSL FLAK50 T5 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHTTC
2753 None 2005 FAKLLAKLAKKSL FLAK50 T5 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =610 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHTTC
1859 None 2005 FAKLA FLAK90 5 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =500 µg/ml 24-h Breast None US_06875744_B2 CCSCC
2011 None 2005 FAKLA FLAK90 5 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =530 µg/ml 24-h Colon None US_06875744_B2 CCSCC
2163 None 2005 FAKLA FLAK90 5 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =330 µg/ml 24-h Skin None US_06875744_B2 CCSCC
2315 None 2005 FAKLA FLAK90 5 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =330 µg/ml 24-h Skin None US_06875744_B2 CCSCC
2468 None 2005 FAKLA FLAK90 5 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CCSCC
2611 None 2005 FAKLA FLAK90 5 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CCSCC
2754 None 2005 FAKLA FLAK90 5 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =700 µg/ml 24-h Cervix None US_06875744_B2 CCSCC
1860 None 2005 FAKLF FLAK91 5 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Breast None US_06875744_B2 CCSCC
2012 None 2005 FAKLF FLAK91 5 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =550 µg/ml 24-h Colon None US_06875744_B2 CCSCC
2164 None 2005 FAKLF FLAK91 5 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CCSCC
2316 None 2005 FAKLF FLAK91 5 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CCSCC
2469 None 2005 FAKLF FLAK91 5 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =790 µg/ml 24-h Lung None US_06875744_B2 CCSCC
2612 None 2005 FAKLF FLAK91 5 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CCSCC
2755 None 2005 FAKLF FLAK91 5 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =550 µg/ml 24-h Cervix None US_06875744_B2 CCSCC
1861 None 2005 KAKLF FLAK92 5 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Breast None US_06875744_B2 CCCCC
2013 None 2005 KAKLF FLAK92 5 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CCCCC
2165 None 2005 KAKLF FLAK92 5 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CCCCC
2317 None 2005 KAKLF FLAK92 5 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CCCCC
2470 None 2005 KAKLF FLAK92 5 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CCCCC
2613 None 2005 KAKLF FLAK92 5 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CCCCC
2756 None 2005 KAKLF FLAK92 5 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CCCCC
1862 None 2005 KWKLF FLAK93 5 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =600 µg/ml 24-h Breast None US_06875744_B2 CCCCC
2014 None 2005 KWKLF FLAK93 5 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =555 µg/ml 24-h Colon None US_06875744_B2 CCCCC
2166 None 2005 KWKLF FLAK93 5 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CCCCC
2318 None 2005 KWKLF FLAK93 5 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CCCCC
2471 None 2005 KWKLF FLAK93 5 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CCCCC
2614 None 2005 KWKLF FLAK93 5 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CCCCC
2757 None 2005 KWKLF FLAK93 5 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CCCCC
1863 None 2005 FGKGIGKVGKKLL FLAK50 Z1 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Breast None US_06875744_B2 CCCCCCCSSCCCC
2015 None 2005 FGKGIGKVGKKLL FLAK50 Z1 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CCCCCCCSSCCCC
2167 None 2005 FGKGIGKVGKKLL FLAK50 Z1 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CCCCCCCSSCCCC
2319 None 2005 FGKGIGKVGKKLL FLAK50 Z1 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CCCCCCCSSCCCC
2472 None 2005 FGKGIGKVGKKLL FLAK50 Z1 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CCCCCCCSSCCCC
2615 None 2005 FGKGIGKVGKKLL FLAK50 Z1 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CCCCCCCSSCCCC
2758 None 2005 FGKGIGKVGKKLL FLAK50 Z1 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CCCCCCCSSCCCC
1864 None 2005 FAFGKGIGKVGKKLL FLAK50 Z2 15 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Breast None US_06875744_B2 CCSTTCCGGGTTCCC
2016 None 2005 FAFGKGIGKVGKKLL FLAK50 Z2 15 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CCSTTCCGGGTTCCC
2168 None 2005 FAFGKGIGKVGKKLL FLAK50 Z2 15 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CCSTTCCGGGTTCCC
2320 None 2005 FAFGKGIGKVGKKLL FLAK50 Z2 15 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CCSTTCCGGGTTCCC
2473 None 2005 FAFGKGIGKVGKKLL FLAK50 Z2 15 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CCSTTCCGGGTTCCC
2616 None 2005 FAFGKGIGKVGKKLL FLAK50 Z2 15 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CCSTTCCGGGTTCCC
2759 None 2005 FAFGKGIGKVGKKLL FLAK50 Z2 15 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CCSTTCCGGGTTCCC
1865 None 2005 FAKAIAKIAFGKGIGKVGKKLL FLAK50 Z3 22 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHCCCSHHHHCCCC
2017 None 2005 FAKAIAKIAFGKGIGKVGKKLL FLAK50 Z3 22 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =740 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHCCCSHHHHCCCC
2169 None 2005 FAKAIAKIAFGKGIGKVGKKLL FLAK50 Z3 22 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHCCCSHHHHCCCC
2321 None 2005 FAKAIAKIAFGKGIGKVGKKLL FLAK50 Z3 22 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHCCCSHHHHCCCC
2474 None 2005 FAKAIAKIAFGKGIGKVGKKLL FLAK50 Z3 22 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHCCCSHHHHCCCC
2617 None 2005 FAKAIAKIAFGKGIGKVGKKLL FLAK50 Z3 22 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHCCCSHHHHCCCC
2760 None 2005 FAKAIAKIAFGKGIGKVGKKLL FLAK50 Z3 22 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHCCCSHHHHCCCC
1866 None 2005 FAKLWAKLAFGKGIGKVGKKLL FLAK50 Z4 22 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =54 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHTTTCCCCSSSCSCC
2018 None 2005 FAKLWAKLAFGKGIGKVGKKLL FLAK50 Z4 22 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =80 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHTTTCCCCSSSCSCC
2170 None 2005 FAKLWAKLAFGKGIGKVGKKLL FLAK50 Z4 22 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =155 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHTTTCCCCSSSCSCC
2322 None 2005 FAKLWAKLAFGKGIGKVGKKLL FLAK50 Z4 22 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =155 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHTTTCCCCSSSCSCC
2475 None 2005 FAKLWAKLAFGKGIGKVGKKLL FLAK50 Z4 22 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =115 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHTTTCCCCSSSCSCC
2618 None 2005 FAKLWAKLAFGKGIGKVGKKLL FLAK50 Z4 22 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =310 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHTTTCCCCSSSCSCC
2761 None 2005 FAKLWAKLAFGKGIGKVGKKLL FLAK50 Z4 22 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =215 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHTTTCCCCSSSCSCC
1867 None 2005 FAKLWAKLAKKL FLAK50 Z5 12 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =500 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHTTC
2019 None 2005 FAKLWAKLAKKL FLAK50 Z5 12 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =600 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHTTC
2171 None 2005 FAKLWAKLAKKL FLAK50 Z5 12 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =530 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTC
2323 None 2005 FAKLWAKLAKKL FLAK50 Z5 12 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =530 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTC
2476 None 2005 FAKLWAKLAKKL FLAK50 Z5 12 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =450 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHTTC
2619 None 2005 FAKLWAKLAKKL FLAK50 Z5 12 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =900 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHTTC
2762 None 2005 FAKLWAKLAKKL FLAK50 Z5 12 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =400 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHTTC
1868 None 2005 FAKGVGKVGKKAL FLAK50 Z6 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Breast None US_06875744_B2 CCSCCCSSSCSCC
2020 None 2005 FAKGVGKVGKKAL FLAK50 Z6 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CCSCCCSSSCSCC
2172 None 2005 FAKGVGKVGKKAL FLAK50 Z6 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CCSCCCSSSCSCC
2324 None 2005 FAKGVGKVGKKAL FLAK50 Z6 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CCSCCCSSSCSCC
2477 None 2005 FAKGVGKVGKKAL FLAK50 Z6 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CCSCCCSSSCSCC
2620 None 2005 FAKGVGKVGKKAL FLAK50 Z6 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CCSCCCSSSCSCC
2763 None 2005 FAKGVGKVGKKAL FLAK50 Z6 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CCSCCCSSSCSCC
1869 None 2005 FAFGKGIGKIGKKGL FLAK50 Z7 15 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Breast None US_06875744_B2 CCCCCCCCCCSCCCC
2021 None 2005 FAFGKGIGKIGKKGL FLAK50 Z7 15 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CCCCCCCCCCSCCCC
2173 None 2005 FAFGKGIGKIGKKGL FLAK50 Z7 15 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CCCCCCCCCCSCCCC
2325 None 2005 FAFGKGIGKIGKKGL FLAK50 Z7 15 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CCCCCCCCCCSCCCC
2478 None 2005 FAFGKGIGKIGKKGL FLAK50 Z7 15 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CCCCCCCCCCSCCCC
2621 None 2005 FAFGKGIGKIGKKGL FLAK50 Z7 15 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CCCCCCCCCCSCCCC
2764 None 2005 FAFGKGIGKIGKKGL FLAK50 Z7 15 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CCCCCCCCCCSCCCC
1870 None 2005 FAKIIAKIAKIAKKIL FLAK50 Z8 16 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =625 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHHTTTC
2022 None 2005 FAKIIAKIAKIAKKIL FLAK50 Z8 16 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHHHTTTC
2174 None 2005 FAKIIAKIAKIAKKIL FLAK50 Z8 16 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =525 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHTTTC
2326 None 2005 FAKIIAKIAKIAKKIL FLAK50 Z8 16 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =525 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHTTTC
2479 None 2005 FAKIIAKIAKIAKKIL FLAK50 Z8 16 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =850 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHHHTTTC
2622 None 2005 FAKIIAKIAKIAKKIL FLAK50 Z8 16 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHHHTTTC
2765 None 2005 FAKIIAKIAKIAKKIL FLAK50 Z8 16 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHHHTTTC
1871 None 2005 FAFAKIIAKIAKKII FLAK50 Z9 15 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Breast None US_06875744_B2 CCTHHHHHHHHTTTC
2023 None 2005 FAFAKIIAKIAKKII FLAK50 Z9 15 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CCTHHHHHHHHTTTC
2175 None 2005 FAFAKIIAKIAKKII FLAK50 Z9 15 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CCTHHHHHHHHTTTC
2327 None 2005 FAFAKIIAKIAKKII FLAK50 Z9 15 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CCTHHHHHHHHTTTC
2480 None 2005 FAFAKIIAKIAKKII FLAK50 Z9 15 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CCTHHHHHHHHTTTC
2623 None 2005 FAFAKIIAKIAKKII FLAK50 Z9 15 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CCTHHHHHHHHTTTC
2766 None 2005 FAFAKIIAKIAKKII FLAK50 Z9 15 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =285 µg/ml 24-h Cervix None US_06875744_B2 CCTHHHHHHHHTTTC
1872 None 2005 FALALKA FLAK94 7 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =430 µg/ml 24-h Breast None US_06875744_B2 CHHHHTC
2024 None 2005 FALALKA FLAK94 7 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =560 µg/ml 24-h Colon None US_06875744_B2 CHHHHTC
2176 None 2005 FALALKA FLAK94 7 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =465 µg/ml 24-h Skin None US_06875744_B2 CHHHHTC
2328 None 2005 FALALKA FLAK94 7 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =465 µg/ml 24-h Skin None US_06875744_B2 CHHHHTC
2481 None 2005 FALALKA FLAK94 7 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CHHHHTC
2624 None 2005 FALALKA FLAK94 7 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay Not Available 24-h Prostate None US_06875744_B2 CHHHHTC
2767 None 2005 FALALKA FLAK94 7 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CHHHHTC
1873 None 2005 KWKLAKKALALL FLAK93B 12 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =44 µg/ml 24-h Breast None US_06875744_B2 CCHHHHHHTTCC
2025 None 2005 KWKLAKKALALL FLAK93B 12 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =38 µg/ml 24-h Colon None US_06875744_B2 CCHHHHHHTTCC
2177 None 2005 KWKLAKKALALL FLAK93B 12 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =38 µg/ml 24-h Skin None US_06875744_B2 CCHHHHHHTTCC
2329 None 2005 KWKLAKKALALL FLAK93B 12 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =38 µg/ml 24-h Skin None US_06875744_B2 CCHHHHHHTTCC
2482 None 2005 KWKLAKKALALL FLAK93B 12 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =115 µg/ml 24-h Lung None US_06875744_B2 CCHHHHHHTTCC
2625 None 2005 KWKLAKKALALL FLAK93B 12 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =60 µg/ml 24-h Prostate None US_06875744_B2 CCHHHHHHTTCC
2768 None 2005 KWKLAKKALALL FLAK93B 12 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =55 µg/ml 24-h Cervix None US_06875744_B2 CCHHHHHHTTCC
1874 None 2005 FAKIIAKIAKKI FLAK50 Z10 12 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHTTC
2026 None 2005 FAKIIAKIAKKI FLAK50 Z10 12 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHTTC
2178 None 2005 FAKIIAKIAKKI FLAK50 Z10 12 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTC
2330 None 2005 FAKIIAKIAKKI FLAK50 Z10 12 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTC
2483 None 2005 FAKIIAKIAKKI FLAK50 Z10 12 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHTTC
2626 None 2005 FAKIIAKIAKKI FLAK50 Z10 12 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHTTC
2769 None 2005 FAKIIAKIAKKI FLAK50 Z10 12 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHTTC
1875 None 2005 FALALKALKKAL FLAK96 12 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =150 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHTTC
2027 None 2005 FALALKALKKAL FLAK96 12 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =285 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHTTC
2179 None 2005 FALALKALKKAL FLAK96 12 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =250 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTC
2331 None 2005 FALALKALKKAL FLAK96 12 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =250 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTC
2484 None 2005 FALALKALKKAL FLAK96 12 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =225 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHTTC
2627 None 2005 FALALKALKKAL FLAK96 12 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =350 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHTTC
2770 None 2005 FALALKALKKAL FLAK96 12 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =275 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHTTC
1876 None 2005 FALKALKK FLAK97 8 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Breast None US_06875744_B2 CBTTBSCC
2028 None 2005 FALKALKK FLAK97 8 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CBTTBSCC
2180 None 2005 FALKALKK FLAK97 8 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CBTTBSCC
2332 None 2005 FALKALKK FLAK97 8 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CBTTBSCC
2485 None 2005 FALKALKK FLAK97 8 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CBTTBSCC
2628 None 2005 FALKALKK FLAK97 8 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CBTTBSCC
2771 None 2005 FALKALKK FLAK97 8 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =240 µg/ml 24-h Cervix None US_06875744_B2 CBTTBSCC
1877 None 2005 KYKKALKKLAKLL FLAK98 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =110 µg/ml 24-h Breast None US_06875744_B2 CGGGGHHHHTTTC
2029 None 2005 KYKKALKKLAKLL FLAK98 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =380 µg/ml 24-h Colon None US_06875744_B2 CGGGGHHHHTTTC
2181 None 2005 KYKKALKKLAKLL FLAK98 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =185 µg/ml 24-h Skin None US_06875744_B2 CGGGGHHHHTTTC
2333 None 2005 KYKKALKKLAKLL FLAK98 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =185 µg/ml 24-h Skin None US_06875744_B2 CGGGGHHHHTTTC
2486 None 2005 KYKKALKKLAKLL FLAK98 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =93 µg/ml 24-h Lung None US_06875744_B2 CGGGGHHHHTTTC
2629 None 2005 KYKKALKKLAKLL FLAK98 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =440 µg/ml 24-h Prostate None US_06875744_B2 CGGGGHHHHTTTC
2772 None 2005 KYKKALKKLAKLL FLAK98 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =640 µg/ml 24-h Cervix None US_06875744_B2 CGGGGHHHHTTTC
1878 None 2005 FKRLAKIKVLRLAKIKR FKRLA 17 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =106 µg/ml 24-h Breast None US_06875744_B2 CCCCTTCTTCCSTTSCC
2030 None 2005 FKRLAKIKVLRLAKIKR FKRLA 17 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =185 µg/ml 24-h Colon None US_06875744_B2 CCCCTTCTTCCSTTSCC
2182 None 2005 FKRLAKIKVLRLAKIKR FKRLA 17 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =110 µg/ml 24-h Skin None US_06875744_B2 CCCCTTCTTCCSTTSCC
2334 None 2005 FKRLAKIKVLRLAKIKR FKRLA 17 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =110 µg/ml 24-h Skin None US_06875744_B2 CCCCTTCTTCCSTTSCC
2487 None 2005 FKRLAKIKVLRLAKIKR FKRLA 17 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =93 µg/ml 24-h Lung None US_06875744_B2 CCCCTTCTTCCSTTSCC
2630 None 2005 FKRLAKIKVLRLAKIKR FKRLA 17 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =340 µg/ml 24-h Prostate None US_06875744_B2 CCCCTTCTTCCSTTSCC
2773 None 2005 FKRLAKIKVLRLAKIKR FKRLA 17 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CCCCTTCTTCCSTTSCC
1879 None 2005 FAKLAKKALAKLL FLAK91B 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =315 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHTTTC
2031 None 2005 FAKLAKKALAKLL FLAK91B 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHTTTC
2183 None 2005 FAKLAKKALAKLL FLAK91B 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =330 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2335 None 2005 FAKLAKKALAKLL FLAK91B 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =330 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2488 None 2005 FAKLAKKALAKLL FLAK91B 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =660 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHTTTC
2631 None 2005 FAKLAKKALAKLL FLAK91B 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHTTTC
2774 None 2005 FAKLAKKALAKLL FLAK91B 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHTTTC
1880 None 2005 KAKLAKKALAKLL FLAK92B 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHTTTC
2032 None 2005 KAKLAKKALAKLL FLAK92B 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHTTTC
2184 None 2005 KAKLAKKALAKLL FLAK92B 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2336 None 2005 KAKLAKKALAKLL FLAK92B 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2489 None 2005 KAKLAKKALAKLL FLAK92B 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHTTTC
2632 None 2005 KAKLAKKALAKLL FLAK92B 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHTTTC
2775 None 2005 KAKLAKKALAKLL FLAK92B 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHTTTC
1881 None 2005 KLALKLALKALKAAKLA FLAK99 17 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =160 µg/ml 24-h Breast None US_06875744_B2 CTTHHHHHHHHHHTTTC
2033 None 2005 KLALKLALKALKAAKLA FLAK99 17 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =235 µg/ml 24-h Colon None US_06875744_B2 CTTHHHHHHHHHHTTTC
2185 None 2005 KLALKLALKALKAAKLA FLAK99 17 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =190 µg/ml 24-h Skin None US_06875744_B2 CTTHHHHHHHHHHTTTC
2337 None 2005 KLALKLALKALKAAKLA FLAK99 17 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =190 µg/ml 24-h Skin None US_06875744_B2 CTTHHHHHHHHHHTTTC
2490 None 2005 KLALKLALKALKAAKLA FLAK99 17 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =185 µg/ml 24-h Lung None US_06875744_B2 CTTHHHHHHHHHHTTTC
2633 None 2005 KLALKLALKALKAAKLA FLAK99 17 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =74 µg/ml 24-h Prostate None US_06875744_B2 CTTHHHHHHHHHHTTTC
2776 None 2005 KLALKLALKALKAAKLA FLAK99 17 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =320 µg/ml 24-h Cervix None US_06875744_B2 CTTHHHHHHHHHHTTTC
1882 None 2005 FAKLLAKLAKK FLAK50T6 11 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHSCC
2034 None 2005 FAKLLAKLAKK FLAK50T6 11 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHSCC
2186 None 2005 FAKLLAKLAKK FLAK50T6 11 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHSCC
2338 None 2005 FAKLLAKLAKK FLAK50T6 11 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHSCC
2491 None 2005 FAKLLAKLAKK FLAK50T6 11 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHSCC
2634 None 2005 FAKLLAKLAKK FLAK50T6 11 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHSCC
2777 None 2005 FAKLLAKLAKK FLAK50T6 11 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHSCC
1883 None 2005 FAKLLAKLAKKGL FLAK50T7 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =430 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHTTTTC
2035 None 2005 FAKLLAKLAKKGL FLAK50T7 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =740 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHTTTTC
2187 None 2005 FAKLLAKLAKKGL FLAK50T7 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHTTTTC
2339 None 2005 FAKLLAKLAKKGL FLAK50T7 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHTTTTC
2492 None 2005 FAKLLAKLAKKGL FLAK50T7 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =410 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHTTTTC
2635 None 2005 FAKLLAKLAKKGL FLAK50T7 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHTTTTC
2778 None 2005 FAKLLAKLAKKGL FLAK50T7 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHTTTTC
1884 None 2005 FALKALKKLKKALKKAL FLAK95 17 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =64 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHHHTTTC
2036 None 2005 FALKALKKLKKALKKAL FLAK95 17 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =61 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHHHHTTTC
2188 None 2005 FALKALKKLKKALKKAL FLAK95 17 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =165 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHHTTTC
2340 None 2005 FALKALKKLKKALKKAL FLAK95 17 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =165 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHHTTTC
2493 None 2005 FALKALKKLKKALKKAL FLAK95 17 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =50 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHHHHTTTC
2636 None 2005 FALKALKKLKKALKKAL FLAK95 17 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =97 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHHHHTTTC
2779 None 2005 FALKALKKLKKALKKAL FLAK95 17 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =140 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHHHHTTTC
1885 None 2005 VAKLLAKLAKKVL FLAK50T8 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =315 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHTTTC
2037 None 2005 VAKLLAKLAKKVL FLAK50T8 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =750 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHTTTC
2189 None 2005 VAKLLAKLAKKVL FLAK50T8 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =330 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2341 None 2005 VAKLLAKLAKKVL FLAK50T8 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =330 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2494 None 2005 VAKLLAKLAKKVL FLAK50T8 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =400 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHTTTC
2637 None 2005 VAKLLAKLAKKVL FLAK50T8 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =640 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHTTTC
2780 None 2005 VAKLLAKLAKKVL FLAK50T8 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHTTTC
1886 None 2005 YAKLLAKLAKKAL FLAK50T9 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHTTTC
2038 None 2005 YAKLLAKLAKKAL FLAK50T9 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHTTTC
2190 None 2005 YAKLLAKLAKKAL FLAK50T9 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2342 None 2005 YAKLLAKLAKKAL FLAK50T9 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2495 None 2005 YAKLLAKLAKKAL FLAK50T9 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHTTTC
2638 None 2005 YAKLLAKLAKKAL FLAK50T9 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay Not Available 24-h Prostate None US_06875744_B2 CHHHHHHHHTTTC
2781 None 2005 YAKLLAKLAKKAL FLAK50T9 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHTTTC
1887 None 2005 KLLKLLLKLYKKLLKLL FLAK100-CO2H 17 Linear L None Free Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =135 µg/ml 24-h Breast None US_06875744_B2 CTHHHHHHHGGGTTTTC
2039 None 2005 KLLKLLLKLYKKLLKLL FLAK100-CO2H 17 Linear L None Free Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =345 µg/ml 24-h Colon None US_06875744_B2 CTHHHHHHHGGGTTTTC
2191 None 2005 KLLKLLLKLYKKLLKLL FLAK100-CO2H 17 Linear L None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =520 µg/ml 24-h Skin None US_06875744_B2 CTHHHHHHHGGGTTTTC
2343 None 2005 KLLKLLLKLYKKLLKLL FLAK100-CO2H 17 Linear L None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =520 µg/ml 24-h Skin None US_06875744_B2 CTHHHHHHHGGGTTTTC
2496 None 2005 KLLKLLLKLYKKLLKLL FLAK100-CO2H 17 Linear L None Free Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay Not Available 24-h Lung None US_06875744_B2 CTHHHHHHHGGGTTTTC
2639 None 2005 KLLKLLLKLYKKLLKLL FLAK100-CO2H 17 Linear L None Free Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =260 µg/ml 24-h Prostate None US_06875744_B2 CTHHHHHHHGGGTTTTC
2782 None 2005 KLLKLLLKLYKKLLKLL FLAK100-CO2H 17 Linear L None Free Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CTHHHHHHHGGGTTTTC
1888 None 2005 FAVGLRAIKRALKKLRRGVRKVAKDL FAGVL 26 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =240 µg/ml 24-h Breast None US_06875744_B2 CCCHHHHTHHHHHHHHHHHHHHHHCC
2040 None 2005 FAVGLRAIKRALKKLRRGVRKVAKDL FAGVL 26 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =530 µg/ml 24-h Colon None US_06875744_B2 CCCHHHHTHHHHHHHHHHHHHHHHCC
2192 None 2005 FAVGLRAIKRALKKLRRGVRKVAKDL FAGVL 26 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =600 µg/ml 24-h Skin None US_06875744_B2 CCCHHHHTHHHHHHHHHHHHHHHHCC
2344 None 2005 FAVGLRAIKRALKKLRRGVRKVAKDL FAGVL 26 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =600 µg/ml 24-h Skin None US_06875744_B2 CCCHHHHTHHHHHHHHHHHHHHHHCC
2497 None 2005 FAVGLRAIKRALKKLRRGVRKVAKDL FAGVL 26 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =315 µg/ml 24-h Lung None US_06875744_B2 CCCHHHHTHHHHHHHHHHHHHHHHCC
2640 None 2005 FAVGLRAIKRALKKLRRGVRKVAKDL FAGVL 26 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =375 µg/ml 24-h Prostate None US_06875744_B2 CCCHHHHTHHHHHHHHHHHHHHHHCC
2783 None 2005 FAVGLRAIKRALKKLRRGVRKVAKDL FAGVL 26 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CCCHHHHTHHHHHHHHHHHHHHHHCC
1889 None 2005 KLAKKLAKLAKLAKAL Modelin-5 16 Linear L None Free Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =61 µg/ml 24-h Breast None US_06875744_B2 CTHHHHHHHHHHHTTC
1890 None 2005 KLAKKLAKLAKLAKAL Modelin-5-CO2H 16 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =320 µg/ml 24-h Breast None US_06875744_B2 CTHHHHHHHHHHTTTC
2041 None 2005 KLAKKLAKLAKLAKAL Modelin-5 16 Linear L None Free Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =140 µg/ml 24-h Colon None US_06875744_B2 CTHHHHHHHHHHHTTC
2042 None 2005 KLAKKLAKLAKLAKAL Modelin-5-CO2H 16 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =370 µg/ml 24-h Colon None US_06875744_B2 CTHHHHHHHHHHTTTC
2193 None 2005 KLAKKLAKLAKLAKAL Modelin-5 16 Linear L None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =140 µg/ml 24-h Skin None US_06875744_B2 CTHHHHHHHHHHHTTC
2194 None 2005 KLAKKLAKLAKLAKAL Modelin-5-CO2H 16 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =220 µg/ml 24-h Skin None US_06875744_B2 CTHHHHHHHHHHTTTC
2345 None 2005 KLAKKLAKLAKLAKAL Modelin-5 16 Linear L None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =140 µg/ml 24-h Skin None US_06875744_B2 CTHHHHHHHHHHHTTC
2346 None 2005 KLAKKLAKLAKLAKAL Modelin-5-CO2H 16 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =220 µg/ml 24-h Skin None US_06875744_B2 CTHHHHHHHHHHTTTC
2498 None 2005 KLAKKLAKLAKLAKAL Modelin-5 16 Linear L None Free Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =74 µg/ml 24-h Lung None US_06875744_B2 CTHHHHHHHHHHHTTC
2499 None 2005 KLAKKLAKLAKLAKAL Modelin-5-CO2H 16 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =470 µg/ml 24-h Lung None US_06875744_B2 CTHHHHHHHHHHTTTC
2641 None 2005 KLAKKLAKLAKLAKAL Modelin-5 16 Linear L None Free Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =145 µg/ml 24-h Prostate None US_06875744_B2 CTHHHHHHHHHHHTTC
2642 None 2005 KLAKKLAKLAKLAKAL Modelin-5-CO2H 16 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =450 µg/ml 24-h Prostate None US_06875744_B2 CTHHHHHHHHHHTTTC
2784 None 2005 KLAKKLAKLAKLAKAL Modelin-5 16 Linear L None Free Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =275 µg/ml 24-h Cervix None US_06875744_B2 CTHHHHHHHHHHHTTC
2785 None 2005 KLAKKLAKLAKLAKAL Modelin-5-CO2H 16 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =550 µg/ml 24-h Cervix None US_06875744_B2 CTHHHHHHHHHHTTTC
1891 None 2005 FALALKALKKL FLAK120 9 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =360 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHTTC
2195 None 2005 FALALKALKKL FLAK120 9 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =240 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHTTC
2347 None 2005 FALALKALKKL FLAK120 9 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =240 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHTTC
2500 None 2005 FALALKALKKL FLAK120 9 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =56 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHTTC
2643 None 2005 FALALKALKKL FLAK120 9 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =340 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHTTC
2786 None 2005 FALALKALKKL FLAK120 9 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =400 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHTTC
1892 None 2005 FALAKALKKAL FLAK121 11 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHTTTC
2044 None 2005 FALAKALKKAL FLAK121 11 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHTTTC
2196 None 2005 FALAKALKKAL FLAK121 11 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHTTTC
2348 None 2005 FALAKALKKAL FLAK121 11 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHTTTC
2501 None 2005 FALAKALKKAL FLAK121 11 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHTTTC
2644 None 2005 FALAKALKKAL FLAK121 11 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHTTTC
2787 None 2005 FALAKALKKAL FLAK121 11 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHTTTC
1893 None 2005 FALALKLAKKAL FLAK96B 12 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =230 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHTTTC
2045 None 2005 FALALKLAKKAL FLAK96B 12 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =360 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHTTTC
2197 None 2005 FALALKLAKKAL FLAK96B 12 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =240 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHTTTC
2349 None 2005 FALALKLAKKAL FLAK96B 12 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =240 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHTTTC
2502 None 2005 FALALKLAKKAL FLAK96B 12 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =300 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHTTTC
2645 None 2005 FALALKLAKKAL FLAK96B 12 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =320 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHTTTC
2788 None 2005 FALALKLAKKAL FLAK96B 12 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =325 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHTTTC
1894 None 2005 FALLKL FLAK96G 6 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =630 µg/ml 24-h Breast None US_06875744_B2 CTTTCC
2046 None 2005 FALLKL FLAK96G 6 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CTTTCC
2198 None 2005 FALLKL FLAK96G 6 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =590 µg/ml 24-h Skin None US_06875744_B2 CTTTCC
2350 None 2005 FALLKL FLAK96G 6 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =590 µg/ml 24-h Skin None US_06875744_B2 CTTTCC
2503 None 2005 FALLKL FLAK96G 6 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CTTTCC
2646 None 2005 FALLKL FLAK96G 6 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CTTTCC
2789 None 2005 FALLKL FLAK96G 6 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CTTTCC
1895 None 2005 FALALKALKK FLAK96F 10 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =510 µg/ml 24-h Breast None US_06875744_B2 CHHHHTTTCC
2047 None 2005 FALALKALKK FLAK96F 10 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CHHHHTTTCC
2199 None 2005 FALALKALKK FLAK96F 10 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =530 µg/ml 24-h Skin None US_06875744_B2 CHHHHTTTCC
2351 None 2005 FALALKALKK FLAK96F 10 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =530 µg/ml 24-h Skin None US_06875744_B2 CHHHHTTTCC
2504 None 2005 FALALKALKK FLAK96F 10 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =640 µg/ml 24-h Lung None US_06875744_B2 CHHHHTTTCC
2647 None 2005 FALALKALKK FLAK96F 10 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHTTTCC
2790 None 2005 FALALKALKK FLAK96F 10 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CHHHHTTTCC
1896 None 2005 FALKALKKAL FLAK96C 10 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =940 µg/ml 24-h Breast None US_06875744_B2 CHHHHHTTTC
2048 None 2005 FALKALKKAL FLAK96C 10 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CHHHHHTTTC
2200 None 2005 FALKALKKAL FLAK96C 10 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHTTTC
2352 None 2005 FALKALKKAL FLAK96C 10 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHTTTC
2505 None 2005 FALKALKKAL FLAK96C 10 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CHHHHHTTTC
2648 None 2005 FALKALKKAL FLAK96C 10 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHTTTC
2791 None 2005 FALKALKKAL FLAK96C 10 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHTTTC
1897 None 2005 FALLKALKKAL FLAK96D 11 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =305 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHTTTC
2049 None 2005 FALLKALKKAL FLAK96D 11 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =770 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHTTTC
2201 None 2005 FALLKALKKAL FLAK96D 11 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =600 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHTTTC
2353 None 2005 FALLKALKKAL FLAK96D 11 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =600 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHTTTC
2506 None 2005 FALLKALKKAL FLAK96D 11 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =540 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHTTTC
2649 None 2005 FALLKALKKAL FLAK96D 11 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =600 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHTTTC
2792 None 2005 FALLKALKKAL FLAK96D 11 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =820 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHTTTC
1898 None 2005 KFKKLAKKF Modelin-8D 9 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Breast None US_06875744_B2 CHHHHTTCC
2050 None 2005 KFKKLAKKF Modelin-8D 9 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CHHHHTTCC
2202 None 2005 KFKKLAKKF Modelin-8D 9 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHTTCC
2354 None 2005 KFKKLAKKF Modelin-8D 9 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHTTCC
2507 None 2005 KFKKLAKKF Modelin-8D 9 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CHHHHTTCC
2650 None 2005 KFKKLAKKF Modelin-8D 9 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHTTCC
2793 None 2005 KFKKLAKKF Modelin-8D 9 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CHHHHTTCC
1899 None 2005 KFKKLAKKW Modelin-8E 9 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Breast None US_06875744_B2 CHHHHHSCC
2051 None 2005 KFKKLAKKW Modelin-8E 9 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =70 µg/ml 24-h Colon None US_06875744_B2 CHHHHHSCC
2203 None 2005 KFKKLAKKW Modelin-8E 9 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHSCC
2355 None 2005 KFKKLAKKW Modelin-8E 9 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHSCC
2508 None 2005 KFKKLAKKW Modelin-8E 9 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CHHHHHSCC
2651 None 2005 KFKKLAKKW Modelin-8E 9 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHSCC
2794 None 2005 KFKKLAKKW Modelin-8E 9 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =510 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHSCC
1900 None 2005 FALALKALKKA Flak 96H 11 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHTTC
2052 None 2005 FALALKALKKA Flak 96H 11 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHTTC
2204 None 2005 FALALKALKKA Flak 96H 11 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHTTC
2356 None 2005 FALALKALKKA Flak 96H 11 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHTTC
2509 None 2005 FALALKALKKA Flak 96H 11 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHTTC
2652 None 2005 FALALKALKKA Flak 96H 11 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHTTC
2795 None 2005 FALALKALKKA Flak 96H 11 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHTTC
1901 None 2005 FALLKALLKKAL Flak 96I 12 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =190 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHC
2053 None 2005 FALLKALLKKAL Flak 96I 12 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =310 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHHC
2205 None 2005 FALLKALLKKAL Flak 96I 12 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =310 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHC
2357 None 2005 FALLKALLKKAL Flak 96I 12 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =310 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHC
2510 None 2005 FALLKALLKKAL Flak 96I 12 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =240 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHHC
2653 None 2005 FALLKALLKKAL Flak 96I 12 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =120 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHHC
2796 None 2005 FALLKALLKKAL Flak 96I 12 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =380 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHHC
1902 None 2005 FALALKLAKKL Flak 96J 11 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =770 µg/ml 24-h Breast None US_06875744_B2 CHHHHHTGGGC
2054 None 2005 FALALKLAKKL Flak 96J 11 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CHHHHHTGGGC
2206 None 2005 FALALKLAKKL Flak 96J 11 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =640 µg/ml 24-h Skin None US_06875744_B2 CHHHHHTGGGC
2358 None 2005 FALALKLAKKL Flak 96J 11 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =640 µg/ml 24-h Skin None US_06875744_B2 CHHHHHTGGGC
2511 None 2005 FALALKLAKKL Flak 96J 11 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CHHHHHTGGGC
2654 None 2005 FALALKLAKKL Flak 96J 11 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHTGGGC
2797 None 2005 FALALKLAKKL Flak 96J 11 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHTGGGC
1903 None 2005 LKKLAKLALAF Flak 96L 11 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =555 µg/ml 24-h Breast None US_06875744_B2 CTTTCHHHHTC
2055 None 2005 LKKLAKLALAF Flak 96L 11 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CTTTCHHHHTC
2207 None 2005 LKKLAKLALAF Flak 96L 11 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =920 µg/ml 24-h Skin None US_06875744_B2 CTTTCHHHHTC
2359 None 2005 LKKLAKLALAF Flak 96L 11 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =920 µg/ml 24-h Skin None US_06875744_B2 CTTTCHHHHTC
2512 None 2005 LKKLAKLALAF Flak 96L 11 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CTTTCHHHHTC
2655 None 2005 LKKLAKLALAF Flak 96L 11 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CTTTCHHHHTC
2798 None 2005 LKKLAKLALAF Flak 96L 11 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CTTTCHHHHTC
1904 None 2005 VALALKALKKL FLAK-120G 11 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =950 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHTTC
2056 None 2005 VALALKALKKL FLAK-120G 11 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =600 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHTTC
2208 None 2005 VALALKALKKL FLAK-120G 11 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =770 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHTTC
2360 None 2005 VALALKALKKL FLAK-120G 11 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =770 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHTTC
2513 None 2005 VALALKALKKL FLAK-120G 11 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHTTC
2656 None 2005 VALALKALKKL FLAK-120G 11 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHTTC
2799 None 2005 VALALKALKKL FLAK-120G 11 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =760 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHTTC
1905 None 2005 FALALKLKKL FLAK-120D 10 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =550 µg/ml 24-h Breast None US_06875744_B2 CCSSCCCTTC
2057 None 2005 FALALKLKKL FLAK-120D 10 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =870 µg/ml 24-h Colon None US_06875744_B2 CCSSCCCTTC
2209 None 2005 FALALKLKKL FLAK-120D 10 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =830 µg/ml 24-h Skin None US_06875744_B2 CCSSCCCTTC
2361 None 2005 FALALKLKKL FLAK-120D 10 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =830 µg/ml 24-h Skin None US_06875744_B2 CCSSCCCTTC
2514 None 2005 FALALKLKKL FLAK-120D 10 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CCSSCCCTTC
2657 None 2005 FALALKLKKL FLAK-120D 10 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CCSSCCCTTC
2800 None 2005 FALALKLKKL FLAK-120D 10 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CCSSCCCTTC
1906 None 2005 FALALKAKKL FLAK-120C 10 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Breast None US_06875744_B2 CCSSCCSTTC
2058 None 2005 FALALKAKKL FLAK-120C 10 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CCSSCCSTTC
2210 None 2005 FALALKAKKL FLAK-120C 10 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CCSSCCSTTC
2362 None 2005 FALALKAKKL FLAK-120C 10 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CCSSCCSTTC
2515 None 2005 FALALKAKKL FLAK-120C 10 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CCSSCCSTTC
2658 None 2005 FALALKAKKL FLAK-120C 10 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CCSSCCSTTC
2801 None 2005 FALALKAKKL FLAK-120C 10 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CCSSCCSTTC
1907 None 2005 FALA FLAK-120B 4 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Breast None US_06875744_B2 CCCC
2059 None 2005 FALA FLAK-120B 4 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CCCC
2211 None 2005 FALA FLAK-120B 4 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CCCC
2363 None 2005 FALA FLAK-120B 4 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Skin None US_06875744_B2 CCCC
2516 None 2005 FALA FLAK-120B 4 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Lung None US_06875744_B2 CCCC
2659 None 2005 FALA FLAK-120B 4 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CCCC
2802 None 2005 FALA FLAK-120B 4 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CCCC
1908 None 2005 WALAL FLAK-120F 5 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =260 µg/ml 24-h Breast None US_06875744_B2 CCSCC
2060 None 2005 WALAL FLAK-120F 5 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =440 µg/ml 24-h Colon None US_06875744_B2 CCSCC
2212 None 2005 WALAL FLAK-120F 5 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =600 µg/ml 24-h Skin None US_06875744_B2 CCSCC
2364 None 2005 WALAL FLAK-120F 5 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =600 µg/ml 24-h Skin None US_06875744_B2 CCSCC
2517 None 2005 WALAL FLAK-120F 5 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =370 µg/ml 24-h Lung None US_06875744_B2 CCSCC
2660 None 2005 WALAL FLAK-120F 5 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =570 µg/ml 24-h Prostate None US_06875744_B2 CCSCC
2803 None 2005 WALAL FLAK-120F 5 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =302 µg/ml 24-h Cervix None US_06875744_B2 CCSCC
1910 None 2005 FAKKFAKKFKKFAKKFAKFAFAF D2A21 23 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =64 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHTTTHHHHHHHHSCC
2062 None 2005 FAKKFAKKFKKFAKKFAKFAFAF D2A21 23 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =76 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHTTTHHHHHHHHSCC
2214 None 2005 FAKKFAKKFKKFAKKFAKFAFAF D2A21 23 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =140 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTHHHHHHHHSCC
2366 None 2005 FAKKFAKKFKKFAKKFAKFAFAF D2A21 23 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =140 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHTTTHHHHHHHHSCC
2519 None 2005 FAKKFAKKFKKFAKKFAKFAFAF D2A21 23 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =77 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHTTTHHHHHHHHSCC
2662 None 2005 FAKKFAKKFKKFAKKFAKFAFAF D2A21 23 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =45 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHTTTHHHHHHHHSCC
2805 None 2005 FAKKFAKKFKKFAKKFAKFAFAF D2A21 23 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =170 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHTTTHHHHHHHHSCC
1911 None 2005 KKVVFKVKFK KSL-1 10 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =340 µg/ml 24-h Breast None US_06875744_B2 CCCCCSSCCC
2063 None 2005 KKVVFKVKFK KSL-1 10 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Colon None US_06875744_B2 CCCCCSSCCC
2215 None 2005 KKVVFKVKFK KSL-1 10 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =700 µg/ml 24-h Skin None US_06875744_B2 CCCCCSSCCC
2367 None 2005 KKVVFKVKFK KSL-1 10 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =700 µg/ml 24-h Skin None US_06875744_B2 CCCCCSSCCC
2520 None 2005 KKVVFKVKFK KSL-1 10 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =720 µg/ml 24-h Lung None US_06875744_B2 CCCCCSSCCC
2663 None 2005 KKVVFKVKFK KSL-1 10 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Prostate None US_06875744_B2 CCCCCSSCCC
2806 None 2005 KKVVFKVKFK KSL-1 10 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CCCCCSSCCC
1912 None 2005 FKVKFKVKVK KSL-7 10 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =315 µg/ml 24-h Breast None US_06875744_B2 CTTTCCSSCC
2064 None 2005 FKVKFKVKVK KSL-7 10 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =530 µg/ml 24-h Colon None US_06875744_B2 CTTTCCSSCC
2216 None 2005 FKVKFKVKVK KSL-7 10 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =330 µg/ml 24-h Skin None US_06875744_B2 CTTTCCSSCC
2368 None 2005 FKVKFKVKVK KSL-7 10 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =330 µg/ml 24-h Skin None US_06875744_B2 CTTTCCSSCC
2521 None 2005 FKVKFKVKVK KSL-7 10 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =345 µg/ml 24-h Lung None US_06875744_B2 CTTTCCSSCC
2664 None 2005 FKVKFKVKVK KSL-7 10 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =530 µg/ml 24-h Prostate None US_06875744_B2 CTTTCCSSCC
2807 None 2005 FKVKFKVKVK KSL-7 10 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =>1000 µg/ml 24-h Cervix None US_06875744_B2 CTTTCCSSCC
1913 None 2005 LPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG LSB-37 38 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =50 µg/ml 24-h Breast None US_06875744_B2 CCSCGGGGGTGGGSCCTTCSBSCCSSSSCCCBSCTTCC
2065 None 2005 LPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG LSB-37 38 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =240 µg/ml 24-h Colon None US_06875744_B2 CCSCGGGGGTGGGSCCTTCSBSCCSSSSCCCBSCTTCC
2217 None 2005 LPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG LSB-37 38 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =170 µg/ml 24-h Skin None US_06875744_B2 CCSCGGGGGTGGGSCCTTCSBSCCSSSSCCCBSCTTCC
2369 None 2005 LPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG LSB-37 38 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =170 µg/ml 24-h Skin None US_06875744_B2 CCSCGGGGGTGGGSCCTTCSBSCCSSSSCCCBSCTTCC
2522 None 2005 LPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG LSB-37 38 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =120 µg/ml 24-h Lung None US_06875744_B2 CCSCGGGGGTGGGSCCTTCSBSCCSSSSCCCBSCTTCC
2665 None 2005 LPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG LSB-37 38 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =370 µg/ml 24-h Prostate None US_06875744_B2 CCSCGGGGGTGGGSCCTTCSBSCCSSSSCCCBSCTTCC
2808 None 2005 LPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG LSB-37 38 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =250 µg/ml 24-h Cervix None US_06875744_B2 CCSCGGGGGTGGGSCCTTCSBSCCSSSSCCCBSCTTCC
1914 None 2005 FAKKLAKKLKKLAKKLAKLAKKL Anubis-2 23 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =38 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHHHHHHHHHHTTC
2066 None 2005 FAKKLAKKLKKLAKKLAKLAKKL Anubis-2 23 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =73 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHHHHHHHHHHHTTC
2218 None 2005 FAKKLAKKLKKLAKKLAKLAKKL Anubis-2 23 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =83 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHHHHHHHHHTTC
2370 None 2005 FAKKLAKKLKKLAKKLAKLAKKL Anubis-2 23 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =83 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHHHHHHHHHTTC
2523 None 2005 FAKKLAKKLKKLAKKLAKLAKKL Anubis-2 23 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =160 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHHHHHHHHHHHTTC
2666 None 2005 FAKKLAKKLKKLAKKLAKLAKKL Anubis-2 23 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =66 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHHHHHHHHHHHTTC
2809 None 2005 FAKKLAKKLKKLAKKLAKLAKKL Anubis-2 23 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =100 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHHHHHHHHHHHTTC
1916 None 2005 VAKFLAKFLKKAL FLAK50 Q1V 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =92 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHHC
2068 None 2005 VAKFLAKFLKKAL FLAK50 Q1V 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay Not Available 24-h Colon None US_06875744_B2 CHHHHHHHHHHHC
2220 None 2005 VAKFLAKFLKKAL FLAK50 Q1V 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay Not Available 24-h Skin None US_06875744_B2 CHHHHHHHHHHHC
2372 None 2005 VAKFLAKFLKKAL FLAK50 Q1V 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay Not Available 24-h Skin None US_06875744_B2 CHHHHHHHHHHHC
1917 None 2005 VAKKFAKKFKKFAKKFAKFAFAF D2A21V 23 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =210 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHTTTHHHHHHHHSCC
2069 None 2005 VAKKFAKKFKKFAKKFAKFAFAF D2A21V 23 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay Not Available 24-h Colon None US_06875744_B2 CHHHHHHHHTTTHHHHHHHHSCC
2221 None 2005 VAKKFAKKFKKFAKKFAKFAFAF D2A21V 23 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay Not Available 24-h Skin None US_06875744_B2 CHHHHHHHHTTTHHHHHHHHSCC
2373 None 2005 VAKKFAKKFKKFAKKFAKFAFAF D2A21V 23 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay Not Available 24-h Skin None US_06875744_B2 CHHHHHHHHTTTHHHHHHHHSCC
1918 None 2005 VAKKLAKLAKKLAKLALAL FLAK 25 AM V 19 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =130 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHHHHHTTTC
2222 None 2005 VAKKLAKLAKKLAKLALAL FLAK 25 AM V 19 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay Not Available 24-h Skin None US_06875744_B2 CHHHHHHHHHHHHHHTTTC
2374 None 2005 VAKKLAKLAKKLAKLALAL FLAK 25 AM V 19 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay Not Available 24-h Skin None US_06875744_B2 CHHHHHHHHHHHHHHTTTC
1919 None 2005 VAKKLAKLAKKLLAL FLAK43 AM V 15 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =86 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHHSCC
2223 None 2005 VAKKLAKLAKKLLAL FLAK43 AM V 15 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay Not Available 24-h Skin None US_06875744_B2 CHHHHHHHHHHHSCC
2375 None 2005 VAKKLAKLAKKLLAL FLAK43 AM V 15 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay Not Available 24-h Skin None US_06875744_B2 CHHHHHHHHHHHSCC
1920 None 2005 VAKLLAKALKKLL FLAK50D V 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =45 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHTTTC
2072 None 2005 VAKLLAKALKKLL FLAK50D V 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay Not Available 24-h Colon None US_06875744_B2 CHHHHHHHHTTTC
2224 None 2005 VAKLLAKALKKLL FLAK50D V 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay Not Available 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2376 None 2005 VAKLLAKALKKLL FLAK50D V 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay Not Available 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
1923 None 2005 VALALKALKKLAKKLKKLAKKAL FLAK04 AM V 23 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =84 µg/ml 24-h Breast None US_06875744_B2 CHHHHTTHHHHHHHHHHHHTTTC
2379 None 2005 VALALKALKKLAKKLKKLAKKAL FLAK04 AM V 23 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay Not Available 24-h Skin None US_06875744_B2 CHHHHTTHHHHHHHHHHHHTTTC
1924 None 2005 FAKLLAKLAKKAA FLAK50J 13 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay Not Available 24-h Breast None US_06875744_B2 CHHHHHHHHTTTC
2076 None 2005 FAKLLAKLAKKAA FLAK50J 13 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay Not Available 24-h Colon None US_06875744_B2 CHHHHHHHHTTTC
2228 None 2005 FAKLLAKLAKKAA FLAK50J 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay Not Available 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2380 None 2005 FAKLLAKLAKKAA FLAK50J 13 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay Not Available 24-h Skin None US_06875744_B2 CHHHHHHHHTTTC
2437 None 2005 FAKLLAKLAKKAA FLAK50J 13 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =320 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHTTTC
2580 None 2005 FAKLLAKLAKKAA FLAK50J 13 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =690 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHTTTC
2723 None 2005 FAKLLAKLAKKAA FLAK50J 13 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 = >1000 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHTTTC
1790 None 2005 FAKKLAKLAKKLLAL FLAK43 AM 15 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =17 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHHTCC
1942 None 2005 FAKKLAKLAKKLLAL FLAK43 AM 15 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =13 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHHHTCC
2071 None 2005 FAKKLAKLAKKLLAL FLAK43 AM V 15 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay Not Available 24-h Colon None US_06875744_B2 CHHHHHHHHHHHTCC
2094 None 2005 FAKKLAKLAKKLLAL FLAK43 AM 15 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =21 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHTCC
2246 None 2005 FAKKLAKLAKKLLAL FLAK43 AM 15 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =21 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHHTCC
2398 None 2005 FAKKLAKLAKKLLAL FLAK43 AM 15 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =33 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHHHTCC
2541 None 2005 FAKKLAKLAKKLLAL FLAK43 AM 15 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =10 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHHHTCC
2684 None 2005 FAKKLAKLAKKLLAL FLAK43 AM 15 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =35 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHHHTCC
2043 None 2005 KWKKLAKKW FLAK120 9 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =240 µg/ml 24-h Colon None US_06875744_B2 CTHHHHCCC
2219 None 2005 VAKALKALLKALKAL FLAK 17 CV 19 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay Not Available 24-h Skin None US_06875744_B2 CHHHHHHHHHHHTTC
2371 None 2005 VAKALAKALLKALKAL FLAK 17 CV 19 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay Not Available 24-h Skin None US_06875744_B2 CHHHHHHHHHHHHTTC
2810 23000474 2012 RRRRRNWMWC 9R 10 Linear L None Free Free Anticancer Nullomer derived anticancer peptides (NulloPs): LNCaP Prostate Cancer MTT/MTS assay IC50=44 µM 2-h Prostate None None CCCCCCSSCC
2812 23000474 2012 RRRRRNWMWC 9R 10 Linear L None Free Free Anticancer Nullomer derived anticancer peptides (NulloPs): LNCaP Prostate Cancer MTT/MTS assay IC50=23 µM 24-h Prostate None None CCCCCCSSCC
2814 23000474 2012 RRRRRNWMWC 9R 10 Linear L None Free Free Anticancer Nullomer derived anticancer peptides (NulloPs): LNCaP Prostate Cancer MTT/MTS assay IC50=28 µM 48-h Prostate None None CCCCCCSSCC
2816 23000474 2012 RRRRRNWMWC 9R 10 Linear L None Free Free Anticancer Nullomer derived anticancer peptides (NulloPs): MDA-MB-231 Breast Cancer MTT/MTS assay IC50=39 µM 2-h Breast None None CCCCCCSSCC
2818 23000474 2012 RRRRRNWMWC 9R 10 Linear L None Free Free Anticancer Nullomer derived anticancer peptides (NulloPs): MDA-MB-231 Breast Cancer MTT/MTS assay IC50=29 µM 24-h Breast None None CCCCCCSSCC
2820 23000474 2012 RRRRRNWMWC 9R 10 Linear L None Free Free Anticancer Nullomer derived anticancer peptides (NulloPs): MDA-MB-231 Breast Cancer MTT/MTS assay IC50=16 µM 48-h Breast None None CCCCCCSSCC
2822 23000474 2012 RRRRRNWMWC 9R 10 Linear L None Free Free Anticancer Nullomer derived anticancer peptides (NulloPs): HUT-102 Lymphoma Cancer MTT/MTS assay IC50=93 µM 2-h Blood None None CCCCCCSSCC
2824 23000474 2012 RRRRRNWMWC 9R 10 Linear L None Free Free Anticancer Nullomer derived anticancer peptides (NulloPs): HUT-102 Lymphoma Cancer MTT/MTS assay IC50=39 µM 24-h Blood None None CCCCCCSSCC
2826 23000474 2012 RRRRRNWMWC 9R 10 Linear L None Free Free Anticancer Nullomer derived anticancer peptides (NulloPs): HUT-102 Lymphoma Cancer MTT/MTS assay IC50=37 µM 48-h Blood None None CCCCCCSSCC
2828 23000474 2012 RRRRRNWMWC 9R 10 Linear L None Free Free Anticancer Nullomer derived anticancer peptides (NulloPs): HUT-102 Lymphoma Cancer MTT/MTS assay IC50=36 µM 72-h Blood None None CCCCCCSSCC
2830 23000474 2012 RRRRRNWMWC 9R 10 Linear L None Free Free Anticancer Nullomer derived anticancer peptides (NulloPs): HUT-102 Lymphoma Cancer MTT/MTS assay IC50=25 µM 96-h Blood None None CCCCCCSSCC
2832 23000474 2012 RRRRRNWMWC 9R 10 Linear L None Free Free Anticancer Nullomer derived anticancer peptides (NulloPs): J774A.1 Tumor MTT/MTS assay IC50=47 µM 24-h Blood None None CCCCCCSSCC
2834 23000474 2012 RRRRRNWMWC 9R 10 Linear L None Free Free Anticancer Nullomer derived anticancer peptides (NulloPs): J774A.1 Tumor MTT/MTS assay IC50=12 µM 96-h Blood None None CCCCCCSSCC
2811 23000474 2012 RRRRRWCMNW 9S1R 10 Linear L None Free Free Anticancer Nullomer derived anticancer peptides (NulloPs): LNCaP Prostate Cancer MTT/MTS assay IC50=26 µM 2-h Prostate None None CCCCCCCCCC
2813 23000474 2012 RRRRRWCMNW 9S1R 10 Linear L None Free Free Anticancer Nullomer derived anticancer peptides (NulloPs): LNCaP Prostate Cancer MTT/MTS assay IC50=9 µM 24-h Prostate None None CCCCCCCCCC
2815 23000474 2012 RRRRRWCMNW 9S1R 10 Linear L None Free Free Anticancer Nullomer derived anticancer peptides (NulloPs): LNCaP Prostate Cancer MTT/MTS assay IC50=8 µM 48-h Prostate None None CCCCCCCCCC
2817 23000474 2012 RRRRRWCMNW 9S1R 10 Linear L None Free Free Anticancer Nullomer derived anticancer peptides (NulloPs): MDA-MB-231 Breast Cancer MTT/MTS assay IC50=18 µM 2-h Breast None None CCCCCCCCCC
2819 23000474 2012 RRRRRWCMNW 9S1R 10 Linear L None Free Free Anticancer Nullomer derived anticancer peptides (NulloPs): MDA-MB-231 Breast Cancer MTT/MTS assay IC50=12 µM 24-h Breast None None CCCCCCCCCC
2821 23000474 2012 RRRRRWCMNW 9S1R 10 Linear L None Free Free Anticancer Nullomer derived anticancer peptides (NulloPs): MDA-MB-231 Breast Cancer MTT/MTS assay IC50=10 µM 48-h Breast None None CCCCCCCCCC
2823 23000474 2012 RRRRRWCMNW 9S1R 10 Linear L None Free Free Anticancer Nullomer derived anticancer peptides (NulloPs): HUT-102 Lymphoma Cancer MTT/MTS assay IC50=38 µM 2-h Blood None None CCCCCCCCCC
2825 23000474 2012 RRRRRWCMNW 9S1R 10 Linear L None Free Free Anticancer Nullomer derived anticancer peptides (NulloPs): HUT-102 Lymphoma Cancer MTT/MTS assay IC50=43 µM 24-h Blood None None CCCCCCCCCC
2827 23000474 2012 RRRRRWCMNW 9S1R 10 Linear L None Free Free Anticancer Nullomer derived anticancer peptides (NulloPs): HUT-102 Lymphoma Cancer MTT/MTS assay IC50=43 µM 48-h Blood None None CCCCCCCCCC
2829 23000474 2012 RRRRRWCMNW 9S1R 10 Linear L None Free Free Anticancer Nullomer derived anticancer peptides (NulloPs): HUT-102 Lymphoma Cancer MTT/MTS assay IC50=45 µM 72-h Blood None None CCCCCCCCCC
2831 23000474 2012 RRRRRWCMNW 9S1R 10 Linear L None Free Free Anticancer Nullomer derived anticancer peptides (NulloPs): HUT-102 Lymphoma Cancer MTT/MTS assay IC50=36 µM 96-h Blood None None CCCCCCCCCC
2833 23000474 2012 RRRRRWCMNW 9S1R 10 Linear L None Free Free Anticancer Nullomer derived anticancer peptides (NulloPs): J774A.1 Tumor MTT/MTS assay IC50=26 µM 24-h Blood None None CCCCCCCCCC
2835 23000474 2012 RRRRRWCMNW 9S1R 10 Linear L None Free Free Anticancer Nullomer derived anticancer peptides (NulloPs): J774A.1 Tumor MTT/MTS assay IC50=17 µM 96-h Blood None None CCCCCCCCCC
2839 24246647 2014 GIIKKIIKKI Short α-helical peptides 10 Linear L None Amidation Free Antimicrobial Alpha-helical proteins HeLa Cervical Cancer MTT/MTS assay 99% Cytotoxicity at 4 µM Approx 24-h Cervix None None CGGGGTTTTC
2842 24246647 2014 GIIKKIIKKI Short α-helical peptides 10 Linear L None Amidation Free Antimicrobial Alpha-helical proteins HL-60 Leukemia Cancer MTT/MTS assay 100% Cytotoxicity at 5 µM Approx 24-h Blood None None CGGGGTTTTC
2840 24246647 2014 GIIKKIIKKIIKKI Short α-helical peptides 14 Linear L None Amidation Free Antimicrobial Alpha-helical proteins HeLa Cervical Cancer MTT/MTS assay 95% Cytotoxicity at 4 µM Approx 24-h Cervix None None CGGGGTHHHHTTTC
2843 24246647 2014 GIIKKIIKKIIKKI Short α-helical peptides 14 Linear L None Amidation Free Antimicrobial Alpha-helical proteins HL-60 Leukemia Cancer MTT/MTS assay 90% Cytotoxicity at 5 µM Approx 24-h Blood None None CGGGGTHHHHTTTC
2841 24246647 2014 GIIKKIIKKIIKKIIKKI Short α-helical peptides 18 Linear L None Amidation Free Antimicrobial Alpha-helical proteins HeLa Cervical Cancer MTT/MTS assay 80% Cytotoxicity at 4 µM Approx 24-h Cervix None None CGGGGTGGGTGGGTTTTC
2844 24246647 2014 GIIKKIIKKIIKKIIKKI Short α-helical peptides 18 Linear L None Amidation Free Antimicrobial Alpha-helical proteins HL-60 Leukemia Cancer MTT/MTS assay 70% Cytotoxicity at 5 µM Approx 24-h Blood None None CGGGGTGGGTGGGTTTTC
2845 15634655 2004 ERRP EGFR-related peptide 4 Linear L None Free Free Anticancer EGFR-related peptide PC-3 Prostate Cancer MTT/MTS assay 30% Cell viability at 5 µg/ml 48-h Prostate None None CCCC
2846 23028527 2012 GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV Adenoregulin 33 Linear L None Free Free Antimicrobial South American frog Phyllomedusa bicolor PC-3 Prostate Cancer LDH leakage assay GI50 =1.24±0.23 µM 24-h Prostate None None CCSTTHHHHHHHHHTHHHHHHHHHHTCCSSCCC
2847 23028527 2012 GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV Adenoregulin 33 Linear L None Free Free Antimicrobial South American frog Phyllomedusa bicolor LNCaP Prostate Cancer LDH leakage assay GI50 =0.31±0.15 µM 24-h Prostate None None CCSTTHHHHHHHHHTHHHHHHHHHHTCCSSCCC
2848 23028527 2012 GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV Adenoregulin 33 Linear L None Free Free Antimicrobial South American frog Phyllomedusa bicolor DU-145 Liver Cancer LDH leakage assay GI50 =0.91±0.04 µM 24-h Prostate None None CCSTTHHHHHHHHHTHHHHHHHHHHTCCSSCCC
2849 23028527 2012 GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV Adenoregulin 33 Linear L None Free Free Antimicrobial South American frog Phyllomedusa bicolor MDA-MB-231 Breast Cancer LDH leakage assay GI50 =8.06±0.50 µM 24-h Breast None None CCSTTHHHHHHHHHTHHHHHHHHHHTCCSSCCC
2850 23028527 2012 GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV Adenoregulin 33 Linear L None Free Free Antimicrobial South American frog Phyllomedusa bicolor Raji Lymphoma Cancer LDH leakage assay GI50 =2.57±0.75 µM 24-h Blood None None CCSTTHHHHHHHHHTHHHHHHHHHHTCCSSCCC
2851 23577112, 21871946 2012 FVDLKKIANIINSIF Tempoprin-1CEa 15 Linear L None Amidation Free Antimicrobial Chinese brown frog Rana chensinensis. MDA-MB-231 Breast Cancer MTT/MTS assay 22% Cell viability at 40 µM 1-h Breast 21871946 None CCCHHHHTHHHHTCC
2852 23577112, 21871946 2012 FVDLKKIANIINSIF Tempoprin-1CEa 15 Linear L None Amidation Free Antimicrobial Chinese brown frog Rana chensinensis. MDA-MB-231 Breast Cancer LDH leakage assay 61% Cytotoxicity at 40 µM 1-h Breast 21871946 None CCCHHHHTHHHHTCC
2853 23577112, 21871946 2012 FVDLKKIANIINSIF Tempoprin-1CEa 15 Linear L None Amidation Free Antimicrobial Chinese brown frog Rana chensinensis. MCF-7 Breast Cancer MTT/MTS assay 61% Cell viability at 40 µM 1-h Breast 21871946 None CCCHHHHTHHHHTCC
2854 23577112, 21871946 2012 FVDLKKIANIINSIF Tempoprin-1CEa 15 Linear L None Amidation Free Antimicrobial Chinese brown frog Rana chensinensis. MCF-7 Breast Cancer LDH leakage assay 32% Cytotoxicity at 40 µM 1-h Breast 21871946 None CCCHHHHTHHHHTCC
2875 23583573 2013 FVDLKKIANIINSIF Tempoprin-1CEa 15 Linear L None Amidation Free Antimicrobial Chinese brown frog Rana chensinensis. Bcap-37 Breast Cancer MTT/MTS assay 70% Cell viability at 20 µM 1-h Breast None None CCCHHHHTHHHHTCC
2876 23583573 2013 FVDLKKIANIINSIF Tempoprin-1CEa 15 Linear L None Amidation Free Antimicrobial Chinese brown frog Rana chensinensis. Bcap-37 Breast Cancer MTT/MTS assay 45% Cell viability at 30 µM 1-h Breast None None CCCHHHHTHHHHTCC
2877 23583573 2013 FVDLKKIANIINSIF Tempoprin-1CEa 15 Linear L None Amidation Free Antimicrobial Chinese brown frog Rana chensinensis. Bcap-37 Breast Cancer MTT/MTS assay 30 % Cell viability at 40 µM 1-h Breast None None CCCHHHHTHHHHTCC
2872 23583573 2013 DEVD caspase 3 inhibitor 4 Linear L None Fluoromethyl ketone(fmk) Free Anticancer caspase 3 inhibitor Bcap-37 Breast Cancer MTT/MTS assay 65% Cell viability at 20 µM 1-h Breast None None NA NA
2873 23583573 2013 DEVD caspase 3 inhibitor 4 Linear L None Fluoromethyl ketone(fmk) Free Anticancer caspase 3 inhibitor Bcap-37 Breast Cancer MTT/MTS assay 40% Cell viability at 30 µM 1-h Breast None None NA NA
2874 23583573 2013 DEVD caspase 3 inhibitor 4 Linear L None Fluoromethyl ketone(fmk) Free Anticancer caspase 3 inhibitor Bcap-37 Breast Cancer MTT/MTS assay 35 % Cell viability at 40 µM 1-h Breast None None NA NA
2886 20383464 2010 MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG Ceropin 63 Linear L None Free Free Antimicrobial Musca domestica BEL-7402 Liver Cancer Trypan blue assay 91.8% Cell viability at 12.5 µM 24-h Liver None None CCCCCCCCCCCCCCCCSCCCCCSSCTTCHHHHHHHHHHHHHHHSSTTTTHHHHHHHHHHHHCC
2887 20383464 2010 MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG Ceropin 63 Linear L None Free Free Antimicrobial Musca domestica BEL-7402 Liver Cancer Trypan blue assay 84.1% Cell viability at 25 µM 24-h Liver None None CCCCCCCCCCCCCCCCSCCCCCSSCTTCHHHHHHHHHHHHHHHSSTTTTHHHHHHHHHHHHCC
2888 20383464 2010 MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG Ceropin 63 Linear L None Free Free Antimicrobial Musca domestica BEL-7402 Liver Cancer Trypan blue assay 76.3% Cell viability at 50 µM 24-h Liver None None CCCCCCCCCCCCCCCCSCCCCCSSCTTCHHHHHHHHHHHHHHHSSTTTTHHHHHHHHHHHHCC
2889 20383464 2010 MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG Ceropin 63 Linear L None Free Free Antimicrobial Musca domestica BEL-7402 Liver Cancer Trypan blue assay 71.5 % Cell viability at 75 µM 24-h Liver None None CCCCCCCCCCCCCCCCSCCCCCSSCTTCHHHHHHHHHHHHHHHSSTTTTHHHHHHHHHHHHCC
2890 20383464 2010 MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG Ceropin 63 Linear L None Free Free Antimicrobial Musca domestica BEL-7402 Liver Cancer Trypan blue assay 54.2 % Cell viability at 100 µM 24-h Liver None None CCCCCCCCCCCCCCCCSCCCCCSSCTTCHHHHHHHHHHHHHHHSSTTTTHHHHHHHHHHHHCC
2891 20383464 2010 MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG Ceropin 63 Linear L None Free Free Antimicrobial Musca domestica BEL-7402 Liver Cancer Trypan blue assay 87.3 % Cell viability at 25 µM 48-h Liver None None CCCCCCCCCCCCCCCCSCCCCCSSCTTCHHHHHHHHHHHHHHHSSTTTTHHHHHHHHHHHHCC
2892 20383464 2010 MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG Ceropin 63 Linear L None Free Free Antimicrobial Musca domestica BEL-7402 Liver Cancer Trypan blue assay 75.6 % Cell viability at 50 µM 48-h Liver None None CCCCCCCCCCCCCCCCSCCCCCSSCTTCHHHHHHHHHHHHHHHSSTTTTHHHHHHHHHHHHCC
2893 20383464 2010 MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG Ceropin 63 Linear L None Free Free Antimicrobial Musca domestica BEL-7402 Liver Cancer Trypan blue assay 62.8 % Cell viability at 75 µM 48-h Liver None None CCCCCCCCCCCCCCCCSCCCCCSSCTTCHHHHHHHHHHHHHHHSSTTTTHHHHHHHHHHHHCC
2894 20383464 2010 MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG Ceropin 63 Linear L None Free Free Antimicrobial Musca domestica BEL-7402 Liver Cancer Trypan blue assay 54.3 % Cell viability at 100 µM 48-h Liver None None CCCCCCCCCCCCCCCCSCCCCCSSCTTCHHHHHHHHHHHHHHHSSTTTTHHHHHHHHHHHHCC
2895 20383464 2010 MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG Ceropin 63 Linear L None Free Free Antimicrobial Musca domestica BEL-7402 Liver Cancer Trypan blue assay 48.6 % Cell viability at 100 µM 48-h Liver None None CCCCCCCCCCCCCCCCSCCCCCSSCTTCHHHHHHHHHHHHHHHSSTTTTHHHHHHHHHHHHCC
2896 20383464 2010 MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG Ceropin 63 Linear L None Free Free Antimicrobial Musca domestica BEL-7402 Liver Cancer Trypan blue assay 72.1 % Cell viability at 12.5 µM 72-h Liver None None CCCCCCCCCCCCCCCCSCCCCCSSCTTCHHHHHHHHHHHHHHHSSTTTTHHHHHHHHHHHHCC
2897 20383464 2010 MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG Ceropin 63 Linear L None Free Free Antimicrobial Musca domestica BEL-7402 Liver Cancer Trypan blue assay 63.3 % Cell viability at 25 µM 72-h Liver None None CCCCCCCCCCCCCCCCSCCCCCSSCTTCHHHHHHHHHHHHHHHSSTTTTHHHHHHHHHHHHCC
2898 20383464 2010 MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG Ceropin 63 Linear L None Free Free Antimicrobial Musca domestica BEL-7402 Liver Cancer Trypan blue assay 49.7 % Cell viability at 50 µM 72-h Liver None None CCCCCCCCCCCCCCCCSCCCCCSSCTTCHHHHHHHHHHHHHHHSSTTTTHHHHHHHHHHHHCC
2899 20383464 2010 MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG Ceropin 63 Linear L None Free Free Antimicrobial Musca domestica BEL-7402 Liver Cancer Trypan blue assay 41.1 % Cell viability at 75 µM 72-h Liver None None CCCCCCCCCCCCCCCCSCCCCCSSCTTCHHHHHHHHHHHHHHHSSTTTTHHHHHHHHHHHHCC
2900 20383464 2010 MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG Ceropin 63 Linear L None Free Free Antimicrobial Musca domestica BEL-7402 Liver Cancer Trypan blue assay 35.2 % Cell viability at 100 µM 72-h Liver None None CCCCCCCCCCCCCCCCSCCCCCSSCTTCHHHHHHHHHHHHHHHSSTTTTHHHHHHHHHHHHCC
2925 23598079 2013 GFIFHIIKGLFHAGKMIHGLV Epinecidin-1 21 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 45% Cytotoxicity at 50 mg/L 3-h Cervix None None CCCSSSSTTTTTTSSCSSSCC
2926 23598079 2013 GFIFHIIKGLFHAGKMIHGLV Epinecidin-1 21 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 38% Cytotoxicity at 25 mg/L 3-h Cervix None None CCCSSSSTTTTTTSSCSSSCC
2927 23598079 2013 GFIFHIIKGLFHAGKMIHGLV Epinecidin-1 21 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 75% Cytotoxicity at 50 mg/L 6-h Cervix None None CCCSSSSTTTTTTSSCSSSCC
2928 23598079 2013 GFIFHIIKGLFHAGKMIHGLV Epinecidin-1 21 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 65% Cytotoxicity at 25 mg/L 6-h Cervix None None CCCSSSSTTTTTTSSCSSSCC
2929 23598079 2013 GFIFHIIKGLFHAGKMIHGLV Epinecidin-1 21 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 75 % Cytotoxicity at 50 mg/L 12-h Cervix None None CCCSSSSTTTTTTSSCSSSCC
2930 23598079 2013 GFIFHIIKGLFHAGKMIHGLV Epinecidin-1 21 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 65% Cytotoxicity at 25 mg/L 12-h Cervix None None CCCSSSSTTTTTTSSCSSSCC
2931 23598079 2013 GFIFHIIKGLFHAGKMIHGLV Epinecidin-1 21 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 83% Cytotoxicity at 50 mg/L 24-h Cervix None None CCCSSSSTTTTTTSSCSSSCC
2932 23598079 2013 GFIFHIIKGLFHAGKMIHGLV Epinecidin-1 21 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 77 % Cytotoxicity at 25 mg/L 24-h Cervix None None CCCSSSSTTTTTTSSCSSSCC
2933 23598079 2013 GFIFHIIKGLFHAGKMIHGLV Epinecidin-1 21 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 82 % Cytotoxicity at 50 mg/L 3-h Fibrous connective tissue  None None CCCSSSSTTTTTTSSCSSSCC
2934 23598079 2013 GFIFHIIKGLFHAGKMIHGLV Epinecidin-1 21 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 85 % Cytotoxicity at 25 mg/L 3-h Fibrous connective tissue  None None CCCSSSSTTTTTTSSCSSSCC
2935 23598079 2013 GFIFHIIKGLFHAGKMIHGLV Epinecidin-1 21 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 42 % Cytotoxicity at 12.5 mg/L 3-h Fibrous connective tissue  None None CCCSSSSTTTTTTSSCSSSCC
2936 23598079 2013 GFIFHIIKGLFHAGKMIHGLV Epinecidin-1 21 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 41 % Cytotoxicity at 6.25 mg/L 3-h Fibrous connective tissue  None None CCCSSSSTTTTTTSSCSSSCC
2937 23598079 2013 GFIFHIIKGLFHAGKMIHGLV Epinecidin-1 21 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 39 % Cytotoxicity at 3.125 mg/L 3-h Fibrous connective tissue  None None CCCSSSSTTTTTTSSCSSSCC
2938 23598079 2013 GFIFHIIKGLFHAGKMIHGLV Epinecidin-1 21 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 41 % Cytotoxicity at 6.25 mg/L 3-h Fibrous connective tissue  None None CCCSSSSTTTTTTSSCSSSCC
2939 23598079 2013 GFIFHIIKGLFHAGKMIHGLV Epinecidin-1 21 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 41 % Cytotoxicity at 6.25 mg/L 3-h Fibrous connective tissue  None None CCCSSSSTTTTTTSSCSSSCC
2940 23598079 2013 GFIFHIIKGLFHAGKMIHGLV Epinecidin-1 21 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 41 % Cytotoxicity at 6.25 mg/L 3-h Fibrous connective tissue  None None CCCSSSSTTTTTTSSCSSSCC
2941 23598079 2013 GFIFHIIKGLFHAGKMIHGLV Epinecidin-1 21 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 90 % Cytotoxicity at 50 mg/L 6-h Fibrous connective tissue  None None CCCSSSSTTTTTTSSCSSSCC
2942 23598079 2013 GFIFHIIKGLFHAGKMIHGLV Epinecidin-1 21 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 95 % Cytotoxicity at 25 mg/L 6-h Fibrous connective tissue  None None CCCSSSSTTTTTTSSCSSSCC
2943 23598079 2013 GFIFHIIKGLFHAGKMIHGLV Epinecidin-1 21 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 45 % Cytotoxicity at 12.5 mg/L 6-h Fibrous connective tissue  None None CCCSSSSTTTTTTSSCSSSCC
2944 23598079 2013 GFIFHIIKGLFHAGKMIHGLV Epinecidin-1 21 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 25 % Cytotoxicity at 6.25 mg/L 6-h Fibrous connective tissue  None None CCCSSSSTTTTTTSSCSSSCC
2945 23598079 2013 GFIFHIIKGLFHAGKMIHGLV Epinecidin-1 21 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 25 % Cytotoxicity at 3.125 mg/L 6-h Fibrous connective tissue  None None CCCSSSSTTTTTTSSCSSSCC
2946 23598079 2013 GFIFHIIKGLFHAGKMIHGLV Epinecidin-1 21 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 95 % Cytotoxicity at 50 mg/L 12-h Fibrous connective tissue  None None CCCSSSSTTTTTTSSCSSSCC
2947 23598079 2013 GFIFHIIKGLFHAGKMIHGLV Epinecidin-1 21 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 96 % Cytotoxicity at 25 mg/L 12-h Fibrous connective tissue  None None CCCSSSSTTTTTTSSCSSSCC
2948 23598079 2013 GFIFHIIKGLFHAGKMIHGLV Epinecidin-1 21 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 46 % Cytotoxicity at 12.5 mg/L 12-h Fibrous connective tissue  None None CCCSSSSTTTTTTSSCSSSCC
2949 23598079 2013 GFIFHIIKGLFHAGKMIHGLV Epinecidin-1 21 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 30 % Cytotoxicity at 6.25 mg/L 12-h Fibrous connective tissue  None None CCCSSSSTTTTTTSSCSSSCC
2950 23598079 2013 GFIFHIIKGLFHAGKMIHGLV Epinecidin-1 21 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 28 % Cytotoxicity at 3.125 mg/L 12-h Fibrous connective tissue  None None CCCSSSSTTTTTTSSCSSSCC
2951 23598079 2013 GFIFHIIKGLFHAGKMIHGLV Epinecidin-1 21 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 84 % Cytotoxicity at 50 mg/L 24-h Fibrous connective tissue  None None CCCSSSSTTTTTTSSCSSSCC
2952 23598079 2013 GFIFHIIKGLFHAGKMIHGLV Epinecidin-1 21 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 85 % Cytotoxicity at 25 mg/L 24-h Fibrous connective tissue  None None CCCSSSSTTTTTTSSCSSSCC
2953 23598079 2013 GFIFHIIKGLFHAGKMIHGLV Epinecidin-1 21 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 38 % Cytotoxicity at 12.5 mg/L 24-h Fibrous connective tissue  None None CCCSSSSTTTTTTSSCSSSCC
2954 23598079 2013 GFIFHIIKGLFHAGKMIHGLV Epinecidin-1 21 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 30 % Cytotoxicity at 6.25 mg/L 24-h Fibrous connective tissue  None None CCCSSSSTTTTTTSSCSSSCC
2955 23598079 2013 GFIFHIIKGLFHAGKMIHGLV Epinecidin-1 21 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 28 % Cytotoxicity at 3.125 mg/L 24-h Fibrous connective tissue  None None CCCSSSSTTTTTTSSCSSSCC
2956 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 60 % Cytotoxicity at 50 mg/L 3-h Cervix None None CCCSSSTTTTTTSSCC
2957 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 50 % Cytotoxicity at 25 mg/L 3-h Cervix None None CCCSSSTTTTTTSSCC
2958 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 8 % Cytotoxicity at 12.5 mg/L 3-h Cervix None None CCCSSSTTTTTTSSCC
2959 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 10 % Cytotoxicity at 6.25 mg/L 3-h Cervix None None CCCSSSTTTTTTSSCC
2960 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 5 % Cytotoxicity at 3.125 mg/L 3-h Cervix None None CCCSSSTTTTTTSSCC
2961 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 75 % Cytotoxicity at 50 mg/L 6-h Cervix None None CCCSSSTTTTTTSSCC
2962 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 70 % Cytotoxicity at 25 mg/L 6-h Cervix None None CCCSSSTTTTTTSSCC
2963 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 5 % Cytotoxicity at 12.5 mg/L 6-h Cervix None None CCCSSSTTTTTTSSCC
2964 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 7 % Cytotoxicity at 6.25 mg/L 6-h Cervix None None CCCSSSTTTTTTSSCC
2965 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 10 % Cytotoxicity at 3.125 mg/L 6-h Cervix None None CCCSSSTTTTTTSSCC
2966 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 76 % Cytotoxicity at 50 mg/L 12-h Cervix None None CCCSSSTTTTTTSSCC
2967 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 70 % Cytotoxicity at 25 mg/L 12-h Cervix None None CCCSSSTTTTTTSSCC
2968 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 12 % Cytotoxicity at 12.5 mg/L 12-h Cervix None None CCCSSSTTTTTTSSCC
2969 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 4 % Cytotoxicity at 6.25 mg/L 12-h Cervix None None CCCSSSTTTTTTSSCC
2970 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 4 % Cytotoxicity at 3.125 mg/L 12-h Cervix None None CCCSSSTTTTTTSSCC
2971 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 90 % Cytotoxicity at 50 mg/L 24-h Cervix None None CCCSSSTTTTTTSSCC
2972 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 75 % Cytotoxicity at 25 mg/L 24-h Cervix None None CCCSSSTTTTTTSSCC
2973 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 8 % Cytotoxicity at 12.5 mg/L 24-h Cervix None None CCCSSSTTTTTTSSCC
2974 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 3 % Cytotoxicity at 6.25 mg/L 24-h Cervix None None CCCSSSTTTTTTSSCC
2975 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 3 % Cytotoxicity at 3.125 mg/L 24-h Cervix None None CCCSSSTTTTTTSSCC
2976 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 60 % Cytotoxicity at 50 mg/L 3-h Fibrous connective tissue  None None CCCSSSTTTTTTSSCC
2977 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 50 % Cytotoxicity at 25 mg/L 3-h Fibrous connective tissue  None None CCCSSSTTTTTTSSCC
2978 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 8 % Cytotoxicity at 12.5 mg/L 3-h Fibrous connective tissue  None None CCCSSSTTTTTTSSCC
2979 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 10 % Cytotoxicity at 6.25 mg/L 3-h Fibrous connective tissue  None None CCCSSSTTTTTTSSCC
2980 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 5 % Cytotoxicity at 3.125 mg/L 3-h Fibrous connective tissue  None None CCCSSSTTTTTTSSCC
2981 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 75 % Cytotoxicity at 50 mg/L 6-h Fibrous connective tissue  None None CCCSSSTTTTTTSSCC
2982 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 70 % Cytotoxicity at 25 mg/L 6-h Fibrous connective tissue  None None CCCSSSTTTTTTSSCC
2983 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 5 %Cytotoxicity at 12.5 mg/L 6-h Fibrous connective tissue  None None CCCSSSTTTTTTSSCC
2984 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 7 % Cytotoxicity at 6.25 mg/L 6-h Fibrous connective tissue  None None CCCSSSTTTTTTSSCC
2985 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 10 % Cytotoxicity at 3.125 mg/L 6-h Fibrous connective tissue  None None CCCSSSTTTTTTSSCC
2986 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 76 % Cytotoxicity at 50 mg/L 12-h Fibrous connective tissue  None None CCCSSSTTTTTTSSCC
2987 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 70 % Cytotoxicity at 25 mg/L 12-h Fibrous connective tissue  None None CCCSSSTTTTTTSSCC
2988 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 12 % Cytotoxicity at 12.5 mg/L 12-h Fibrous connective tissue  None None CCCSSSTTTTTTSSCC
2989 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 4 % Cytotoxicity at 6.25 mg/L 12-h Fibrous connective tissue  None None CCCSSSTTTTTTSSCC
2990 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 4 % Cytotoxicity at 3.125 mg/L 12-h Fibrous connective tissue  None None CCCSSSTTTTTTSSCC
2991 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 90 % Cytotoxicity at 50 mg/L 24-h Fibrous connective tissue  None None CCCSSSTTTTTTSSCC
2992 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 75 % Cytotoxicity at 25 mg/L 24-h Fibrous connective tissue  None None CCCSSSTTTTTTSSCC
2993 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 8 % Cytotoxicity at 12.5 mg/L 24-h Fibrous connective tissue  None None CCCSSSTTTTTTSSCC
2994 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 3 % Cytotoxicity at 6.25 mg/L 24-h Fibrous connective tissue  None None CCCSSSTTTTTTSSCC
2995 23598079 2013 FIFHIIKGLFHAGKMI Epinecidin-8 16 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 3 % Cytotoxicity at 3.125 mg/L 24-h Fibrous connective tissue  None None CCCSSSTTTTTTSSCC
3032 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 70 % Cytotoxicity at 50 mg/L 3-h Cervix None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3033 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 60 % Cytotoxicity at 25 mg/L 3-h Cervix None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3034 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 4 % Cytotoxicity at 12.5 mg/L 3-h Cervix None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3035 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 5 % Cytotoxicity at 6.25 mg/L 3-h Cervix None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3036 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 1 % Cytotoxicity at 3.125 mg/L 3-h Cervix None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3037 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 78 % Cytotoxicity at 50 mg/L 6-h Cervix None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3038 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 70 % Cytotoxicity at 25 mg/L 6-h Cervix None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3039 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 10 % Cytotoxicity at 12.5 mg/L 6-h Cervix None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3040 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 10 % Cytotoxicity at 6.25 mg/L 6-h Cervix None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3041 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 5 % Cytotoxicity at 3.125 mg/L 6-h Cervix None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3042 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 82 % Cytotoxicity at 50 mg/L 12-h Cervix None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3043 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 70 % Cytotoxicity at 25 mg/L 12-h Cervix None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3044 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 18 % Cytotoxicity at 12.5 mg/L 12-h Cervix None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3045 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 4 % Cytotoxicity at 6.25 mg/L 12-h Cervix None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3046 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 10 % Cytotoxicity at 3.125 mg/L 12-h Cervix None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3047 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 90 % Cytotoxicity at 50 mg/L 24-h Cervix None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3048 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 82 % Cytotoxicity at 25 mg/L 24-h Cervix None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3049 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 18 % Cytotoxicity at 12.5 mg/L 24-h Cervix None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3050 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 18 % Cytotoxicity at 6.25 mg/L 24-h Cervix None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3051 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HeLa Cervical Cancer MTT/MTS assay 18 % Cytotoxicity at 3.125 mg/L 24-h Cervix None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3052 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 80 % Cytotoxicity at 50 mg/L 3-h Fibrous connective tissue  None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3053 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 85 % Cytotoxicity at 25 mg/L 3-h Fibrous connective tissue  None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3054 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 45 % Cytotoxicity at 12.5 mg/L 3-h Fibrous connective tissue  None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3055 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 30 % Cytotoxicity at 6.25 mg/L 3-h Fibrous connective tissue  None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3056 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 25 % Cytotoxicity at 3.125 mg/L 3-h Fibrous connective tissue  None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3057 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 84 % Cytotoxicity at 50 mg/L 6-h Fibrous connective tissue  None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3058 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 84% Cytotoxicity at 25 mg/L 6-h Fibrous connective tissue  None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3059 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 48 % Cytotoxicity at 12.5 mg/L 6-h Fibrous connective tissue  None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3060 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 30 % Cytotoxicity at 6.25 mg/L 6-h Fibrous connective tissue  None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3061 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 35 % Cytotoxicity at 3.125 mg/L 6-h Fibrous connective tissue  None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3062 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 90 % Cytotoxicity at 50 mg/L 12-h Fibrous connective tissue  None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3063 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 85 % Cytotoxicity at 25 mg/L 12-h Fibrous connective tissue  None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3064 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 30 % Cytotoxicity at 12.5 mg/L 12-h Fibrous connective tissue  None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3065 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 35 % Cytotoxicity at 6.25 mg/L 12-h Fibrous connective tissue  None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3066 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 15 % Cytotoxicity at 3.125 mg/L 12-h Fibrous connective tissue  None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3067 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 90 % Cytotoxicity at 50 mg/L 24-h Fibrous connective tissue  None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3068 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 90 % Cytotoxicity at 25 mg/L 24-h Fibrous connective tissue  None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3069 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 20 % Cytotoxicity at 12.5 mg/L 24-h Fibrous connective tissue  None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3070 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 1 % Cytotoxicity at 6.25 mg/L 24-h Fibrous connective tissue  None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3071 23598079 2013 GFFALIPKIISSPLFKTLLSAVGSALS Pardaxin-6 27 Linear L None Free Free Antimicrobial Epinephelus nebulosus HT-1080 Fibrosarcoma MTT/MTS assay 10 % Cytotoxicity at 3.125 mg/L 24-h Fibrous connective tissue  None None CCCCCCTTGGGSHHHHHHHHHHHHHHC
3072 16004618 2005 MRKEFHNVLSSGQLLADKRPARDYNRK Pep27 27 Linear L None Free Free Anticancer S. pneumoniae AML-2 Leukemia Cancer MTT/MTS assay Not Available 14.54-Min Blood None None CCCGGGGTCCTTCTTTCCSSCCTTTCC
3078 16004618 2005 MRKEFHNVLSSGQLLADKRPARDYNRK Pep27 27 Linear L None Free Free Anticancer S. pneumoniae HL-60 Leukemia Cancer MTT/MTS assay IC50= >70 µM 14.54-Min Blood None None CCCGGGGTCCTTCTTTCCSSCCTTTCC
3084 16004618 2005 MRKEFHNVLSSGQLLADKRPARDYNRK Pep27 27 Linear L None Free Free Anticancer S. pneumoniae Jurkat Blood Cancer MTT/MTS assay IC50=>70 µM 14.54-Min Blood None None CCCGGGGTCCTTCTTTCCSSCCTTTCC
3090 16004618 2005 MRKEFHNVLSSGQLLADKRPARDYNRK Pep27 27 Linear L None Free Free Anticancer S. pneumoniae SNU-601 Gastric Cancer MTT/MTS assay IC50= >70 µM 14.54-Min Stomach None None CCCGGGGTCCTTCTTTCCSSCCTTTCC
3096 16004618 2005 MRKEFHNVLSSGQLLADKRPARDYNRK Pep27 27 Linear L None Free Free Anticancer S. pneumoniae MCF-7 Breast Cancer MTT/MTS assay IC50= >70 µM 14.54-Min Breast None None CCCGGGGTCCTTCTTTCCSSCCTTTCC
3073 16004618 2005 MWKWFHNVLSSWQLLADKRPARDYNRK Pep27anal1 27 Linear L None Free Free Anticancer S. pneumoniae AML-2 Leukemia Cancer MTT/MTS assay IC50= 50 µM 18.67-Min Blood None None CHHHHHHHHHHCSSSSSSCCCSSSCCC
3079 16004618 2005 MWKWFHNVLSSWQLLADKRPARDYNRK Pep27anal1 27 Linear L None Free Free Anticancer S. pneumoniae HL-60 Leukemia Cancer MTT/MTS assay IC50= 53 µM 18.67-Min Blood None None CHHHHHHHHHHCSSSSSSCCCSSSCCC
3085 16004618 2005 MWKWFHNVLSSWQLLADKRPARDYNRK Pep27anal1 27 Linear L None Free Free Anticancer S. pneumoniae Jurkat Blood Cancer MTT/MTS assay IC50= 47 µM 18.67-Min Blood None None CHHHHHHHHHHCSSSSSSCCCSSSCCC
3091 16004618 2005 MWKWFHNVLSSWQLLADKRPARDYNRK Pep27anal1 27 Linear L None Free Free Anticancer S. pneumoniae SNU-601 Gastric Cancer MTT/MTS assay IC50= 37 µM 18.67-Min Stomach None None CHHHHHHHHHHCSSSSSSCCCSSSCCC
3097 16004618 2005 MWKWFHNVLSSWQLLADKRPARDYNRK Pep27anal1 27 Linear L None Free Free Anticancer S. pneumoniae MCF-7 Breast Cancer MTT/MTS assay IC50= 55 µM 18.67-Min Breast None None CHHHHHHHHHHCSSSSSSCCCSSSCCC
3074 16004618 2005 MWKWFHNVLSWWWLLADKRPARDYNRK Pep27anal2 27 Linear L None Free Free Anticancer S. pneumoniae AML-2 Leukemia Cancer MTT/MTS assay IC50= 29 µM 22.5-Min Blood None None CHHHHHHHTCSCSSSSSSSSSSCCCCC
3080 16004618 2005 MWKWFHNVLSWWWLLADKRPARDYNRK Pep27anal2 27 Linear L None Free Free Anticancer S. pneumoniae HL-60 Leukemia Cancer MTT/MTS assay IC50= 20 µM 22.5-Min Blood None None CHHHHHHHTCSCSSSSSSSSSSCCCCC
3086 16004618 2005 MWKWFHNVLSWWWLLADKRPARDYNRK Pep27anal2 27 Linear L None Free Free Anticancer S. pneumoniae Jurkat Blood Cancer MTT/MTS assay IC50= 23 µM 22.5-Min Blood None None CHHHHHHHTCSCSSSSSSSSSSCCCCC
3092 16004618 2005 MWKWFHNVLSWWWLLADKRPARDYNRK Pep27anal2 27 Linear L None Free Free Anticancer S. pneumoniae SNU-601 Gastric Cancer MTT/MTS assay IC50= 25 µM 22.5-Min Stomach None None CHHHHHHHTCSCSSSSSSSSSSCCCCC
3098 16004618 2005 MWKWFHNVLSWWWLLADKRPARDYNRK Pep27anal2 27 Linear L None Free Free Anticancer S. pneumoniae MCF-7 Breast Cancer MTT/MTS assay IC50= <10 µM 22.5-Min Breast None None CHHHHHHHTCSCSSSSSSSSSSCCCCC
3075 16004618 2005 MRKWFHNVLSSGQLLADKWPAWDYNRK Pep27anal3 27 Linear L None Free Free Anticancer S. pneumoniae AML-2 Leukemia Cancer MTT/MTS assay IC50= 67 µM 20.08-Min Blood None None CTTGGGGSGGGGHHHHCCCCCSSSCCC
3081 16004618 2005 MRKWFHNVLSSGQLLADKWPAWDYNRK Pep27anal3 27 Linear L None Free Free Anticancer S. pneumoniae HL-60 Leukemia Cancer MTT/MTS assay IC50= 52 µM 20.08-Min Blood None None CTTGGGGSGGGGHHHHCCCCCSSSCCC
3087 16004618 2005 MRKWFHNVLSSGQLLADKWPAWDYNRK Pep27anal3 27 Linear L None Free Free Anticancer S. pneumoniae Jurkat Blood Cancer MTT/MTS assay IC50= 50 µM 20.08-Min Blood None None CTTGGGGSGGGGHHHHCCCCCSSSCCC
3093 16004618 2005 MRKWFHNVLSSGQLLADKWPAWDYNRK Pep27anal3 27 Linear L None Free Free Anticancer S. pneumoniae SNU-601 Gastric Cancer MTT/MTS assay IC50= 50 µM 20.08-Min Stomach None None CTTGGGGSGGGGHHHHCCCCCSSSCCC
3099 16004618 2005 MRKWFHNVLSSGQLLADKWPAWDYNRK Pep27anal3 27 Linear L None Free Free Anticancer S. pneumoniae MCF-7 Breast Cancer MTT/MTS assay IC50= 38 µM 20.08-Min Breast None None CTTGGGGSGGGGHHHHCCCCCSSSCCC
3076 16004618 2005 MWKEFHNVLSSGQLLADKRWARWYNRW Pep27anal4 27 Linear L None Free Free Anticancer S. pneumoniae AML-2 Leukemia Cancer MTT/MTS assay IC50= 50 µM 19.15-Min Blood None None CCGGGGTTTTSCCSSCCSSTHHHHSCC
3082 16004618 2005 MWKEFHNVLSSGQLLADKRWARWYNRW Pep27anal4 27 Linear L None Free Free Anticancer S. pneumoniae HL-60 Leukemia Cancer MTT/MTS assay IC50=51 µM 19.15-Min Blood None None CCGGGGTTTTSCCSSCCSSTHHHHSCC
3088 16004618 2005 MWKEFHNVLSSGQLLADKRWARWYNRW Pep27anal4 27 Linear L None Free Free Anticancer S. pneumoniae Jurkat Blood Cancer MTT/MTS assay IC50= 46 µM 19.15-Min Blood None None CCGGGGTTTTSCCSSCCSSTHHHHSCC
3094 16004618 2005 MWKEFHNVLSSGQLLADKRWARWYNRW Pep27anal4 27 Linear L None Free Free Anticancer S. pneumoniae SNU-601 Gastric Cancer MTT/MTS assay IC50= 37 µM 19.15-Min Stomach None None CCGGGGTTTTSCCSSCCSSTHHHHSCC
3100 16004618 2005 MWKEFHNVLSSGQLLADKRWARWYNRW Pep27anal4 27 Linear L None Free Free Anticancer S. pneumoniae MCF-7 Breast Cancer MTT/MTS assay IC50= 29 µM 19.15-Min Breast None None CCGGGGTTTTSCCSSCCSSTHHHHSCC
3077 16004618 2005 MWKWFHNVLSSGQLLADKWWAWWYNWW Pep27anal5 27 Linear L None Free Free Anticancer S. pneumoniae AML-2 Leukemia Cancer MTT/MTS assay IC50= >70 µM 19.17-Min Blood None None CCTTHHHHTTSGGGSTTHHHHTTTCCC
3083 16004618 2005 MWKWFHNVLSSGQLLADKWWAWWYNWW Pep27anal5 27 Linear L None Free Free Anticancer S. pneumoniae HL-60 Leukemia Cancer MTT/MTS assay IC50= >70 µM 19.17-Min Blood None None CCTTHHHHTTSGGGSTTHHHHTTTCCC
3089 16004618 2005 MWKWFHNVLSSGQLLADKWWAWWYNWW Pep27anal5 27 Linear L None Free Free Anticancer S. pneumoniae Jurkat Blood Cancer MTT/MTS assay IC50=>70 µM 19.17-Min Blood None None CCTTHHHHTTSGGGSTTHHHHTTTCCC
3095 16004618 2005 MWKWFHNVLSSGQLLADKWWAWWYNWW Pep27anal5 27 Linear L None Free Free Anticancer S. pneumoniae SNU-601 Gastric Cancer MTT/MTS assay IC50=>70 µM 19.17-Min Stomach None None CCTTHHHHTTSGGGSTTHHHHTTTCCC
3101 16004618 2005 MWKWFHNVLSSGQLLADKWWAWWYNWW Pep27anal5 27 Linear L None Free Free Anticancer S. pneumoniae MCF-7 Breast Cancer MTT/MTS assay IC50=>70 µM 19.17-Min Breast None None CCTTHHHHTTSGGGSTTHHHHTTTCCC
3102 22783018 2012 PDEDAINNALNKVCSTGRRQRSICKQLLKK N29N 30 Linear L None Free Free Antibacterial and Anticancer Synthetic peptide SW-480 Colon Cancer Cell Viability assay 100% cell viability at 5 µM 24-h Colon None None CCSHHHHHHHTTTSCSSSSHHHHHHHHHHC
3103 22783018 2012 PDEDAINNALNKVCSTGRRQRSICKQLLKK N29N 30 Linear L None Free Free Antibacterial and Anticancer Synthetic peptide SW-480 Colon Cancer Cell Viability assay 40% cell viability at 50 µM 24-h Colon None None CCSHHHHHHHTTTSCSSSSHHHHHHHHHHC
3104 22783018 2012 PDEDAINNALNKVCSTGRRQRSICKQLLKK N29N 30 Linear L None Free Free Antibacterial and Anticancer Synthetic peptide U-937 Lymphoma Cancer Cell Viability assay 100% cell viability at 5 µM 24-h Blood None None CCSHHHHHHHTTTSCSSSSHHHHHHHHHHC
3105 22783018 2012 PDEDAINNALNKVCSTGRRQRSICKQLLKK N29N 30 Linear L None Free Free Antibacterial and Anticancer Synthetic peptide U-937 Lymphoma Cancer Cell Viability assay <40% cell viability at 50 µM 24-h Blood None None CCSHHHHHHHTTTSCSSSSHHHHHHHHHHC
3106 22783018 2012 PDEDAINNALNKVCSTGRRQRSICKQLLKK N29N 30 Linear L None Free Free Antibacterial and Anticancer Synthetic peptide SNU-1 Gastric Cancer Cell Viability assay <100% cell viability at 5 µM 24-h Stomach None None CCSHHHHHHHTTTSCSSSSHHHHHHHHHHC
3107 22783018 2012 PDEDAINNALNKVCSTGRRQRSICKQLLKK N29N 30 Linear L None Free Free Antibacterial and Anticancer Synthetic peptide SNU-1 Gastric Cancer Cell Viability assay <20% cell viability at 50 µM 24-h Stomach None None CCSHHHHHHHTTTSCSSSSHHHHHHHHHHC
3254 22783018 2012 PDEDAINNALNKVCSTGRRQRSICKQLLKK N29N 30 Linear L None Free Free Antibacterial and Anticancer Synthetic peptide SW-480 Colon Cancer Cell Viability assay 100% cell viability at 5 µM NA Colon None None CCSHHHHHHHTTTSCSSSSHHHHHHHHHHC
3255 22783018 2012 PDEDAINNALNKVCSTGRRQRSICKQLLKK N29N 30 Linear L None Free Free Antibacterial and Anticancer Synthetic peptide SW-480 Colon Cancer Cell Viability assay 40% cell viability at 50 µM NA Colon None None CCSHHHHHHHTTTSCSSSSHHHHHHHHHHC
3256 22783018 2012 PDEDAINNALNKVCSTGRRQRSICKQLLKK N29N 30 Linear L None Free Free Antibacterial and Anticancer Synthetic peptide U-937 Lymphoma Cancer Cell Viability assay 100% cell viability at 5 µM NA Blood None None CCSHHHHHHHTTTSCSSSSHHHHHHHHHHC
3257 22783018 2012 PDEDAINNALNKVCSTGRRQRSICKQLLKK N29N 30 Linear L None Free Free Antibacterial and Anticancer Synthetic peptide U-937 Lymphoma Cancer Cell Viability assay <40% cell viability at 50 µM NA Blood None None CCSHHHHHHHTTTSCSSSSHHHHHHHHHHC
3258 22783018 2012 PDEDAINNALNKVCSTGRRQRSICKQLLKK N29N 30 Linear L None Free Free Antibacterial and Anticancer Synthetic peptide SNU-1 Gastric Cancer Cell Viability assay <100% cell viability at 5 µM NA Stomach None None CCSHHHHHHHTTTSCSSSSHHHHHHHHHHC
3259 22783018 2012 PDEDAINNALNKVCSTGRRQRSICKQLLKK N29N 30 Linear L None Free Free Antibacterial and Anticancer Synthetic peptide SNU-1 Gastric Cancer Cell Viability assay <20% cell viability at 50 µM NA Stomach None None CCSHHHHHHHTTTSCSSSSHHHHHHHHHHC
3108 22783018 2012 PDEDAINDALNKVCSTGRRQRSICKQLLKK N29D 30 Linear L None Free Free Antibacterial and Anticancer Synthetic peptide SW-480 Colon Cancer Cell Viability assay >100% cell viability at 5 µM 24-h Colon None None CCTTTTTHHHHHHHCTTTSTTHHHHHTSCC
3109 22783018 2012 PDEDAINDALNKVCSTGRRQRSICKQLLKK N29D 30 Linear L None Free Free Antibacterial and Anticancer Synthetic peptide SW-480 Colon Cancer Cell Viability assay 60% cell viability at 50 µM 24-h Colon None None CCTTTTTHHHHHHHCTTTSTTHHHHHTSCC
3110 22783018 2012 PDEDAINDALNKVCSTGRRQRSICKQLLKK N29D 30 Linear L None Free Free Antibacterial and Anticancer Synthetic peptide U-937 Lymphoma Cancer Cell Viability assay 100% cell viability at 5 µM 24-h Blood None None CCTTTTTHHHHHHHCTTTSTTHHHHHTSCC
3111 22783018 2012 PDEDAINDALNKVCSTGRRQRSICKQLLKK N29D 30 Linear L None Free Free Antibacterial and Anticancer Synthetic peptide U-937 Lymphoma Cancer Cell Viability assay <60% cell viability at 50 µM 24-h Blood None None CCTTTTTHHHHHHHCTTTSTTHHHHHTSCC
3112 22783018 2012 PDEDAINDALNKVCSTGRRQRSICKQLLKK N29D 30 Linear L None Free Free Antibacterial and Anticancer Synthetic peptide SNU-1 Gastric Cancer Cell Viability assay <100% cell viability at 5 µM 24-h Stomach None None CCTTTTTHHHHHHHCTTTSTTHHHHHTSCC
3113 22783018 2012 PDEDAINDALNKVCSTGRRQRSICKQLLKK N29D 30 Linear L None Free Free Antibacterial and Anticancer Synthetic peptide SNU-1 Gastric Cancer Cell Viability assay <40% cell viability at 50 µM 24-h Stomach None None CCTTTTTHHHHHHHCTTTSTTHHHHHTSCC
3260 22783018 2012 PDEDAINDALNKVCSTGRRQRSICKQLLKK N29D 30 Linear L None Free Free Antibacterial and Anticancer Synthetic peptide SW-480 Colon Cancer Cell Viability assay >100% cell viability at 5 µM NA Colon None None CCTTTTTHHHHHHHCTTTSTTHHHHHTSCC
3261 22783018 2012 PDEDAINDALNKVCSTGRRQRSICKQLLKK N29D 30 Linear L None Free Free Antibacterial and Anticancer Synthetic peptide SW-480 Colon Cancer Cell Viability assay 60% cell viability at 50 µM NA Colon None None CCTTTTTHHHHHHHCTTTSTTHHHHHTSCC
3262 22783018 2012 PDEDAINDALNKVCSTGRRQRSICKQLLKK N29D 30 Linear L None Free Free Antibacterial and Anticancer Synthetic peptide U-937 Lymphoma Cancer Cell Viability assay 100% cell viability at 5 µM NA Blood None None CCTTTTTHHHHHHHCTTTSTTHHHHHTSCC
3263 22783018 2012 PDEDAINDALNKVCSTGRRQRSICKQLLKK N29D 30 Linear L None Free Free Antibacterial and Anticancer Synthetic peptide U-937 Lymphoma Cancer Cell Viability assay <60% cell viability at 50 µM NA Blood None None CCTTTTTHHHHHHHCTTTSTTHHHHHTSCC
3264 22783018 2012 PDEDAINDALNKVCSTGRRQRSICKQLLKK N29D 30 Linear L None Free Free Antibacterial and Anticancer Synthetic peptide SNU-1 Gastric Cancer Cell Viability assay 100% cell viability at 5 µM NA Stomach None None CCTTTTTHHHHHHHCTTTSTTHHHHHTSCC
3265 22783018 2012 PDEDAINDALNKVCSTGRRQRSICKQLLKK N29D 30 Linear L None Free Free Antibacterial and Anticancer Synthetic peptide SNU-1 Gastric Cancer Cell Viability assay <40% cell viability at 50 µM NA Stomach None None CCTTTTTHHHHHHHCTTTSTTHHHHHTSCC
3114 23993331 2013 KWLRRVWRWWR MAP-04-03 11 Linear L None Amidation Free Antimicrobial Analogs of Ixosin-B amide MCF-7 Breast Cancer MTT/MTS assay Cell viability >80% at 25 µM 48-h Breast None None CTHHHHTTTCC
3115 23993331 2013 KWLRRVWRWWR MAP-04-03 11 Linear L None Amidation Free Antimicrobial Analogs of Ixosin-B amide MCF-7 Breast Cancer MTT/MTS assay Cell viability ~50% at 50 µM 48-h Breast None None CTHHHHTTTCC
3116 23993331 2013 KWLRRVWRWWR MAP-04-03 11 Linear L None Amidation Free Antimicrobial Analogs of Ixosin-B amide MCF-7 Breast Cancer MTT/MTS assay Cell viability <40% at 75 µM 48-h Breast None None CTHHHHTTTCC
3117 23993331 2013 KWLRRVWRWWR MAP-04-03 11 Linear L None Amidation Free Antimicrobial Analogs of Ixosin-B amide MCF-7 Breast Cancer MTT/MTS assay Cell viability >20% at 100 µM 48-h Breast None None CTHHHHTTTCC
3118 23993331 2013 KWLRRVWRWWR MAP-04-03 11 Linear L None Amidation Free Antimicrobial Analogs of Ixosin-B amide MCF-7 Breast Cancer MTT/MTS assay Cell viability ~100% at 25 µM 48-h Breast None None CTHHHHTTTCC
3122 23993331 2013 KWLRRVWRWWR MAP-04-03 11 Linear L None Amidation Free Antimicrobial Analogs of Ixosin-B amide MCF-7 Breast Cancer MTT/MTS assay IC50=61.5 µM 48-h Breast None None CTHHHHTTTCC
3119 23993331 2013 KRLRRVWRRWR MAP-04-04 11 Linear L None Amidation Free Antimicrobial Analogs of Ixosin-B amide MCF-7 Breast Cancer MTT/MTS assay Cell viability >80% at 50 µM 48-h Breast None None CGGGGTTTTCC
3120 23993331 2013 KRLRRVWRRWR MAP-04-04 11 Linear L None Amidation Free Antimicrobial Analogs of Ixosin-B amide MCF-7 Breast Cancer MTT/MTS assay Cell viability >80% at 75 µM 48-h Breast None None CGGGGTTTTCC
3121 23993331 2013 KRLRRVWRRWR MAP-04-04 11 Linear L None Amidation Free Antimicrobial Analogs of Ixosin-B amide MCF-7 Breast Cancer MTT/MTS assay Cell viability >80% at 100 µM 48-h Breast None None CGGGGTTTTCC
3123 23770440 2013 FLSLIPSLVGGSISAFK TsAP-1 17 Linear L None Amidation Free Antimicrobial Venom-derived cDNot Available library of the Brazilian yellow scorpion, Tityus serrulatus HI-57 Lung Cancer MTT/MTS assay IC50 =55.9 µM 24-h Lung None None CCSSCSSCCCEETTEEC
3124 23770440 2013 FLSLIPSLVGGSISAFK TsAP-1 17 Linear L None Amidation Free Antimicrobial Venom-derived cDNot Available library of the Brazilian yellow scorpion, Tityus serrulatus H-838 Lung Cancer MTT/MTS assay IC50 =52.5 µM 24-h Lung None None CCSSCSSCCCEETTEEC
3125 23770440 2013 FLGMIPGLIGGLISAFK TsAP-2 17 Linear L None Amidation Free Antimicrobial Venom-derived cDNot Available library of the Brazilian yellow scorpion, Tityus serrulatus HI-57 Lung Cancer MTT/MTS assay IC50 = 4.1 µM 24-h Lung None None CCSCCCSTHHHHTTTTC
3126 23770440 2013 FLGMIPGLIGGLISAFK TsAP-2 17 Linear L None Amidation Free Antimicrobial Venom-derived cDNot Available library of the Brazilian yellow scorpion, Tityus serrulatus H-838 Lung Cancer MTT/MTS assay IC50 = 11.0 µM 24-h Lung None None CCSCCCSTHHHHTTTTC
3127 23770440 2013 FLGMIPGLIGGLISAFK TsAP-2 17 Linear L None Amidation Free Antimicrobial Venom-derived cDNot Available library of the Brazilian yellow scorpion, Tityus serrulatus MCF-7 Breast Cancer MTT/MTS assay IC50 = 6.4 µM 24-h Breast None None CCSCCCSTHHHHTTTTC
3128 23770440 2013 FLGMIPGLIGGLISAFK TsAP-2 17 Linear L None Amidation Free Antimicrobial Venom-derived cDNot Available library of the Brazilian yellow scorpion, Tityus serrulatus PC-3 Prostate Cancer MTT/MTS assay IC50 = 13.3 µM 24-h Prostate None None CCSCCCSTHHHHTTTTC
3129 23770440 2013 FLGMIPGLIGGLISAFK TsAP-2 17 Linear L None Amidation Free Antimicrobial Venom-derived cDNot Available library of the Brazilian yellow scorpion, Tityus serrulatus U251-MG Brain Tumor MTT/MTS assay IC50 = 15.4 µM 24-h Brain None None CCSCCCSTHHHHTTTTC
3130 23770440 2013 FLSLIPKLVKKIIKAFK TsAP-S1 17 Linear L None Amidation Free Antimicrobial Derivative of TsAP-1, Brazilian yellow scorpion venom peptide HI-57 Lung Cancer MTT/MTS assay IC50 = 1.5 µM 24-h Lung None None CCCCTHHHHHHHTTTCC
3131 23770440 2013 FLSLIPKLVKKIIKAFK TsAP-S1 17 Linear L None Amidation Free Antimicrobial Derivative of TsAP-1, Brazilian yellow scorpion venom peptide H-838 Lung Cancer MTT/MTS assay IC50 = 1.6 µM 24-h Lung None None CCCCTHHHHHHHTTTCC
3132 23770440 2013 FLSLIPKLVKKIIKAFK TsAP-S1 17 Linear L None Amidation Free Antimicrobial Derivative of TsAP-1, Brazilian yellow scorpion venom peptide MCF-7 Breast Cancer MTT/MTS assay IC50 = 1.8 µM 24-h Breast None None CCCCTHHHHHHHTTTCC
3133 23770440 2013 FLSLIPKLVKKIIKAFK TsAP-S1 17 Linear L None Amidation Free Antimicrobial Derivative of TsAP-1, Brazilian yellow scorpion venom peptide PC-3 Prostate Cancer MTT/MTS assay IC50 = 2.1 µM 24-h Prostate None None CCCCTHHHHHHHTTTCC
3134 23770440 2013 FLSLIPKLVKKIIKAFK TsAP-S1 17 Linear L None Amidation Free Antimicrobial Derivative of TsAP-1, Brazilian yellow scorpion venom peptide U251-MG Brain Tumor MTT/MTS assay IC50 = 2.9 µM 24-h Brain None None CCCCTHHHHHHHTTTCC
3135 23770440 2013 FLGMIPKLIKKLIKAFK TsAP-S2 17 Linear L None Amidation Free Antimicrobial Derivative of TsAP-1, Brazilian yellow scorpion venom peptide HI-57 Lung Cancer MTT/MTS assay IC50 = 0.83 µM 24-h Lung None None CCCCTHHHHHHHTTTCC
3136 23770440 2013 FLGMIPKLIKKLIKAFK TsAP-S2 17 Linear L None Amidation Free Antimicrobial Derivative of TsAP-1, Brazilian yellow scorpion venom peptide H-838 Lung Cancer MTT/MTS assay IC50 = 1.6 µM 24-h Lung None None CCCCTHHHHHHHTTTCC
3137 23770440 2013 FLGMIPKLIKKLIKAFK TsAP-S2 17 Linear L None Amidation Free Antimicrobial Derivative of TsAP-1, Brazilian yellow scorpion venom peptide MCF-7 Breast Cancer MTT/MTS assay IC50 = 1.8 µM 24-h Breast None None CCCCTHHHHHHHTTTCC
3138 23770440 2013 FLGMIPKLIKKLIKAFK TsAP-S2 17 Linear L None Amidation Free Antimicrobial Derivative of TsAP-1, Brazilian yellow scorpion venom peptide PC-3 Prostate Cancer MTT/MTS assay IC50 = 1.6 µM 24-h Prostate None None CCCCTHHHHHHHTTTCC
3139 23770440 2013 FLGMIPKLIKKLIKAFK TsAP-S2 17 Linear L None Amidation Free Antimicrobial Derivative of TsAP-1, Brazilian yellow scorpion venom peptide U251-MG Brain Tumor MTT/MTS assay IC50 = 2.0 µM 24-h Brain None None CCCCTHHHHHHHTTTCC
3140 23627474 2013 CHHNLTHAC PTPRJ-pep19 9 Cyclic(C1-C9) L None Free Free Anticancer PTPRJ agonist peptides HeLa Cervical Cancer Trypan blue assay 4.5 ± 0.1.4% cell growth inhibition at 160 µM in 48 hours 48-h Cervix None None CCSSSSSCC
3141 23627474 2013 CHHNLTHAC PTPRJ-pep19 9 Cyclic(C1-C9) L None Free Free Anticancer PTPRJ agonist peptides HeLa Cervical Cancer Trypan blue assay 19 ± 2.82% cell growth inhibition at 160 µM in 72 hours 72-h Cervix None None CCSSSSSCC
3142 23627474 2013 CHHNLTHAC PTPRJ-pep19.0 9 Linear L None Free Free Anticancer PTPRJ agonist peptides HeLa Cervical Cancer Trypan blue assay 4 ± 1.4% cell growth inhibition at 160 µM in 72 hours 72-h Cervix None None CCCCSSSCC
3143 23627474 2013 CAHNLTHAC PTPRJ-pep19.2 9 Cyclic(C1-C9) L None Free Free Anticancer PTPRJ agonist peptides HeLa Cervical Cancer Trypan blue assay 16.5 ± 2.12% cell growth inhibition at 160 µM in 24 hours 24-h Cervix None None CCSSSCSCC
3144 23627474 2013 CAHNLTHAC PTPRJ-pep19.2 9 Cyclic(C1-C9) L None Free Free Anticancer PTPRJ agonist peptides HeLa Cervical Cancer Trypan blue assay 30 ± 2.82% cell growth inhibition at 160 µM in 48 hours 48-h Cervix None None CCSSSCSCC
3145 23627474 2013 CAHNLTHAC PTPRJ-pep19.2 9 Cyclic(C1-C9) L None Free Free Anticancer PTPRJ agonist peptides HeLa Cervical Cancer Trypan blue assay 32.0 ± 4.2% cell growth inhibition at 160 µM in 72 hours 72-h Cervix None None CCSSSCSCC
3146 23627474 2013 CHANLTHAC PTPRJ-pep19.3 9 Cyclic(C1-C9) L None Free Free Anticancer PTPRJ agonist peptides HeLa Cervical Cancer Trypan blue assay 28 ± 5.5% cell growth inhibition at 160 µM in 24 hours 24-h Cervix None None CCCBTTBCC
3147 23627474 2013 CHANLTHAC PTPRJ-pep19.3 9 Cyclic(C1-C9) L None Free Free Anticancer PTPRJ agonist peptides HeLa Cervical Cancer Trypan blue assay 46 ± 4.2% cell growth inhibition at 160 µM in 48 hours 48-h Cervix None None CCCBTTBCC
3148 23627474 2013 CHANLTHAC PTPRJ-pep19.3 9 Cyclic(C1-C9) L None Free Free Anticancer PTPRJ agonist peptides HeLa Cervical Cancer Trypan blue assay 51 ± 1.4% cell growth inhibition at 160 µM in 72 hours 72-h Cervix None None CCCBTTBCC
3149 23627474 2013 CHHALTHAC PTPRJ-pep19.4 9 Cyclic(C1-C9) L None Free Free Anticancer PTPRJ agonist peptides HeLa Cervical Cancer Trypan blue assay 48.0 ± 2.82% cell growth inhibition at 160 µM in 24 hours 24-h Cervix None None CTTTCCSCC
3150 23627474 2013 CHHALTHAC PTPRJ-pep19.4 9 Cyclic(C1-C9) L None Free Free Anticancer PTPRJ agonist peptides HeLa Cervical Cancer Trypan blue assay 62.5 ± 4.9% cell growth inhibition at 160 µM in 48 hours 48-h Cervix None None CTTTCCSCC
3151 23627474 2013 CHHALTHAC PTPRJ-pep19.4 9 Cyclic(C1-C9) L None Free Free Anticancer PTPRJ agonist peptides HeLa Cervical Cancer Trypan blue assay 66.5 ± 2.12% cell growth inhibition at 160 µM in 72 hours 72-h Cervix None None CTTTCCSCC
3152 23627474 2013 CHHNATHAC PTPRJ-pep19.5 9 Cyclic(C1-C9) L None Free Free Anticancer PTPRJ agonist peptides HeLa Cervical Cancer Trypan blue assay 2 ± 1.5% cell growth inhibition at 160 µM in 48 hours 48-h Cervix None None CCTTTSCCC
3153 23627474 2013 CHHNATHAC PTPRJ-pep19.5 9 Cyclic(C1-C9) L None Free Free Anticancer PTPRJ agonist peptides HeLa Cervical Cancer Trypan blue assay 19 ± 4.2% cell growth inhibition at 160 µM in 72 hours 72-h Cervix None None CCTTTSCCC
3154 23627474 2013 CHHNLAHAC PTPRJ-pep19.6 9 Cyclic(C1-C9) L None Free Free Anticancer PTPRJ agonist peptides HeLa Cervical Cancer Trypan blue assay 19 ± 4.2% cell growth inhibition at 160 µM in 72 hours 72-h Cervix None None CCSCSSCCC
3155 23627474 2013 CHHNLTAAC PTPRJ-pep19.7 9 Cyclic(C1-C9) L None Free Free Anticancer PTPRJ agonist peptides HeLa Cervical Cancer Trypan blue assay 4.5 ± 2.13% cell growth inhibition at 160 µM in 48 hours 48-h Cervix None None CCGGGSSCC
3156 23627474 2013 CHHNLTAAC PTPRJ-pep19.7 9 Cyclic(C1-C9) L None Free Free Anticancer PTPRJ agonist peptides HeLa Cervical Cancer Trypan blue assay 20 ± 1.4% cell growth inhibition at 160 µM in 72 hours 72-h Cervix None None CCGGGSSCC
3198 22184121 2011 MTLTG BPP-II 5 Linear L None Free Free Antitumor Immunomodulatory bursal-derived Pentapeptide-II CEF Tumor MTT/MTS assay NA 48-h Not Available None None CCCCC
3200 22184121 2011 MTLTG BPP-II 5 Linear L None Free Free Antitumor Immunomodulatory bursal-derived Pentapeptide-II Vero Renal Cancer MTT/MTS assay NA 48-h Renal None None CCCCC
3201 22184121 2011 MTLTG BPP-II 5 Linear L None Free Free Antitumor Immunomodulatory bursal-derived Pentapeptide-II MDBK Renal Cancer MTT/MTS assay NA 48-h Renal None None CCCCC
3202 22184121 2011 MTLTG BPP-II 5 Linear L None Free Free Antitumor Immunomodulatory bursal-derived Pentapeptide-II MDBK Renal Cancer MTT/MTS assay NA 48-h Renal None None CCCCC
3203 22184121 2011 MTLTG BPP-II 5 Linear L None Free Free Antitumor Immunomodulatory bursal-derived Pentapeptide-II MDBK Renal Cancer MTT/MTS assay NA 48-h Renal None None CCCCC
3204 22184121 2011 MTLTG BPP-II 5 Linear L None Free Free Antitumor Immunomodulatory bursal-derived Pentapeptide-II MDBK Renal Cancer MTT/MTS assay NA 48-h Renal None None CCCCC
3205 22184121 2011 MTLTG BPP-II 5 Linear L None Free Free Antitumor Immunomodulatory bursal-derived Pentapeptide-II MDBK Renal Cancer MTT/MTS assay NA 48-h Renal None None CCCCC
3208 22184121 2011 MTLTG BPP-II 5 Linear L None Free Free Antitumor Immunomodulatory bursal-derived Pentapeptide-II CEF Tumor MTT/MTS assay NA 48-h Not Available None None CCCCC
3210 22184121 2011 MTLTG BPP-II 5 Linear L None Free Free Antitumor Immunomodulatory bursal-derived Pentapeptide-II Vero Renal Cancer MTT/MTS assay NA 48-h Renal None None CCCCC
3211 22184121 2011 MTLTG BPP-II 5 Linear L None Free Free Antitumor Immunomodulatory bursal-derived Pentapeptide-II MDBK Renal Cancer MTT/MTS assay NA 48-h Renal None None CCCCC
3212 22184121 2011 MTLTG BPP-II 5 Linear L None Free Free Antitumor Immunomodulatory bursal-derived Pentapeptide-II MDBK Renal Cancer MTT/MTS assay NA 48-h Renal None None CCCCC
3213 22184121 2011 MTLTG BPP-II 5 Linear L None Free Free Antitumor Immunomodulatory bursal-derived Pentapeptide-II MDBK Renal Cancer MTT/MTS assay NA 48-h Renal None None CCCCC
3214 22184121 2011 MTLTG BPP-II 5 Linear L None Free Free Antitumor Immunomodulatory bursal-derived Pentapeptide-II MDBK Renal Cancer MTT/MTS assay NA 48-h Renal None None CCCCC
3215 22184121 2011 MTLTG BPP-II 5 Linear L None Free Free Antitumor Immunomodulatory bursal-derived Pentapeptide-II MDBK Renal Cancer MTT/MTS assay NA 48-h Renal None None CCCCC
3206 22413859 2012 KVKVKVKVpPTKVKVKVK SVS-1 18 Linear Mix None Amidation Free Antimicrobial Synthetic peptide A-549 Lung Cancer MTT/MTS assay NA 24-h Lung None None CCSCCCCSSCSSCCCSCC
3207 22413859 2012 KVKVKVKVpPTKVKVKVK SVS-1 18 Linear Mix None Amidation Free Antimicrobial Bovine lactoferrin (Lf-B) KB Oral Cancer MTT/MTS assay NA 24-h Oral mucosa None None CCSCCCCSSCSSCCCSCC
3216 22413859 2012 KVKVKVKVpPTKVKVKVK SVS-1 18 Linear Mix None Amidation Free Antimicrobial Synthetic peptide MCF-7 Breast Cancer MTT/MTS assay IC50 =8.1±0.8 µM 24-h Breast None None CCSCCCCSSCSSCCCSCC
3217 22413859 2012 KVKVKVKVpPTKVKVKVK SVS-1 18 Linear Mix None Amidation Free Antimicrobial Synthetic peptide MDA-MB-436 Breast Cancer MTT/MTS assay IC50 =5.6±0.5 µM 24-h Breast None None CCSCCCCSSCSSCCCSCC
3218 22413859 2012 kvkvkvkvPptkvkvkvk D-SVS-1 18 Linear Mix None Amidation Free Antimicrobial Synthetic peptide A-549 Lung Cancer MTT/MTS assay IC50 =3.2±0.6 µM 24-h Lung None None CGGGTCSCCCTTTTTTTC
3219 22413859 2012 kvkvkvkvPptkvkvkvk D-SVS-1 18 Linear Mix None Amidation Free Antimicrobial Synthetic peptide KB Oral Cancer MTT/MTS assay IC50 =4.5±0.5 µM 24-h Oral mucosa None None CGGGTCSCCCTTTTTTTC
3220 22413859 2012 kvkvkvkvPptkvkvkvk D-SVS-1 18 Linear Mix None Amidation Free Antimicrobial Synthetic peptide MCF-7 Breast Cancer MTT/MTS assay IC50 =4.7±0.4 µM 24-h Breast None None CGGGTCSCCCTTTTTTTC
3221 22413859 2012 kvkvkvkvPptkvkvkvk D-SVS-1 18 Linear Mix None Amidation Free Antimicrobial Synthetic peptide MDA-MB-436 Breast Cancer MTT/MTS assay IC50 =3.2±0.4 µM 24-h Breast None None CGGGTCSCCCTTTTTTTC
3222 22413859 2012 KVKVKVKVPPTKVKVKVK SVS-2 18 Linear L None Amidation Free Antimicrobial Synthetic peptide A-549 Lung Cancer MTT/MTS assay IC50 >100 µM 24-h Lung None None CGGGCCCSSSSSSCCSCC
3223 22413859 2012 KVKVKVKVPPTKVKVKVK SVS-2 18 Linear L None Amidation Free Antimicrobial Synthetic peptide KB Oral Cancer MTT/MTS assay IC50 >100 µM 24-h Oral mucosa None None CGGGCCCSSSSSSCCSCC
3224 22413859 2012 KVKVKVKVPPTKVKVKVK SVS-2 18 Linear L None Amidation Free Antimicrobial Synthetic peptide MCF-7 Breast Cancer MTT/MTS assay IC50 >100 µM 24-h Breast None None CGGGCCCSSSSSSCCSCC
3225 22413859 2012 KVKVKVKVPPTKVKVKVK SVS-2 18 Linear L None Amidation Free Antimicrobial Synthetic peptide MDA-MB-436 Breast Cancer MTT/MTS assay IC50 >100 µM 24-h Breast None None CGGGCCCSSSSSSCCSCC
3266 22934601 2012 FLGALFHALSKLL PTP-7a 13 Linear L None Free Free Anticancer Synthetic peptide A-549 Lung Cancer MTT/MTS assay IC50 =28 µM NA Lung None None CHHHHHHHHHHHC
3267 22934601 2012 FLGALFKALSHLL PTP-7b 13 Linear L None Free Free Anticancer Synthetic peptide A-549 Lung Cancer MTT/MTS assay IC50 =32 µM NA Lung None None CHHHHHHHHTTCC
3268 18815734 2008 VRRFPWWWPFLRR Tritrpticin 13 Linear L None Amidation Free Antimicrobial Derivative of tritrpticin A-549 Lung Cancer MTT/MTS assay IC50 >200 µg/ml NA Lung None None CCCCCSSGGGCCC
3269 18815734 2008 VRRFPWWWPFLRR Tritrpticin 13 Linear L None Amidation Free Antimicrobial Derivative of tritrpticin MDA-MB-361 Breast Cancer MTT/MTS assay IC50 =142 µg/ml NA Breast None None CCCCCSSGGGCCC
3271 18815734 2008 KKKFPWWWPFKKK PST13-RK 13 Linear L None Amidation Free Antimicrobial Derivative of tritrpticin A-549 Lung Cancer MTT/MTS assay IC50 =90 µg/ml NA Lung None None CCCCCCSSTTTCC
3272 18815734 2008 KKKFPWWWPFKKK PST13-RK 13 Linear L None Amidation Free Antimicrobial Derivative of tritrpticin MDA-MB-361 Breast Cancer MTT/MTS assay IC50 =80 µg/ml NA Breast None None CCCCCCSSTTTCC
3280 19527490, 23533710 2009 FKCRRWQWRMKK LfcinB 12 Linear L None Free Free Anticancer Bovine lactoferrin (Lf-B) FEMX Skin Cancer MTT/MTS assay IC50 =40±7 µM NA Skin 23533710 None CTTTSSCCTTTC
3281 19527490, 23533710 2009 FKCRRWQWRMKK LfcinB 12 Linear L None Free Free Anticancer Bovine lactoferrin (Lf-B) HT-29 Colon Cancer MTT/MTS assay IC50 =148±8 µM NA Colon 23533710 None CTTTSSCCTTTC
3282 19527490, 23533710 2009 FKCRRWQWRMKK LfcinB 12 Linear L None Free Free Anticancer Bovine lactoferrin (Lf-B) KMS-5 Skin Cancer MTT/MTS assay IC50 = 38 µM NA Skin 23533710 None CTTTSSCCTTTC
3283 19527490, 23533710 2009 FKCRRWQWRMKK LfcinB 12 Linear L None Free Free Anticancer Bovine lactoferrin (Lf-B) U-266 Lymphoma Cancer MTT/MTS assay IC50 = 55 µM NA Blood 23533710 None CTTTSSCCTTTC
3284 19527490, 23533710 2009 FKCRRWQWRMKK LfcinB 12 Linear L None Free Free Anticancer Bovine lactoferrin (Lf-B) KMM-1 Skin Cancer MTT/MTS assay IC50 = 57 µM NA Skin 23533710 None CTTTSSCCTTTC
3285 19527490, 23533710 2009 FKCRRWQWRMKK LfcinB 12 Linear L None Free Free Anticancer Bovine lactoferrin (Lf-B) Sudhl-4 Skin Cancer MTT/MTS assay IC50 = 16 µM NA Skin 23533710 None CTTTSSCCTTTC
3286 19527490, 23533710 2009 FKCRRWQWRMKK LfcinB 12 Linear L None Free Free Anticancer Bovine lactoferrin (Lf-B) Raji Lymphoma Cancer MTT/MTS assay IC50 = 13 µM NA Blood 23533710 None CTTTSSCCTTTC
3287 19527490, 23533710 2009 FKCRRWQWRMKK LfcinB 12 Linear L None Free Free Anticancer Bovine lactoferrin (Lf-B) Ramos Lymphoma Cancer MTT/MTS assay IC50 = 10 µM NA Blood 23533710 None CTTTSSCCTTTC
3314 21453492, 23533710 2011 FKCRRWQWRMKK LfcinB 12 Linear L None Free Free Antimicrobial and Anticancer Bovine lactoferrin (Lf-B) HT-29 Colon Cancer MTT/MTS assay IC50 > 160 µM 30-Min Colon 23533710 None CTTTSSCCTTTC
3315 21453492, 23533710 2011 FKCRRWQWRMKK LfcinB 12 Linear L None Free Free Antimicrobial and Anticancer Bovine lactoferrin (Lf-B) MT-1 Breast Cancer MTT/MTS assay IC50 > 160 µM 30-Min Breast 23533710 None CTTTSSCCTTTC
3316 21453492, 23533710 2011 FKCRRWQWRMKK LfcinB 12 Linear L None Free Free Antimicrobial and Anticancer Bovine lactoferrin (Lf-B) Kelly Brain Tumor MTT/MTS assay IC50 =141 ± 3 µM 30-Min Brain 23533710 None CTTTSSCCTTTC
3341 23533710 2013 FKCRRWQWRMKK LfcinB 12 Linear L None Amidation Free Antihypertensive and Antimicrobial and Antiviral and Antioxidant Bovine milk AZ-97 Colon Cancer MTT/MTS assay Inhibition at 0.1g/l NA Colon 23649168 None CCCSSCCCGGGC
3288 19527490 2009 KAAKKAAKAAKKAAKAAKKAA KW5 21 Linear L None Free Free Anticancer Bovine lactoferrin (Lf-B) FEMX Skin Cancer MTT/MTS assay IC50 =30±3 µM NA Skin None None CTHHHHHHHHHHHHHHHHHHC
3289 19527490 2009 KAAKKAAKAAKKAAKAAKKAA KW5 21 Linear L None Free Free Anticancer Synthetic peptide HT-29 Colon Cancer MTT/MTS assay IC50 =55±14 µM NA Colon None None CTHHHHHHHHHHHHHHHHHHC
3290 19957017 2010 KWKLFKKIPKFLHLAKKF P18 18 Linear L None Free Free Antibacterial Bovine lactoferrin (Lf-B) M14 Skin Cancer MTT/MTS assay 92.2 ± 1.02% cell viability at 10 µM NA Skin None None CCCSCCCCHHHHSTTSCC
3291 19957017 2010 KWKLFKKIPKFLHLAKKF P18 18 Linear L None Free Free Antibacterial Synthetic peptide M14 Skin Cancer MTT/MTS assay 71.1 ± 2.84% cell viability at 20 µM NA Skin None None CCCSCCCCHHHHSTTSCC
3292 19957017 2010 KWKLFKKIPKFLHLAKKF P18 18 Linear L None Free Free Antibacterial Synthetic peptide M14 Skin Cancer MTT/MTS assay 50 ± 3.09% cell viability at 40 µM NA Skin None None CCCSCCCCHHHHSTTSCC
3293 19957017 2010 KWKLFKKIPKFLHLAKKF P18 18 Linear L None Free Free Antibacterial Synthetic peptide M14 Skin Cancer MTT/MTS assay 31.5 ± 1.49% cell viability at 60 µM NA Skin None None CCCSCCCCHHHHSTTSCC
3294 19957017 2010 KWKLFKKIPKFLHLAKKF P18 18 Linear L None Free Free Antibacterial Synthetic peptide M14 Skin Cancer MTT/MTS assay 13.8 ± 1.44% cell viability at 80 µM NA Skin None None CCCSCCCCHHHHSTTSCC
3295 19957017 2010 KWKLFKKIPKFLHLAKKF P18 18 Linear L None Free Free Antibacterial Synthetic peptide A-375 Skin Cancer MTT/MTS assay 86 ± 0.57% cell viability at 10 µM NA Skin None None CCCSCCCCHHHHSTTSCC
3296 19957017 2010 KWKLFKKIPKFLHLAKKF P18 18 Linear L None Free Free Antibacterial Synthetic peptide A-375 Skin Cancer MTT/MTS assay 63.8 ± 0.8% cell viability at 20 µM NA Skin None None CCCSCCCCHHHHSTTSCC
3297 19957017 2010 KWKLFKKIPKFLHLAKKF P18 18 Linear L None Free Free Antibacterial Synthetic peptide A-375 Skin Cancer MTT/MTS assay 47.5 ± 1.66% cell viability at 40 µM NA Skin None None CCCSCCCCHHHHSTTSCC
3298 19957017 2010 KWKLFKKIPKFLHLAKKF P18 18 Linear L None Free Free Antibacterial Synthetic peptide A-375 Skin Cancer MTT/MTS assay 26.9 ± 0.5% cell viability at 60 µM NA Skin None None CCCSCCCCHHHHSTTSCC
3299 19957017 2010 KWKLFKKIPKFLHLAKKF P18 18 Linear L None Free Free Antibacterial Synthetic peptide A-375 Skin Cancer MTT/MTS assay 6.5 ± 1.07% cell viability at 80 µM NA Skin None None CCCSCCCCHHHHSTTSCC
3321 23893605 2013 KILRGVAKKIMRTFLRRISKDILTGKK C7A 27 Linear L None Amidation Free Antimicrobial Synthetic peptide E42/02 Skin Cancer MTT/MTS assay IC50 =10.6 ± 0.4 µM 30-Min Skin None None CCCGGGGGGGCHHHHHHHSGGGSSSCC
3322 23893605 2013 KILRGVAKKIMRTFLRRISKDILTGKK C7A 27 Linear L None Amidation Free Antimicrobial Synthetic peptide E42/02 Skin Cancer MTT/MTS assay IC50 =13.0 ± 1.0 µM 2-h Skin None None CCCGGGGGGGCHHHHHHHSGGGSSSCC
3323 23893605 2013 KILRGVAKKIMRTFLRRISKDILTGKK C7A 27 Linear L None Amidation Free Antimicrobial Synthetic peptide E42/02 Skin Cancer MTT/MTS assay IC50 =12.1 ± 1.6 µM 4-h Skin None None CCCGGGGGGGCHHHHHHHSGGGSSSCC
3324 23893605 2013 KILRGVAKKIMRTFLRRISKDILTGKK C7A 27 Linear L None Amidation Free Antimicrobial Synthetic peptide E42/02 Skin Cancer MTT/MTS assay IC50 =37 ± 4.3 µM 24-h Skin None None CCCGGGGGGGCHHHHHHHSGGGSSSCC
5016 24962950 2014 KILRGVAKKIMRTFLRRISKDILTGKK C7A 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HCT-116 Colorectal Cancer Cell Viability assay Cell viability >50% at 25μM approx 1-h Colon None None CCCGGGGGGGCHHHHHHHSGGGSSSCC
5018 24962950 2014 KILRGVAKKIMRTFLRRISKDILTGKK C7A-Δ 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HCT-116 Colorectal Cancer Cell Viability assay Cell viability >50% at 12.5μM approx. 1-h Colon None None CCCGGGGGGGCHHHHHHHSGGGSSSCC
5019 24962950 2014 KILRGVAKKIMRTFLRRISKDILTGKK C7A 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC24 Colorectal Cancer Cell Viability assay Cell viability >60% at 25μM approx 1-h Colon None None CCCGGGGGGGCHHHHHHHSGGGSSSCC
5021 24962950 2014 KILRGVAKKIMRTFLRRISKDILTGKK C7A-Δ 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC24 Colorectal Cancer Cell Viability assay Cell viability >60% at 25μM approx 1-h Colon None None CCCGGGGGGGCHHHHHHHSGGGSSSCC
5022 24962950 2014 KILRGVAKKIMRTFLRRISKDILTGKK C7A 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC40 Colorectal Cancer Cell Viability assay Cell viability >60% at 25μM approx 1-h Colon None None CCCGGGGGGGCHHHHHHHSGGGSSSCC
5024 24962950 2014 KILRGVAKKIMRTFLRRISKDILTGKK C7A-Δ 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC40 Colorectal Cancer Cell Viability assay Cell viability >50% at 25μM approx 1-h Colon None None CCCGGGGGGGCHHHHHHHSGGGSSSCC
5025 24962950 2014 KILRGVAKKIMRTFLRRISKDILTGKK C7A 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC60 Colorectal Cancer Cell Viability assay Cell viability >50% at 25μM approx 1-h Colon None None CCCGGGGGGGCHHHHHHHSGGGSSSCC
5027 24962950 2014 KILRGVAKKIMRTFLRRISKDILTGKK C7A-Δ 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC60 Colorectal Cancer Cell Viability assay Cell viability >50% at 25μM approx 1-h Colon None None CCCGGGGGGGCHHHHHHHSGGGSSSCC
5028 24962950 2014 KILRGVAKKIMRTFLRRISKDILTGKK C7A 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC32 Colorectal Cancer Cell Viability assay Cell viability >60% at 25μM approx 1-h Colon None None CCCGGGGGGGCHHHHHHHSGGGSSSCC
5030 24962950 2014 KILRGVAKKIMRTFLRRISKDILTGKK C7A-Δ 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC32 Colorectal Cancer Cell Viability assay Cell viability =50% at 12.5μM approx. 1-h Colon None None CCCGGGGGGGCHHHHHHHSGGGSSSCC
5031 24962950 2014 KILRGVAKKIMRTFLRRISKDILTGKK C7A 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HCT-116 Colorectal Cancer Cell Viability assay Cell viability >40% at 12.5μM approx 24-h Colon None None CCCGGGGGGGCHHHHHHHSGGGSSSCC
5033 24962950 2014 KILRGVAKKIMRTFLRRISKDILTGKK C7A-Δ 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HCT-116 Colorectal Cancer Cell Viability assay Cell viability >50% at 12.5μM approx 24-h Colon None None CCCGGGGGGGCHHHHHHHSGGGSSSCC
5034 24962950 2014 KILRGVAKKIMRTFLRRISKDILTGKK C7A 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC18 Colorectal Cancer Cell Viability assay Cell viability >55% at 12.5μM approx 24-h Colon None None CCCGGGGGGGCHHHHHHHSGGGSSSCC
5036 24962950 2014 KILRGVAKKIMRTFLRRISKDILTGKK C7A-Δ 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC18 Colorectal Cancer Cell Viability assay Cell viability >75% at 12.5μM approx 24-h Colon None None CCCGGGGGGGCHHHHHHHSGGGSSSCC
5037 24962950 2014 KILRGVAKKIMRTFLRRISKDILTGKK C7A 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC24 Colorectal Cancer Cell Viability assay Cell viability >55% at 12.5μM approx 24-h Colon None None CCCGGGGGGGCHHHHHHHSGGGSSSCC
5039 24962950 2014 KILRGVAKKIMRTFLRRISKDILTGKK C7A-Δ 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC24 Colorectal Cancer Cell Viability assay Cell viability >70% at 12.5μM approx 24-h Colon None None CCCGGGGGGGCHHHHHHHSGGGSSSCC
5040 24962950 2014 KILRGVAKKIMRTFLRRISKDILTGKK C7A 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC40 Colorectal Cancer Cell Viability assay Cell viability >45% at 12.5μM approx 24-h Colon None None CCCGGGGGGGCHHHHHHHSGGGSSSCC
5042 24962950 2014 KILRGVAKKIMRTFLRRISKDILTGKK C7A-Δ 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC40 Colorectal Cancer Cell Viability assay Cell viability >85% at 12.5μM approx 24-h Colon None None CCCGGGGGGGCHHHHHHHSGGGSSSCC
5043 24962950 2014 KILRGVAKKIMRTFLRRISKDILTGKK C7A 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC60 Colorectal Cancer Cell Viability assay Cell viability >70% at 12.5μM approx 24-h Colon None None CCCGGGGGGGCHHHHHHHSGGGSSSCC
5045 24962950 2014 KILRGVAKKIMRTFLRRISKDILTGKK C7A-Δ 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC60 Colorectal Cancer Cell Viability assay Cell viability >70% at 12.5μM approx 24-h Colon None None CCCGGGGGGGCHHHHHHHSGGGSSSCC
5046 24962950 2014 KILRGVAKKIMRTFLRRISKDILTGKK C7A 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC113 Colorectal Cancer Cell Viability assay Cell viability >80% at 12.5μM approx 24-h Colon None None CCCGGGGGGGCHHHHHHHSGGGSSSCC
5048 24962950 2014 KILRGVAKKIMRTFLRRISKDILTGKK C7A-Δ 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC113 Colorectal Cancer Cell Viability assay Cell viability >70% at 12.5μM approx 24-h Colon None None CCCGGGGGGGCHHHHHHHSGGGSSSCC
5049 24962950 2014 KILRGVAKKIMRTFLRRISKDILTGKK C7A 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC32 Colorectal Cancer Cell Viability assay Cell viability >55% at 12.5μM approx 24-h Colon None None CCCGGGGGGGCHHHHHHHSGGGSSSCC
5051 24962950 2014 KILRGVAKKIMRTFLRRISKDILTGKK C7A-Δ 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC32 Colorectal Cancer Cell Viability assay Cell viability >85% at 12.5μM approx 24-h Colon None None CCCGGGGGGGCHHHHHHHSGGGSSSCC
5052 24962950 2014 KILRGVAKKIMRTFLRRISKDILTGKK C7A 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC107 Colorectal Cancer Cell Viability assay Cell viability >50% at 12.5μM approx 24-h Colon None None CCCGGGGGGGCHHHHHHHSGGGSSSCC
5054 24962950 2014 KILRGVAKKIMRTFLRRISKDILTGKK C7A-Δ 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC107 Colorectal Cancer Cell Viability assay Cell viability >70% at 12.5μM approx 24-h Colon None None CCCGGGGGGGCHHHHHHHSGGGSSSCC
3325 23893605 2013 KILRGVAKKIMRTFLRRISKKILTGKK C7A-D21K 27 Linear L None Amidation Free Antimicrobial Synthetic peptide E42/02 Skin Cancer MTT/MTS assay IC50 =8.4 ± 0.2 µM 30-Min Skin None None CCCGGGGGGTTHHHHHHCCCHHHHTTC
3326 23893605 2013 KILRGVAKKIMRTFLRRISKKILTGKK C7A-D21K 27 Linear L None Amidation Free Antimicrobial Synthetic peptide E42/02 Skin Cancer MTT/MTS assay IC50 =12.3 ± 2.0 µM 2-h Skin None None CCCGGGGGGTTHHHHHHCCCHHHHTTC
3327 23893605 2013 KILRGVAKKIMRTFLRRISKKILTGKK C7A-D21K 27 Linear L None Amidation Free Antimicrobial Synthetic peptide E42/02 Skin Cancer MTT/MTS assay IC50 =8.3 ± 0.5 µM 4-h Skin None None CCCGGGGGGTTHHHHHHCCCHHHHTTC
3328 23893605 2013 KILRGVAKKIMRTFLRRISKKILTGKK C7A-D21K 27 Linear L None Amidation Free Antimicrobial Synthetic peptide E42/02 Skin Cancer MTT/MTS assay IC50 =12.3 ± 1.0 µM 24-h Skin None None CCCGGGGGGTTHHHHHHCCCHHHHTTC
3794 23893605 2013 KILRGVAKKIMRTFLRRISKKILTGKK C7A-D21k 27 Linear L None Amidation Free Anticancer NK-2 variants E42/02 Skin Cancer MTT/MTS assay IC50= 8.4±0.2 µM 30-Min Skin None None CCCGGGGGGTTHHHHHHCCCHHHHTTC
3800 23893605 2013 KILRGVAKKIMRTFLRRISKKILTGKK C7A-D21k 27 Linear L None Amidation Free Anticancer NK-2 variants E42/02 Skin Cancer MTT/MTS assay IC50= 12.3±2.0 µM 2-h Skin None None CCCGGGGGGTTHHHHHHCCCHHHHTTC
3806 23893605 2013 KILRGVAKKIMRTFLRRISKKILTGKK C7A-D21k 27 Linear L None Amidation Free Anticancer NK-2 variants E42/02 Skin Cancer MTT/MTS assay IC50= 8.3±0.5 µM 4-h Skin None None CCCGGGGGGTTHHHHHHCCCHHHHTTC
3812 23893605 2013 KILRGVAKKIMRTFLRRISKKILTGKK C7A-D21k 27 Linear L None Amidation Free Anticancer NK-2 variants E42/02 Skin Cancer MTT/MTS assay IC50= 12.3±1.0 µM 24-h Skin None None CCCGGGGGGTTHHHHHHCCCHHHHTTC
5017 24962950 2014 KILRGVAKKIMRTFLRRISKKILTGKK C7A-D21K 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HCT-116 Colorectal Cancer Cell Viability assay Cell viability =50% at 12.5μM approx. 1-h Colon None None CCCGGGGGGTTHHHHHHCCCHHHHTTC
5020 24962950 2014 KILRGVAKKIMRTFLRRISKKILTGKK C7A-D21K 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC24 Colorectal Cancer Cell Viability assay Cell viability >50% at 25μM approx 1-h Colon None None CCCGGGGGGTTHHHHHHCCCHHHHTTC
5023 24962950 2014 KILRGVAKKIMRTFLRRISKKILTGKK C7A-D21K 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC40 Colorectal Cancer Cell Viability assay Cell viability >50% at 25μM approx 1-h Colon None None CCCGGGGGGTTHHHHHHCCCHHHHTTC
5026 24962950 2014 KILRGVAKKIMRTFLRRISKKILTGKK C7A-D21K 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC60 Colorectal Cancer Cell Viability assay Cell viability >50% at 25μM approx 1-h Colon None None CCCGGGGGGTTHHHHHHCCCHHHHTTC
5029 24962950 2014 KILRGVAKKIMRTFLRRISKKILTGKK C7A-D21K 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC32 Colorectal Cancer Cell Viability assay Cell viability =50% at 12.5μM approx. 1-h Colon None None CCCGGGGGGTTHHHHHHCCCHHHHTTC
5032 24962950 2014 KILRGVAKKIMRTFLRRISKKILTGKK C7A-D21K 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HCT-116 Colorectal Cancer Cell Viability assay Cell viability >40% at 12.5μM approx 24-h Colon None None CCCGGGGGGTTHHHHHHCCCHHHHTTC
5035 24962950 2014 KILRGVAKKIMRTFLRRISKKILTGKK C7A-D21K 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC18 Colorectal Cancer Cell Viability assay Cell viability >55% at 12.5μM approx 24-h Colon None None CCCGGGGGGTTHHHHHHCCCHHHHTTC
5038 24962950 2014 KILRGVAKKIMRTFLRRISKKILTGKK C7A-D21K 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC24 Colorectal Cancer Cell Viability assay Cell viability >55% at 12.5μM approx 24-h Colon None None CCCGGGGGGTTHHHHHHCCCHHHHTTC
5041 24962950 2014 KILRGVAKKIMRTFLRRISKKILTGKK C7A-D21K 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC40 Colorectal Cancer Cell Viability assay Cell viability >80% at 12.5μM approx 24-h Colon None None CCCGGGGGGTTHHHHHHCCCHHHHTTC
5044 24962950 2014 KILRGVAKKIMRTFLRRISKKILTGKK C7A-D21K 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC60 Colorectal Cancer Cell Viability assay Cell viability >60% at 12.5μM approx 24-h Colon None None CCCGGGGGGTTHHHHHHCCCHHHHTTC
5047 24962950 2014 KILRGVAKKIMRTFLRRISKKILTGKK C7A-D21K 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC113 Colorectal Cancer Cell Viability assay Cell viability >65% at 12.5μM approx 24-h Colon None None CCCGGGGGGTTHHHHHHCCCHHHHTTC
5050 24962950 2014 KILRGVAKKIMRTFLRRISKKILTGKK C7A-D21K 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC32 Colorectal Cancer Cell Viability assay Cell viability >80% at 12.5μM approx 24-h Colon None None CCCGGGGGGTTHHHHHHCCCHHHHTTC
5053 24962950 2014 KILRGVAKKIMRTFLRRISKKILTGKK C7A-D21K 27 Linear L None Amidation Free Antitumor NK-2 peptide based derivatives HROC107 Colorectal Cancer Cell Viability assay Cell viability >65% at 12.5μM approx 24-h Colon None None CCCGGGGGGTTHHHHHHCCCHHHHTTC
3329 23893605 2013 KILRGVAKKIMRTFLRRILTGKK C7A-Δ 24 Linear L None Amidation Free Antimicrobial Synthetic peptide E42/02 Skin Cancer MTT/MTS assay IC50 =7.5 ± 0.4 µM 30-Min Skin None None CCCTTHHHHHHHHHHHHHHSSCC
3330 23893605 2013 KILRGVAKKIMRTFLRRILTGKK C7A-Δ 24 Linear L None Amidation Free Antimicrobial Synthetic peptide E42/02 Skin Cancer MTT/MTS assay IC50 =13.8 ± 2.0 µM 2-h Skin None None CCCTTHHHHHHHHHHHHHHSSCC
3331 23893605 2013 KILRGVAKKIMRTFLRRILTGKK C7A-Δ 24 Linear L None Amidation Free Antimicrobial Synthetic peptide E42/02 Skin Cancer MTT/MTS assay IC50 =9.3 ± 1.5 µM 4-h Skin None None CCCTTHHHHHHHHHHHHHHSSCC
3332 23893605 2013 KILRGVAKKIMRTFLRRILTGKK C7A-Δ 24 Linear L None Amidation Free Antimicrobial Synthetic peptide E42/02 Skin Cancer MTT/MTS assay IC50 =13.1 ± 0.9 µM 24-h Skin None None CCCTTHHHHHHHHHHHHHHSSCC
3795 23893605 2013 KILRGVAKKIMRTFLRRILTGKK C7A- Δ 23 Linear L None Amidation Free Anticancer NK-2 variants E42/02 Skin Cancer MTT/MTS assay IC50= 7.5±0.4 µM 30-Min Skin None None CCCTTHHHHHHHHHHHHHHSSCC
3801 23893605 2013 KILRGVAKKIMRTFLRRILTGKK C7A- Δ 23 Linear L None Amidation Free Anticancer NK-2 variants E42/02 Skin Cancer MTT/MTS assay IC50= 13.8±2.0 µM 2-h Skin None None CCCTTHHHHHHHHHHHHHHSSCC
3807 23893605 2013 KILRGVAKKIMRTFLRRILTGKK C7A- Δ 23 Linear L None Amidation Free Anticancer NK-2 variants E42/02 Skin Cancer MTT/MTS assay IC50= 9.3±1.5 µM 4-h Skin None None CCCTTHHHHHHHHHHHHHHSSCC
3813 23893605 2013 KILRGVAKKIMRTFLRRILTGKK C7A- Δ 23 Linear L None Amidation Free Anticancer NK-2 variants E42/02 Skin Cancer MTT/MTS assay IC50= 13.1±0.9 µM 24-h Skin None None CCCTTHHHHHHHHHHHHHHSSCC
3333 23893605 2013 KISKRILTGKK NK11 11 Linear L None Amidation Free Antimicrobial Synthetic peptide E42/02 Skin Cancer MTT/MTS assay IC50 >>100 µM 30-Min Skin None None CCCCCCCTTCC
3334 23893605 2013 KISKRILTGKK NK11 11 Linear L None Amidation Free Antimicrobial Synthetic peptide E42/02 Skin Cancer MTT/MTS assay IC50 >>100 µM 2-h Skin None None CCCCCCCTTCC
3335 23893605 2013 KISKRILTGKK NK11 11 Linear L None Amidation Free Antimicrobial Synthetic peptide E42/02 Skin Cancer MTT/MTS assay IC50 >>100 µM 4-h Skin None None CCCCCCCTTCC
3336 23893605 2013 KISKRILTGKK NK11 11 Linear L None Amidation Free Antimicrobial Synthetic peptide E42/02 Skin Cancer MTT/MTS assay IC50 >>100 µM 24-h Skin None None CCCCCCCTTCC
3790 23893605 2013 KISKRILTGKK NK-11 11 Linear L None Amidation Free Anticancer NK2 derived inactive control peptide E42/02 Skin Cancer MTT/MTS assay IC-50 >> 100 µM 4-h Skin None None CCCCCCCTTCC
3796 23893605 2013 KISKRILTGKK NK-11 11 Linear L None Amidation Free Anticancer NK2 derived inactive control peptide E42/02 Skin Cancer MTT/MTS assay IC-50>> 100 µM 30-Min Skin None None CCCCCCCTTCC
3802 23893605 2013 KISKRILTGKK NK-11 11 Linear L None Amidation Free Anticancer NK2 derived inactive control peptide E42/02 Skin Cancer MTT/MTS assay IC-50 >> 100 µM 2-h Skin None None CCCCCCCTTCC
3808 23893605 2013 KISKRILTGKK NK-11 11 Linear L None Amidation Free Anticancer NK2 derived inactive control peptide E42/02 Skin Cancer MTT/MTS assay IC-50 >> 100 µM 4-h Skin None None CCCCCCCTTCC
3814 23893605 2013 KISKRILTGKK NK-11 11 Linear L None Amidation Free Anticancer NK2 derived inactive control peptide E42/02 Skin Cancer MTT/MTS assay IC50 >> 100 µM 24-h Skin None None CCCCCCCTTCC
3342 23533710 2013 YPFPG β-Casomorphins 5 f(60_64) 4 Linear L None Amidation Free Immunomodulant, Antihypertensive, Antimicrobial,Antiviral, and Antioxidant Bovine milk AZ-97 Colon Cancer MTT/MTS assay Inhibition at 9-11g/l NA Colon 23649168 None CCSCC
3343 23533710 2013 RYLGYL αs1-casein f(90_95) 6 Linear L None Amidation Free Immunomodulant, Antihypertensive, Antimicrobial,Antiviral, and Antioxidant Bovine milk AZ-97 Colon Cancer MTT/MTS assay Inhibition at 12-15g/l NA Colon 23649168 None CCCCCC
3344 23533710 2013 PPPEE Caseinphosphopeptides 5 Linear L None Amidation Free Immunomodulant, Antihypertensive, Antimicrobial,Antiviral, and Antioxidant Bovine milk AZ-97 Colon Cancer MTT/MTS assay Inhibition at 24-28g/l NA Colon 23649168 None CCSCC
3356 None 2004 KWKKLLKKPPPLLKKLLKKL Synthetic peptide 20 Linear L None Amidation Free Antimicrobial and Anticancer, antibacterial, antifungal Synthetic peptide Calu-6 Lung Cancer MTT/MTS assay 35% survival rate at 10 µM NA Lung None US_6800727_B2 CTTSSCCCCCTTHHHHTTTC
3357 None 2004 KWKKLLKKPPPLLKKLLKKL Synthetic peptide 20 Linear L None Amidation Free Antimicrobial and Anticancer, antibacterial, antifungal Synthetic peptide Calu-6 Lung Cancer MTT/MTS assay 0% survival rate at 100 µM NA Lung None US_6800727_B2 CTTSSCCCCCTTHHHHTTTC
3358 None 2004 KWKKLLKKPPPLLKKLLKKL Synthetic peptide 20 Linear L None Amidation Free Antimicrobial and Anticancer, antibacterial, antifungal Synthetic peptide Jurkat Blood Cancer MTT/MTS assay ~60% survival rate at 10 µM NA Blood None US_6800727_B2 CTTSSCCCCCTTHHHHTTTC
3359 None 2004 KWKKLLKKPPPLLKKLLKKL Synthetic peptide 20 Linear L None Free Free Antimicrobial and Anticancer, antibacterial, antifungal Synthetic peptide Jurkat Blood Cancer MTT/MTS assay 0% survival rate at 100 µM NA Blood None US_6800727_B2 CCTTTCSCCCHHHHHHTTTC
3360 None 2004 KWKKLLKKPPPLLKKLLKKL Synthetic peptide 20 Linear L None Free Free Antimicrobial and Anticancer, antibacterial, antifungal Synthetic peptide SNU-601 Gastric Cancer MTT/MTS assay ~20% survival rate at 10 µM NA Stomach None US_6800727_B2 CCTTTCSCCCHHHHHHTTTC
3361 None 2004 KWKKLLKKPPPLLKKLLKKL Synthetic peptide 20 Linear L None Free Free Antimicrobial and Anticancer, antibacterial, antifungal Synthetic peptide SNU-601 Gastric Cancer MTT/MTS assay 0% survival rate at 100 µM NA Stomach None US_6800727_B2 CCTTTCSCCCHHHHHHTTTC
3362 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii COLO-205 Colon Cancer MTT/MTS assay <5% cytotoxicity at 1 µM 24-h Colon None WO_2012042540_A2 CCCCCCCSSCCSSSSSTTTC
3363 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii COLO-205 Colon Cancer MTT/MTS assay <20% cytotoxicity at 10 µM 24-h Colon None WO_2012042540_A2 CCCCCCCSSCCSSSSSTTTC
3364 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii COLO-205 Colon Cancer MTT/MTS assay ~15% cytotoxicity at 1 µM 48-h Colon None WO2012042540A2 CCCCCCCSSCCSSSSSTTTC
3365 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii COLO-205 Colon Cancer MTT/MTS assay >20% cytotoxicity at 10 µM 48-h Colon None WO_2012042540_A2 CCCCCCCSSCCSSSSSTTTC
3366 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii COLO-205 Colon Cancer MTT/MTS assay <5% cytotoxicity at 1 µM 72-h Colon None WO_2012042540_A2 CCCCCCCSSCCSSSSSTTTC
3367 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii COLO-205 Colon Cancer MTT/MTS assay <5% cytotoxicity at 10 µM 72-h Colon None WO_2012042540_A2 CCCCCCCSSCCSSSSSTTTC
3380 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii UM-UC-3 Bladder Cancer MTT/MTS assay 10% cytotoxicity at 1 µM 24-h Bladder None WO2012042540A2 CCCCCCCSSCCSSSSSTTTC
3381 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii UM-UC-3 Bladder Cancer MTT/MTS assay <10% cytotoxicity at 10 µM 24-h Bladder None WO_2012042540_A2 CCCCCCCSSCCSSSSSTTTC
3382 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii UM-UC-3 Bladder Cancer MTT/MTS assay ~25% cytotoxicity at 1 µM 48-h Bladder None WO_2012042540_A2 CCCCCCCSSCCSSSSSTTTC
3383 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii UM-UC-3 Bladder Cancer MTT/MTS assay <25% cytotoxicity at 10 µM 48-h Bladder None WO_2012042540_A2 CCCCCCCSSCCSSSSSTTTC
3384 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii UM-UC-3 Bladder Cancer MTT/MTS assay ~45% cytotoxicity at 1 µM 72-h Bladder None WO_2012042540_A2 CCCCCCCSSCCSSSSSTTTC
3385 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii UM-UC-3 Bladder Cancer MTT/MTS assay <45% cytotoxicity at 10 µM 72-h Bladder None WO_2012042540_A2 CCCCCCCSSCCSSSSSTTTC
3398 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii HCT-116 Colon Cancer MTT/MTS assay 20% cytotoxicity at 1 µM 24-h Colon None WO_2012042540_A2 CCCCCCCSSCCSSSSSTTTC
3399 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii HCT-116 Colon Cancer MTT/MTS assay 10% cytotoxicity at 10 µM 24-h Colon None WO_2012042540_A2 CCCCCCCSSCCSSSSSTTTC
3400 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii HCT-116 Colon Cancer MTT/MTS assay <5% cytotoxicity at 1 µM 48-h Colon None WO_2012042540_A2 CCCCCCCSSCCSSSSSTTTC
3401 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii HCT-116 Colon Cancer MTT/MTS assay <3% cytotoxicity at 10 µM 48-h Colon None WO_2012042540_A2 CCCCCCCSSCCSSSSSTTTC
3402 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii HCT-116 Colon Cancer MTT/MTS assay <20% cytotoxicity at 1 µM 72-h Colon None WO_2012042540_A2 CCCCCCCSSCCSSSSSTTTC
3403 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii HCT-116 Colon Cancer MTT/MTS assay 15% cytotoxicity at 10 µM 72-h Colon None WO_2012042540_A2 CCCCCCCSSCCSSSSSTTTC
3416 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii SiHa Cervical Cancer MTT/MTS assay ~15% cytotoxicity at 1 µM 24-h Cervix None WO_2012042540_A2 CCCCCCCSSCCSSSSSTTTC
3417 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii SiHa Cervical Cancer MTT/MTS assay 5% cytotoxicity at 10 µM 24-h Cervix None WO_2012042540_A2 CCCCCCCSSCCSSSSSTTTC
3418 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii SiHa Cervical Cancer MTT/MTS assay 10% cytotoxicity at 1 µM 48-h Cervix None WO_2012042540_A2 CCCCCCCSSCCSSSSSTTTC
3419 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii SiHa Cervical Cancer MTT/MTS assay <10% cytotoxicity at 10 µM 48-h Cervix None WO_2012042540_A2 CCCCCCCSSCCSSSSSTTTC
3420 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii SiHa Cervical Cancer MTT/MTS assay <20% cytotoxicity at 1 µM 72-h Cervix None WO2012042540A2 CCCCCCCSSCCSSSSSTTTC
3421 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii SiHa Cervical Cancer MTT/MTS assay 20% cytotoxicity at 10 µM 72-h Cervix None WO_2012042540_A2 CCCCCCCSSCCSSSSSTTTC
3434 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii CaSki Cervical Cancer MTT/MTS assay ~15% cytotoxicity at 1 µM 24-h Cervix None WO_2012042540_A2 CCCCCCCSSCCSSSSSTTTC
3435 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii CaSki Cervical Cancer MTT/MTS assay ~5% cytotoxicity at 10 µM 24-h Cervix None WO_2012042540_A2 CCCCCCCSSCCSSSSSTTTC
3436 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii CaSki Cervical Cancer MTT/MTS assay ~10% cytotoxicity at 1 µM 48-h Cervix None WO2012042540A2 CCCCCCCSSCCSSSSSTTTC
3437 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii CaSki Cervical Cancer MTT/MTS assay <10% cytotoxicity at 10 µM 48-h Cervix None WO_2012042540_A2 CCCCCCCSSCCSSSSSTTTC
3438 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii CaSki Cervical Cancer MTT/MTS assay <20% cytotoxicity at 1 µM 72-h Cervix None WO_2012042540_A2 CCCCCCCSSCCSSSSSTTTC
3439 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii CaSki Cervical Cancer MTT/MTS assay 20% cytotoxicity at 10 µM 72-h Cervix None WO_2012042540_A2 CCCCCCCSSCCSSSSSTTTC
3452 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii HTB-9 Bladder Cancer MTT/MTS assay 20% cytotoxicity at 1 µM 24-h Bladder None WO2012042540A2 CCCCCCCSSCCSSSSSTTTC
3453 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii HTB-9 Bladder Cancer MTT/MTS assay ~10% cytotoxicity at 10 µM 24-h Bladder None WO_2012042540_A2 CCCCCCCSSCCSSSSSTTTC
3454 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii HTB-9 Bladder Cancer MTT/MTS assay <5% cytotoxicity at 1 µM 48-h Bladder None WO_2012042540_A2 CCCCCCCSSCCSSSSSTTTC
3455 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii HTB-9 Bladder Cancer MTT/MTS assay <3% cytotoxicity at 10 µM 48-h Bladder None WO_2012042540_A2 CCCCCCCSSCCSSSSSTTTC
3456 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii HTB-9 Bladder Cancer MTT/MTS assay <20% cytotoxicity at 1 µM 72-h Bladder None WO_2012042540_A2 CCCCCCCSSCCSSSSSTTTC
3457 None 2012 NHFTLKCPKTALTEPPTLAY TG20 20 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii HTB-9 Bladder Cancer MTT/MTS assay ~15% cytotoxicity at 10 µM 72-h Bladder None WO_2012042540_A2 CCCCCCCSSCCSSSSSTTTC
3368 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii COLO-205 Colon Cancer MTT/MTS assay <5% cytotoxicity at 1 µM 24-h Colon None WO_2012042540_A2 CCSSCCSSSSTTSSSCCSSCCC
3369 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii COLO-205 Colon Cancer MTT/MTS assay ~10% cytotoxicity at 10 µM 24-h Colon None WO_2012042540_A2 CCSSCCSSSSTTSSSCCSSCCC
3370 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii COLO-205 Colon Cancer MTT/MTS assay 10% cytotoxicity at 1 µM 48-h Colon None WO_2012042540_A2 CCSSCCSSSSTTSSSCCSSCCC
3371 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii COLO-205 Colon Cancer MTT/MTS assay >10% cytotoxicity at 10 µM 48-h Colon None WO_2012042540_A2 CCSSCCSSSSTTSSSCCSSCCC
3372 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii COLO-205 Colon Cancer MTT/MTS assay >10% cytotoxicity at 1 µM 72-h Colon None WO2012042540A2 CCSSCCSSSSTTSSSCCSSCCC
3373 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii COLO-205 Colon Cancer MTT/MTS assay <5% cytotoxicity at 10 µM 72-h Colon None WO_2012042540_A2 CCSSCCSSSSTTSSSCCSSCCC
3386 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii UM-UC-3 Bladder Cancer MTT/MTS assay ~25% cytotoxicity at 1 µM 24-h Bladder None WO_2012042540_A2 CCSSCCSSSSTTSSSCCSSCCC
3387 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii UM-UC-3 Bladder Cancer MTT/MTS assay ~25% cytotoxicity at 10 µM 24-h Bladder None WO_2012042540_A2 CCSSCCSSSSTTSSSCCSSCCC
3388 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii UM-UC-3 Bladder Cancer MTT/MTS assay ~25% cytotoxicity at 1 µM 48-h Bladder None WO2012042540A2 CCSSCCSSSSTTSSSCCSSCCC
3389 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii UM-UC-3 Bladder Cancer MTT/MTS assay >25% cytotoxicity at 10 µM 48-h Bladder None WO_2012042540_A2 CCSSCCSSSSTTSSSCCSSCCC
3390 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii UM-UC-3 Bladder Cancer MTT/MTS assay ~45% cytotoxicity at 1 µM 72-h Bladder None WO_2012042540_A2 CCSSCCSSSSTTSSSCCSSCCC
3391 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii UM-UC-3 Bladder Cancer MTT/MTS assay <45% cytotoxicity at 10 µM 72-h Bladder None WO_2012042540_A2 CCSSCCSSSSTTSSSCCSSCCC
3404 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii HCT-116 Colon Cancer MTT/MTS assay <15% cytotoxicity at 1 µM 24-h Colon None WO2012042540A2 CCSSCCSSSSTTSSSCCSSCCC
3405 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii HCT-116 Colon Cancer MTT/MTS assay 15% cytotoxicity at 10 µM 24-h Colon None WO_2012042540_A2 CCSSCCSSSSTTSSSCCSSCCC
3406 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii HCT-116 Colon Cancer MTT/MTS assay ~5% cytotoxicity at 1 µM 48-h Colon None WO_2012042540_A2 CCSSCCSSSSTTSSSCCSSCCC
3407 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii HCT-116 Colon Cancer MTT/MTS assay <5% cytotoxicity at 10 µM 48-h Colon None WO_2012042540_A2 CCSSCCSSSSTTSSSCCSSCCC
3408 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii HCT-116 Colon Cancer MTT/MTS assay <5% cytotoxicity at 1 µM 72-h Colon None WO_2012042540_A2 CCSSCCSSSSTTSSSCCSSCCC
3409 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii HCT-116 Colon Cancer MTT/MTS assay <5% cytotoxicity at 10 µM 72-h Colon None WO_2012042540_A2 CCSSCCSSSSTTSSSCCSSCCC
3422 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii SiHa Cervical Cancer MTT/MTS assay 5% cytotoxicity at 1 µM 24-h Cervix None WO_2012042540_A2 CCSSCCSSSSTTSSSCCSSCCC
3423 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii SiHa Cervical Cancer MTT/MTS assay >10% cytotoxicity at 10 µM 24-h Cervix None WO_2012042540_A2 CCSSCCSSSSTTSSSCCSSCCC
3424 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii SiHa Cervical Cancer MTT/MTS assay <3% cytotoxicity at 1 µM 48-h Cervix None WO_2012042540_A2 CCSSCCSSSSTTSSSCCSSCCC
3425 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii SiHa Cervical Cancer MTT/MTS assay >20% cytotoxicity at 10 µM 48-h Cervix None WO_2012042540_A2 CCSSCCSSSSTTSSSCCSSCCC
3426 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii SiHa Cervical Cancer MTT/MTS assay ~20% cytotoxicity at 1 µM 72-h Cervix None WO_2012042540_A2 CCSSCCSSSSTTSSSCCSSCCC
3427 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii SiHa Cervical Cancer MTT/MTS assay ~40% cytotoxicity at 10 µM 72-h Cervix None WO_2012042540_A2 CCSSCCSSSSTTSSSCCSSCCC
3440 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii CaSki Cervical Cancer MTT/MTS assay ~5% cytotoxicity at 1 µM 24-h Cervix None WO_2012042540_A2 CCSSCCSSSSTTSSSCCSSCCC
3441 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii CaSki Cervical Cancer MTT/MTS assay ~15% cytotoxicity at 10 µM 24-h Cervix None WO_2012042540_A2 CCSSCCSSSSTTSSSCCSSCCC
3442 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii CaSki Cervical Cancer MTT/MTS assay <3% cytotoxicity at 1 µM 48-h Cervix None WO_2012042540_A2 CCSSCCSSSSTTSSSCCSSCCC
3443 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii CaSki Cervical Cancer MTT/MTS assay >20% cytotoxicity at 10 µM 48-h Cervix None WO_2012042540_A2 CCSSCCSSSSTTSSSCCSSCCC
3444 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii CaSki Cervical Cancer MTT/MTS assay ~15% cytotoxicity at 1 µM 72-h Cervix None WO2012042540A2 CCSSCCSSSSTTSSSCCSSCCC
3445 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii CaSki Cervical Cancer MTT/MTS assay >20% cytotoxicity at 10 µM 72-h Cervix None WO_2012042540_A2 CCSSCCSSSSTTSSSCCSSCCC
3458 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii HTB-9 Bladder Cancer MTT/MTS assay <15% cytotoxicity at 1 µM 24-h Bladder None WO_2012042540_A2 CCSSCCSSSSTTSSSCCSSCCC
3459 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii HTB-9 Bladder Cancer MTT/MTS assay ~15% cytotoxicity at 10 µM 24-h Bladder None WO_2012042540_A2 CCSSCCSSSSTTSSSCCSSCCC
3460 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii HTB-9 Bladder Cancer MTT/MTS assay <5% cytotoxicity at 1 µM 48-h Bladder None WO2012042540A2 CCSSCCSSSSTTSSSCCSSCCC
3461 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii HTB-9 Bladder Cancer MTT/MTS assay <3% cytotoxicity at 10 µM 48-h Bladder None WO_2012042540_A2 CCSSCCSSSSTTSSSCCSSCCC
3462 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii HTB-9 Bladder Cancer MTT/MTS assay <5% cytotoxicity at 1 µM 72-h Bladder None WO_2012042540_A2 CCSSCCSSSSTTSSSCCSSCCC
3463 None 2012 TAGIKLTVPIEKFPVTTQTFWG TG23 22 Linear L None Free Free Anticancer Derived from the SAG1 surface protein from the parasite Toxoplasma gondii HTB-9 Bladder Cancer MTT/MTS assay <5% cytotoxicity at 10 µM 72-h Bladder None WO_2012042540_A2 CCSSCCSSSSTTSSSCCSSCCC
3374 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein COLO-205 Colon Cancer MTT/MTS assay <5% cytotoxicity at 1 µM 24-h Colon None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3375 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein COLO-205 Colon Cancer MTT/MTS assay <5% cytotoxicity at 10 µM 24-h Colon None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3376 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein COLO-205 Colon Cancer MTT/MTS assay >20% cytotoxicity at 1 µM 48-h Colon None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3377 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein COLO-205 Colon Cancer MTT/MTS assay ~35% cytotoxicity at 10 µM 48-h Colon None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3378 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein COLO-205 Colon Cancer MTT/MTS assay <5% cytotoxicity at 1 µM 72-h Colon None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3379 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein COLO-205 Colon Cancer MTT/MTS assay ~20% cytotoxicity at 10 µM 72-h Colon None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3392 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein UM-UC-3 Bladder Cancer MTT/MTS assay ~30% cytotoxicity at 1 µM 24-h Bladder None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3393 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein UM-UC-3 Bladder Cancer MTT/MTS assay <30% cytotoxicity at 10 µM 24-h Bladder None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3394 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein UM-UC-3 Bladder Cancer MTT/MTS assay <30% cytotoxicity at 1 µM 48-h Bladder None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3395 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein UM-UC-3 Bladder Cancer MTT/MTS assay ~50% cytotoxicity at 10 µM 48-h Bladder None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3396 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein UM-UC-3 Bladder Cancer MTT/MTS assay >40% cytotoxicity at 1 µM 72-h Bladder None WO2012042540A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3397 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein UM-UC-3 Bladder Cancer MTT/MTS assay ~50% cytotoxicity at 10 µM 72-h Bladder None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3410 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein HCT-116 Colon Cancer MTT/MTS assay >40% cytotoxicity at 1 µM 24-h Colon None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3411 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein HCT-116 Colon Cancer MTT/MTS assay 50% cytotoxicity at 10 µM 24-h Colon None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3412 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein HCT-116 Colon Cancer MTT/MTS assay <20% cytotoxicity at 1 µM 48-h Colon None WO2012042540A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3413 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein HCT-116 Colon Cancer MTT/MTS assay >20% cytotoxicity at 10 µM 48-h Colon None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3414 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein HCT-116 Colon Cancer MTT/MTS assay >30% cytotoxicity at 1 µM 72-h Colon None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3415 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein HCT-116 Colon Cancer MTT/MTS assay ~40% cytotoxicity at 10 µM 72-h Colon None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3428 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein SiHa Cervical Cancer MTT/MTS assay >20% cytotoxicity at 1 µM 24-h Cervix None WO2012042540A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3429 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein SiHa Cervical Cancer MTT/MTS assay >40% cytotoxicity at 10 µM 24-h Cervix None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3430 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein SiHa Cervical Cancer MTT/MTS assay <20% cytotoxicity at 1 µM 48-h Cervix None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3431 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein SiHa Cervical Cancer MTT/MTS assay ~50% cytotoxicity at 10 µM 48-h Cervix None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3432 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein SiHa Cervical Cancer MTT/MTS assay ~20% cytotoxicity at 1 µM 72-h Cervix None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3433 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein SiHa Cervical Cancer MTT/MTS assay ~45% cytotoxicity at 10 µM 72-h Cervix None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3446 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein CaSki Cervical Cancer MTT/MTS assay ~20% cytotoxicity at 1 µM 24-h Cervix None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3447 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein CaSki Cervical Cancer MTT/MTS assay ~40% cytotoxicity at 10 µM 24-h Cervix None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3448 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein CaSki Cervical Cancer MTT/MTS assay ~20% cytotoxicity at 1 µM 48-h Cervix None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3449 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein CaSki Cervical Cancer MTT/MTS assay ~55% cytotoxicity at 10 µM 48-h Cervix None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3450 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein CaSki Cervical Cancer MTT/MTS assay ~20% cytotoxicity at 1 µM 72-h Cervix None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3451 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein CaSki Cervical Cancer MTT/MTS assay ~45% cytotoxicity at 10 µM 72-h Cervix None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3464 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein HTB-9 Bladder Cancer MTT/MTS assay 40% cytotoxicity at 1 µM 24-h Bladder None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3465 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein HTB-9 Bladder Cancer MTT/MTS assay ~50% cytotoxicity at 10 µM 24-h Bladder None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3466 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein HTB-9 Bladder Cancer MTT/MTS assay <20% cytotoxicity at 1 µM 48-h Bladder None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3467 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein HTB-9 Bladder Cancer MTT/MTS assay 20% cytotoxicity at 10 µM 48-h Bladder None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3468 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein HTB-9 Bladder Cancer MTT/MTS assay ~30% cytotoxicity at 1 µM 72-h Bladder None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3469 None 2012 GQVWEATATVNAIRGSVTPAVSQFNARTAD MB30 30 Linear L None Free Free Anticancer Derived from the MPT63 secreted protein HTB-9 Bladder Cancer MTT/MTS assay >40% cytotoxicity at 10 µM 72-h Bladder None WO_2012042540_A2 CCCCCCSSSSCSSSCSSSCSSSCCSTTSCC
3495 22100226 2012 VNWKKILGKIIKVVK LL-III 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 4±1 µM 48-h Cervix None None CCHHHHHHHHHHHHC
3501 22100226 2012 VNWKKILGKIIKVVK LL-III/8 15 Linear L None Free Free Antimicrobial and Antifungal Lasioglossin III and its analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 12±1 µM 48-h Cervix None None CCHHHHHHHHTTTCC
3502 22100226 2012 VNWKKILGKIIKVVK LL-III/9 15 Linear L None Methoxylation Free Antimicrobial and Antifungal Lasioglossin III and its analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 3±1 µM 48-h Cervix None None NA NA
3505 22100226 2012 vnwkkilgkiikvvk LL-III/12 15 Linear D None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 6±2 µM 48-h Cervix None None CHHHHHHHHHHTTTC
3519 22100226 2012 VNWKKILGKIIKVVK LL-III/37 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs SW Colon Cancer MTT/MTS assay IC50 = 5±1 µM 48-h Colon None None CCHHHHHHHHHHHHC
3520 22100226 2012 VNWKKILGKIIKVVK LL-III 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs SW Colon Cancer MTT/MTS assay IC50 = 18±4 µM 48-h Colon None None CCHHHHHHHHHHHHC
3526 22100226 2012 VNWKKILGKIIKVVK LL-III/8 15 Linear L None Free Free Antimicrobial and Antifungal Lasioglossin III and its analogs SW Colon Cancer MTT/MTS assay Not tested 48-h Colon None None CCHHHHHHHHTTTCC
3527 22100226 2012 VNWKKILGKIIKVVK LL-III/9 15 Linear L None Methoxylation Free Antimicrobial and Antifungal Lasioglossin III and its analogs SW Colon Cancer MTT/MTS assay IC50 = 25± 5 µM 48-h Colon None None NA NA
3530 22100226 2012 vnwkkilgkiikvvk LL-III/12 15 Linear D None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs SW Colon Cancer MTT/MTS assay IC50 = 20 µM 48-h Colon None None CHHHHHHHHHHTTTC
3544 22100226 2012 VNWKKILGKIIKVVK LL-III/37 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs SW Colon Cancer MTT/MTS assay IC50 = 13 µM 48-h Colon None None CCHHHHHHHHHHHHC
3545 22100226 2012 VNWKKILGKIIKVVK LL-III 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 5±3 µM 48-h Blood None None CCHHHHHHHHHHHHC
3551 22100226 2012 VNWKKILGKIIKVVK LL-III/8 15 Linear L None Free Free Antimicrobial and Antifungal Lasioglossin III and its analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 9 µM 48-h Blood None None CCHHHHHHHHTTTCC
3552 22100226 2012 VNWKKILGKIIKVVK LL-III/9 15 Linear L None Methoxylation Free Antimicrobial and Antifungal Lasioglossin III and its analogs CCRF-CEM Leukemia Cancer MTT/MTS assay Not tested 48-h Blood None None NA NA
3555 22100226 2012 vnwkkilgkiikvvk LL-III/12 15 Linear D None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 5±2 µM 48-h Blood None None CHHHHHHHHHHTTTC
3569 22100226 2012 VNWKKILGKIIKVVK LL-III/37 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50= 4±1 µM 48-h Blood None None CCHHHHHHHHHHHHC
3496 22100226 2012 VNWKKILAKIIKVVK LL-III/1 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 3±1 µM 48-h Cervix None None CCHHHHHHHHHHHCC
3518 22100226 2012 VNWKKILAKIIKVVK LL-III/36 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 8 µM 48-h Cervix None None CCHHHHHHHHHHHCC
3521 22100226 2012 VNWKKILAKIIKVVK LL-III/1 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs SW Colon Cancer MTT/MTS assay IC50 = 12± 3 µM 48-h Colon None None CCHHHHHHHHHHHCC
3543 22100226 2012 VNWKKILAKIIKVVK LL-III/36 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs SW Colon Cancer MTT/MTS assay Not tested 48-h Colon None None CCHHHHHHHHHHHCC
3546 22100226 2012 VNWKKILAKIIKVVK LL-III/1 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 3±1 µM 48-h Blood None None CCHHHHHHHHHHHCC
3568 22100226 2012 VNWKKILAKIIKVVK LL-III/36 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs CCRF-CEM Leukemia Cancer MTT/MTS assay Not tested 48-h Blood None None CCHHHHHHHHHHHCC
3497 22100226 2012 NVWKKILGKIIKVVK LL-III/2 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs HeLa Cervical Cancer MTT/MTS assay Not tested 48-h Cervix None None CTTHHHHGGGTTTCC
3522 22100226 2012 NVWKKILGKIIKVVK LL-III/2 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs SW Colon Cancer MTT/MTS assay IC50 = 11 µM 48-h Colon None None CTTHHHHGGGTTTCC
3547 22100226 2012 NVWKKILGKIIKVVK LL-III/2 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 7±2 µM 48-h Blood None None CTTHHHHGGGTTTCC
3498 22100226 2012 VNWKKILKKIIKVVK LL-III/3 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs HeLa Cervical Cancer MTT/MTS assay Not tested 48-h Cervix None None CCGGGTHHHHHHHHC
3523 22100226 2012 VNWKKILKKIIKVVK LL-III/3 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs SW Colon Cancer MTT/MTS assay IC50 > 40 µM 48-h Colon None None CCGGGTHHHHHHHHC
3548 22100226 2012 VNWKKILKKIIKVVK LL-III/3 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs CCRF-CEM Leukemia Cancer MTT/MTS assay Not tested 48-h Blood None None CCGGGTHHHHHHHHC
3499 22100226 2012 VNWKKILGKIKKVVK LL-III/4 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 7±1 µM 48-h Cervix None None CCHHHHHHHHHTTCC
3524 22100226 2012 VNWKKILGKIKKVVK LL-III/4 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs SW Colon Cancer MTT/MTS assay IC50 > 40 µM 48-h Colon None None CCHHHHHHHHHTTCC
3549 22100226 2012 VNWKKILGKIKKVVK LL-III/4 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 18 µM 48-h Blood None None CCHHHHHHHHHTTCC
3500 22100226 2012 VNWKKILPKIIKVVK LL-III/6 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs HeLa Cervical Cancer MTT/MTS assay IC50 > 40 µM 48-h Cervix None None CCSCCTGGGTSSCCC
3525 22100226 2012 VNWKKILPKIIKVVK LL-III/6 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs SW Colon Cancer MTT/MTS assay Not tested 48-h Colon None None CCSCCTGGGTSSCCC
3550 22100226 2012 VNWKKILPKIIKVVK LL-III/6 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 6±3 µM 48-h Blood None None CCSCCTGGGTSSCCC
3503 22100226 2012 KNWKKILGKIIKVVK LL-III/10 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 9±4 µM 48-h Cervix None None CCHHHHHHHTTCCCC
3528 22100226 2012 KNWKKILGKIIKVVK LL-III/10 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs SW Colon Cancer MTT/MTS assay Not tested 48-h Colon None None CCHHHHHHHTTCCCC
3553 22100226 2012 KNWKKILGKIIKVVK LL-III/10 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 9 µM 48-h Blood None None CCHHHHHHHTTCCCC
3504 22100226 2012 VNWKKIILGKIIKVVK LL-III/11 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 8±1 µM 48-h Cervix None None CCSCCSCGGGSCCCCC
3529 22100226 2012 VNWKKIILGKIIKVVK LL-III/11 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs SW Colon Cancer MTT/MTS assay IC50 = 48 µM 48-h Colon None None CCSCCSCGGGSCCCCC
3554 22100226 2012 VNWKKIILGKIIKVVK LL-III/11 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 4±1 µM 48-h Blood None None CCSCCSCGGGSCCCCC
3506 22100226 2012 VNFKKLLGKLLKVVK LL-III/15 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 7±1 µM 48-h Cervix None None CCHHHHHHHHHHHCC
3531 22100226 2012 VNFKKLLGKLLKVVK LL-III/15 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs SW Colon Cancer MTT/MTS assay IC50 = 42 µM 48-h Colon None None CCHHHHHHHHHHHCC
3556 22100226 2012 VNFKKLLGKLLKVVK LL-III/15 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 9±3 µM 48-h Blood None None CCHHHHHHHHHHHCC
3508 22100226 2012 VNWRRILGRIIRVVR LL-III/17 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs HeLa Cervical Cancer MTT/MTS assay IC50= 9 µM 48-h Cervix None None CCGGGTHHHHCCCCC
3533 22100226 2012 VNWRRILGRIIRVVR LL-III/17 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs SW Colon Cancer MTT/MTS assay Not tested 48-h Colon None None CCGGGTHHHHCCCCC
3558 22100226 2012 VNWRRILGRIIRVVR LL-III/17 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs CCRF-CEM Leukemia Cancer MTT/MTS assay Not tested 48-h Blood None None CCGGGTHHHHCCCCC
3509 22100226 2012 KNWKKILKKIIKVVK LL-III/18 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 3 µM 48-h Cervix None None CCHHHHHHHHHHHHC
3534 22100226 2012 KNWKKILKKIIKVVK LL-III/18 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs SW Colon Cancer MTT/MTS assay Not tested 48-h Colon None None CCHHHHHHHHHHHHC
3559 22100226 2012 KNWKKILKKIIKVVK LL-III/18 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 7±2 µM 48-h Blood None None CCHHHHHHHHHHHHC
3512 22100226 2012 VNWKKLLGKLLKVVK LL-III/23 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 4 µM 48-h Cervix None None CCHHHHHHHHHTTCC
3514 22100226 2012 vnwkkllgkllkvvk LL-III/25 15 Linear D None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 4±2 µM 48-h Cervix None None CHHHHHHHHHHHTTC
3537 22100226 2012 VNWKKLLGKLLKVVK LL-III/23 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs SW Colon Cancer MTT/MTS assay IC50 = 15 µM 48-h Colon None None CCHHHHHHHHHTTCC
3539 22100226 2012 vnwkkllgkllkvvk LL-III/25 15 Linear D None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs SW Colon Cancer MTT/MTS assay IC50 = 20 µM 48-h Colon None None CHHHHHHHHHHHTTC
3562 22100226 2012 VNWKKLLGKLLKVVK LL-III/23 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 6 µM 48-h Blood None None CCHHHHHHHHHTTCC
3564 22100226 2012 vnwkkllgkllkvvk LL-III/25 15 Linear D None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 4 µM 48-h Blood None None CHHHHHHHHHHHTTC
3515 22100226 2012 VYWKKILGKIIKVVK LL-III/26 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 5±1 µM 48-h Cervix None None CTHHHHTTTGGGCCC
3540 22100226 2012 VYWKKILGKIIKVVK LL-III/26 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs SW Colon Cancer MTT/MTS assay IC50 = 30 µM 48-h Colon None None CTHHHHTTTGGGCCC
3565 22100226 2012 VYWKKILGKIIKVVK LL-III/26 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 6 µM 48-h Blood None None CTHHHHTTTGGGCCC
3516 22100226 2012 VNWKKVLGKVVKVVK LL-III/27 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 13±2 µM 48-h Cervix None None CCHHHHHHHHSCCCC
3541 22100226 2012 VNWKKVLGKVVKVVK LL-III/27 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs SW Colon Cancer MTT/MTS assay IC50 > 100 µM 48-h Colon None None CCHHHHHHHHSCCCC
3566 22100226 2012 VNWKKVLGKVVKVVK LL-III/27 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 18 µM 48-h Blood None None CCHHHHHHHHSCCCC
3517 22100226 2012 NKWKKILGKIIKVVK LL-III/34 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 5±2 µM 48-h Cervix None None CHHHHHHHHHHHHHC
3542 22100226 2012 NKWKKILGKIIKVVK LL-III/34 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs SW Colon Cancer MTT/MTS assay IC50 = 37 µM 48-h Colon None None CHHHHHHHHHHHHHC
3567 22100226 2012 NKWKKILGKIIKVVK LL-III/34 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 5±3 µM 48-h Blood None None CHHHHHHHHHHHHHC
3586 22100226 2012 GFGMALKLLKKVL MAC1 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 10±4 µM 48-h Cervix None None CCSTTHHHHTTTC
3588 22100226 2012 gfgmalkllkkvl MAC1/1 13 Linear D None Amidation Free Antimicrobial and Antifungal Macropins and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 12±4 µM 48-h Cervix None None CCSHHHHHHHHHC
3591 22100226 2012 GFGMALKLLKKVL MAC1/4 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 15±5 µM 48-h Cervix None None CCSTTHHHHTTTC
3592 22100226 2012 GFGMALKLLKKVL MAC1/6 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 8±2 µM 48-h Cervix None None CCSTTHHHHTTTC
3595 22100226 2012 GFGMALKLLKKVL MAC1/16 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 32±2 µM 48-h Cervix None None CCSTTHHHHTTTC
3596 22100226 2012 GFGMALKLLKKVL MAC1/19 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 21±4 µM 48-h Cervix None None CCSTTHHHHTTTC
3602 22100226 2012 GFGMALKLLKKVL MAC1 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs SW Colon Cancer MTT/MTS assay IC50 = 23±4 µM 48-h Colon None None CCSTTHHHHTTTC
3604 22100226 2012 gfgmalkllkkvl MAC1/1 13 Linear D None Amidation Free Antimicrobial and Antifungal Macropins and their analogs SW Colon Cancer MTT/MTS assay IC50 = 19±2 µM 48-h Colon None None CCSHHHHHHHHHC
3607 22100226 2012 GFGMALKLLKKVL MAC1/4 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs SW Colon Cancer MTT/MTS assay IC50 = 49±9 µM 48-h Colon None None CCSTTHHHHTTTC
3608 22100226 2012 GFGMALKLLKKVL MAC1/6 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs SW Colon Cancer MTT/MTS assay IC50 = 29±3 µM 48-h Colon None None CCSTTHHHHTTTC
3611 22100226 2012 GFGMALKLLKKVL MAC1/16 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs SW Colon Cancer MTT/MTS assay IC50 > 100 µM 48-h Colon None None CCSTTHHHHTTTC
3612 22100226 2012 GFGMALKLLKKVL MAC1/19 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs SW Colon Cancer MTT/MTS assay IC50 = 68±2 µM 48-h Colon None None CCSTTHHHHTTTC
3618 22100226 2012 GFGMALKLLKKVL MAC1 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 12±6 µM 48-h Blood None None CCSTTHHHHTTTC
3620 22100226 2012 gfgmalkllkkvl MAC1/1 13 Linear D None Amidation Free Antimicrobial and Antifungal Macropins and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 11 µM 48-h Blood None None CCSHHHHHHHHHC
3623 22100226 2012 GFGMALKLLKKVL MAC1/4 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 29 µM 48-h Blood None None CCSTTHHHHTTTC
3624 22100226 2012 GFGMALKLLKKVL MAC1/6 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 15 µM 48-h Blood None None CCSTTHHHHTTTC
3627 22100226 2012 GFGMALKLLKKVL MAC1/16 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 70 µM 48-h Blood None None CCSTTHHHHTTTC
3628 22100226 2012 GFGMALKLLKKVL MAC1/19 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 43±11 µM 48-h Blood None None CCSTTHHHHTTTC
4387 22100226, 18957441 2012 GFGMALKLLKKVL Macropin 1 13 Not Available L None Free Free Antibacterial Venom, the solitary beeMacropis fulvipes Not Available Not Available Not Available Not Available Not Available Not Available 18957441 None CCSHHHHHHHTTC
3587 22100226 2012 GTGLPMSERRKIMLMMR MAC2 17 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 > 100 µM 48-h Cervix None None CCSCCSSGGGTSTTCCC
3603 22100226 2012 GTGLPMSERRKIMLMMR MAC2 17 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs SW Colon Cancer MTT/MTS assay IC50 > 100 µM 48-h Colon None None CCSCCSSGGGTSTTCCC
3619 22100226 2012 GTGLPMSERRKIMLMMR MAC2 17 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 32 µM 48-h Blood None None CCSCCSSGGGTSTTCCC
4386 22100226, 18957441 2012 GTGLPMSERRKIMLMMR Macropin 2 17 Not Available L None Free Free Antibacterial Venom, the solitary beeMacropis fulvipes Not Available Not Available Not Available Not Available Not Available Not Available 18957441 None CCSCCSSGGGTCTTCCC
3589 22100226 2012 AFGMALKLLKKVL MAC1/2 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 16±3 µM 48-h Cervix None None CTTTHHHHHTTTC
3605 22100226 2012 AFGMALKLLKKVL MAC1/2 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs SW Colon Cancer MTT/MTS assay IC50 = 16 µM 48-h Colon None None CTTTHHHHHTTTC
3621 22100226 2012 AFGMALKLLKKVL MAC1/2 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 17 µM 48-h Blood None None CTTTHHHHHTTTC
3590 22100226 2012 LFGMALKLLKKVL MAC1/3 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 9±2 µM 48-h Cervix None None CCCTTHHHHTTTC
3606 22100226 2012 LFGMALKLLKKVL MAC1/3 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs SW Colon Cancer MTT/MTS assay IC50 = 11±1 µM 48-h Colon None None CCCTTHHHHTTTC
3622 22100226 2012 LFGMALKLLKKVL MAC1/3 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 22 µM 48-h Blood None None CCCTTHHHHTTTC
3593 22100226 2012 GFKMALKLLKKVL MAC1/9 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 8±1 µM 48-h Cervix None None CHHHHHHHHTTTC
3594 22100226 2012 GFKMALKLLKKVL MAC1/10 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 15±6 µM 48-h Cervix None None CHHHHHHHHTTTC
3609 22100226 2012 GFKMALKLLKKVL MAC1/9 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs SW Colon Cancer MTT/MTS assay IC50 = 13±3 µM 48-h Colon None None CHHHHHHHHTTTC
3610 22100226 2012 GFKMALKLLKKVL MAC1/10 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs SW Colon Cancer MTT/MTS assay Not tested 48-h Colon None None CHHHHHHHHTTTC
3625 22100226 2012 GFKMALKLLKKVL MAC1/9 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 14±4 µM 48-h Blood None None CHHHHHHHHTTTC
3626 22100226 2012 GFKMALKLLKKVL MAC1/10 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 16 µM 48-h Blood None None CHHHHHHHHTTTC
3598 22100226 2012 GFGMALRLLRRVL MAC1/21 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 9±3 µM 48-h Cervix None None CCCCTHHHHTTTC
3614 22100226 2012 GFGMALRLLRRVL MAC1/21 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs SW Colon Cancer MTT/MTS assay IC50 = 17±2 µM 48-h Colon None None CCCCTHHHHTTTC
3630 22100226 2012 GFGMALRLLRRVL MAC1/21 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 22±4 µM 48-h Blood None None CCCCTHHHHTTTC
3636 22100226 2012 GMWSKILGHLIK HAL-1/6 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 15±1 µM 48-h Cervix None None CCGGGTTTTTTC
3664 22100226 2012 GMWSKILGHLIK HAL-1/6 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay IC50 > 100 µM 48-h Colon None None CCGGGTTTTTTC
3692 22100226 2012 GMWSKILGHLIK HAL-1/6 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay Not tested 48-h Blood None None CCGGGTTTTTTC
3637 22100226 2012 GMWSKILGHLKR HAL-1/4 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 > 100 µM 48-h Cervix None None CCTTTSSSSCCC
3665 22100226 2012 GMWSKILGHLKR HAL-1/4 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay Not tested 48-h Colon None None CCTTTSSSSCCC
3693 22100226 2012 GMWSKILGHLKR HAL-1/4 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay Not tested 48-h Blood None None CCTTTSSSSCCC
3638 22100226 2012 GMWSKILGKLIR HAL-1/9 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 9±1 µM 48-h Cervix None None CCTHHHHHHHCC
3666 22100226 2012 GMWSKILGKLIR HAL-1/9 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay IC50 > 50 µM 48-h Colon None None CCTHHHHHHHCC
3694 22100226 2012 GMWSKILGKLIR HAL-1/9 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 30±10 µM 48-h Blood None None CCTHHHHHHHCC
3639 22100226 2012 GMWSKILKHLIR HAL-1/18 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 4±2 µM 48-h Cervix None None CCTHHHHHHHTC
3667 22100226 2012 GMWSKILKHLIR HAL-1/18 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay IC50 = 18±2 µM 48-h Colon None None CCTHHHHHHHTC
3695 22100226 2012 GMWSKILKHLIR HAL-1/18 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay Not tested 48-h Blood None None CCTHHHHHHHTC
3641 22100226 2012 GKWSKILGHLIR HAL-1/12 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 43±14 µM 48-h Cervix None None CCCSGGGCSSCC
3669 22100226 2012 GKWSKILGHLIR HAL-1/12 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay IC50 > 100 µM 48-h Colon None None CCCSGGGCSSCC
3697 22100226 2012 GKWSKILGHLIR HAL-1/12 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 > 40 µM 48-h Blood None None CCCSGGGCSSCC
3642 22100226 2012 KMWSKILGHLIR HAL-1/17 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 35±3 µM 48-h Cervix None None CCGGGTTTSSCC
3670 22100226 2012 KMWSKILGHLIR HAL-1/17 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay IC50 > 100 µM 48-h Colon None None CCGGGTTTSSCC
3698 22100226 2012 KMWSKILGHLIR HAL-1/17 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay Not tested 48-h Blood None None CCGGGTTTSSCC
3643 22100226 2012 GMWKKILGKLIR HAL-1/10 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 13±2 µM 48-h Cervix None None CCHHHHHHHTTC
3671 22100226 2012 GMWKKILGKLIR HAL-1/10 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay IC50 > 60 µM 48-h Colon None None CCHHHHHHHTTC
3699 22100226 2012 GMWKKILGKLIR HAL-1/10 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay Not tested 48-h Blood None None CCHHHHHHHTTC
3644 22100226 2012 GKWSKILGKLIR HAL-1/20 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 22±3 µM 48-h Cervix None None CTTSHHHHHHCC
3672 22100226 2012 GKWSKILGKLIR HAL-1/20 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay IC50 > 40 µM 48-h Colon None None CTTSHHHHHHCC
3700 22100226 2012 GKWSKILGKLIR HAL-1/20 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 > 40 µM 48-h Blood None None CTTSHHHHHHCC
3645 22100226 2012 GKWKKILGHLIR HAL-1/19 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 > 100 µM 48-h Cervix None None CCGGGTTTSCCC
3673 22100226 2012 GKWKKILGHLIR HAL-1/19 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay IC50 > 100 µM 48-h Colon None None CCGGGTTTSCCC
3701 22100226 2012 GKWKKILGHLIR HAL-1/19 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay Not tested 48-h Blood None None CCGGGTTTSCCC
3646 22100226 2012 GKWKKILGKLIR HAL-1/21 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 30±3 µM 48-h Cervix None None CTTGGGGGGTCC
3674 22100226 2012 GKWKKILGKLIR HAL-1/21 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay IC50 > 100 µM 48-h Colon None None CTTGGGGGGTCC
3702 22100226 2012 GKWKKILGKLIR HAL-1/21 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay Not tested 48-h Blood None None CTTGGGGGGTCC
3634 22100226 2012 GMWSKILGHLIR HAL-1 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 11±2 µM 48-h Cervix None None CCGGGTTTTTCC
3635 22100226 2012 gmwskilghlir HAL-1/22 12 Linear D None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 15±3 µM 48-h Cervix None None CCHHHHTCCCCC
3647 22100226 2012 GMWSKILGHLIR HAL-1/29 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 > 100 µM 48-h Cervix None None CCGGGTTTTTCC
3662 22100226 2012 GMWSKILGHLIR HAL-1 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay IC50 = 44±8 µM 48-h Colon None None CCGGGTTTTTCC
3663 22100226 2012 gmwskilghlir HAL-1/22 12 Linear D None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay IC50 > 40 µM 48-h Colon None None CCHHHHTCCCCC
3675 22100226 2012 GMWSKILGHLIR HAL-1/29 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay Not tested 48-h Colon None None CCGGGTTTTTCC
3690 22100226 2012 GMWSKILGHLIR HAL-1 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 49±9 µM 48-h Blood None None CCGGGTTTTTCC
3691 22100226 2012 gmwskilghlir HAL-1/22 12 Linear D None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay Not tested 48-h Blood None None CCHHHHTCCCCC
3703 22100226 2012 GMWSKILGHLIR HAL-1/29 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay Not tested 48-h Blood None None CCGGGTTTTTCC
4402 20198492, 18957441 2010 GMWSKILGHLIR Halictine 1 12 Not Available L None Free Free Anticancer venom, the eusocial bee, Halictus sexcinctus Not Available Not Available Not Available Not Available Not Available Not Available 18957441 None CCHHHHTTTTCC
3648 22100226 2012 GMWSKLLGHLLR HAL-1/15 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 14±2 µM 48-h Cervix None None CCHHHHHHHHTC
3676 22100226 2012 GMWSKLLGHLLR HAL-1/15 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay IC50 > 40 µM 48-h Colon None None CCHHHHHHHHTC
3704 22100226 2012 GMWSKLLGHLLR HAL-1/15 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 > 40 µM 48-h Blood None None CCHHHHHHHHTC
3649 22100226 2012 GKWMSLLKHILK HAL-2 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 12±1 µM 48-h Cervix None None CTHHHHHHHHCC
3650 22100226 2012 gkwmsllkhilk HAL-2/22 12 Linear D None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 12 µM 48-h Cervix None None CCSHHHHHTTCC
3654 22100226 2012 GKWMSLLKHILK HAL-2/8 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 15±3 µM 48-h Cervix None None CTHHHHHHHHCC
3677 22100226 2012 GKWMSLLKHILK HAL-2 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay IC50 = 35±3 µM 48-h Colon None None CTHHHHHHHHCC
3678 22100226 2012 gkwmsllkhilk HAL-2/22 12 Linear D None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay IC50 > 100 µM 48-h Colon None None CCSHHHHHTTCC
3682 22100226 2012 GKWMSLLKHILK HAL-2/8 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay IC50 > 40 µM 48-h Colon None None CTHHHHHHHHCC
3705 22100226 2012 GKWMSLLKHILK HAL-2 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 34 µM 48-h Blood None None CTHHHHHHHHCC
3706 22100226 2012 gkwmsllkhilk HAL-2/22 12 Linear D None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay Not tested 48-h Blood None None CCSHHHHHTTCC
3710 22100226 2012 GKWMSLLKHILK HAL-2/8 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay Not tested 48-h Blood None None CTHHHHHHHHCC
4403 20198492, 18957441 2010 GKWMSLLKHILK Halictine 2 12 Not Available L None Free Free Anticancer Venom, the eusocial bee, Halictus sexcinctus Not Available Not Available Not Available Not Available Not Available Not Available 18957441 None CHHHHHHTTTCC
3651 22100226 2012 GKWMSLLKKILK HAL-2/4 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 > 40 µM 48-h Cervix None None CTTHHHHTTTCC
3679 22100226 2012 GKWMSLLKKILK HAL-2/4 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay IC50 = 38±6 µM 48-h Colon None None CTTHHHHTTTCC
3707 22100226 2012 GKWMSLLKKILK HAL-2/4 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay Not tested 48-h Blood None None CTTHHHHTTTCC
3652 22100226 2012 GKWMKLLKHILK HAL-2/2 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 6±1 µM 48-h Cervix None None CTHHHHHHHHTC
3680 22100226 2012 GKWMKLLKHILK HAL-2/2 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay IC50 = 35±5 µM 48-h Colon None None CTHHHHHHHHTC
3708 22100226 2012 GKWMKLLKHILK HAL-2/2 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 > 40 µM 48-h Blood None None CTHHHHHHHHTC
3653 22100226 2012 GKWKSLLKHILK HAL-2/1 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 14±2 µM 48-h Cervix None None CCHHHHHHHTTC
3681 22100226 2012 GKWKSLLKHILK HAL-2/1 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay IC50 > 100 µM 48-h Colon None None CCHHHHHHHTTC
3709 22100226 2012 GKWKSLLKHILK HAL-2/1 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 > 40 µM 48-h Blood None None CCHHHHHHHTTC
3655 22100226 2012 GKWMSLLKHIWK HAL-2/18 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 14±2 µM 48-h Cervix None None CGGGGTGGGTCC
3683 22100226 2012 GKWMSLLKHIWK HAL-2/18 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay IC50 > 40 µM 48-h Colon None None CGGGGTGGGTCC
3711 22100226 2012 GKWMSLLKHIWK HAL-2/18 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay Not tested 48-h Blood None None CGGGGTGGGTCC
3656 22100226 2012 GKWMSLLKHWLK HAL-2/19 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 16±4 µM 48-h Cervix None None CTHHHHHHHHCC
3684 22100226 2012 GKWMSLLKHWLK HAL-2/19 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay IC50 > 40 µM 48-h Colon None None CTHHHHHHHHCC
3712 22100226 2012 GKWMSLLKHWLK HAL-2/19 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay Not tested 48-h Blood None None CTHHHHHHHHCC
3658 22100226 2012 GKFMSLLKHILK HAL-2/24 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 34 µM 48-h Cervix None None CCCTHHHHHHHC
3686 22100226 2012 GKFMSLLKHILK HAL-2/24 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay IC50 > 40 µM 48-h Colon None None CCCTHHHHHHHC
3714 22100226 2012 GKFMSLLKHILK HAL-2/24 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay Not tested 48-h Blood None None CCCTHHHHHHHC
3659 22100226 2012 GKWMSFLKHILK HAL-2/6 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 23±3 µM 48-h Cervix None None CCCHHHHHHHHC
3687 22100226 2012 GKWMSFLKHILK HAL-2/6 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay IC50 > 40 µM 48-h Colon None None CCCHHHHHHHHC
3715 22100226 2012 GKWMSFLKHILK HAL-2/6 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay Not tested 48-h Blood None None CCCHHHHHHHHC
3660 22100226 2012 GKWMTLLKHILK HAL-2/13 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 13±3 µM 48-h Cervix None None CCSHHHHHHHCC
3688 22100226 2012 GKWMTLLKHILK HAL-2/13 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay IC50 > 60 µM 48-h Colon None None CCSHHHHHHHCC
3716 22100226 2012 GKWMTLLKHILK HAL-2/13 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay Not tested 48-h Blood None None CCSHHHHHHHCC
3661 22100226 2012 GKWLSLLKHILK HAL-2/11 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 14±3 µM 48-h Cervix None None CCCHHHHTTTTC
3689 22100226 2012 GKWLSLLKHILK HAL-2/11 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay IC50 = 40 µM 48-h Colon None None CCCHHHHTTTTC
3717 22100226 2012 GKWLSLLKHILK HAL-2/11 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay Not tested 48-h Blood None None CCCHHHHTTTTC
3640 22100226 2012 GMWKKILGHLIR HAL-1/5 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 9±1 µM 48-h Cervix None None CCGGGTTTSCCC
3668 22100226 2012 GMWKKILGHLIR HAL-1/5 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay IC50 = 44±5 µM 48-h Colon None None CCGGGTTTSCCC
3696 22100226 2012 GMWKKILGHLIR HAL-1/5 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 > 40 µM 48-h Blood None None CCGGGTTTSCCC
3657 22100226 2012 GKWMSLWKHILK HAL-2/20 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 30±5 µM 48-h Cervix None None CCCTHHHHCSCC
3685 22100226 2012 GKWMSLWKHILK HAL-2/20 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay IC50 > 40 µM 48-h Colon None None CCCTHHHHCSCC
3713 22100226 2012 GKWMSLWKHILK HAL-2/20 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay Not tested 48-h Blood None None CCCTHHHHCSCC
3718 24176852 2013 YGRKKRRQRRRREADFFWSLCTADMS KilerFLIP 26 linear L None Free Free NA NA Jurkat Blood Cancer Not Available NA NA Blood None None CGGGGTTTCCSSCCCSSCCSSCSCCC
3726 22481251 2012 PLLQATLGGGS P7 11 Linear L None Free Free Antiproliferative and Antiangiogenic NA B16-F10 Skin Cancer WST-1 assay IC50= 1 µM 48-h Skin None None CCCCSCSCCCC
3793 23893605 2013 KILRGVAKKILRTFLRRISKDILTGKK C7A 27 Linear L None Amidation Free Anticancer NK-2 variants E42/02 Skin Cancer MTT/MTS assay IC50= 10.6±0.4 µM 30-Min Skin None None CCCTTGGGGTCGGGSGGGCCCSSSTTC
3799 23893605 2013 KILRGVAKKILRTFLRRISKDILTGKK C7A 27 Linear L None Amidation Free Anticancer NK-2 variants E42/02 Skin Cancer MTT/MTS assay IC50= 13.0±1.0 µM 2-h Skin None None CCCTTGGGGTCGGGSGGGCCCSSSTTC
3805 23893605 2013 KILRGVAKKILRTFLRRISKDILTGKK C7A 27 Linear L None Amidation Free Anticancer NK-2 variants E42/02 Skin Cancer MTT/MTS assay IC50= 12.1±1.6 µM 4-h Skin None None CCCTTGGGGTCGGGSGGGCCCSSSTTC
3811 23893605 2013 KILRGVAKKILRTFLRRISKDILTGKK C7A 27 Linear L None Amidation Free Anticancer NK-2 variants E42/02 Skin Cancer MTT/MTS assay IC50= 3.7± 4.3 µM 24-h Skin None None CCCTTGGGGTCGGGSGGGCCCSSSTTC
3834 20515045 2010 IVRRADRAAVP ES-2 11 Linear L None Free Free Antitumor Endostatin derived synthetic peptide BAE Tumor MTT/MTS assay 60% inhibition at 2.5µg/ml NA Not Available None None CCCCCCCSSCC
3835 20515045 2010 IVRRADRAAVP ES-2 11 Linear L None Free Free Antitumor Endostatin derived synthetic peptide BAE Tumor MTT/MTS assay 60% inhibition at 5µg/ml NA Not Available None None CCCCCCCSSCC
3836 20515045 2010 IVRRADRAAVP ES-2 11 Linear L None Free Free Antitumor Endostatin derived synthetic peptide BAE Tumor MTT/MTS assay 60% inhibition at 10µg/ml NA Not Available None None CCCCCCCSSCC
3837 20515045 2010 ACDCRGDCFCGGGGIVRRADRAAVP AP 25 Linear L None Free Free Antitumor Endostatin derived synthetic peptide BAE Tumor MTT/MTS assay 50% inhibition at 2.5µg/ml NA Not Available None None CCCCTTHHHHTTTTTSSCCCSSSCC
3838 20515045 2010 ACDCRGDCFCGGGGIVRRADRAAVP AP 25 Linear L None Free Free Antitumor Endostatin derived synthetic peptide BAE Tumor MTT/MTS assay 40% inhibition at 5µg/ml NA Not Available None None CCCCTTHHHHTTTTTSSCCCSSSCC
3839 20515045 2010 ACDCRGDCFCGGGGIVRRADRAAVP AP 25 Linear L None Free Free Antitumor Endostatin derived synthetic peptide BAE Tumor MTT/MTS assay 75% inhibition at 10µg/ml NA Not Available None None CCCCTTHHHHTTTTTSSCCCSSSCC
3840 20515045 2010 ACDCRGDCFCGGGGIVRRADRAAVP AP(O) 25 Cyclic(C2-C10,C L None Free Free Antitumor Endostatin derived synthetic peptide BAE Tumor MTT/MTS assay 40% inhibition at 2.5µg/ml NA Not Available None None CCSTTTTCTTTGGGSTTCCCCCSCC
3841 20515045 2010 ACDCRGDCFCGGGGIVRRADRAAVP AP(O) 25 Cyclic(C2-C10,C L None Free Free Antitumor Endostatin derived synthetic peptide BAE Tumor MTT/MTS assay 42% inhibition at 5µg/ml NA Not Available None None CCSTTTTCTTTGGGSTTCCCCCSCC
3842 20515045 2010 ACDCRGDCFCGGGGIVRRADRAAVP AP(O) 25 Cyclic(C2-C10,C L None Free Free Antitumor Endostatin derived synthetic peptide BAE Tumor MTT/MTS assay 52% inhibition at 10µg/ml NA Not Available None None CCSTTTTCTTTGGGSTTCCCCCSCC
4048 12631273, 9266696 2003 GLFAVIKKVASVIGGL 3 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Leukemia tumor cellline Leukemia Cancer Sulforhodamine B assay IC50= 6 M Not Available Blood 9266696 None CCTHHHHTTTTTTSCC
4049 12631273, 9266696 2003 GLFAVIKKVASVIGGL 3 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Lung tumor cellline Lung Cancer Sulforhodamine B assay IC50= 6 M Not Available Lung 9266696 None CCTHHHHTTTTTTSCC
4050 12631273, 9266696 2003 GLFAVIKKVASVIGGL 3 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Colon tumor cellline Colon Cancer Sulforhodamine B assay IC50= 6 M Not Available Colon 9266696 None CCTHHHHTTTTTTSCC
4051 12631273, 9266696 2003 GLFAVIKKVASVIGGL 3 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Brain tumor cellline Brain Tumor Sulforhodamine B assay IC50= 6 M Not Available Brain 9266696 None CCTHHHHTTTTTTSCC
4052 12631273, 9266696 2003 GLFAVIKKVASVIGGL 3 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Skin tumor cellline Skin Cancer Sulforhodamine B assay IC50= 6 M Not Available Skin 9266696 None CCTHHHHTTTTTTSCC
4053 12631273, 9266696 2003 GLFAVIKKVASVIGGL 3 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Ovary tumor cellline Ovarian Cancer Sulforhodamine B assay IC50= 6 M Not Available Ovary 9266696 None CCTHHHHTTTTTTSCC
4054 12631273, 9266696 2003 GLFAVIKKVASVIGGL 3 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Liver tumor celline Liver Cancer Sulforhodamine B assay IC50= > 1 µM Not Available Liver 9266696 None CCTHHHHTTTTTTSCC
4055 12631273, 9266696 2003 GLFAVIKKVASVIGGL 3 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Prostate tumor cellline Prostate Cancer Sulforhodamine B assay IC50= 6 M Not Available Prostate 9266696 None CCTHHHHTTTTTTSCC
4056 12631273, 9266696 2003 GLFAVIKKVASVIGGL 3 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Breast tumor cellline Breast Cancer Sulforhodamine B assay IC50= 6 M Not Available Breast 9266696 None CCTHHHHTTTTTTSCC
4057 12631273, 9266696 2003 GLFDVIKAVASVIGGL 5 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Leukemia tumor cellline Leukemia Cancer Sulforhodamine B assay IC50= 5 M Not Available Blood 9266696 None CGGGHHHHHHGGGTTC
4058 12631273, 9266696 2003 GLFDVIKAVASVIGGL 5 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Lung tumor cellline Lung Cancer Sulforhodamine B assay IC50= 5 M Not Available Lung 9266696 None CGGGHHHHHHGGGTTC
4059 12631273, 9266696 2003 GLFDVIKAVASVIGGL 5 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Colon tumor cellline Colon Cancer Sulforhodamine B assay IC50= 5 M Not Available Colon 9266696 None CGGGHHHHHHGGGTTC
4060 12631273, 9266696 2003 GLFDVIKAVASVIGGL 5 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Brain tumor cellline Brain Tumor Sulforhodamine B assay IC50= 5 M Not Available Brain 9266696 None CGGGHHHHHHGGGTTC
4061 12631273, 9266696 2003 GLFDVIKAVASVIGGL 5 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Skin tumor cellline Skin Cancer Sulforhodamine B assay IC50= >100 µM Not Available Skin 9266696 None CGGGHHHHHHGGGTTC
4062 12631273, 9266696 2003 GLFDVIKAVASVIGGL 5 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Ovary tumor cellline Ovarian Cancer Sulforhodamine B assay IC50= 5 M Not Available Ovary 9266696 None CGGGHHHHHHGGGTTC
4063 12631273, 9266696 2003 GLFDVIKAVASVIGGL 5 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Liver tumor celline Liver Cancer Sulforhodamine B assay IC50= >100 µM Not Available Liver 9266696 None CGGGHHHHHHGGGTTC
4064 12631273, 9266696 2003 GLFDVIKAVASVIGGL 5 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Prostate tumor cellline Prostate Cancer Sulforhodamine B assay IC50= 5 M Not Available Prostate 9266696 None CGGGHHHHHHGGGTTC
4065 12631273, 9266696 2003 GLFDVIKAVASVIGGL 5 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Breast tumor cellline Breast Cancer Sulforhodamine B assay IC50= 5 M Not Available Breast 9266696 None CGGGHHHHHHGGGTTC
4066 12631273, 9266696 2003 GLFDVIKKVAAVIGGL 7 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Leukemia tumor cellline Leukemia Cancer Sulforhodamine B assay IC50= 5 M Not Available Blood 9266696 None CCGGGTTTHHHHTTTC
4067 12631273, 9266696 2003 GLFDVIKKVAAVIGGL 7 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Lung tumor cellline Lung Cancer Sulforhodamine B assay IC50= 5 M Not Available Lung 9266696 None CCGGGTTTHHHHTTTC
4068 12631273, 9266696 2003 GLFDVIKKVAAVIGGL 7 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Colon tumor cellline Colon Cancer Sulforhodamine B assay IC50= 5 M Not Available Colon 9266696 None CCGGGTTTHHHHTTTC
4069 12631273, 9266696 2003 GLFDVIKKVAAVIGGL 7 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Brain tumor cellline Brain Tumor Sulforhodamine B assay IC50= 5 M Not Available Brain 9266696 None CCGGGTTTHHHHTTTC
4070 12631273, 9266696 2003 GLFDVIKKVAAVIGGL 7 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Skin tumor cellline Skin Cancer Sulforhodamine B assay IC50= 5 M Not Available Skin 9266696 None CCGGGTTTHHHHTTTC
4071 12631273, 9266696 2003 GLFDVIKKVAAVIGGL 7 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Ovary tumor cellline Ovarian Cancer Sulforhodamine B assay IC50= 5 M Not Available Ovary 9266696 None CCGGGTTTHHHHTTTC
4072 12631273, 9266696 2003 GLFDVIKKVAAVIGGL 7 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Liver tumor celline Liver Cancer Sulforhodamine B assay IC50= 5 M Not Available Liver 9266696 None CCGGGTTTHHHHTTTC
4073 12631273, 9266696 2003 GLFDVIKKVAAVIGGL 7 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Prostate tumor cellline Prostate Cancer Sulforhodamine B assay IC50= 5 M Not Available Prostate 9266696 None CCGGGTTTHHHHTTTC
4074 12631273, 9266696 2003 GLFDVIKKVAAVIGGL 7 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Breast tumor cellline Breast Cancer Sulforhodamine B assay IC50= 5 M Not Available Breast 9266696 None CCGGGTTTHHHHTTTC
4084 12631273, 9266696 2003 GLFDVIKKVASVIKKL 13 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Leukemia tumor cellline Leukemia Cancer Sulforhodamine B assay IC50= 5 M Not Available Blood 9266696 None CTHHHHHHHHHHHTCC
4085 12631273, 9266696 2003 GLFDVIKKVASVIKKL 13 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Lung tumor cellline Lung Cancer Sulforhodamine B assay IC50= 5 M Not Available Lung 9266696 None CTHHHHHHHHHHHTCC
4086 12631273, 9266696 2003 GLFDVIKKVASVIKKL 13 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Colon tumor cellline Colon Cancer Sulforhodamine B assay IC50= 5 M Not Available Colon 9266696 None CTHHHHHHHHHHHTCC
4087 12631273, 9266696 2003 GLFDVIKKVASVIKKL 13 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Brain tumor cellline Brain Tumor Sulforhodamine B assay IC50= 5 M Not Available Brain 9266696 None CTHHHHHHHHHHHTCC
4088 12631273, 9266696 2003 GLFDVIKKVASVIKKL 13 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Skin tumor cellline Skin Cancer Sulforhodamine B assay IC50= 5 M Not Available Skin 9266696 None CTHHHHHHHHHHHTCC
4089 12631273, 9266696 2003 GLFDVIKKVASVIKKL 13 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Ovary tumor cellline Ovarian Cancer Sulforhodamine B assay IC50= 5 M Not Available Ovary 9266696 None CTHHHHHHHHHHHTCC
4090 12631273, 9266696 2003 GLFDVIKKVASVIKKL 13 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Liver tumor celline Liver Cancer Sulforhodamine B assay IC50= 5 M Not Available Liver 9266696 None CTHHHHHHHHHHHTCC
4091 12631273, 9266696 2003 GLFDVIKKVASVIKKL 13 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Prostate tumor cellline Prostate Cancer Sulforhodamine B assay IC50= 5 M Not Available Prostate 9266696 None CTHHHHHHHHHHHTCC
4092 12631273, 9266696 2003 GLFDVIKKVASVIKKL 13 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Breast tumor cellline Breast Cancer Sulforhodamine B assay IC50= 5 M Not Available Breast 9266696 None CTHHHHHHHHHHHTCC
4093 12631273, 9266696 2003 GLFDVIAKVASVIKKL 14 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Leukemia tumor cellline Leukemia Cancer Sulforhodamine B assay IC50= 5 M Not Available Blood 9266696 None CHHHHHHHHHHHTTTC
4094 12631273, 9266696 2003 GLFDVIAKVASVIKKL 14 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Lung tumor cellline Lung Cancer Sulforhodamine B assay IC50= 5 M Not Available Lung 9266696 None CHHHHHHHHHHHTTTC
4095 12631273, 9266696 2003 GLFDVIAKVASVIKKL 14 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Colon tumor cellline Colon Cancer Sulforhodamine B assay IC50= 5 M Not Available Colon 9266696 None CHHHHHHHHHHHTTTC
4096 12631273, 9266696 2003 GLFDVIAKVASVIKKL 14 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Brain tumor cellline Brain Tumor Sulforhodamine B assay IC50= 5 M Not Available Brain 9266696 None CHHHHHHHHHHHTTTC
4097 12631273, 9266696 2003 GLFDVIAKVASVIKKL 14 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Skin tumor cellline Skin Cancer Sulforhodamine B assay IC50= 5 M Not Available Skin 9266696 None CHHHHHHHHHHHTTTC
4098 12631273, 9266696 2003 GLFDVIAKVASVIKKL 14 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Ovary tumor cellline Ovarian Cancer Sulforhodamine B assay IC50= 5 M Not Available Ovary 9266696 None CHHHHHHHHHHHTTTC
4099 12631273, 9266696 2003 GLFDVIAKVASVIKKL 14 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Liver tumor celline Liver Cancer Sulforhodamine B assay IC50= 5 M Not Available Liver 9266696 None CHHHHHHHHHHHTTTC
4100 12631273, 9266696 2003 GLFDVIAKVASVIKKL 14 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Prostate tumor cellline Prostate Cancer Sulforhodamine B assay IC50= 5 M Not Available Prostate 9266696 None CHHHHHHHHHHHTTTC
4101 12631273, 9266696 2003 GLFDVIAKVASVIKKL 14 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Breast tumor cellline Breast Cancer Sulforhodamine B assay IC50= 5 M Not Available Breast 9266696 None CHHHHHHHHHHHTTTC
4102 12631273, 9266696 2003 GLFAVIKKVASVIKGL 15 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Leukemia tumor cellline Leukemia Cancer Sulforhodamine B assay IC50= 5 M Not Available Blood 9266696 None CCHHHHHHHHHHTTCC
4103 12631273, 9266696 2003 GLFAVIKKVASVIKGL 15 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Lung tumor cellline Lung Cancer Sulforhodamine B assay IC50= 5 M Not Available Lung 9266696 None CCHHHHHHHHHHTTCC
4104 12631273, 9266696 2003 GLFAVIKKVASVIKGL 15 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Colon tumor cellline Colon Cancer Sulforhodamine B assay IC50= 5 M Not Available Colon 9266696 None CCHHHHHHHHHHTTCC
4105 12631273, 9266696 2003 GLFAVIKKVASVIKGL 15 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Brain tumor cellline Brain Tumor Sulforhodamine B assay IC50= 5 M Not Available Brain 9266696 None CCHHHHHHHHHHTTCC
4106 12631273, 9266696 2003 GLFAVIKKVASVIKGL 15 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Skin tumor cellline Skin Cancer Sulforhodamine B assay IC50= 5 M Not Available Skin 9266696 None CCHHHHHHHHHHTTCC
4107 12631273, 9266696 2003 GLFAVIKKVASVIKGL 15 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Ovary tumor cellline Ovarian Cancer Sulforhodamine B assay IC50= 5 M Not Available Ovary 9266696 None CCHHHHHHHHHHTTCC
4108 12631273, 9266696 2003 GLFAVIKKVASVIKGL 15 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Liver tumor celline Liver Cancer Sulforhodamine B assay IC50= 5 M Not Available Liver 9266696 None CCHHHHHHHHHHTTCC
4109 12631273, 9266696 2003 GLFAVIKKVASVIKGL 15 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Prostate tumor cellline Prostate Cancer Sulforhodamine B assay IC50= 5 M Not Available Prostate 9266696 None CCHHHHHHHHHHTTCC
4110 12631273, 9266696 2003 GLFAVIKKVASVIKGL 15 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Breast tumor cellline Breast Cancer Sulforhodamine B assay IC50= 5 M Not Available Breast 9266696 None CCHHHHHHHHHHTTCC
4111 12631273, 9266696 2003 GLFAVIKKVASVIKKL 16 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Leukemia tumor cellline Leukemia Cancer Sulforhodamine B assay IC50= 5 M Not Available Blood 9266696 None CCHHHHHHHHHHHTTC
4112 12631273, 9266696 2003 GLFAVIKKVASVIKKL 16 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Lung tumor cellline Lung Cancer Sulforhodamine B assay IC50= 5 M Not Available Lung 9266696 None CCHHHHHHHHHHHTTC
4113 12631273, 9266696 2003 GLFAVIKKVASVIKKL 16 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Colon tumor cellline Colon Cancer Sulforhodamine B assay IC50= 5 M Not Available Colon 9266696 None CCHHHHHHHHHHHTTC
4114 12631273, 9266696 2003 GLFAVIKKVASVIKKL 16 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Brain tumor cellline Brain Tumor Sulforhodamine B assay IC50= 5 M Not Available Brain 9266696 None CCHHHHHHHHHHHTTC
4115 12631273, 9266696 2003 GLFAVIKKVASVIKKL 16 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Skin tumor cellline Skin Cancer Sulforhodamine B assay IC50= 5 M Not Available Skin 9266696 None CCHHHHHHHHHHHTTC
4116 12631273, 9266696 2003 GLFAVIKKVASVIKKL 16 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Ovary tumor cellline Ovarian Cancer Sulforhodamine B assay IC50= 5 M Not Available Ovary 9266696 None CCHHHHHHHHHHHTTC
4117 12631273, 9266696 2003 GLFAVIKKVASVIKKL 16 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Liver tumor celline Liver Cancer Sulforhodamine B assay IC50= 5 M Not Available Liver 9266696 None CCHHHHHHHHHHHTTC
4118 12631273, 9266696 2003 GLFAVIKKVASVIKKL 16 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Prostate tumor cellline Prostate Cancer Sulforhodamine B assay IC50= 5 M Not Available Prostate 9266696 None CCHHHHHHHHHHHTTC
4119 12631273, 9266696 2003 GLFAVIKKVASVIKKL 16 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Breast tumor cellline Breast Cancer Sulforhodamine B assay IC50= 5 M Not Available Breast 9266696 None CCHHHHHHHHHHHTTC
4120 12631273, 9266696 2003 GLFAVIKKVAAVIKKL 17 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Leukemia tumor cellline Leukemia Cancer Sulforhodamine B assay IC50= 5 M Not Available Blood 9266696 None CCHHHHHHHHHHHTTC
4121 12631273, 9266696 2003 GLFAVIKKVAAVIKKL 17 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Lung tumor cellline Lung Cancer Sulforhodamine B assay IC50= 5 M Not Available Lung 9266696 None CCHHHHHHHHHHHTTC
4122 12631273, 9266696 2003 GLFAVIKKVAAVIKKL 17 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Colon tumor cellline Colon Cancer Sulforhodamine B assay IC50= 5 M Not Available Colon 9266696 None CCHHHHHHHHHHHTTC
4123 12631273, 9266696 2003 GLFAVIKKVAAVIKKL 17 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Brain tumor cellline Brain Tumor Sulforhodamine B assay IC50= 5 M Not Available Brain 9266696 None CCHHHHHHHHHHHTTC
4124 12631273, 9266696 2003 GLFAVIKKVAAVIKKL 17 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Skin tumor cellline Skin Cancer Sulforhodamine B assay IC50= 5 M Not Available Skin 9266696 None CCHHHHHHHHHHHTTC
4125 12631273, 9266696 2003 GLFAVIKKVAAVIKKL 17 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Ovary tumor cellline Ovarian Cancer Sulforhodamine B assay IC50= 5 M Not Available Ovary 9266696 None CCHHHHHHHHHHHTTC
4126 12631273, 9266696 2003 GLFAVIKKVAAVIKKL 17 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Liver tumor celline Liver Cancer Sulforhodamine B assay IC50= 5 M Not Available Liver 9266696 None CCHHHHHHHHHHHTTC
4127 12631273, 9266696 2003 GLFAVIKKVAAVIKKL 17 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Prostate tumor cellline Prostate Cancer Sulforhodamine B assay IC50= 5 M Not Available Prostate 9266696 None CCHHHHHHHHHHHTTC
4128 12631273, 9266696 2003 GLFAVIKKVAAVIKKL 17 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Breast tumor cellline Breast Cancer Sulforhodamine B assay IC50= 5 M Not Available Breast 9266696 None CCHHHHHHHHHHHTTC
4129 12631273, 9266696 2003 GLFAVIKKVAAVIRRL 18 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Leukemia tumor cellline Leukemia Cancer Sulforhodamine B assay IC50= 5 M Not Available Blood 9266696 None CCTTSTHHHHHHHHTC
4130 12631273, 9266696 2003 GLFAVIKKVAAVIRRL 18 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Lung tumor cellline Lung Cancer Sulforhodamine B assay IC50= 5 M Not Available Lung 9266696 None CCTTSTHHHHHHHHTC
4131 12631273, 9266696 2003 GLFAVIKKVAAVIRRL 18 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Colon tumor cellline Colon Cancer Sulforhodamine B assay IC50= 5 M Not Available Colon 9266696 None CCTTSTHHHHHHHHTC
4132 12631273, 9266696 2003 GLFAVIKKVAAVIRRL 18 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Brain tumor cellline Brain Tumor Sulforhodamine B assay IC50= 5 M Not Available Brain 9266696 None CCTTSTHHHHHHHHTC
4133 12631273, 9266696 2003 GLFAVIKKVAAVIRRL 18 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Skin tumor cellline Skin Cancer Sulforhodamine B assay IC50= 5 M Not Available Skin 9266696 None CCTTSTHHHHHHHHTC
4134 12631273, 9266696 2003 GLFAVIKKVAAVIRRL 18 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Ovary tumor cellline Ovarian Cancer Sulforhodamine B assay IC50= 5 M Not Available Ovary 9266696 None CCTTSTHHHHHHHHTC
4135 12631273, 9266696 2003 GLFAVIKKVAAVIRRL 18 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Liver tumor celline Liver Cancer Sulforhodamine B assay IC50= >10 µM Not Available Liver 9266696 None CCTTSTHHHHHHHHTC
4136 12631273, 9266696 2003 GLFAVIKKVAAVIRRL 18 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Prostate tumor cellline Prostate Cancer Sulforhodamine B assay IC50= 5 M Not Available Prostate 9266696 None CCTTSTHHHHHHHHTC
4137 12631273, 9266696 2003 GLFAVIKKVAAVIRRL 18 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Breast tumor cellline Breast Cancer Sulforhodamine B assay IC50= 5 M Not Available Breast 9266696 None CCTTSTHHHHHHHHTC
4138 12631273, 9266696 2003 GLFAVIKKVAKVIKKL 19 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Leukemia tumor cellline Leukemia Cancer Sulforhodamine B assay IC50= 5 M Not Available Blood 9266696 None CCTTTHHHHHHHHTTC
4139 12631273, 9266696 2003 GLFAVIKKVAKVIKKL 19 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Lung tumor cellline Lung Cancer Sulforhodamine B assay IC50= 6 M Not Available Lung 9266696 None CCTTTHHHHHHHHTTC
4140 12631273, 9266696 2003 GLFAVIKKVAKVIKKL 19 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Colon tumor cellline Colon Cancer Sulforhodamine B assay IC50= 5 M Not Available Colon 9266696 None CCTTTHHHHHHHHTTC
4141 12631273, 9266696 2003 GLFAVIKKVAKVIKKL 19 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Brain tumor cellline Brain Tumor Sulforhodamine B assay IC50= 5 M Not Available Brain 9266696 None CCTTTHHHHHHHHTTC
4142 12631273, 9266696 2003 GLFAVIKKVAKVIKKL 19 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Skin tumor cellline Skin Cancer Sulforhodamine B assay IC50= 5 M Not Available Skin 9266696 None CCTTTHHHHHHHHTTC
4143 12631273, 9266696 2003 GLFAVIKKVAKVIKKL 19 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Ovary tumor cellline Ovarian Cancer Sulforhodamine B assay IC50= 5 M Not Available Ovary 9266696 None CCTTTHHHHHHHHTTC
4144 12631273, 9266696 2003 GLFAVIKKVAKVIKKL 19 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Liver tumor celline Liver Cancer Sulforhodamine B assay IC50= 5 M Not Available Liver 9266696 None CCTTTHHHHHHHHTTC
4145 12631273, 9266696 2003 GLFAVIKKVAKVIKKL 19 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Prostate tumor cellline Prostate Cancer Sulforhodamine B assay IC50= 5 M Not Available Prostate 9266696 None CCTTTHHHHHHHHTTC
4146 12631273, 9266696 2003 GLFAVIKKVAKVIKKL 19 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Breast tumor cellline Breast Cancer Sulforhodamine B assay IC50= 5 M Not Available Breast 9266696 None CCTTTHHHHHHHHTTC
4147 12631273, 9266696 2003 GLFKVIKKVASVIGGL 22 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Leukemia tumor cellline Leukemia Cancer Sulforhodamine B assay IC50= 5 M Not Available Blood 9266696 None CTHHHHHHHSTTTTCC
4148 12631273, 9266696 2003 GLFKVIKKVASVIGGL 22 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Lung tumor cellline Lung Cancer Sulforhodamine B assay IC50= 5 M Not Available Lung 9266696 None CTHHHHHHHSTTTTCC
4149 12631273, 9266696 2003 GLFKVIKKVASVIGGL 22 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Colon tumor cellline Colon Cancer Sulforhodamine B assay IC50= 5 M Not Available Colon 9266696 None CTHHHHHHHSTTTTCC
4150 12631273, 9266696 2003 GLFKVIKKVASVIGGL 22 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Brain tumor cellline Brain Tumor Sulforhodamine B assay IC50= 5 M Not Available Brain 9266696 None CTHHHHHHHSTTTTCC
4151 12631273, 9266696 2003 GLFKVIKKVASVIGGL 22 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Skin tumor cellline Skin Cancer Sulforhodamine B assay IC50= 5 M Not Available Skin 9266696 None CTHHHHHHHSTTTTCC
4152 12631273, 9266696 2003 GLFKVIKKVASVIGGL 22 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Ovary tumor cellline Ovarian Cancer Sulforhodamine B assay IC50= 5 M Not Available Ovary 9266696 None CTHHHHHHHSTTTTCC
4153 12631273, 9266696 2003 GLFKVIKKVASVIGGL 22 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Liver tumor celline Liver Cancer Sulforhodamine B assay IC50= >10 µM Not Available Liver 9266696 None CTHHHHHHHSTTTTCC
4154 12631273, 9266696 2003 GLFKVIKKVASVIGGL 22 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Prostate tumor cellline Prostate Cancer Sulforhodamine B assay IC50= >10 µM Not Available Prostate 9266696 None CTHHHHHHHSTTTTCC
4155 12631273, 9266696 2003 GLFKVIKKVASVIGGL 22 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Breast tumor cellline Breast Cancer Sulforhodamine B assay IC50= 5 M Not Available Breast 9266696 None CTHHHHHHHSTTTTCC
4156 12631273, 9266696 2003 GLFKVIKKVAKVIKKL 23 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Leukemia tumor cellline Leukemia Cancer Sulforhodamine B assay IC50= 5 M Not Available Blood 9266696 None CCTTTTHHHHHHHTTC
4157 12631273, 9266696 2003 GLFKVIKKVAKVIKKL 23 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Lung tumor cellline Lung Cancer Sulforhodamine B assay IC50= 5 M Not Available Lung 9266696 None CCTTTTHHHHHHHTTC
4158 12631273, 9266696 2003 GLFKVIKKVAKVIKKL 23 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Colon tumor cellline Colon Cancer Sulforhodamine B assay IC50= 5 M Not Available Colon 9266696 None CCTTTTHHHHHHHTTC
4159 12631273, 9266696 2003 GLFKVIKKVAKVIKKL 23 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Brain tumor cellline Brain Tumor Sulforhodamine B assay IC50= 5 M Not Available Brain 9266696 None CCTTTTHHHHHHHTTC
4160 12631273, 9266696 2003 GLFKVIKKVAKVIKKL 23 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Skin tumor cellline Skin Cancer Sulforhodamine B assay IC50= 5 M Not Available Skin 9266696 None CCTTTTHHHHHHHTTC
4161 12631273, 9266696 2003 GLFKVIKKVAKVIKKL 23 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Ovary tumor cellline Ovarian Cancer Sulforhodamine B assay IC50= 5 M Not Available Ovary 9266696 None CCTTTTHHHHHHHTTC
4162 12631273, 9266696 2003 GLFKVIKKVAKVIKKL 23 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Liver tumor celline Liver Cancer Sulforhodamine B assay IC50= >10 µM Not Available Liver 9266696 None CCTTTTHHHHHHHTTC
4163 12631273, 9266696 2003 GLFKVIKKVAKVIKKL 23 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Prostate tumor cellline Prostate Cancer Sulforhodamine B assay IC50= 5 M Not Available Prostate 9266696 None CCTTTTHHHHHHHTTC
4164 12631273, 9266696 2003 GLFKVIKKVAKVIKKL 23 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Breast tumor cellline Breast Cancer Sulforhodamine B assay IC50= 5 M Not Available Breast 9266696 None CCTTTTHHHHHHHTTC
4165 12631273, 9266696 2003 LGGIVSAVKKIVDFLG retro 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Leukemia tumor cellline Leukemia Cancer Sulforhodamine B assay IC50= 5 M Not Available Blood 9266696 None CTTHHHHHTTTSSCCC
4166 12631273, 9266696 2003 LGGIVSAVKKIVDFLG retro 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Lung tumor cellline Lung Cancer Sulforhodamine B assay IC50= 5 M Not Available Lung 9266696 None CTTHHHHHTTTSSCCC
4167 12631273, 9266696 2003 LGGIVSAVKKIVDFLG retro 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Colon tumor cellline Colon Cancer Sulforhodamine B assay IC50= >10 µM Not Available Colon 9266696 None CTTHHHHHTTTSSCCC
4168 12631273, 9266696 2003 LGGIVSAVKKIVDFLG retro 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Brain tumor cellline Brain Tumor Sulforhodamine B assay IC50= 5 M Not Available Brain 9266696 None CTTHHHHHTTTSSCCC
4169 12631273, 9266696 2003 LGGIVSAVKKIVDFLG retro 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Skin tumor cellline Skin Cancer Sulforhodamine B assay IC50= 5 M Not Available Skin 9266696 None CTTHHHHHTTTSSCCC
4170 12631273, 9266696 2003 LGGIVSAVKKIVDFLG retro 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Ovary tumor cellline Ovarian Cancer Sulforhodamine B assay IC50= 5 M Not Available Ovary 9266696 None CTTHHHHHTTTSSCCC
4171 12631273, 9266696 2003 LGGIVSAVKKIVDFLG retro 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Liver tumor celline Liver Cancer Sulforhodamine B assay IC50= >10 µM Not Available Liver 9266696 None CTTHHHHHTTTSSCCC
4172 12631273, 9266696 2003 LGGIVSAVKKIVDFLG retro 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Prostate tumor cellline Prostate Cancer Sulforhodamine B assay IC50= >10 µM Not Available Prostate 9266696 None CTTHHHHHTTTSSCCC
4173 12631273, 9266696 2003 LGGIVSAVKKIVDFLG retro 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Breast tumor cellline Breast Cancer Sulforhodamine B assay IC50= >10 µM Not Available Breast 9266696 None CTTHHHHHTTTSSCCC
4174 14991605 2004 KIFGSLAFL p369-CTL-A2xneu 9 Linear L None Free Free Antitumor Synthetic Peptide N202.A2 Tumor Peptide dose curve assay 0.1% Inhibition at 10-10 M Not Available Not Available None None CCCCCCTTC
4175 14991605 2004 KIFGSLAFL p369-CTL-A2xneu 9 Linear L None Free Free Antitumor Synthetic Peptide N202.A2 Tumor Peptide dose curve assay 1% Inhibition at 10-9 M Not Available Not Available None None CCCCCCTTC
4176 14991605 2004 KIFGSLAFL p369-CTL-A2xneu 9 Linear L None Free Free Antitumor Synthetic Peptide N202.A2 Tumor Peptide dose curve assay 5% Inhibition at 10-8 M Not Available Not Available None None CCCCCCTTC
4177 14991605 2004 KIFGSLAFL p369-CTL-A2xneu 9 Linear L None Free Free Antitumor Synthetic Peptide N202.A2 Tumor Peptide dose curve assay 10% Inhibition at 10-7 M Not Available Not Available None None CCCCCCTTC
4178 14991605 2004 KIFGSLAFL p369-CTL-A2xneu 9 Linear L None Free Free Antitumor Synthetic Peptide N202.A2 Tumor Peptide dose curve assay 20% Inhibition at 10-6 M Not Available Not Available None None CCCCCCTTC
4179 14991605 2004 KIFGSLAFL p369-CTL-A2xFVB 9 Linear L None Free Free Antitumor Synthetic Peptide N202.A2 Tumor Peptide dose curve assay 8% Inhibition at 10-10 M Not Available Not Available None None CCCCCCTTC
4180 14991605 2004 KIFGSLAFL p369-CTL-A2xFVB 9 Linear L None Free Free Antitumor Synthetic Peptide N202.A2 Tumor Peptide dose curve assay 25% Inhibition at 10-9 M Not Available Not Available None None CCCCCCTTC
4181 14991605 2004 KIFGSLAFL p369-CTL-A2xFVB 9 Linear L None Free Free Antitumor Synthetic Peptide N202.A2 Tumor Peptide dose curve assay 80% Inhibition at 10-8 M Not Available Not Available None None CCCCCCTTC
4182 14991605 2004 KIFGSLAFL p369-CTL-A2xFVB 9 Linear L None Free Free Antitumor Synthetic Peptide N202.A2 Tumor Peptide dose curve assay 85% Inhibition at 10-7 M Not Available Not Available None None CCCCCCTTC
4183 14991605 2004 KIFGSLAFL p369-CTL-A2xFVB 9 Linear L None Free Free Antitumor Synthetic Peptide N202.A2 Tumor Peptide dose curve assay 92% Inhibition at 10-6 M Not Available Not Available None None CCCCCCTTC
4184 15313924 2004 HHPHG HHPHG 5 Linear L None Free Free Antiangiogenesis and Antitumor Synthetic Peptide Not Available Tumor Tropomyosin binding assay IC50=92 µM Not Available Not Available None None CCSCC
4185 15313924 2004 HHPHGHHPHG (HHPHG)2 10 Linear L None Free Free Antiangiogenesis and Antitumor Synthetic Peptide Not Available Tumor Tropomyosin binding assay IC50=11.6 µM Not Available Not Available None None CCSCCCCSCC
4186 15313924 2004 HHPHGHHPHG (HHPHG)2 10 Linear L None Amidation Acetylation Antiangiogenesis and Antitumor Synthetic Peptide Not Available Tumor Tropomyosin binding assay IC50=26.9 µM Not Available Not Available None None CCCCCCCSCC
4187 15313924 2004 HHPHGHHPHGHHPHG (HHPHG)3 15 Linear L None Free Free Antiangiogenesis and Antitumor Synthetic Peptide Not Available Tumor Tropomyosin binding assay IC50=1.25 µM Not Available Not Available None None CCSSCSSCSSSCCCC
4188 15313924 2004 HHPHGHHPHGHHPHG (HHPHG)3 15 Linear L None Amidation Acetylation Antiangiogenesis and Antitumor Synthetic Peptide Not Available Tumor Tropomyosin binding assay IC50=1.56 µM Not Available Not Available None None CCTTCBTTTBCCTTC
4189 15313924 2004 HHPHGHHPHGHHPHGHHPHG (HHPHG)4 20 Linear L None Free Free Antiangiogenesis and Antitumor Synthetic Peptide Not Available Tumor Tropomyosin binding assay IC50=0.256 µM Not Available Not Available None None CCSCCSSSSSCCCSSSCCCC
4190 15313924 2004 HHPHGHHPHGHHPHGHHPHG (HHPHG)4 20 Linear L None Amidation Acetylation Antiangiogenesis and Antitumor Synthetic Peptide Not Available Tumor Tropomyosin binding assay IC50=0.245 µM Not Available Not Available None None CCSSSSSSCCCCCSSSCCCC
4191 15467750 2004 GRKKRRQRRR HIV-TAT48-57 10 Linear L None Free Free Anticancer Not Available HeLa Cervical Cancer LDH leakage assay 7% apoptosis at 10 µM 16 to 24-h Cervix None None CTTTTTCCCC
4192 15467750 2004 GRKKRRQRRR HIV-TAT48-57 10 Linear L None Free Free Anticancer Not Available HeLa Cervical Cancer LDH leakage assay 15% apoptosis at 20 µM 16 to 24-h Cervix None None CTTTTTCCCC
4193 15467750 2004 GRKKRRQRRR HIV-TAT48-57 10 Linear L None Free Free Anticancer Not Available HeLa Cervical Cancer LDH leakage assay 35% apoptosis at 30 µM 16 to 24-h Cervix None None CTTTTTCCCC
4194 15467750 2004 GRKKRRQRRR HIV-TAT48-57 10 Linear L None Free Free Anticancer Not Available HeLa Cervical Cancer LDH leakage assay 65% apoptosis at 50 µM 16 to 24-h Cervix None None CTTTTTCCCC
4195 15467750 2004 GRKKRRQRRRGGWMWVTNLRTD TAT-Ras-GAP317-326 22 Linear L None Free Free Anticancer Not Available HeLa Cervical Cancer LDH leakage assay 15% apoptosis at 10 µM 16 to 24-h Cervix None None CGGGGGCCSSSCCCSSCSSSCC
4196 15467750 2004 GRKKRRQRRRGGWMWVTNLRTD TAT-Ras-GAP317-326 22 Linear L None Free Free Anticancer Not Available HeLa Cervical Cancer LDH leakage assay 47% apoptosis at 20 µM 16 to 24-h Cervix None None CGGGGGCCSSSCCCSSCSSSCC
4197 15467750 2004 GRKKRRQRRRGGWMWVTNLRTD TAT-Ras-GAP317-326 22 Linear L None Free Free Anticancer Not Available HeLa Cervical Cancer LDH leakage assay 72% apoptosis at 30 µM 16 to 24-h Cervix None None CGGGGGCCSSSCCCSSCSSSCC
4198 15467750 2004 GRKKRRQRRRGGWMWVTNLRTD TAT-Ras-GAP317-326 22 Linear L None Free Free Anticancer Not Available HeLa Cervical Cancer LDH leakage assay 79% apoptosis at 50 µM 16 to 24-h Cervix None None CGGGGGCCSSSCCCSSCSSSCC
4200 15867360 2005 HSHRDFQPVLHLVALNSPLSGGMRG hP1 25 Linear L None Free Free Antiangiogenesis Human endostatin peptides BxPC-3 Pancreatic Cancer Matrigel Assay 39% inhibition at 7 mg/kg/d 672-h Pancreatic None None CCCCCSSCGGGGGTSCCSBSSSBCC
4201 15867360 2005 MRGIRGADFQAFQQARAVGLAGTFR hP2 25 Linear L None Free Free Antiangiogenesis Human endostatin peptides BxPC-3 Pancreatic Cancer Matrigel Assay 19% inhibition at 7 mg/kg/d 672-h Pancreatic None None CCSSCSSCCSSSCHHHHSSCCSSCC
4202 15867360 2005 TFRAFLSSRLQDLYSIVRRADRAAV hP3 25 Linear L None Free Free Antiangiogenesis Human endostatin peptides BxPC-3 Pancreatic Cancer Matrigel Assay No inhibition at 7 mg/kg/d 672-h Pancreatic None None CCTTHHHHTTSCHHHHHCCSCSSCC
4203 15867360 2005 AAVPIVNLKDELLFPSWEALFSGSE hP4 25 Linear L None Free Free Antiangiogenesis Human endostatin peptides BxPC-3 Pancreatic Cancer Matrigel Assay No inhibition at 7 mg/kg/d 672-h Pancreatic None None CCCSSSCCCCSSCCSSTTTCCSSCC
4204 15867360 2005 GSEGPLKPGARIFSFDGKDVLRHPT hP5 25 Linear L None Free Free Antiangiogenesis Human endostatin peptides BxPC-3 Pancreatic Cancer Matrigel Assay 29% inhibition at 7 mg/kg/d 672-h Pancreatic None None CCCCSSCCSSSCSCCCSSCCSCCCC
4205 15867360 2005 HPTWPQKSVWHGSDPNGRRLTESY hP6 24 Linear L None Free Free Antiangiogenesis Human endostatin peptides BxPC-3 Pancreatic Cancer Matrigel Assay No inhibition at 7 mg/kg/d 672-h Pancreatic None None CTTCSSSCSSSCSSSSSCTTSCCC
4206 15867360 2005 ETWRTEAPSATGQASSLLGGRLLGQ hP7 25 Linear L None Free Free Antiangiogenesis Human endostatin peptides BxPC-3 Pancreatic Cancer Matrigel Assay No inhibition at 7 mg/kg/d 672-h Pancreatic None None CCCCCSSSSCCHHHHHHHHHTTSCC
4207 15867360 2005 LGQSAASAHHAYIVLAIENSFMTASKKK hP8 28 Linear L None Free Free Antiangiogenesis Human endostatin peptides BxPC-3 Pancreatic Cancer Matrigel Assay No inhibition at 7 mg/kg/d 672-h Pancreatic None None CCCCTTCSSGGGHHHHHCCCBSSSSBCC
4219 16091933 2005 YSL Tyroserleutide 3 Linear L None Free Free Antitumor Synthetic Peptide B16-F10 Skin Cancer MTT/MTS assay 49.4% cytotoxic at 0.1 µg/ml 96-h Skin None None CCC
4220 16091933 2005 YSL Tyroserleutide 3 Linear L None Free Free Antitumor Synthetic Peptide B16-F10 Skin Cancer MTT/MTS assay 51.2% cytotoxic at 1 µg/ml 96-h Skin None None CCC
4221 16091933 2005 YSL Tyroserleutide 3 Linear L None Free Free Antitumor Synthetic Peptide B16-F10 Skin Cancer MTT/MTS assay 53.0% cytotoxic at 10 µg/ml 96-h Skin None None CCC
4222 16091933 2005 YSL Tyroserleutide 3 Linear L None Free Free Antitumor Synthetic Peptide B16-F10 Skin Cancer MTT/MTS assay 61.2% cytotoxic at 100 µg/ml 96-h Skin None None CCC
4223 16091933 2005 YSL Tyroserleutide 3 Linear L None Free Free Antitumor Synthetic Peptide BEL-7402 Liver Cancer MTT/MTS assay 39.0% cytotoxic at 0.1 µg/ml 96-h Liver None None CCC
4224 16091933 2005 YSL Tyroserleutide 3 Linear L None Free Free Antitumor Synthetic Peptide BEL-7402 Liver Cancer MTT/MTS assay 20.8% cytotoxic at 1 µg/ml 96-h Liver None None CCC
4225 16091933 2005 YSL Tyroserleutide 3 Linear L None Free Free Antitumor Synthetic Peptide BEL-7402 Liver Cancer MTT/MTS assay 33.8% cytotoxic at 10 µg/ml 96-h Liver None None CCC
4226 16091933 2005 YSL Tyroserleutide 3 Linear L None Free Free Antitumor Synthetic Peptide BEL-7402 Liver Cancer MTT/MTS assay 35.6% cytotoxic at 100 µg/ml 96-h Liver None None CCC
4475 22057278 2011 KAAKKWAKAAKKAAKAWKKAA Z1 21 Linear L None Free Free Anticancer Synthetic Meth A Skin Cancer MTT/MTS assay EC50 >211 µM Not Available Skin None None CTHHHHHHHHHHHHHHHTTTC
4476 22057278 2011 KAAKKWAKAWKKAAKAWKKAA Z2 21 Linear L None Free Free Anticancer Synthetic Meth A Skin Cancer MTT/MTS assay EC50 >211 µM Not Available Skin None None CGGGGTTTTTTTTHHHHTTTC
4486 22057278 2011 KAAKKWAKAWKKAAKAWKKAA Z2 21 Linear L None Free Free Anticancer Synthetic MT-1 Breast Cancer MTT/MTS assay EC50 =173 µM Not Available Breast None None CGGGGTTTTTTTTHHHHTTTC
4496 22057278 2011 KAAKKWAKAWKKAAKAWKKAA Z2 21 Linear L None Free Free Anticancer Synthetic HT-29 Colon Cancer MTT/MTS assay EC50 >211 µM Not Available Colon None None CGGGGTTTTTTTTHHHHTTTC
4477 22057278 2011 KAAKKAWKAWKKAAKAAWKKAA Z3 21 Linear L None Free Free Anticancer Synthetic Meth A Skin Cancer MTT/MTS assay EC50 >211 µM Not Available Skin None None CTHHHHTTTTHHHHHHHGGGTC
4487 22057278 2011 KAAKKAWKAWKKAAKAAWKKAA Z3 21 Linear L None Free Free Anticancer Synthetic MT-1 Breast Cancer MTT/MTS assay EC50 =128 µM Not Available Breast None None CTHHHHTTTTHHHHHHHGGGTC
4497 22057278 2011 KAAKKAWKAWKKAAKAAWKKAA Z3 21 Linear L None Free Free Anticancer Synthetic HT-29 Colon Cancer MTT/MTS assay EC50 >211 µM Not Available Colon None None CTHHHHTTTTHHHHHHHGGGTC
4478 22057278 2011 KAAKKAWKAAKKAAKWWKKAA Z4 21 Linear L None Free Free Anticancer Synthetic Meth A Skin Cancer MTT/MTS assay EC50 =155 µM Not Available Skin None None CTHHHHHHHTHHHHHHHHTTC
4488 22057278 2011 KAAKKAWKAAKKAAKWWKKAA Z4 21 Linear L None Free Free Anticancer Synthetic MT-1 Breast Cancer MTT/MTS assay EC50 =68 µM Not Available Breast None None CTHHHHHHHTHHHHHHHHTTC
4498 22057278 2011 KAAKKAWKAAKKAAKWWKKAA Z4 21 Linear L None Free Free Anticancer Synthetic HT-29 Colon Cancer MTT/MTS assay EC50 =173 µM Not Available Colon None None CTHHHHHHHTHHHHHHHHTTC
4479 22057278 2011 KAAKKAWKWAKKAAKWAKKAA Z5 21 Linear L None Free Free Anticancer Synthetic Meth A Skin Cancer MTT/MTS assay EC50 =42 µM Not Available Skin None None CTHHHHHHHTHHHHHHHTTTC
4489 22057278 2011 KAAKKAWKWAKKAAKWAKKAA Z5 21 Linear L None Free Free Anticancer Synthetic MT-1 Breast Cancer MTT/MTS assay EC50 =28 µM Not Available Breast None None CTHHHHHHHTHHHHHHHTTTC
4499 22057278 2011 KAAKKAWKWAKKAAKWAKKAA Z5 21 Linear L None Free Free Anticancer Synthetic HT-29 Colon Cancer MTT/MTS assay EC50 =67 µM Not Available Colon None None CTHHHHHHHTHHHHHHHTTTC
4480 22057278 2011 KWWKKAAKAAKKAAKAAKKWA Z6 21 Linear L None Free Free Anticancer Synthetic Meth A Skin Cancer MTT/MTS assay EC50 =17 µM Not Available Skin None None CHHHHHHHHHHHHHHHHHHCC
4490 22057278 2011 KWWKKAAKAAKKAAKAAKKWA Z6 21 Linear L None Free Free Anticancer Synthetic MT-1 Breast Cancer MTT/MTS assay EC50 =16 µM Not Available Breast None None CHHHHHHHHHHHHHHHHHHCC
4500 22057278 2011 KWWKKAAKAAKKAAKAAKKWA Z6 21 Linear L None Free Free Anticancer Synthetic HT-29 Colon Cancer MTT/MTS assay EC50 =31 µM Not Available Colon None None CHHHHHHHHHHHHHHHHHHCC
4481 22057278 2011 KAAKKAWKAAKKAWKAAKKAA Z7 21 Linear L None Free Free Anticancer Synthetic Meth A Skin Cancer MTT/MTS assay EC50 =15 µM Not Available Skin None None CTHHHHTTGGGGGHHHHTTTC
4491 22057278 2011 KAAKKAWKAAKKAWKAAKKAA Z7 21 Linear L None Free Free Anticancer Synthetic MT-1 Breast Cancer MTT/MTS assay EC50 =15 µM Not Available Breast None None CTHHHHTTGGGGGHHHHTTTC
4501 22057278 2011 KAAKKAWKAAKKAWKAAKKAA Z7 21 Linear L None Free Free Anticancer Synthetic HT-29 Colon Cancer MTT/MTS assay EC50 =21 µM Not Available Colon None None CTHHHHTTGGGGGHHHHTTTC
4482 22057278 2011 AWKKWAKAWKWAKAKWWAKAA Z8 21 Linear L None Free Free Anticancer Synthetic Meth A Skin Cancer MTT/MTS assay EC50 =19 µM Not Available Skin None None CHHHHHHHHHHHHHHHTTTCC
4492 22057278 2011 AWKKWAKAWKWAKAKWWAKAA Z8 21 Linear L None Free Free Anticancer Synthetic MT-1 Breast Cancer MTT/MTS assay EC50 =14 µM Not Available Breast None None CHHHHHHHHHHHHHHHTTTCC
4502 22057278 2011 AWKKWAKAWKWAKAKWWAKAA Z8 21 Linear L None Free Free Anticancer Synthetic HT-29 Colon Cancer MTT/MTS assay EC50 =23 µM Not Available Colon None None CHHHHHHHHHHHHHHHTTTCC
4483 22057278 2011 AAWKWAWAKKWAKAKKWAKAA Z9 21 Linear L None Free Free Anticancer Synthetic Meth A Skin Cancer MTT/MTS assay EC50 =9 µM Not Available Skin None None CCCHHHHHHHHHHGGGTTTCC
4493 22057278 2011 AAWKWAWAKKWAKAKKWAKAA Z9 21 Linear L None Free Free Anticancer Synthetic MT-1 Breast Cancer MTT/MTS assay EC50 =16 µM Not Available Breast None None CCCHHHHHHHHHHGGGTTTCC
4503 22057278 2011 AAWKWAWAKKWAKAKKWAKAA Z9 21 Linear L None Free Free Anticancer Synthetic HT-29 Colon Cancer MTT/MTS assay EC50 =13 µM Not Available Colon None None CCCHHHHHHHHHHGGGTTTCC
4484 22057278 2011 AAKKWAKAKWAKAKKWAKAA Z10 21 Linear L None Free Free Anticancer Synthetic Meth A Skin Cancer MTT/MTS assay EC50 >211 µM Not Available Skin None None CHHHHHHHHHHHGGGTTTCC
4494 22057278 2011 AAKKWAKAKWAKAKKWAKAA Z10 21 Linear L None Free Free Anticancer Synthetic MT-1 Breast Cancer MTT/MTS assay EC50 >211 µM Not Available Breast None None CHHHHHHHHHHHGGGTTTCC
4504 22057278 2011 AAKKWAKAKWAKAKKWAKAA Z10 21 Linear L None Free Free Anticancer Synthetic HT-29 Colon Cancer MTT/MTS assay EC50 >211 µM Not Available Colon None None CHHHHHHHHHHHGGGTTTCC
4485 22057278 2011 KAAKKWAKAAKKWAKAWKKAA Z1 21 Linear L None Free Free Anticancer Synthetic MT-1 Breast Cancer MTT/MTS assay EC50 =186 µM Not Available Breast None None CTHHHHHHHHHHHHHHHTTTC
4495 22057278 2011 KAAKKWAKAAKKWAKAWKKAA Z1 21 Linear L None Free Free Anticancer Synthetic HT-29 Colon Cancer MTT/MTS assay EC50 >211 µM Not Available Colon None None CTHHHHHHHHHHHHHHHTTTC
4511 22023734 2011 GRRKRKWLRRIGKGVKIIGGAALDHL NRC-03 26 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family MDA-MB-231 Breast Cancer MTT/MTS assay 5% cytotoxic at 5 µM 24-h Breast None None NA NA
4512 22023734 2011 GRRKRKWLRRIGKGVKIIGGAALDHL NRC-03 26 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family MDA-MB-231 Breast Cancer MTT/MTS assay 5% cytotoxic at 10 µM 24-h Breast None None NA NA
4513 22023734 2011 GRRKRKWLRRIGKGVKIIGGAALDHL NRC-03 26 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family MDA-MB-231 Breast Cancer MTT/MTS assay 30-35% cytotoxic at 25 µM 24-h Breast None None NA NA
4514 22023734 2011 GRRKRKWLRRIGKGVKIIGGAALDHL NRC-03 26 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family MDA-MB-231 Breast Cancer MTT/MTS assay 60% cytotoxic at 50 µM 24-h Breast None None NA NA
4515 22023734 2011 GRRKRKWLRRIGKGVKIIGGAALDHL NRC-03 26 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family T-47D Breast Cancer MTT/MTS assay 5-10% cytotoxic at 5 µM 24-h Breast None None NA NA
4516 22023734 2011 GRRKRKWLRRIGKGVKIIGGAALDHL NRC-03 26 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family T-47D Breast Cancer MTT/MTS assay 10% cytotoxic at 10 µM 24-h Breast None None NA NA
4517 22023734 2011 GRRKRKWLRRIGKGVKIIGGAALDHL NRC-03 26 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family T-47D Breast Cancer MTT/MTS assay 30-35% cytotoxic at 25 µM 24-h Breast None None NA NA
4518 22023734 2011 GRRKRKWLRRIGKGVKIIGGAALDHL NRC-03 26 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family T-47D Breast Cancer MTT/MTS assay 60% cytotoxic at 50 µM 24-h Breast None None NA NA
4519 22023734 2011 GRRKRKWLRRIGKGVKIIGGAALDHL NRC-03 26 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family SKBR-3 Breast Cancer MTT/MTS assay 30% cytotoxic at 5 µM 24-h Breast None None NA NA
4520 22023734 2011 GRRKRKWLRRIGKGVKIIGGAALDHL NRC-03 26 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family SKBR-3 Breast Cancer MTT/MTS assay 50% cytotoxic at 10 µM 24-h Breast None None NA NA
4521 22023734 2011 GRRKRKWLRRIGKGVKIIGGAALDHL NRC-03 26 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family SKBR-3 Breast Cancer MTT/MTS assay 70% cytotoxic at 25 µM 24-h Breast None None NA NA
4522 22023734 2011 GRRKRKWLRRIGKGVKIIGGAALDHL NRC-03 26 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family SKBR-3 Breast Cancer MTT/MTS assay 80-85% cytotoxic at 50 µM 24-h Breast None None NA NA
4523 22023734 2011 GRRKRKWLRRIGKGVKIIGGAALDHL NRC-03 26 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family MDA-MB-468 Breast Cancer MTT/MTS assay 30% cytotoxic at 5 µM 24-h Breast None None NA NA
4524 22023734 2011 GRRKRKWLRRIGKGVKIIGGAALDHL NRC-03 26 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family MDA-MB-468 Breast Cancer MTT/MTS assay 40-50% cytotoxic at 10 µM 24-h Breast None None NA NA
4525 22023734 2011 GRRKRKWLRRIGKGVKIIGGAALDHL NRC-03 26 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family MDA-MB-468 Breast Cancer MTT/MTS assay 60-70% cytotoxic at 25 µM 24-h Breast None None NA NA
4526 22023734 2011 GRRKRKWLRRIGKGVKIIGGAALDHL NRC-03 26 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family MDA-MB-468 Breast Cancer MTT/MTS assay 80-85% cytotoxic at 50 µM 24-h Breast None None NA NA
4527 22023734 2011 GRRKRKWLRRIGKGVKIIGGAALDHL NRC-03 26 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family 4T1 Breast Cancer MTT/MTS assay 15-20% cytotoxic at 5 µM 24-h Breast None None NA NA
4528 22023734 2011 GRRKRKWLRRIGKGVKIIGGAALDHL NRC-03 26 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family 4T1 Breast Cancer MTT/MTS assay 40-50% cytotoxic at 10 µM 24-h Breast None None NA NA
4529 22023734 2011 GRRKRKWLRRIGKGVKIIGGAALDHL NRC-03 26 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family 4T1 Breast Cancer MTT/MTS assay 80% cytotoxic at 25 µM 24-h Breast None None NA NA
4530 22023734 2011 GRRKRKWLRRIGKGVKIIGGAALDHL NRC-03 26 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family 4T1 Breast Cancer MTT/MTS assay 85-90% cytotoxic at 50 µM 24-h Breast None None NA NA
4531 22023734 2011 GRRKRKWLRRIGKGVKIIGGAALDHL NRC-07 25 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family MDA-MB-231 Breast Cancer MTT/MTS assay ~0% cytotoxic at 5 µM 24-h Breast None None NA NA
4570 22023734 2011 GRRKRKWLRRIGKGVKIIGGAALDHL NRC-03 26 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family MCF-7 Breast Cancer MTT/MTS assay 70% cytotoxic at 50 µM 24-h Breast None None NA NA
4573 22023734 2011 GRRKRKWLRRIGKGVKIIGGAALDHL NRC-03 26 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family MCF-7-TX400 Breast Cancer MTT/MTS assay 60-70% cytotoxic at 50 µM 24-h Breast None None NA NA
4532 22023734 2011 RWGKWFKKATHVGKHVGKAALTAYL NRC-07 25 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family MDA-MB-231 Breast Cancer MTT/MTS assay 5% cytotoxic at 10 µM 24-h Breast None None NA NA
4533 22023734 2011 RWGKWFKKATHVGKHVGKAALTAYL NRC-07 25 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family MDA-MB-231 Breast Cancer MTT/MTS assay 20-30% cytotoxic at 25 µM 24-h Breast None None NA NA
4534 22023734 2011 RWGKWFKKATHVGKHVGKAALTAYL NRC-07 25 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family MDA-MB-231 Breast Cancer MTT/MTS assay 40-50% cytotoxic at 50 µM 24-h Breast None None NA NA
4535 22023734 2011 RWGKWFKKATHVGKHVGKAALTAYL NRC-07 25 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family T-47D Breast Cancer MTT/MTS assay ~0% cytotoxic at 5 µM 24-h Breast None None NA NA
4536 22023734 2011 RWGKWFKKATHVGKHVGKAALTAYL NRC-07 25 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family T-47D Breast Cancer MTT/MTS assay 10% cytotoxic at 10 µM 24-h Breast None None NA NA
4537 22023734 2011 RWGKWFKKATHVGKHVGKAALTAYL NRC-07 25 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family T-47D Breast Cancer MTT/MTS assay 20% cytotoxic at 25 µM 24-h Breast None None NA NA
4538 22023734 2011 RWGKWFKKATHVGKHVGKAALTAYL NRC-07 25 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family T-47D Breast Cancer MTT/MTS assay 40-50% cytotoxic at 50 µM 24-h Breast None None NA NA
4539 22023734 2011 RWGKWFKKATHVGKHVGKAALTAYL NRC-07 25 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family SKBR-3 Breast Cancer MTT/MTS assay ~0% cytotoxic at 5 µM 24-h Breast None None NA NA
4540 22023734 2011 RWGKWFKKATHVGKHVGKAALTAYL NRC-07 25 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family SKBR-3 Breast Cancer MTT/MTS assay 20% cytotoxic at 10 µM 24-h Breast None None NA NA
4541 22023734 2011 RWGKWFKKATHVGKHVGKAALTAYL NRC-07 25 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family SKBR-3 Breast Cancer MTT/MTS assay 70-80% cytotoxic at 25 µM 24-h Breast None None NA NA
4542 22023734 2011 RWGKWFKKATHVGKHVGKAALTAYL NRC-07 25 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family SKBR-3 Breast Cancer MTT/MTS assay 80-85% cytotoxic at 50 µM 24-h Breast None None NA NA
4543 22023734 2011 RWGKWFKKATHVGKHVGKAALTAYL NRC-07 25 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family MDA-MB-468 Breast Cancer MTT/MTS assay 10% cytotoxic at 5 µM 24-h Breast None None NA NA
4544 22023734 2011 RWGKWFKKATHVGKHVGKAALTAYL NRC-07 25 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family MDA-MB-468 Breast Cancer MTT/MTS assay 50% cytotoxic at 10 µM 24-h Breast None None NA NA
4545 22023734 2011 RWGKWFKKATHVGKHVGKAALTAYL NRC-07 25 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family MDA-MB-468 Breast Cancer MTT/MTS assay 80% cytotoxic at 25 µM 24-h Breast None None NA NA
4546 22023734 2011 RWGKWFKKATHVGKHVGKAALTAYL NRC-07 25 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family MDA-MB-468 Breast Cancer MTT/MTS assay 80-90% cytotoxic at 50 µM 24-h Breast None None NA NA
4547 22023734 2011 RWGKWFKKATHVGKHVGKAALTAYL NRC-07 25 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family 4T1 Breast Cancer MTT/MTS assay 30-40% cytotoxic at 5 µM 24-h Breast None None NA NA
4548 22023734 2011 RWGKWFKKATHVGKHVGKAALTAYL NRC-07 25 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family 4T1 Breast Cancer MTT/MTS assay 60-70% cytotoxic at 10 µM 24-h Breast None None NA NA
4549 22023734 2011 RWGKWFKKATHVGKHVGKAALTAYL NRC-07 25 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family 4T1 Breast Cancer MTT/MTS assay 80-90% cytotoxic at 25 µM 24-h Breast None None NA NA
4550 22023734 2011 RWGKWFKKATHVGKHVGKAALTAYL NRC-07 25 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family 4T1 Breast Cancer MTT/MTS assay 85-90% cytotoxic at 50 µM 24-h Breast None None NA NA
4571 22023734 2011 RWGKWFKKATHVGKHVGKAALTAYL NRC-07 25 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family MCF-7 Breast Cancer MTT/MTS assay 70% cytotoxic at 50 µM 24-h Breast None None NA NA
4574 22023734 2011 RWGKWFKKATHVGKHVGKAALTAYL NRC-07 25 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family MCF-7-TX400 Breast Cancer MTT/MTS assay 60-70% cytotoxic at 50 µM 24-h Breast None None NA NA
4551 22023734 2011 GWRTLLKKAEVKTVGKLALKHYL NRC-13 23 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family MDA-MB-231 Breast Cancer MTT/MTS assay ~5% cytotoxic at 10 µM 24-h Breast None None NA NA
4552 22023734 2011 GWRTLLKKAEVKTVGKLALKHYL NRC-13 23 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family MDA-MB-231 Breast Cancer MTT/MTS assay 10% cytotoxic at 25 µM 24-h Breast None None NA NA
4553 22023734 2011 GWRTLLKKAEVKTVGKLALKHYL NRC-13 23 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family MDA-MB-231 Breast Cancer MTT/MTS assay 10-15% cytotoxic at 50 µM 24-h Breast None None NA NA
4554 22023734 2011 GWRTLLKKAEVKTVGKLALKHYL NRC-13 23 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family T-47D Breast Cancer MTT/MTS assay ~0% cytotoxic at 5 µM 24-h Breast None None NA NA
4555 22023734 2011 GWRTLLKKAEVKTVGKLALKHYL NRC-13 23 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family T-47D Breast Cancer MTT/MTS assay ~0% cytotoxic at 10 µM 24-h Breast None None NA NA
4556 22023734 2011 GWRTLLKKAEVKTVGKLALKHYL NRC-13 23 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family T-47D Breast Cancer MTT/MTS assay 10% cytotoxic at 25 µM 24-h Breast None None NA NA
4557 22023734 2011 GWRTLLKKAEVKTVGKLALKHYL NRC-13 23 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family T-47D Breast Cancer MTT/MTS assay 10-15% cytotoxic at 50 µM 24-h Breast None None NA NA
4558 22023734 2011 GWRTLLKKAEVKTVGKLALKHYL NRC-13 23 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family SKBR-3 Breast Cancer MTT/MTS assay 10% cytotoxic at 5 µM 24-h Breast None None NA NA
4559 22023734 2011 GWRTLLKKAEVKTVGKLALKHYL NRC-13 23 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family SKBR-3 Breast Cancer MTT/MTS assay 10% cytotoxic at 10 µM 24-h Breast None None NA NA
4560 22023734 2011 GWRTLLKKAEVKTVGKLALKHYL NRC-13 23 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family SKBR-3 Breast Cancer MTT/MTS assay 10-15% cytotoxic at 25 µM 24-h Breast None None NA NA
4561 22023734 2011 GWRTLLKKAEVKTVGKLALKHYL NRC-13 23 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family SKBR-3 Breast Cancer MTT/MTS assay 15-20% cytotoxic at 50 µM 24-h Breast None None NA NA
4562 22023734 2011 GWRTLLKKAEVKTVGKLALKHYL NRC-13 23 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family MDA-MB-468 Breast Cancer MTT/MTS assay ~5% cytotoxic at 5 µM 24-h Breast None None NA NA
4563 22023734 2011 GWRTLLKKAEVKTVGKLALKHYL NRC-13 23 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family MDA-MB-468 Breast Cancer MTT/MTS assay ~5% cytotoxic at 10 µM 24-h Breast None None NA NA
4564 22023734 2011 GWRTLLKKAEVKTVGKLALKHYL NRC-13 23 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family MDA-MB-468 Breast Cancer MTT/MTS assay 5% cytotoxic at 25 µM 24-h Breast None None NA NA
4565 22023734 2011 GWRTLLKKAEVKTVGKLALKHYL NRC-13 23 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family MDA-MB-468 Breast Cancer MTT/MTS assay 10-15% cytotoxic at 50 µM 24-h Breast None None NA NA
4566 22023734 2011 GWRTLLKKAEVKTVGKLALKHYL NRC-13 23 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family 4T1 Breast Cancer MTT/MTS assay ~0% cytotoxic at 5 µM 24-h Breast None None NA NA
4567 22023734 2011 GWRTLLKKAEVKTVGKLALKHYL NRC-13 23 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family 4T1 Breast Cancer MTT/MTS assay ~0% cytotoxic at 10 µM 24-h Breast None None NA NA
4568 22023734 2011 GWRTLLKKAEVKTVGKLALKHYL NRC-13 23 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family 4T1 Breast Cancer MTT/MTS assay 5-10% cytotoxic at 25 µM 24-h Breast None None NA NA
4569 22023734 2011 GWRTLLKKAEVKTVGKLALKHYL NRC-13 23 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family 4T1 Breast Cancer MTT/MTS assay 20% cytotoxic at 50 µM 24-h Breast None None NA NA
4572 22023734 2011 GWRTLLKKAEVKTVGKLALKHYL NRC-13 23 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family MCF-7 Breast Cancer MTT/MTS assay 0% cytotoxic at 50 µM 24-h Breast None None NA NA
4575 22023734 2011 GWRTLLKKAEVKTVGKLALKHYL NRC-13 23 Linear L None Amidation Biotinylated Antimicrobial Pleurocidin-family MCF-7-TX400 Breast Cancer MTT/MTS assay ~5% cytotoxic at 50 µM 24-h Breast None None NA NA
4576 21928125 2012 LIAHNQVRQV p85 10 Linear L None Free Free Antitumor Synthetic Peptide Not Available Tumor ELISPOT assay Not Available Not Available Not Available None None CCTTCSSSCC
4577 21928125 2012 GVGSPYVSRLLGICL p776 15 Linear L None Free Free Antitumor Synthetic Peptide Not Available Tumor ELISPOT assay Not Available Not Available Not Available None None CCSSGGGHHHHCCCC
4578 21423613 2011 PRFWEYWLRLME MIP 12 Linear L None Free Free Antitumor E3 ubiquitin-protein ligase HCT-116-p53+/+ Colon Cancer Immunoprecipitation assay IC50 =0.01 µM Not Available Colon None None CCTTCSSCSSCC
4588 21423613 2011 PRFWEYWLRLME MIP 12 Linear L None Free Free Antitumor E3 ubiquitin-protein ligase HCT-116-p53+/+ Colon Cancer Immunoprecipitation assay IC50 =0.12 µM Not Available Colon None None CCTTCSSCSSCC
4579 21423613 2011 LTFEHYWAQLTS DI 12 Linear L None Free Free Antitumor E3 ubiquitin-protein ligase HCT-116-p53+/+ Colon Cancer Immunoprecipitation assay IC50 =0.29 µM Not Available Colon None None CCHHHHHHTTCC
4589 21423613 2011 LTFEHYWAQLTS DI 12 Linear L None Free Free Antitumor E3 ubiquitin-protein ligase HCT-116-p53+/+ Colon Cancer Immunoprecipitation assay IC50 =1.6 µM Not Available Colon None None CCHHHHHHTTCC
4580 21423613 2011 LTAEHYAAQATS 3A 12 Linear L None Free Free Antitumor E3 ubiquitin-protein ligase HCT-116-p53+/+ Colon Cancer Immunoprecipitation assay IC50 >100 µM Not Available Colon None None CCHHHHHHHTTC
4590 21423613 2011 LTAEHYAAQATS 3A 12 Linear L None Free Free Antitumor E3 ubiquitin-protein ligase HCT-116-p53+/+ Colon Cancer Immunoprecipitation assay IC50 >100 µM Not Available Colon None None CCHHHHHHHTTC
4581 21423613 2011 QETFSDLWKLLP P5317-28 12 Linear L None Free Free Antitumor E3 ubiquitin-protein ligase HCT-116-p53+/+ Colon Cancer Immunoprecipitation assay IC50 =4.7 µM Not Available Colon None None CCCHHHHHHTCC
4591 21423613 2011 QETFSDLWKLLP P5317-28 12 Linear L None Free Free Antitumor E3 ubiquitin-protein ligase HCT-116-p53+/+ Colon Cancer Immunoprecipitation assay IC50 =30 µM Not Available Colon None None CCCHHHHHHTCC
1117 8319212 1993 GIGKFLKKAKKFAKAFVKIINN MSI-136 22 Linear L None Amidation Free Antibacterial African clawed frog Xenopus laevis skin A-549 Lung Cancer MTT/MTS assay IC50=10 µM 48-h Lung None None CTHHHHHHHTTTHHHHHHHHCC
1118 8319212 1993 gigkflkkakkfakafvkiinn MSI-238 22 Linear D None Amidation Free Antibacterial African clawed frog Xenopus laevis skin A-549 Lung Cancer MTT/MTS assay IC50=6 µM 48-h Lung None None CTHHHHHHHTHHHHHHHHHTCC
3495 22100226 2012 VNWKKILGKIIKVVK LL-III 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 4±1 µM 48-h Cervix None None CCHHHHHHHHHHHHC
3501 22100226 2012 VNWKKILGKIIKVVK LL-III/8 15 Linear L None Free Free Antimicrobial and Antifungal Lasioglossin III and its analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 12±1 µM 48-h Cervix None None CCHHHHHHHHTTTCC
3502 22100226 2012 VNWKKILGKIIKVVK LL-III/9 15 Linear L None Methoxylation Free Antimicrobial and Antifungal Lasioglossin III and its analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 3±1 µM 48-h Cervix None None NA NA
3505 22100226 2012 vnwkkilgkiikvvk LL-III/12 15 Linear D None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 6±2 µM 48-h Cervix None None CHHHHHHHHHHTTTC
3519 22100226 2012 VNWKKILGKIIKVVK LL-III/37 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs SW Colon Cancer MTT/MTS assay IC50 = 5±1 µM 48-h Colon None None CCHHHHHHHHHHHHC
3520 22100226 2012 VNWKKILGKIIKVVK LL-III 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs SW Colon Cancer MTT/MTS assay IC50 = 18±4 µM 48-h Colon None None CCHHHHHHHHHHHHC
3526 22100226 2012 VNWKKILGKIIKVVK LL-III/8 15 Linear L None Free Free Antimicrobial and Antifungal Lasioglossin III and its analogs SW Colon Cancer MTT/MTS assay Not tested 48-h Colon None None CCHHHHHHHHTTTCC
3527 22100226 2012 VNWKKILGKIIKVVK LL-III/9 15 Linear L None Methoxylation Free Antimicrobial and Antifungal Lasioglossin III and its analogs SW Colon Cancer MTT/MTS assay IC50 = 25± 5 µM 48-h Colon None None NA NA
3530 22100226 2012 vnwkkilgkiikvvk LL-III/12 15 Linear D None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs SW Colon Cancer MTT/MTS assay IC50 = 20 µM 48-h Colon None None CHHHHHHHHHHTTTC
3544 22100226 2012 VNWKKILGKIIKVVK LL-III/37 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs SW Colon Cancer MTT/MTS assay IC50 = 13 µM 48-h Colon None None CCHHHHHHHHHHHHC
3545 22100226 2012 VNWKKILGKIIKVVK LL-III 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 5±3 µM 48-h Blood None None CCHHHHHHHHHHHHC
3551 22100226 2012 VNWKKILGKIIKVVK LL-III/8 15 Linear L None Free Free Antimicrobial and Antifungal Lasioglossin III and its analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 9 µM 48-h Blood None None CCHHHHHHHHTTTCC
3552 22100226 2012 VNWKKILGKIIKVVK LL-III/9 15 Linear L None Methoxylation Free Antimicrobial and Antifungal Lasioglossin III and its analogs CCRF-CEM Leukemia Cancer MTT/MTS assay Not tested 48-h Blood None None NA NA
3555 22100226 2012 vnwkkilgkiikvvk LL-III/12 15 Linear D None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 5±2 µM 48-h Blood None None CHHHHHHHHHHTTTC
3569 22100226 2012 VNWKKILGKIIKVVK LL-III/37 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50= 4±1 µM 48-h Blood None None CCHHHHHHHHHHHHC
3512 22100226 2012 VNWKKLLGKLLKVVK LL-III/23 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 4 µM 48-h Cervix None None CCHHHHHHHHHTTCC
3514 22100226 2012 vnwkkllgkllkvvk LL-III/25 15 Linear D None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 4±2 µM 48-h Cervix None None CHHHHHHHHHHHTTC
3537 22100226 2012 VNWKKLLGKLLKVVK LL-III/23 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs SW Colon Cancer MTT/MTS assay IC50 = 15 µM 48-h Colon None None CCHHHHHHHHHTTCC
3539 22100226 2012 vnwkkllgkllkvvk LL-III/25 15 Linear D None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs SW Colon Cancer MTT/MTS assay IC50 = 20 µM 48-h Colon None None CHHHHHHHHHHHTTC
3562 22100226 2012 VNWKKLLGKLLKVVK LL-III/23 15 Linear L None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 6 µM 48-h Blood None None CCHHHHHHHHHTTCC
3564 22100226 2012 vnwkkllgkllkvvk LL-III/25 15 Linear D None Amidation Free Antimicrobial and Antifungal Lasioglossin III and its analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 4 µM 48-h Blood None None CHHHHHHHHHHHTTC
3586 22100226 2012 GFGMALKLLKKVL MAC1 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 10±4 µM 48-h Cervix None None CCSTTHHHHTTTC
3588 22100226 2012 gfgmalkllkkvl MAC1/1 13 Linear D None Amidation Free Antimicrobial and Antifungal Macropins and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 12±4 µM 48-h Cervix None None CCSHHHHHHHHHC
3591 22100226 2012 GFGMALKLLKKVL MAC1/4 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 15±5 µM 48-h Cervix None None CCSTTHHHHTTTC
3592 22100226 2012 GFGMALKLLKKVL MAC1/6 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 8±2 µM 48-h Cervix None None CCSTTHHHHTTTC
3595 22100226 2012 GFGMALKLLKKVL MAC1/16 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 32±2 µM 48-h Cervix None None CCSTTHHHHTTTC
3596 22100226 2012 GFGMALKLLKKVL MAC1/19 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 21±4 µM 48-h Cervix None None CCSTTHHHHTTTC
3602 22100226 2012 GFGMALKLLKKVL MAC1 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs SW Colon Cancer MTT/MTS assay IC50 = 23±4 µM 48-h Colon None None CCSTTHHHHTTTC
3604 22100226 2012 gfgmalkllkkvl MAC1/1 13 Linear D None Amidation Free Antimicrobial and Antifungal Macropins and their analogs SW Colon Cancer MTT/MTS assay IC50 = 19±2 µM 48-h Colon None None CCSHHHHHHHHHC
3607 22100226 2012 GFGMALKLLKKVL MAC1/4 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs SW Colon Cancer MTT/MTS assay IC50 = 49±9 µM 48-h Colon None None CCSTTHHHHTTTC
3608 22100226 2012 GFGMALKLLKKVL MAC1/6 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs SW Colon Cancer MTT/MTS assay IC50 = 29±3 µM 48-h Colon None None CCSTTHHHHTTTC
3611 22100226 2012 GFGMALKLLKKVL MAC1/16 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs SW Colon Cancer MTT/MTS assay IC50 > 100 µM 48-h Colon None None CCSTTHHHHTTTC
3612 22100226 2012 GFGMALKLLKKVL MAC1/19 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs SW Colon Cancer MTT/MTS assay IC50 = 68±2 µM 48-h Colon None None CCSTTHHHHTTTC
3618 22100226 2012 GFGMALKLLKKVL MAC1 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 12±6 µM 48-h Blood None None CCSTTHHHHTTTC
3620 22100226 2012 gfgmalkllkkvl MAC1/1 13 Linear D None Amidation Free Antimicrobial and Antifungal Macropins and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 11 µM 48-h Blood None None CCSHHHHHHHHHC
3623 22100226 2012 GFGMALKLLKKVL MAC1/4 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 29 µM 48-h Blood None None CCSTTHHHHTTTC
3624 22100226 2012 GFGMALKLLKKVL MAC1/6 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 15 µM 48-h Blood None None CCSTTHHHHTTTC
3627 22100226 2012 GFGMALKLLKKVL MAC1/16 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 70 µM 48-h Blood None None CCSTTHHHHTTTC
3628 22100226 2012 GFGMALKLLKKVL MAC1/19 13 Linear L None Amidation Free Antimicrobial and Antifungal Macropins and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 43±11 µM 48-h Blood None None CCSTTHHHHTTTC
4387 22100226, 18957441 2012 GFGMALKLLKKVL Macropin 1 13 Not Available L None Free Free Antibacterial Venom, the solitary beeMacropis fulvipes Not Available Not Available Not Available Not Available Not Available Not Available 18957441 None CCSHHHHHHHTTC
3634 22100226 2012 GMWSKILGHLIR HAL-1 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 11±2 µM 48-h Cervix None None CCGGGTTTTTCC
3635 22100226 2012 gmwskilghlir HAL-1/22 12 Linear D None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 15±3 µM 48-h Cervix None None CCHHHHTCCCCC
3647 22100226 2012 GMWSKILGHLIR HAL-1/29 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 > 100 µM 48-h Cervix None None CCGGGTTTTTCC
3662 22100226 2012 GMWSKILGHLIR HAL-1 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay IC50 = 44±8 µM 48-h Colon None None CCGGGTTTTTCC
3663 22100226 2012 gmwskilghlir HAL-1/22 12 Linear D None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay IC50 > 40 µM 48-h Colon None None CCHHHHTCCCCC
3675 22100226 2012 GMWSKILGHLIR HAL-1/29 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay Not tested 48-h Colon None None CCGGGTTTTTCC
3690 22100226 2012 GMWSKILGHLIR HAL-1 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 49±9 µM 48-h Blood None None CCGGGTTTTTCC
3691 22100226 2012 gmwskilghlir HAL-1/22 12 Linear D None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay Not tested 48-h Blood None None CCHHHHTCCCCC
3703 22100226 2012 GMWSKILGHLIR HAL-1/29 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay Not tested 48-h Blood None None CCGGGTTTTTCC
4402 20198492, 18957441 2010 GMWSKILGHLIR Halictine 1 12 Not Available L None Free Free Anticancer venom, the eusocial bee, Halictus sexcinctus Not Available Not Available Not Available Not Available Not Available Not Available 18957441 None CCHHHHTTTTCC
3649 22100226 2012 GKWMSLLKHILK HAL-2 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 12±1 µM 48-h Cervix None None CTHHHHHHHHCC
3650 22100226 2012 gkwmsllkhilk HAL-2/22 12 Linear D None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 12 µM 48-h Cervix None None CCSHHHHHTTCC
3654 22100226 2012 GKWMSLLKHILK HAL-2/8 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs HeLa Cervical Cancer MTT/MTS assay IC50 = 15±3 µM 48-h Cervix None None CTHHHHHHHHCC
3677 22100226 2012 GKWMSLLKHILK HAL-2 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay IC50 = 35±3 µM 48-h Colon None None CTHHHHHHHHCC
3678 22100226 2012 gkwmsllkhilk HAL-2/22 12 Linear D None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay IC50 > 100 µM 48-h Colon None None CCSHHHHHTTCC
3682 22100226 2012 GKWMSLLKHILK HAL-2/8 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs SW Colon Cancer MTT/MTS assay IC50 > 40 µM 48-h Colon None None CTHHHHHHHHCC
3705 22100226 2012 GKWMSLLKHILK HAL-2 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay IC50 = 34 µM 48-h Blood None None CTHHHHHHHHCC
3706 22100226 2012 gkwmsllkhilk HAL-2/22 12 Linear D None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay Not tested 48-h Blood None None CCSHHHHHTTCC
3710 22100226 2012 GKWMSLLKHILK HAL-2/8 12 Linear L None Amidation Free Antimicrobial and Antifungal Halictines and their analogs CCRF-CEM Leukemia Cancer MTT/MTS assay Not tested 48-h Blood None None CTHHHHHHHHCC
4403 20198492, 18957441 2010 GKWMSLLKHILK Halictine 2 12 Not Available L None Free Free Anticancer Venom, the eusocial bee, Halictus sexcinctus Not Available Not Available Not Available Not Available Not Available Not Available 18957441 None CHHHHHHTTTCC
1421 10455241, 21403917 2009 GLFDVIKKVASVIGGL Citropin1.1 16 Linear L None Amidation Free Antibacterial Australian blue mountains tree frog, Litoria citropa U-937 Lymphoma Cancer MTT/MTS assay 60% Cytotoxicity at 0.5 µg/ml 6-h Blood 21403917 None CHHHHHHHHHTTTSCC
1422 10504394, 21403917 2009 GLFDVIKKVASVIGGL Citropin1.1 16 Linear L None Amidation Free Antibacterial Australian blue mountains tree frog, Litoria citropa U-937 Lymphoma Cancer MTT/MTS assay 60% Cytotoxicity at 0.5 µg/ml 6-h Blood 21403917 None CHHHHHHHHHTTTSCC
4030 12631273, 9266696 2003 GLFDVIKKVASVIGGL Citropin 1.1 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Leukemia tumor cellline Leukemia Cancer Sulforhodamine B assay IC50= 5 M Not Available Blood 9266696 None CHHHHHHHHHTTTSCC
4031 12631273, 9266696 2003 GLFDVIKKVASVIGGL Citropin 1.1 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Lung tumor cellline Lung Cancer Sulforhodamine B assay IC50= 5 M Not Available Lung 9266696 None CHHHHHHHHHTTTSCC
4032 12631273, 9266696 2003 GLFDVIKKVASVIGGL Citropin 1.1 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Colon tumor cellline Colon Cancer Sulforhodamine B assay IC50= 5 M Not Available Colon 9266696 None CHHHHHHHHHTTTSCC
4033 12631273, 9266696 2003 GLFDVIKKVASVIGGL Citropin 1.1 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Brain tumor cellline Brain Tumor Sulforhodamine B assay IC50= 5 M Not Available Brain 9266696 None CHHHHHHHHHTTTSCC
4034 12631273, 9266696 2003 GLFDVIKKVASVIGGL Citropin 1.1 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Skin tumor cellline Skin Cancer Sulforhodamine B assay IC50= 5 M Not Available Skin 9266696 None CHHHHHHHHHTTTSCC
4035 12631273, 9266696 2003 GLFDVIKKVASVIGGL Citropin 1.1 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Ovary tumor cellline Ovarian Cancer Sulforhodamine B assay IC50= 5 M Not Available Ovary 9266696 None CHHHHHHHHHTTTSCC
4036 12631273, 9266696 2003 GLFDVIKKVASVIGGL Citropin 1.1 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Liver tumor celline Liver Cancer Sulforhodamine B assay IC50= 5 M Not Available Liver 9266696 None CHHHHHHHHHTTTSCC
4037 12631273, 9266696 2003 GLFDVIKKVASVIGGL Citropin 1.1 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Prostate tumor cellline Prostate Cancer Sulforhodamine B assay IC50= 5 M Not Available Prostate 9266696 None CHHHHHHHHHTTTSCC
4038 12631273, 9266696 2003 GLFDVIKKVASVIGGL Citropin 1.1 16 Linear L None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Breast tumor cellline Breast Cancer Sulforhodamine B assay IC50= 5 M Not Available Breast 9266696 None CHHHHHHHHHTTTSCC
4039 12631273, 9266696 2003 glfdvikkvasviggl Citropin 1.1D 16 Linear D None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Leukemia tumor cellline Leukemia Cancer Sulforhodamine B assay IC50= 5 M Not Available Blood 9266696 None CHHHHHHHHHHGGGTC
4040 12631273, 9266696 2003 glfdvikkvasviggl Citropin 1.1D 16 Linear D None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Lung tumor cellline Lung Cancer Sulforhodamine B assay IC50= 5 M Not Available Lung 9266696 None CHHHHHHHHHHGGGTC
4041 12631273, 9266696 2003 glfdvikkvasviggl Citropin 1.1D 16 Linear D None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Colon tumor cellline Colon Cancer Sulforhodamine B assay IC50= 5 M Not Available Colon 9266696 None CHHHHHHHHHHGGGTC
4042 12631273, 9266696 2003 glfdvikkvasviggl Citropin 1.1D 16 Linear D None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Brain tumor cellline Brain Tumor Sulforhodamine B assay IC50= 5 M Not Available Brain 9266696 None CHHHHHHHHHHGGGTC
4043 12631273, 9266696 2003 glfdvikkvasviggl Citropin 1.1D 16 Linear D None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Skin tumor cellline Skin Cancer Sulforhodamine B assay IC50= 5 M Not Available Skin 9266696 None CHHHHHHHHHHGGGTC
4044 12631273, 9266696 2003 glfdvikkvasviggl Citropin 1.1D 16 Linear D None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Ovary tumor cellline Ovarian Cancer Sulforhodamine B assay IC50= 5 M Not Available Ovary 9266696 None CHHHHHHHHHHGGGTC
4045 12631273, 9266696 2003 glfdvikkvasviggl Citropin 1.1D 16 Linear D None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Liver tumor celline Liver Cancer Sulforhodamine B assay IC50= 5 M Not Available Liver 9266696 None CHHHHHHHHHHGGGTC
4046 12631273, 9266696 2003 glfdvikkvasviggl Citropin 1.1D 16 Linear D None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Prostate tumor cellline Prostate Cancer Sulforhodamine B assay IC50= 5 M Not Available Prostate 9266696 None CHHHHHHHHHHGGGTC
4047 12631273, 9266696 2003 glfdvikkvasviggl Citropin 1.1D 16 Linear D None Amidation Free Antimicrobial and Anticancer Amphibian skin secretions Breast tumor cellline Breast Cancer Sulforhodamine B assay IC50= 5 M Not Available Breast 9266696 None CHHHHHHHHHHGGGTC
4593 21403917 2011 GLFDVIKKVASVIGGL Citropin 1.1 16 Linear L None Amidation Free Antimicrobial Australian blue mountains tree frog, Litoria citropa U-938 Lymphoma Cancer MTT/MTS assay IC50 =40 µg/ml Not Available Blood None None CHHHHHHHHHTTTSCC
1441 12646578 2003 KLlRLLkkLlRLlLK l3,10,13K7,8K4R2L9 15 Linear Mix None Free Free Antibacterial Diastereomeric peptide B16-F10 Skin Cancer XTT assay LC50 = 2.5 µM 24-h Skin None None CHHHHHHHHHHHHTC
1443 12646578 2003 KLlRLLkkLlRLlLK l3,10,13K7,8K4R2L9 15 Linear Mix None Free Free Antibacterial Diastereomeric peptide D-122 Lung Cancer XTT assay LC50= 4.5 µM 24-h Lung None None CHHHHHHHHHHHHTC
1442 12646578 2003 KlllKLKlKlLK l3,4,8,10K5L7 12 Linear Mix None Free Free Antibacterial Diastereomeric peptide B16-F10 Skin Cancer XTT assay LC50 = 100 µM 24-h Skin None None CTTTTCTTSTTC
1444 12646578 2003 KLllKLKlKlLK l3,4,8,10K5L7 12 Linear Mix None Free Free Antibacterial Diastereomeric peptide D-122 Lung Cancer XTT assay LC50 = >50 µM 24-h Lung None None CCCSSCTTSSCC
1442 12646578 2003 KlllKLKlKlLK l3,4,8,10K5L7 12 Linear Mix None Free Free Antibacterial Diastereomeric peptide B16-F10 Skin Cancer XTT assay LC50 = 100 µM 24-h Skin None None CTTTTCTTSTTC
1444 12646578 2003 KLllKLKlKlLK l3,4,8,10K5L7 12 Linear Mix None Free Free Antibacterial Diastereomeric peptide D-122 Lung Cancer XTT assay LC50 = >50 µM 24-h Lung None None CCCSSCTTSSCC
1527 16637646 2006 FKRIVQRIKDFLRNLV LL-37(17-32)b 16 Linear L None Free Free Antibacterial LL-37,a series of peptide fragments KBv Tumor MTT/MTS assay LC50=30 µM 24-h Not Available None None CGGGHHHHHHHGGGTC
1530 16637646 2006 FKRiVQRiKDFlRNLV dLL-37(17-32)c 16 Linear Mix None Free Free Antibacterial LL-37,a series of peptide fragments KBv Tumor MTT/MTS assay Not Available 24-h Not Available None None CGGGHHHHHHHGGGCC
1533 16637646 2006 FKRIVQRIKDFLRNLV LL-37(17-32)b 16 Linear L None Free Free Antibacterial LL-37,a series of peptide fragments KB Oral Cancer MTT/MTS assay LC50=30 µM 24-h Not Available None None CGGGHHHHHHHGGGTC
1536 16637646 2006 FKRIVQRIKDFLRNLV dLL-37(17-32)c 16 Linear L None Free Free Antibacterial LL-37,a series of peptide fragments KB Oral Cancer MTT/MTS assay Not Available 24-h Not Available None None CGGGHHHHHHHGGGTC
1539 16637646 2006 FKRIVQRIKDFLRNLV LL-37(17-32)b 16 Linear L None Free Free Antibacterial LL-37,a series of peptide fragments HBMEC Prostate Cancer MTT/MTS assay LC50=25 µM 24-h Not Available None None CGGGHHHHHHHGGGTC
1542 16637646 2006 FKRIVQRIKDFLRNLV dLL-37(17-32)c 16 Linear L None Free Free Antibacterial LL-37,a series of peptide fragments HBMEC Prostate Cancer MTT/MTS assay Not Available 24-h Not Available None None CGGGHHHHHHHGGGTC
1773 None 2005 FALALKALKKALKKLKKALKKAL Hecate Ac 23 Linear L None Free Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =54 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHGGGTTTHHHHHGGGTC
1774 None 2005 FALALKALKKALKKLKKALKKAL Hecate AM 23 Linear L None Amidation Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =23 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHHTTHHHHHHTTTC
1789 None 2005 FALALKALKKALkkLKKALKKAL HECATE 2DAc 23 Linear Mix None Free Free Anticancer FLAK peptides MCF-7 Breast Cancer MTT/MTS assay LD50 =14 µg/ml 24-h Breast None US_06875744_B2 CHHHHHHHHHSSCGGGGTCTTTC
1925 None 2005 FALALKALKKALKKLKKALKKAL Hecate AC 23 Linear L None Free Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =6 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHGGGTTTHHHHHGGGTC
1926 None 2005 FALALKALKKALKKLKKALKKAL Hecate AM 23 Linear L None Amidation Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =46 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHHTTHHHHHHTTTC
1941 None 2005 FALALKALKKALkkLKKALKKAL HECATE 2DAc 23 Linear Mix None Free Free Anticancer FLAK peptides SW-480 Colon Cancer MTT/MTS assay LD50 =57 µg/ml 24-h Colon None US_06875744_B2 CHHHHHHHHHSSCGGGGTCTTTC
2077 None 2005 FALALKALKKALKKLKKALKKAL Hecate AC 23 Linear L None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =72 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHGGGTTTHHHHHGGGTC
2078 None 2005 FALALKALKKALKKLKKALKKAL Hecate AM 23 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =128 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHTTHHHHHHTTTC
2093 None 2005 FALALKALKKALkkLKKALKKAL HECATE 2DAc 23 Linear Mix None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =150 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHSSCGGGGTCTTTC
2229 None 2005 FALALKALKKALKKLKKALKKAL Hecate AC 23 Linear L None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =72 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHGGGTTTHHHHHGGGTC
2230 None 2005 FALALKALKKALKKLKKALKKAL Hecate AM 23 Linear L None Amidation Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =128 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHHTTHHHHHHTTTC
2245 None 2005 FALALKALKKALkkLKKALKKAL HECATE 2DAc 23 Linear Mix None Free Free Anticancer FLAK peptides BMKC Skin Cancer MTT/MTS assay LD50 =150 µg/ml 24-h Skin None US_06875744_B2 CHHHHHHHHHSSCGGGGTCTTTC
2381 None 2005 FALALKALKKALKKLKKALKKAL Hecate AC 23 Linear L None Free Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =44 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHGGGTTTHHHHHGGGTC
2382 None 2005 FALALKALKKALKKLKKALKKAL Hecate AM 23 Linear L None Amidation Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =140 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHHTTHHHHHHTTTC
2397 None 2005 FALALKALKKALkkLKKALKKAL HECATE 2DAc 23 Linear Mix None Free Free Anticancer FLAK peptides H-1299 Lung Cancer MTT/MTS assay LD50 =150 µg/ml 24-h Lung None US_06875744_B2 CHHHHHHHHHSSCGGGGTCTTTC
2524 None 2005 FALALKALKKALKKLKKALKKAL Hecate AC 23 Linear L None Free Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =61 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHGGGTTTHHHHHGGGTC
2525 None 2005 FALALKALKKALKKLKKALKKAL Hecate AM 23 Linear L None Amidation Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =44 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHHTTHHHHHHTTTC
2540 None 2005 FALALKALKKALkkLKKALKKAL HECATE 2DAc 23 Linear Mix None Free Free Anticancer FLAK peptides PC-3 Prostate Cancer MTT/MTS assay LD50 =64 µg/ml 24-h Prostate None US_06875744_B2 CHHHHHHHHHSSCGGGGTCTTTC
2667 None 2005 FALALKALKKALKKLKKALKKAL Hecate AC 23 Linear L None Free Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =95 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHGGGTTTHHHHHGGGTC
2668 None 2005 FALALKALKKALKKLKKALKKAL Hecate AM 23 Linear L None Amidation Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay LD50 =50 µg/ml 24-h Cervix None US_06875744_B2 CHHHHHHHHHHTTHHHHHHTTTC
2683 None 2005 FALALKALKKALkkLKKALKKAL HECATE 2DAc 23 Linear Mix None Free Free Anticancer FLAK peptides HeLa Cervical Cancer MTT/MTS assay Not Available 24-h Cervix None US_06875744_B2 CHHHHHHHHHSSCGGGGTCTTTC
2855 22084165 2011 KLlLKlLkkLLKlLKKK Lytik 17 Linear Mix None Free Free Anticancer Interleukin-4 receptor a (IL-4Ra) chain BXPC-3 Pancreatic Cancer WST-1 assay IC50=37.1 µMol/L 24-h Pancreatic None None CTHHHHHHHHHHHHHHC
2856 22084165 2011 KLlLKlLkkLLKlLKKK Lytik 17 Linear Mix None Free Free Anticancer Interleukin-4 receptor a (IL-4Ra) chain SU.86.86 Pancreatic Cancer WST-1 assay IC50=28.0 µMol/L 24-h Pancreatic None None CTHHHHHHHHHHHHHHC
2857 22084165 2011 KLlLKlLkkLLKlLKKK Lytik 17 Linear Mix None Free Free Anticancer Bovine lactoferrin (Lf-B) KB Oral Cancer WST-1 assay IC50=37.4 µMol/L 24-h Oral mucosa None None CTHHHHHHHHHHHHHHC
2858 22084165 2011 KLlLKlLkkLLKlLKKK Lytik 17 Linear Mix None Free Free Anticancer Interleukin-4 receptor a (IL-4Ra) chain T98G Brain Tumor WST-1 assay IC50=77.3 µMol/L 24-h Brain None None CTHHHHHHHHHHHHHHC
2859 22084165 2011 KLlLKlLkkLLKlLKKK Lytik 17 Linear Mix None Free Free Anticancer Interleukin-4 receptor a (IL-4Ra) chain A-172 Brain Tumor WST-1 assay IC50=30.5 µMol/L 24-h Brain None None CTHHHHHHHHHHHHHHC
2860 22084165 2011 KLlLKlLkkLLKlLKKK Lytik 17 Linear Mix None Free Free Anticancer Interleukin-4 receptor a (IL-4Ra) chain H-322 Lung Cancer WST-1 assay IC50=27.1 µMol/L 24-h Lung None None CTHHHHHHHHHHHHHHC
2861 22084165 2011 KLlLKlLkkLLKlLKKK Lytik 17 Linear Mix None Free Free Anticancer Interleukin-4 receptor a (IL-4Ra) chain MDA-MB-231 Breast Cancer WST-1 assay IC50=18.5 µMol/L 24-h Breast None None CTHHHHHHHHHHHHHHC
2901 21849092 2011 KLlLKlLkkLLKlLKKK Lytik 17 Linear Mix None Free Free Anticancer Transferrin receptor (TfR) BT-474 Breast Cancer WST-1 assay IC50= 34.5 µM 72-h Breast None None CTHHHHHHHHHHHHHHC
2902 21849092 2011 KLlLKlLkkLLKlLKKK Lytik 17 Linear Mix None Free Free Anticancer Transferrin receptor (TfR) T-47D Breast Cancer WST-1 assay IC50= 14.1 µM 72-h Breast None None CTHHHHHHHHHHHHHHC
2903 21849092 2011 KLlLKlLkkLLKlLKKK Lytik 17 Linear Mix None Free Free Anticancer Transferrin receptor (TfR) SK-BR-3 Breast Cancer WST-1 assay IC50= 25.7 µM 72-h Breast None None CTHHHHHHHHHHHHHHC
2904 21849092 2011 KLlLKlLkkLLKlLKKK Lytik 17 Linear Mix None Free Free Anticancer Transferrin receptor (TfR) MDA-MB-231 Breast Cancer WST-1 assay IC50= 27.0 µM 72-h Breast None None CTHHHHHHHHHHHHHHC
2905 21849092 2011 KLlLKlLkkLLKlLKKK Lytik 17 Linear Mix None Free Free Anticancer Transferrin receptor (TfR) BT-20 Breast Cancer WST-1 assay IC50= 20.0 µM 72-h Breast None None CTHHHHHHHHHHHHHHC
2906 21849092 2011 KLlLKlLkkLLKlLKKK Lytik 17 Linear Mix None Free Free Anticancer Transferrin receptor (TfR) ZR75-1 Breast Cancer WST-1 assay IC50= 19.4 µM 72-h Breast None None CTHHHHHHHHHHHHHHC
2907 21849092 2011 KLlLKlLkkLLKlLKKK Lytik 17 Linear Mix None Free Free Anticancer Transferrin receptor (TfR) SF-295 Brain Tumor WST-1 assay IC50= 19.1 µM 72-h Brain None None CTHHHHHHHHHHHHHHC
2908 21849092 2011 KLlLKlLkkLLKlLKKK Lytik 17 Linear Mix None Free Free Anticancer Transferrin receptor (TfR) SN-19 Brain Tumor WST-1 assay IC50= 21.9 µM 72-h Brain None None CTHHHHHHHHHHHHHHC
2909 21849092 2011 KLlLKlLkkLLKlLKKK Lytik 17 Linear Mix None Free Free Anticancer Transferrin receptor (TfR) U-251 Brain Tumor WST-1 assay IC50= 17.0 µM 72-h Brain None None CTHHHHHHHHHHHHHHC
2910 21849092 2011 KLlLKlLkkLLKlLKKK Lytik 17 Linear Mix None Free Free Anticancer Transferrin receptor (TfR) HuCCT-1 Human epithelial Cancer WST-1 assay IC50= 17.1 µM 72-h Bileduct None None CTHHHHHHHHHHHHHHC
2911 21849092 2011 KLlLKlLkkLLKlLKKK Lytik 17 Linear Mix None Free Free Anticancer Transferrin receptor (TfR) LNCaP Prostate Cancer WST-1 assay IC50= 15.8 µM 72-h Prostate None None CTHHHHHHHHHHHHHHC
2912 21849092 2011 KLlLKlLkkLLKlLKKK Lytik 17 Linear Mix None Free Free Anticancer Transferrin receptor (TfR) COLO-587 Human epithelial Cancer WST-1 assay IC50= 13.5 µM 72-h Pancreatic None None CTHHHHHHHHHHHHHHC
2862 22084165 2011 KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK IL-4RaÐlytic hybrid peptide 33 Linear Mix None Free Free Anticancer Interleukin-4 receptor a (IL-4Ra) chain BXPC-3 Pancreatic Cancer WST-1 assay IC50=6.8 µMol/L 24-h Pancreatic None None CTTHHHHTTTCSSGGGHHHHHHHHHHHHHHTTC
2863 22084165 2011 KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK IL-4RaÐlytic hybrid peptide 33 Linear Mix None Free Free Anticancer Interleukin-4 receptor a (IL-4Ra) chain SU.86.86 Pancreatic Cancer WST-1 assay IC50=7.5 µMol/L 24-h Pancreatic None None CTTHHHHTTTCSSGGGHHHHHHHHHHHHHHTTC
2864 22084165 2011 KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK IL-4RaÐlytic hybrid peptide 33 Linear Mix None Free Free Anticancer Bovine lactoferrin (Lf-B) KB Oral Cancer WST-1 assay IC50=13.2 µMol/L 24-h Oral mucosa None None CTTHHHHTTTCSSGGGHHHHHHHHHHHHHHTTC
2865 22084165 2011 KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK IL-4RaÐlytic hybrid peptide 33 Linear Mix None Free Free Anticancer Interleukin-4 receptor a (IL-4Ra) chain T98G Brain Tumor WST-1 assay IC50=18.5 µMol/L 24-h Brain None None CTTHHHHTTTCSSGGGHHHHHHHHHHHHHHTTC
2866 22084165 2011 KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK IL-4RaÐlytic hybrid peptide 33 Linear Mix None Free Free Anticancer Interleukin-4 receptor a (IL-4Ra) chain A-172 Brain Tumor WST-1 assay IC50=6.8 µMol/L 24-h Brain None None CTTHHHHTTTCSSGGGHHHHHHHHHHHHHHTTC
2867 22084165 2011 KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK IL-4RaÐlytic hybrid peptide 33 Linear Mix None Free Free Anticancer Interleukin-4 receptor a (IL-4Ra) chain H-322 Lung Cancer WST-1 assay IC50=3.6 µMol/L 24-h Lung None None CTTHHHHTTTCSSGGGHHHHHHHHHHHHHHTTC
2868 22084165 2011 KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK IL-4RaÐlytic hybrid peptide 33 Linear Mix None Free Free Anticancer Interleukin-4 receptor a (IL-4Ra) chain MDA-MB-231 Breast Cancer WST-1 assay IC50=5.7 µMol/L 24-h Breast None None CTTHHHHTTTCSSGGGHHHHHHHHHHHHHHTTC
2869 16707464 2006 LKlLKKLlkKLLkLL D-K6L9 15 Linear Mix None Amidation Free Anticancer Host Defense lytic Peptide 22RV1 Prostate Cancer Enzyme Immunoassay (EIA) LC50=6 µMol/L Not Available Prostate None None CTTHHHHHHHHHTTC
2870 16707464 2006 LKlLKKLlkKLLkLL D-K6L9 15 Linear Mix None Amidation Free Anticancer Host DefenseÐLike Lytic Peptide CL-1 Lung Cancer Enzyme Immunoassay (EIA) LC50=3 µMol/L Not Available Lung None None CTTHHHHHHHHHTTC
2871 16707464 2006 LKlLKKLlkKLLkLL D-K6L9 15 Linear Mix None Amidation Free Anticancer Host Defense lytic Peptide MB-231 Prostate Cancer Enzyme Immunoassay (EIA) LC50=3 µMol/L 960-h Prostate None None CTTHHHHHHHHHTTC
2913 21849092 2011 THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK Transferrin receptor (TfR)-lytic hybrid peptide 32 Linear Mix None Free Free Anticancer Transferrin receptor (TfR) BT-474 Breast Cancer WST-1 assay IC50= 8.8 µM 72-h Breast None None CCSSSSSCSSCCCTHHHHHHHHHHHHHHHHHC
2914 21849092 2011 THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK Transferrin receptor (TfR)-lytic hybrid peptide 32 Linear Mix None Free Free Anticancer Transferrin receptor (TfR) T-47D Breast Cancer WST-1 assay IC50= 4.0 µM 72-h Breast None None CCSSSSSCSSCCCTHHHHHHHHHHHHHHHHHC
2915 21849092 2011 THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK Transferrin receptor (TfR)-lytic hybrid peptide 32 Linear Mix None Free Free Anticancer Transferrin receptor (TfR) SK-BR-3 Breast Cancer WST-1 assay IC50= 6.5 µM 72-h Breast None None CCSSSSSCSSCCCTHHHHHHHHHHHHHHHHHC
2916 21849092 2011 THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK Transferrin receptor (TfR)-lytic hybrid peptide 32 Linear Mix None Free Free Anticancer Transferrin receptor (TfR) MDA-MB-231 Breast Cancer WST-1 assay IC50= 7.8 µM 72-h Breast None None CCSSSSSCSSCCCTHHHHHHHHHHHHHHHHHC
2917 21849092 2011 THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK Transferrin receptor (TfR)-lytic hybrid peptide 32 Linear Mix None Free Free Anticancer Transferrin receptor (TfR) BT-20 Breast Cancer WST-1 assay IC50= 4.8 µM 72-h Breast None None CCSSSSSCSSCCCTHHHHHHHHHHHHHHHHHC
2918 21849092 2011 THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK Transferrin receptor (TfR)-lytic hybrid peptide 32 Linear Mix None Free Free Anticancer Transferrin receptor (TfR) ZR75-1 Breast Cancer WST-1 assay IC50= 9.3 µM 72-h Breast None None CCSSSSSCSSCCCTHHHHHHHHHHHHHHHHHC
2919 21849092 2011 THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK Transferrin receptor (TfR)-lytic hybrid peptide 32 Linear Mix None Free Free Anticancer Transferrin receptor (TfR) SF-295 Brain Tumor WST-1 assay IC50= 6.3 µM 72-h Brain None None CCSSSSSCSSCCCTHHHHHHHHHHHHHHHHHC
2920 21849092 2011 THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK Transferrin receptor (TfR)-lytic hybrid peptide 32 Linear Mix None Free Free Anticancer Transferrin receptor (TfR) SN-19 Brain Tumor WST-1 assay IC50= 7.8 µM 72-h Brain None None CCSSSSSCSSCCCTHHHHHHHHHHHHHHHHHC
2921 21849092 2011 THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK Transferrin receptor (TfR)-lytic hybrid peptide 32 Linear Mix None Free Free Anticancer Transferrin receptor (TfR) U-251 Brain Tumor WST-1 assay IC50=7.0 µM 72-h Brain None None CCSSSSSCSSCCCTHHHHHHHHHHHHHHHHHC
2922 21849092 2011 THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK Transferrin receptor (TfR)-lytic hybrid peptide 32 Linear Mix None Free Free Anticancer Transferrin receptor (TfR) HuCCT-1 Human epithelial Cancer WST-1 assay IC50= 8.3 µM 72-h Bileduct None None CCSSSSSCSSCCCTHHHHHHHHHHHHHHHHHC
2923 21849092 2011 THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK Transferrin receptor (TfR)-lytic hybrid peptide 32 Linear Mix None Free Free Anticancer Transferrin receptor (TfR) LNCaP Prostate Cancer WST-1 assay IC50= 6.2 µM 72-h Prostate None None CCSSSSSCSSCCCTHHHHHHHHHHHHHHHHHC
2924 21849092 2011 THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK Transferrin receptor (TfR)-lytic hybrid peptide 32 Linear Mix None Free Free Anticancer Transferrin receptor (TfR) COLO-587 Human epithelial Cancer WST-1 assay IC50=6.4 µM 72-h Pancreatic None None CCSSSSSCSSCCCTHHHHHHHHHHHHHHHHHC
3206 22413859 2012 KVKVKVKVpPTKVKVKVK SVS-1 18 Linear Mix None Amidation Free Antimicrobial Synthetic peptide A-549 Lung Cancer MTT/MTS assay NA 24-h Lung None None CCSCCCCSSCSSCCCSCC
3207 22413859 2012 KVKVKVKVpPTKVKVKVK SVS-1 18 Linear Mix None Amidation Free Antimicrobial Bovine lactoferrin (Lf-B) KB Oral Cancer MTT/MTS assay NA 24-h Oral mucosa None None CCSCCCCSSCSSCCCSCC
3216 22413859 2012 KVKVKVKVpPTKVKVKVK SVS-1 18 Linear Mix None Amidation Free Antimicrobial Synthetic peptide MCF-7 Breast Cancer MTT/MTS assay IC50 =8.1±0.8 µM 24-h Breast None None CCSCCCCSSCSSCCCSCC
3217 22413859 2012 KVKVKVKVpPTKVKVKVK SVS-1 18 Linear Mix None Amidation Free Antimicrobial Synthetic peptide MDA-MB-436 Breast Cancer MTT/MTS assay IC50 =5.6±0.5 µM 24-h Breast None None CCSCCCCSSCSSCCCSCC
3218 22413859 2012 kvkvkvkvPptkvkvkvk D-SVS-1 18 Linear Mix None Amidation Free Antimicrobial Synthetic peptide A-549 Lung Cancer MTT/MTS assay IC50 =3.2±0.6 µM 24-h Lung None None CGGGTCSCCCTTTTTTTC
3219 22413859 2012 kvkvkvkvPptkvkvkvk D-SVS-1 18 Linear Mix None Amidation Free Antimicrobial Synthetic peptide KB Oral Cancer MTT/MTS assay IC50 =4.5±0.5 µM 24-h Oral mucosa None None CGGGTCSCCCTTTTTTTC
3220 22413859 2012 kvkvkvkvPptkvkvkvk D-SVS-1 18 Linear Mix None Amidation Free Antimicrobial Synthetic peptide MCF-7 Breast Cancer MTT/MTS assay IC50 =4.7±0.4 µM 24-h Breast None None CGGGTCSCCCTTTTTTTC
3221 22413859 2012 kvkvkvkvPptkvkvkvk D-SVS-1 18 Linear Mix None Amidation Free Antimicrobial Synthetic peptide MDA-MB-436 Breast Cancer MTT/MTS assay IC50 =3.2±0.4 µM 24-h Breast None None CGGGTCSCCCTTTTTTTC
3222 22413859 2012 KVKVKVKVPPTKVKVKVK SVS-2 18 Linear L None Amidation Free Antimicrobial Synthetic peptide A-549 Lung Cancer MTT/MTS assay IC50 >100 µM 24-h Lung None None CGGGCCCSSSSSSCCSCC
3223 22413859 2012 KVKVKVKVPPTKVKVKVK SVS-2 18 Linear L None Amidation Free Antimicrobial Synthetic peptide KB Oral Cancer MTT/MTS assay IC50 >100 µM 24-h Oral mucosa None None CGGGCCCSSSSSSCCSCC
3224 22413859 2012 KVKVKVKVPPTKVKVKVK SVS-2 18 Linear L None Amidation Free Antimicrobial Synthetic peptide MCF-7 Breast Cancer MTT/MTS assay IC50 >100 µM 24-h Breast None None CGGGCCCSSSSSSCCSCC
3225 22413859 2012 KVKVKVKVPPTKVKVKVK SVS-2 18 Linear L None Amidation Free Antimicrobial Synthetic peptide MDA-MB-436 Breast Cancer MTT/MTS assay IC50 >100 µM 24-h Breast None None CGGGCCCSSSSSSCCSCC
3206 22413859 2012 KVKVKVKVpPTKVKVKVK SVS-1 18 Linear Mix None Amidation Free Antimicrobial Synthetic peptide A-549 Lung Cancer MTT/MTS assay NA 24-h Lung None None CCSCCCCSSCSSCCCSCC
3207 22413859 2012 KVKVKVKVpPTKVKVKVK SVS-1 18 Linear Mix None Amidation Free Antimicrobial Bovine lactoferrin (Lf-B) KB Oral Cancer MTT/MTS assay NA 24-h Oral mucosa None None CCSCCCCSSCSSCCCSCC
3216 22413859 2012 KVKVKVKVpPTKVKVKVK SVS-1 18 Linear Mix None Amidation Free Antimicrobial Synthetic peptide MCF-7 Breast Cancer MTT/MTS assay IC50 =8.1±0.8 µM 24-h Breast None None CCSCCCCSSCSSCCCSCC
3217 22413859 2012 KVKVKVKVpPTKVKVKVK SVS-1 18 Linear Mix None Amidation Free Antimicrobial Synthetic peptide MDA-MB-436 Breast Cancer MTT/MTS assay IC50 =5.6±0.5 µM 24-h Breast None None CCSCCCCSSCSSCCCSCC
3218 22413859 2012 kvkvkvkvPptkvkvkvk D-SVS-1 18 Linear Mix None Amidation Free Antimicrobial Synthetic peptide A-549 Lung Cancer MTT/MTS assay IC50 =3.2±0.6 µM 24-h Lung None None CGGGTCSCCCTTTTTTTC
3219 22413859 2012 kvkvkvkvPptkvkvkvk D-SVS-1 18 Linear Mix None Amidation Free Antimicrobial Synthetic peptide KB Oral Cancer MTT/MTS assay IC50 =4.5±0.5 µM 24-h Oral mucosa None None CGGGTCSCCCTTTTTTTC
3220 22413859 2012 kvkvkvkvPptkvkvkvk D-SVS-1 18 Linear Mix None Amidation Free Antimicrobial Synthetic peptide MCF-7 Breast Cancer MTT/MTS assay IC50 =4.7±0.4 µM 24-h Breast None None CGGGTCSCCCTTTTTTTC
3221 22413859 2012 kvkvkvkvPptkvkvkvk D-SVS-1 18 Linear Mix None Amidation Free Antimicrobial Synthetic peptide MDA-MB-436 Breast Cancer MTT/MTS assay IC50 =3.2±0.4 µM 24-h Breast None None CGGGTCSCCCTTTTTTTC
3222 22413859 2012 KVKVKVKVPPTKVKVKVK SVS-2 18 Linear L None Amidation Free Antimicrobial Synthetic peptide A-549 Lung Cancer MTT/MTS assay IC50 >100 µM 24-h Lung None None CGGGCCCSSSSSSCCSCC
3223 22413859 2012 KVKVKVKVPPTKVKVKVK SVS-2 18 Linear L None Amidation Free Antimicrobial Synthetic peptide KB Oral Cancer MTT/MTS assay IC50 >100 µM 24-h Oral mucosa None None CGGGCCCSSSSSSCCSCC
3224 22413859 2012 KVKVKVKVPPTKVKVKVK SVS-2 18 Linear L None Amidation Free Antimicrobial Synthetic peptide MCF-7 Breast Cancer MTT/MTS assay IC50 >100 µM 24-h Breast None None CGGGCCCSSSSSSCCSCC
3225 22413859 2012 KVKVKVKVPPTKVKVKVK SVS-2 18 Linear L None Amidation Free Antimicrobial Synthetic peptide MDA-MB-436 Breast Cancer MTT/MTS assay IC50 >100 µM 24-h Breast None None CGGGCCCSSSSSSCCSCC
1453 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-549 Lung Cancer MTT/MTS assay IC50=9.7 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1463 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-375 Skin Cancer MTT/MTS assay IC50=8.7 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1473 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K MCF-7 Breast Cancer MTT/MTS assay IC50=6.2 µMo/L 36-h Breast None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1483 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K SW-1116 Colorectal Cancer MTT/MTS assay IC50=4.3 µMo/L 36-h Colon None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1493 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K RD Rhabdomyosarcoma Cancer MTT/MTS assay IC50=6.4 µMo/L 36-h Muscle None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1503 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K H-1299 Lung Cancer MTT/MTS assay IC50=4.1 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1513 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K B-16 Skin Cancer MTT/MTS assay IC50=4.4 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1523 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K HeLa Cervical Cancer MTT/MTS assay IC50=2 µMo/L 36-h Cervix None None CCHHHHHTHHHHTTTHHHHHHHHHTC
3755 22837667 2012 KWKSFLKTFKSLKKTVLHTLLKAISS Peptide P 26 Linear L None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.71±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHGGGTHHHHHHHHHTC
3756 22837667 2012 KWKSFLkTFKSLKKTVLHTLLKAISS Peptide K7D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.29±0.03 µMol/L 1-h Cervix None None CCGGGGTTHHHHTTTHHHHHHHHHTC
3757 22837667 2012 KWKSFLKTFKSLKkTVLHTLLKAISS Peptide K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.52±0.05 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGGHHHHHHHHHCC
3758 22837667 2012 KWKSFLKTFKSLKKTVLHTLLkAISS Peptide K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.39±0.02 µMol/L 1-h Cervix None None CCTTHHHHHHHHHHHHHHHHHHHHTC
3759 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.06±0.01 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3760 22837667 2012 KWKSFLKTFKSLKkTVLHTLLkAISS Peptide K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.40±0.09 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGTHHHHHHHHHCC
3761 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.45±0.19 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3762 22837667 2012 KWKSFLkTFkSLKkTVLHTLLkAISS Peptide K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.79±0.23 µMol/L 1-h Cervix None None CCGGGHHHHHHHHTTTTHHHHTTTCC
3763 22837667 2012 KWkSFLkTFkSLKkTVLHTLLkAISS Peptide K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 20.41±0.64 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3764 22837667 2012 kWkSFLkTFkSLKkTVLHTLLkAISS Peptide K1D/K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 18.07±0.48 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3765 22837667 2012 KWKSFlKTFKSLKKTVLHTLLKAISS Peptide L6D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.23±0.10 µMol/L 1-h Cervix None None CCGGGHHHHHHGGGGHHHHHHHHHCC
3766 22837667 2012 KWKSFLKTFKSlKKTVLHTLLKAISS Peptide L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.63±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHHTTTHHHHHHHHHTC
3767 22837667 2012 KWKSFLKTFKSLKKTVLHTlLKAISS Peptide L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.33±0.06 µMol/L 1-h Cervix None None CCGGGHHHHHTTTHHHHHHHHTTTCC
3768 22837667 2012 KWKSFlKTFKSlKKTVLHTLLKAISS Peptide L6D/L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.01±0.08 µMol/L 1-h Cervix None None CCTHHHHHHHHHHHHHHHHTGGGTCC
3769 22837667 2012 KWKSFLKTFKSlKKTVLHTlLKAISS Peptide L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.14±0.06 µMol/L 1-h Cervix None None CCTTHHHHHHHTTHHHHHHHHTTTCC
3770 22837667 2012 KWKSFlKTFKSlKKTVLHTlLKAISS Peptide L6D/L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 7.80±0.26 µMol/L 1-h Cervix None None CCSGGGHHHHHGGGTHHHHHHHHHTC
3771 22837667 2012 KWKSFlKTFKSlKKTVlHTlLKAISS Peptide L6D/L12D/L17D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 9.69±0.38 µMol/L 1-h Cervix None None CCTHHHHIIIIITHHHHHHHHTTTCC
3772 22837667 2012 KWKSFlKTFKSlKKTVlHTllKAISS Peptide L6D/L12D/L17D/L20D/L21D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 12.88±0.15 µMol/L 1-h Cervix None None CCGGGHHHHHHTTHHHHHHHHTTTCC
1453 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-549 Lung Cancer MTT/MTS assay IC50=9.7 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1463 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-375 Skin Cancer MTT/MTS assay IC50=8.7 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1473 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K MCF-7 Breast Cancer MTT/MTS assay IC50=6.2 µMo/L 36-h Breast None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1483 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K SW-1116 Colorectal Cancer MTT/MTS assay IC50=4.3 µMo/L 36-h Colon None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1493 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K RD Rhabdomyosarcoma Cancer MTT/MTS assay IC50=6.4 µMo/L 36-h Muscle None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1503 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K H-1299 Lung Cancer MTT/MTS assay IC50=4.1 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1513 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K B-16 Skin Cancer MTT/MTS assay IC50=4.4 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1523 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K HeLa Cervical Cancer MTT/MTS assay IC50=2 µMo/L 36-h Cervix None None CCHHHHHTHHHHTTTHHHHHHHHHTC
3755 22837667 2012 KWKSFLKTFKSLKKTVLHTLLKAISS Peptide P 26 Linear L None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.71±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHGGGTHHHHHHHHHTC
3756 22837667 2012 KWKSFLkTFKSLKKTVLHTLLKAISS Peptide K7D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.29±0.03 µMol/L 1-h Cervix None None CCGGGGTTHHHHTTTHHHHHHHHHTC
3757 22837667 2012 KWKSFLKTFKSLKkTVLHTLLKAISS Peptide K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.52±0.05 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGGHHHHHHHHHCC
3758 22837667 2012 KWKSFLKTFKSLKKTVLHTLLkAISS Peptide K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.39±0.02 µMol/L 1-h Cervix None None CCTTHHHHHHHHHHHHHHHHHHHHTC
3759 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.06±0.01 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3760 22837667 2012 KWKSFLKTFKSLKkTVLHTLLkAISS Peptide K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.40±0.09 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGTHHHHHHHHHCC
3761 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.45±0.19 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3762 22837667 2012 KWKSFLkTFkSLKkTVLHTLLkAISS Peptide K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.79±0.23 µMol/L 1-h Cervix None None CCGGGHHHHHHHHTTTTHHHHTTTCC
3763 22837667 2012 KWkSFLkTFkSLKkTVLHTLLkAISS Peptide K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 20.41±0.64 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3764 22837667 2012 kWkSFLkTFkSLKkTVLHTLLkAISS Peptide K1D/K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 18.07±0.48 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3765 22837667 2012 KWKSFlKTFKSLKKTVLHTLLKAISS Peptide L6D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.23±0.10 µMol/L 1-h Cervix None None CCGGGHHHHHHGGGGHHHHHHHHHCC
3766 22837667 2012 KWKSFLKTFKSlKKTVLHTLLKAISS Peptide L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.63±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHHTTTHHHHHHHHHTC
3767 22837667 2012 KWKSFLKTFKSLKKTVLHTlLKAISS Peptide L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.33±0.06 µMol/L 1-h Cervix None None CCGGGHHHHHTTTHHHHHHHHTTTCC
3768 22837667 2012 KWKSFlKTFKSlKKTVLHTLLKAISS Peptide L6D/L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.01±0.08 µMol/L 1-h Cervix None None CCTHHHHHHHHHHHHHHHHTGGGTCC
3769 22837667 2012 KWKSFLKTFKSlKKTVLHTlLKAISS Peptide L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.14±0.06 µMol/L 1-h Cervix None None CCTTHHHHHHHTTHHHHHHHHTTTCC
3770 22837667 2012 KWKSFlKTFKSlKKTVLHTlLKAISS Peptide L6D/L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 7.80±0.26 µMol/L 1-h Cervix None None CCSGGGHHHHHGGGTHHHHHHHHHTC
3771 22837667 2012 KWKSFlKTFKSlKKTVlHTlLKAISS Peptide L6D/L12D/L17D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 9.69±0.38 µMol/L 1-h Cervix None None CCTHHHHIIIIITHHHHHHHHTTTCC
3772 22837667 2012 KWKSFlKTFKSlKKTVlHTllKAISS Peptide L6D/L12D/L17D/L20D/L21D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 12.88±0.15 µMol/L 1-h Cervix None None CCGGGHHHHHHTTHHHHHHHHTTTCC
1453 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-549 Lung Cancer MTT/MTS assay IC50=9.7 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1463 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-375 Skin Cancer MTT/MTS assay IC50=8.7 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1473 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K MCF-7 Breast Cancer MTT/MTS assay IC50=6.2 µMo/L 36-h Breast None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1483 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K SW-1116 Colorectal Cancer MTT/MTS assay IC50=4.3 µMo/L 36-h Colon None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1493 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K RD Rhabdomyosarcoma Cancer MTT/MTS assay IC50=6.4 µMo/L 36-h Muscle None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1503 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K H-1299 Lung Cancer MTT/MTS assay IC50=4.1 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1513 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K B-16 Skin Cancer MTT/MTS assay IC50=4.4 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1523 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K HeLa Cervical Cancer MTT/MTS assay IC50=2 µMo/L 36-h Cervix None None CCHHHHHTHHHHTTTHHHHHHHHHTC
3755 22837667 2012 KWKSFLKTFKSLKKTVLHTLLKAISS Peptide P 26 Linear L None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.71±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHGGGTHHHHHHHHHTC
3756 22837667 2012 KWKSFLkTFKSLKKTVLHTLLKAISS Peptide K7D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.29±0.03 µMol/L 1-h Cervix None None CCGGGGTTHHHHTTTHHHHHHHHHTC
3757 22837667 2012 KWKSFLKTFKSLKkTVLHTLLKAISS Peptide K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.52±0.05 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGGHHHHHHHHHCC
3758 22837667 2012 KWKSFLKTFKSLKKTVLHTLLkAISS Peptide K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.39±0.02 µMol/L 1-h Cervix None None CCTTHHHHHHHHHHHHHHHHHHHHTC
3759 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.06±0.01 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3760 22837667 2012 KWKSFLKTFKSLKkTVLHTLLkAISS Peptide K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.40±0.09 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGTHHHHHHHHHCC
3761 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.45±0.19 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3762 22837667 2012 KWKSFLkTFkSLKkTVLHTLLkAISS Peptide K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.79±0.23 µMol/L 1-h Cervix None None CCGGGHHHHHHHHTTTTHHHHTTTCC
3763 22837667 2012 KWkSFLkTFkSLKkTVLHTLLkAISS Peptide K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 20.41±0.64 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3764 22837667 2012 kWkSFLkTFkSLKkTVLHTLLkAISS Peptide K1D/K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 18.07±0.48 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3765 22837667 2012 KWKSFlKTFKSLKKTVLHTLLKAISS Peptide L6D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.23±0.10 µMol/L 1-h Cervix None None CCGGGHHHHHHGGGGHHHHHHHHHCC
3766 22837667 2012 KWKSFLKTFKSlKKTVLHTLLKAISS Peptide L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.63±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHHTTTHHHHHHHHHTC
3767 22837667 2012 KWKSFLKTFKSLKKTVLHTlLKAISS Peptide L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.33±0.06 µMol/L 1-h Cervix None None CCGGGHHHHHTTTHHHHHHHHTTTCC
3768 22837667 2012 KWKSFlKTFKSlKKTVLHTLLKAISS Peptide L6D/L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.01±0.08 µMol/L 1-h Cervix None None CCTHHHHHHHHHHHHHHHHTGGGTCC
3769 22837667 2012 KWKSFLKTFKSlKKTVLHTlLKAISS Peptide L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.14±0.06 µMol/L 1-h Cervix None None CCTTHHHHHHHTTHHHHHHHHTTTCC
3770 22837667 2012 KWKSFlKTFKSlKKTVLHTlLKAISS Peptide L6D/L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 7.80±0.26 µMol/L 1-h Cervix None None CCSGGGHHHHHGGGTHHHHHHHHHTC
3771 22837667 2012 KWKSFlKTFKSlKKTVlHTlLKAISS Peptide L6D/L12D/L17D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 9.69±0.38 µMol/L 1-h Cervix None None CCTHHHHIIIIITHHHHHHHHTTTCC
3772 22837667 2012 KWKSFlKTFKSlKKTVlHTllKAISS Peptide L6D/L12D/L17D/L20D/L21D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 12.88±0.15 µMol/L 1-h Cervix None None CCGGGHHHHHHTTHHHHHHHHTTTCC
1453 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-549 Lung Cancer MTT/MTS assay IC50=9.7 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1463 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-375 Skin Cancer MTT/MTS assay IC50=8.7 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1473 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K MCF-7 Breast Cancer MTT/MTS assay IC50=6.2 µMo/L 36-h Breast None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1483 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K SW-1116 Colorectal Cancer MTT/MTS assay IC50=4.3 µMo/L 36-h Colon None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1493 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K RD Rhabdomyosarcoma Cancer MTT/MTS assay IC50=6.4 µMo/L 36-h Muscle None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1503 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K H-1299 Lung Cancer MTT/MTS assay IC50=4.1 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1513 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K B-16 Skin Cancer MTT/MTS assay IC50=4.4 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1523 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K HeLa Cervical Cancer MTT/MTS assay IC50=2 µMo/L 36-h Cervix None None CCHHHHHTHHHHTTTHHHHHHHHHTC
3755 22837667 2012 KWKSFLKTFKSLKKTVLHTLLKAISS Peptide P 26 Linear L None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.71±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHGGGTHHHHHHHHHTC
3756 22837667 2012 KWKSFLkTFKSLKKTVLHTLLKAISS Peptide K7D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.29±0.03 µMol/L 1-h Cervix None None CCGGGGTTHHHHTTTHHHHHHHHHTC
3757 22837667 2012 KWKSFLKTFKSLKkTVLHTLLKAISS Peptide K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.52±0.05 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGGHHHHHHHHHCC
3758 22837667 2012 KWKSFLKTFKSLKKTVLHTLLkAISS Peptide K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.39±0.02 µMol/L 1-h Cervix None None CCTTHHHHHHHHHHHHHHHHHHHHTC
3759 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.06±0.01 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3760 22837667 2012 KWKSFLKTFKSLKkTVLHTLLkAISS Peptide K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.40±0.09 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGTHHHHHHHHHCC
3761 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.45±0.19 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3762 22837667 2012 KWKSFLkTFkSLKkTVLHTLLkAISS Peptide K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.79±0.23 µMol/L 1-h Cervix None None CCGGGHHHHHHHHTTTTHHHHTTTCC
3763 22837667 2012 KWkSFLkTFkSLKkTVLHTLLkAISS Peptide K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 20.41±0.64 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3764 22837667 2012 kWkSFLkTFkSLKkTVLHTLLkAISS Peptide K1D/K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 18.07±0.48 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3765 22837667 2012 KWKSFlKTFKSLKKTVLHTLLKAISS Peptide L6D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.23±0.10 µMol/L 1-h Cervix None None CCGGGHHHHHHGGGGHHHHHHHHHCC
3766 22837667 2012 KWKSFLKTFKSlKKTVLHTLLKAISS Peptide L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.63±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHHTTTHHHHHHHHHTC
3767 22837667 2012 KWKSFLKTFKSLKKTVLHTlLKAISS Peptide L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.33±0.06 µMol/L 1-h Cervix None None CCGGGHHHHHTTTHHHHHHHHTTTCC
3768 22837667 2012 KWKSFlKTFKSlKKTVLHTLLKAISS Peptide L6D/L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.01±0.08 µMol/L 1-h Cervix None None CCTHHHHHHHHHHHHHHHHTGGGTCC
3769 22837667 2012 KWKSFLKTFKSlKKTVLHTlLKAISS Peptide L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.14±0.06 µMol/L 1-h Cervix None None CCTTHHHHHHHTTHHHHHHHHTTTCC
3770 22837667 2012 KWKSFlKTFKSlKKTVLHTlLKAISS Peptide L6D/L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 7.80±0.26 µMol/L 1-h Cervix None None CCSGGGHHHHHGGGTHHHHHHHHHTC
3771 22837667 2012 KWKSFlKTFKSlKKTVlHTlLKAISS Peptide L6D/L12D/L17D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 9.69±0.38 µMol/L 1-h Cervix None None CCTHHHHIIIIITHHHHHHHHTTTCC
3772 22837667 2012 KWKSFlKTFKSlKKTVlHTllKAISS Peptide L6D/L12D/L17D/L20D/L21D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 12.88±0.15 µMol/L 1-h Cervix None None CCGGGHHHHHHTTHHHHHHHHTTTCC
1453 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-549 Lung Cancer MTT/MTS assay IC50=9.7 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1463 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-375 Skin Cancer MTT/MTS assay IC50=8.7 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1473 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K MCF-7 Breast Cancer MTT/MTS assay IC50=6.2 µMo/L 36-h Breast None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1483 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K SW-1116 Colorectal Cancer MTT/MTS assay IC50=4.3 µMo/L 36-h Colon None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1493 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K RD Rhabdomyosarcoma Cancer MTT/MTS assay IC50=6.4 µMo/L 36-h Muscle None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1503 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K H-1299 Lung Cancer MTT/MTS assay IC50=4.1 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1513 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K B-16 Skin Cancer MTT/MTS assay IC50=4.4 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1523 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K HeLa Cervical Cancer MTT/MTS assay IC50=2 µMo/L 36-h Cervix None None CCHHHHHTHHHHTTTHHHHHHHHHTC
3755 22837667 2012 KWKSFLKTFKSLKKTVLHTLLKAISS Peptide P 26 Linear L None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.71±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHGGGTHHHHHHHHHTC
3756 22837667 2012 KWKSFLkTFKSLKKTVLHTLLKAISS Peptide K7D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.29±0.03 µMol/L 1-h Cervix None None CCGGGGTTHHHHTTTHHHHHHHHHTC
3757 22837667 2012 KWKSFLKTFKSLKkTVLHTLLKAISS Peptide K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.52±0.05 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGGHHHHHHHHHCC
3758 22837667 2012 KWKSFLKTFKSLKKTVLHTLLkAISS Peptide K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.39±0.02 µMol/L 1-h Cervix None None CCTTHHHHHHHHHHHHHHHHHHHHTC
3759 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.06±0.01 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3760 22837667 2012 KWKSFLKTFKSLKkTVLHTLLkAISS Peptide K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.40±0.09 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGTHHHHHHHHHCC
3761 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.45±0.19 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3762 22837667 2012 KWKSFLkTFkSLKkTVLHTLLkAISS Peptide K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.79±0.23 µMol/L 1-h Cervix None None CCGGGHHHHHHHHTTTTHHHHTTTCC
3763 22837667 2012 KWkSFLkTFkSLKkTVLHTLLkAISS Peptide K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 20.41±0.64 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3764 22837667 2012 kWkSFLkTFkSLKkTVLHTLLkAISS Peptide K1D/K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 18.07±0.48 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3765 22837667 2012 KWKSFlKTFKSLKKTVLHTLLKAISS Peptide L6D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.23±0.10 µMol/L 1-h Cervix None None CCGGGHHHHHHGGGGHHHHHHHHHCC
3766 22837667 2012 KWKSFLKTFKSlKKTVLHTLLKAISS Peptide L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.63±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHHTTTHHHHHHHHHTC
3767 22837667 2012 KWKSFLKTFKSLKKTVLHTlLKAISS Peptide L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.33±0.06 µMol/L 1-h Cervix None None CCGGGHHHHHTTTHHHHHHHHTTTCC
3768 22837667 2012 KWKSFlKTFKSlKKTVLHTLLKAISS Peptide L6D/L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.01±0.08 µMol/L 1-h Cervix None None CCTHHHHHHHHHHHHHHHHTGGGTCC
3769 22837667 2012 KWKSFLKTFKSlKKTVLHTlLKAISS Peptide L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.14±0.06 µMol/L 1-h Cervix None None CCTTHHHHHHHTTHHHHHHHHTTTCC
3770 22837667 2012 KWKSFlKTFKSlKKTVLHTlLKAISS Peptide L6D/L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 7.80±0.26 µMol/L 1-h Cervix None None CCSGGGHHHHHGGGTHHHHHHHHHTC
3771 22837667 2012 KWKSFlKTFKSlKKTVlHTlLKAISS Peptide L6D/L12D/L17D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 9.69±0.38 µMol/L 1-h Cervix None None CCTHHHHIIIIITHHHHHHHHTTTCC
3772 22837667 2012 KWKSFlKTFKSlKKTVlHTllKAISS Peptide L6D/L12D/L17D/L20D/L21D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 12.88±0.15 µMol/L 1-h Cervix None None CCGGGHHHHHHTTHHHHHHHHTTTCC
1453 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-549 Lung Cancer MTT/MTS assay IC50=9.7 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1463 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-375 Skin Cancer MTT/MTS assay IC50=8.7 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1473 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K MCF-7 Breast Cancer MTT/MTS assay IC50=6.2 µMo/L 36-h Breast None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1483 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K SW-1116 Colorectal Cancer MTT/MTS assay IC50=4.3 µMo/L 36-h Colon None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1493 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K RD Rhabdomyosarcoma Cancer MTT/MTS assay IC50=6.4 µMo/L 36-h Muscle None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1503 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K H-1299 Lung Cancer MTT/MTS assay IC50=4.1 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1513 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K B-16 Skin Cancer MTT/MTS assay IC50=4.4 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1523 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K HeLa Cervical Cancer MTT/MTS assay IC50=2 µMo/L 36-h Cervix None None CCHHHHHTHHHHTTTHHHHHHHHHTC
3755 22837667 2012 KWKSFLKTFKSLKKTVLHTLLKAISS Peptide P 26 Linear L None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.71±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHGGGTHHHHHHHHHTC
3756 22837667 2012 KWKSFLkTFKSLKKTVLHTLLKAISS Peptide K7D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.29±0.03 µMol/L 1-h Cervix None None CCGGGGTTHHHHTTTHHHHHHHHHTC
3757 22837667 2012 KWKSFLKTFKSLKkTVLHTLLKAISS Peptide K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.52±0.05 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGGHHHHHHHHHCC
3758 22837667 2012 KWKSFLKTFKSLKKTVLHTLLkAISS Peptide K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.39±0.02 µMol/L 1-h Cervix None None CCTTHHHHHHHHHHHHHHHHHHHHTC
3759 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.06±0.01 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3760 22837667 2012 KWKSFLKTFKSLKkTVLHTLLkAISS Peptide K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.40±0.09 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGTHHHHHHHHHCC
3761 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.45±0.19 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3762 22837667 2012 KWKSFLkTFkSLKkTVLHTLLkAISS Peptide K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.79±0.23 µMol/L 1-h Cervix None None CCGGGHHHHHHHHTTTTHHHHTTTCC
3763 22837667 2012 KWkSFLkTFkSLKkTVLHTLLkAISS Peptide K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 20.41±0.64 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3764 22837667 2012 kWkSFLkTFkSLKkTVLHTLLkAISS Peptide K1D/K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 18.07±0.48 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3765 22837667 2012 KWKSFlKTFKSLKKTVLHTLLKAISS Peptide L6D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.23±0.10 µMol/L 1-h Cervix None None CCGGGHHHHHHGGGGHHHHHHHHHCC
3766 22837667 2012 KWKSFLKTFKSlKKTVLHTLLKAISS Peptide L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.63±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHHTTTHHHHHHHHHTC
3767 22837667 2012 KWKSFLKTFKSLKKTVLHTlLKAISS Peptide L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.33±0.06 µMol/L 1-h Cervix None None CCGGGHHHHHTTTHHHHHHHHTTTCC
3768 22837667 2012 KWKSFlKTFKSlKKTVLHTLLKAISS Peptide L6D/L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.01±0.08 µMol/L 1-h Cervix None None CCTHHHHHHHHHHHHHHHHTGGGTCC
3769 22837667 2012 KWKSFLKTFKSlKKTVLHTlLKAISS Peptide L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.14±0.06 µMol/L 1-h Cervix None None CCTTHHHHHHHTTHHHHHHHHTTTCC
3770 22837667 2012 KWKSFlKTFKSlKKTVLHTlLKAISS Peptide L6D/L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 7.80±0.26 µMol/L 1-h Cervix None None CCSGGGHHHHHGGGTHHHHHHHHHTC
3771 22837667 2012 KWKSFlKTFKSlKKTVlHTlLKAISS Peptide L6D/L12D/L17D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 9.69±0.38 µMol/L 1-h Cervix None None CCTHHHHIIIIITHHHHHHHHTTTCC
3772 22837667 2012 KWKSFlKTFKSlKKTVlHTllKAISS Peptide L6D/L12D/L17D/L20D/L21D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 12.88±0.15 µMol/L 1-h Cervix None None CCGGGHHHHHHTTHHHHHHHHTTTCC
1453 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-549 Lung Cancer MTT/MTS assay IC50=9.7 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1463 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-375 Skin Cancer MTT/MTS assay IC50=8.7 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1473 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K MCF-7 Breast Cancer MTT/MTS assay IC50=6.2 µMo/L 36-h Breast None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1483 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K SW-1116 Colorectal Cancer MTT/MTS assay IC50=4.3 µMo/L 36-h Colon None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1493 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K RD Rhabdomyosarcoma Cancer MTT/MTS assay IC50=6.4 µMo/L 36-h Muscle None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1503 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K H-1299 Lung Cancer MTT/MTS assay IC50=4.1 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1513 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K B-16 Skin Cancer MTT/MTS assay IC50=4.4 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1523 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K HeLa Cervical Cancer MTT/MTS assay IC50=2 µMo/L 36-h Cervix None None CCHHHHHTHHHHTTTHHHHHHHHHTC
3755 22837667 2012 KWKSFLKTFKSLKKTVLHTLLKAISS Peptide P 26 Linear L None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.71±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHGGGTHHHHHHHHHTC
3756 22837667 2012 KWKSFLkTFKSLKKTVLHTLLKAISS Peptide K7D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.29±0.03 µMol/L 1-h Cervix None None CCGGGGTTHHHHTTTHHHHHHHHHTC
3757 22837667 2012 KWKSFLKTFKSLKkTVLHTLLKAISS Peptide K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.52±0.05 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGGHHHHHHHHHCC
3758 22837667 2012 KWKSFLKTFKSLKKTVLHTLLkAISS Peptide K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.39±0.02 µMol/L 1-h Cervix None None CCTTHHHHHHHHHHHHHHHHHHHHTC
3759 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.06±0.01 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3760 22837667 2012 KWKSFLKTFKSLKkTVLHTLLkAISS Peptide K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.40±0.09 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGTHHHHHHHHHCC
3761 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.45±0.19 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3762 22837667 2012 KWKSFLkTFkSLKkTVLHTLLkAISS Peptide K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.79±0.23 µMol/L 1-h Cervix None None CCGGGHHHHHHHHTTTTHHHHTTTCC
3763 22837667 2012 KWkSFLkTFkSLKkTVLHTLLkAISS Peptide K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 20.41±0.64 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3764 22837667 2012 kWkSFLkTFkSLKkTVLHTLLkAISS Peptide K1D/K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 18.07±0.48 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3765 22837667 2012 KWKSFlKTFKSLKKTVLHTLLKAISS Peptide L6D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.23±0.10 µMol/L 1-h Cervix None None CCGGGHHHHHHGGGGHHHHHHHHHCC
3766 22837667 2012 KWKSFLKTFKSlKKTVLHTLLKAISS Peptide L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.63±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHHTTTHHHHHHHHHTC
3767 22837667 2012 KWKSFLKTFKSLKKTVLHTlLKAISS Peptide L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.33±0.06 µMol/L 1-h Cervix None None CCGGGHHHHHTTTHHHHHHHHTTTCC
3768 22837667 2012 KWKSFlKTFKSlKKTVLHTLLKAISS Peptide L6D/L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.01±0.08 µMol/L 1-h Cervix None None CCTHHHHHHHHHHHHHHHHTGGGTCC
3769 22837667 2012 KWKSFLKTFKSlKKTVLHTlLKAISS Peptide L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.14±0.06 µMol/L 1-h Cervix None None CCTTHHHHHHHTTHHHHHHHHTTTCC
3770 22837667 2012 KWKSFlKTFKSlKKTVLHTlLKAISS Peptide L6D/L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 7.80±0.26 µMol/L 1-h Cervix None None CCSGGGHHHHHGGGTHHHHHHHHHTC
3771 22837667 2012 KWKSFlKTFKSlKKTVlHTlLKAISS Peptide L6D/L12D/L17D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 9.69±0.38 µMol/L 1-h Cervix None None CCTHHHHIIIIITHHHHHHHHTTTCC
3772 22837667 2012 KWKSFlKTFKSlKKTVlHTllKAISS Peptide L6D/L12D/L17D/L20D/L21D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 12.88±0.15 µMol/L 1-h Cervix None None CCGGGHHHHHHTTHHHHHHHHTTTCC
1453 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-549 Lung Cancer MTT/MTS assay IC50=9.7 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1463 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-375 Skin Cancer MTT/MTS assay IC50=8.7 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1473 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K MCF-7 Breast Cancer MTT/MTS assay IC50=6.2 µMo/L 36-h Breast None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1483 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K SW-1116 Colorectal Cancer MTT/MTS assay IC50=4.3 µMo/L 36-h Colon None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1493 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K RD Rhabdomyosarcoma Cancer MTT/MTS assay IC50=6.4 µMo/L 36-h Muscle None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1503 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K H-1299 Lung Cancer MTT/MTS assay IC50=4.1 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1513 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K B-16 Skin Cancer MTT/MTS assay IC50=4.4 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1523 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K HeLa Cervical Cancer MTT/MTS assay IC50=2 µMo/L 36-h Cervix None None CCHHHHHTHHHHTTTHHHHHHHHHTC
3755 22837667 2012 KWKSFLKTFKSLKKTVLHTLLKAISS Peptide P 26 Linear L None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.71±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHGGGTHHHHHHHHHTC
3756 22837667 2012 KWKSFLkTFKSLKKTVLHTLLKAISS Peptide K7D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.29±0.03 µMol/L 1-h Cervix None None CCGGGGTTHHHHTTTHHHHHHHHHTC
3757 22837667 2012 KWKSFLKTFKSLKkTVLHTLLKAISS Peptide K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.52±0.05 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGGHHHHHHHHHCC
3758 22837667 2012 KWKSFLKTFKSLKKTVLHTLLkAISS Peptide K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.39±0.02 µMol/L 1-h Cervix None None CCTTHHHHHHHHHHHHHHHHHHHHTC
3759 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.06±0.01 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3760 22837667 2012 KWKSFLKTFKSLKkTVLHTLLkAISS Peptide K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.40±0.09 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGTHHHHHHHHHCC
3761 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.45±0.19 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3762 22837667 2012 KWKSFLkTFkSLKkTVLHTLLkAISS Peptide K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.79±0.23 µMol/L 1-h Cervix None None CCGGGHHHHHHHHTTTTHHHHTTTCC
3763 22837667 2012 KWkSFLkTFkSLKkTVLHTLLkAISS Peptide K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 20.41±0.64 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3764 22837667 2012 kWkSFLkTFkSLKkTVLHTLLkAISS Peptide K1D/K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 18.07±0.48 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3765 22837667 2012 KWKSFlKTFKSLKKTVLHTLLKAISS Peptide L6D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.23±0.10 µMol/L 1-h Cervix None None CCGGGHHHHHHGGGGHHHHHHHHHCC
3766 22837667 2012 KWKSFLKTFKSlKKTVLHTLLKAISS Peptide L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.63±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHHTTTHHHHHHHHHTC
3767 22837667 2012 KWKSFLKTFKSLKKTVLHTlLKAISS Peptide L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.33±0.06 µMol/L 1-h Cervix None None CCGGGHHHHHTTTHHHHHHHHTTTCC
3768 22837667 2012 KWKSFlKTFKSlKKTVLHTLLKAISS Peptide L6D/L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.01±0.08 µMol/L 1-h Cervix None None CCTHHHHHHHHHHHHHHHHTGGGTCC
3769 22837667 2012 KWKSFLKTFKSlKKTVLHTlLKAISS Peptide L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.14±0.06 µMol/L 1-h Cervix None None CCTTHHHHHHHTTHHHHHHHHTTTCC
3770 22837667 2012 KWKSFlKTFKSlKKTVLHTlLKAISS Peptide L6D/L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 7.80±0.26 µMol/L 1-h Cervix None None CCSGGGHHHHHGGGTHHHHHHHHHTC
3771 22837667 2012 KWKSFlKTFKSlKKTVlHTlLKAISS Peptide L6D/L12D/L17D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 9.69±0.38 µMol/L 1-h Cervix None None CCTHHHHIIIIITHHHHHHHHTTTCC
3772 22837667 2012 KWKSFlKTFKSlKKTVlHTllKAISS Peptide L6D/L12D/L17D/L20D/L21D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 12.88±0.15 µMol/L 1-h Cervix None None CCGGGHHHHHHTTHHHHHHHHTTTCC
1453 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-549 Lung Cancer MTT/MTS assay IC50=9.7 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1463 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-375 Skin Cancer MTT/MTS assay IC50=8.7 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1473 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K MCF-7 Breast Cancer MTT/MTS assay IC50=6.2 µMo/L 36-h Breast None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1483 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K SW-1116 Colorectal Cancer MTT/MTS assay IC50=4.3 µMo/L 36-h Colon None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1493 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K RD Rhabdomyosarcoma Cancer MTT/MTS assay IC50=6.4 µMo/L 36-h Muscle None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1503 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K H-1299 Lung Cancer MTT/MTS assay IC50=4.1 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1513 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K B-16 Skin Cancer MTT/MTS assay IC50=4.4 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1523 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K HeLa Cervical Cancer MTT/MTS assay IC50=2 µMo/L 36-h Cervix None None CCHHHHHTHHHHTTTHHHHHHHHHTC
3755 22837667 2012 KWKSFLKTFKSLKKTVLHTLLKAISS Peptide P 26 Linear L None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.71±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHGGGTHHHHHHHHHTC
3756 22837667 2012 KWKSFLkTFKSLKKTVLHTLLKAISS Peptide K7D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.29±0.03 µMol/L 1-h Cervix None None CCGGGGTTHHHHTTTHHHHHHHHHTC
3757 22837667 2012 KWKSFLKTFKSLKkTVLHTLLKAISS Peptide K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.52±0.05 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGGHHHHHHHHHCC
3758 22837667 2012 KWKSFLKTFKSLKKTVLHTLLkAISS Peptide K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.39±0.02 µMol/L 1-h Cervix None None CCTTHHHHHHHHHHHHHHHHHHHHTC
3759 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.06±0.01 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3760 22837667 2012 KWKSFLKTFKSLKkTVLHTLLkAISS Peptide K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.40±0.09 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGTHHHHHHHHHCC
3761 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.45±0.19 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3762 22837667 2012 KWKSFLkTFkSLKkTVLHTLLkAISS Peptide K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.79±0.23 µMol/L 1-h Cervix None None CCGGGHHHHHHHHTTTTHHHHTTTCC
3763 22837667 2012 KWkSFLkTFkSLKkTVLHTLLkAISS Peptide K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 20.41±0.64 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3764 22837667 2012 kWkSFLkTFkSLKkTVLHTLLkAISS Peptide K1D/K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 18.07±0.48 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3765 22837667 2012 KWKSFlKTFKSLKKTVLHTLLKAISS Peptide L6D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.23±0.10 µMol/L 1-h Cervix None None CCGGGHHHHHHGGGGHHHHHHHHHCC
3766 22837667 2012 KWKSFLKTFKSlKKTVLHTLLKAISS Peptide L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.63±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHHTTTHHHHHHHHHTC
3767 22837667 2012 KWKSFLKTFKSLKKTVLHTlLKAISS Peptide L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.33±0.06 µMol/L 1-h Cervix None None CCGGGHHHHHTTTHHHHHHHHTTTCC
3768 22837667 2012 KWKSFlKTFKSlKKTVLHTLLKAISS Peptide L6D/L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.01±0.08 µMol/L 1-h Cervix None None CCTHHHHHHHHHHHHHHHHTGGGTCC
3769 22837667 2012 KWKSFLKTFKSlKKTVLHTlLKAISS Peptide L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.14±0.06 µMol/L 1-h Cervix None None CCTTHHHHHHHTTHHHHHHHHTTTCC
3770 22837667 2012 KWKSFlKTFKSlKKTVLHTlLKAISS Peptide L6D/L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 7.80±0.26 µMol/L 1-h Cervix None None CCSGGGHHHHHGGGTHHHHHHHHHTC
3771 22837667 2012 KWKSFlKTFKSlKKTVlHTlLKAISS Peptide L6D/L12D/L17D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 9.69±0.38 µMol/L 1-h Cervix None None CCTHHHHIIIIITHHHHHHHHTTTCC
3772 22837667 2012 KWKSFlKTFKSlKKTVlHTllKAISS Peptide L6D/L12D/L17D/L20D/L21D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 12.88±0.15 µMol/L 1-h Cervix None None CCGGGHHHHHHTTHHHHHHHHTTTCC
1453 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-549 Lung Cancer MTT/MTS assay IC50=9.7 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1463 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-375 Skin Cancer MTT/MTS assay IC50=8.7 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1473 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K MCF-7 Breast Cancer MTT/MTS assay IC50=6.2 µMo/L 36-h Breast None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1483 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K SW-1116 Colorectal Cancer MTT/MTS assay IC50=4.3 µMo/L 36-h Colon None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1493 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K RD Rhabdomyosarcoma Cancer MTT/MTS assay IC50=6.4 µMo/L 36-h Muscle None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1503 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K H-1299 Lung Cancer MTT/MTS assay IC50=4.1 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1513 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K B-16 Skin Cancer MTT/MTS assay IC50=4.4 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1523 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K HeLa Cervical Cancer MTT/MTS assay IC50=2 µMo/L 36-h Cervix None None CCHHHHHTHHHHTTTHHHHHHHHHTC
3755 22837667 2012 KWKSFLKTFKSLKKTVLHTLLKAISS Peptide P 26 Linear L None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.71±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHGGGTHHHHHHHHHTC
3756 22837667 2012 KWKSFLkTFKSLKKTVLHTLLKAISS Peptide K7D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.29±0.03 µMol/L 1-h Cervix None None CCGGGGTTHHHHTTTHHHHHHHHHTC
3757 22837667 2012 KWKSFLKTFKSLKkTVLHTLLKAISS Peptide K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.52±0.05 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGGHHHHHHHHHCC
3758 22837667 2012 KWKSFLKTFKSLKKTVLHTLLkAISS Peptide K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.39±0.02 µMol/L 1-h Cervix None None CCTTHHHHHHHHHHHHHHHHHHHHTC
3759 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.06±0.01 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3760 22837667 2012 KWKSFLKTFKSLKkTVLHTLLkAISS Peptide K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.40±0.09 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGTHHHHHHHHHCC
3761 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.45±0.19 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3762 22837667 2012 KWKSFLkTFkSLKkTVLHTLLkAISS Peptide K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.79±0.23 µMol/L 1-h Cervix None None CCGGGHHHHHHHHTTTTHHHHTTTCC
3763 22837667 2012 KWkSFLkTFkSLKkTVLHTLLkAISS Peptide K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 20.41±0.64 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3764 22837667 2012 kWkSFLkTFkSLKkTVLHTLLkAISS Peptide K1D/K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 18.07±0.48 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3765 22837667 2012 KWKSFlKTFKSLKKTVLHTLLKAISS Peptide L6D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.23±0.10 µMol/L 1-h Cervix None None CCGGGHHHHHHGGGGHHHHHHHHHCC
3766 22837667 2012 KWKSFLKTFKSlKKTVLHTLLKAISS Peptide L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.63±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHHTTTHHHHHHHHHTC
3767 22837667 2012 KWKSFLKTFKSLKKTVLHTlLKAISS Peptide L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.33±0.06 µMol/L 1-h Cervix None None CCGGGHHHHHTTTHHHHHHHHTTTCC
3768 22837667 2012 KWKSFlKTFKSlKKTVLHTLLKAISS Peptide L6D/L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.01±0.08 µMol/L 1-h Cervix None None CCTHHHHHHHHHHHHHHHHTGGGTCC
3769 22837667 2012 KWKSFLKTFKSlKKTVLHTlLKAISS Peptide L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.14±0.06 µMol/L 1-h Cervix None None CCTTHHHHHHHTTHHHHHHHHTTTCC
3770 22837667 2012 KWKSFlKTFKSlKKTVLHTlLKAISS Peptide L6D/L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 7.80±0.26 µMol/L 1-h Cervix None None CCSGGGHHHHHGGGTHHHHHHHHHTC
3771 22837667 2012 KWKSFlKTFKSlKKTVlHTlLKAISS Peptide L6D/L12D/L17D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 9.69±0.38 µMol/L 1-h Cervix None None CCTHHHHIIIIITHHHHHHHHTTTCC
3772 22837667 2012 KWKSFlKTFKSlKKTVlHTllKAISS Peptide L6D/L12D/L17D/L20D/L21D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 12.88±0.15 µMol/L 1-h Cervix None None CCGGGHHHHHHTTHHHHHHHHTTTCC
1453 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-549 Lung Cancer MTT/MTS assay IC50=9.7 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1463 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-375 Skin Cancer MTT/MTS assay IC50=8.7 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1473 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K MCF-7 Breast Cancer MTT/MTS assay IC50=6.2 µMo/L 36-h Breast None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1483 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K SW-1116 Colorectal Cancer MTT/MTS assay IC50=4.3 µMo/L 36-h Colon None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1493 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K RD Rhabdomyosarcoma Cancer MTT/MTS assay IC50=6.4 µMo/L 36-h Muscle None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1503 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K H-1299 Lung Cancer MTT/MTS assay IC50=4.1 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1513 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K B-16 Skin Cancer MTT/MTS assay IC50=4.4 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1523 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K HeLa Cervical Cancer MTT/MTS assay IC50=2 µMo/L 36-h Cervix None None CCHHHHHTHHHHTTTHHHHHHHHHTC
3755 22837667 2012 KWKSFLKTFKSLKKTVLHTLLKAISS Peptide P 26 Linear L None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.71±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHGGGTHHHHHHHHHTC
3756 22837667 2012 KWKSFLkTFKSLKKTVLHTLLKAISS Peptide K7D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.29±0.03 µMol/L 1-h Cervix None None CCGGGGTTHHHHTTTHHHHHHHHHTC
3757 22837667 2012 KWKSFLKTFKSLKkTVLHTLLKAISS Peptide K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.52±0.05 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGGHHHHHHHHHCC
3758 22837667 2012 KWKSFLKTFKSLKKTVLHTLLkAISS Peptide K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.39±0.02 µMol/L 1-h Cervix None None CCTTHHHHHHHHHHHHHHHHHHHHTC
3759 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.06±0.01 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3760 22837667 2012 KWKSFLKTFKSLKkTVLHTLLkAISS Peptide K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.40±0.09 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGTHHHHHHHHHCC
3761 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.45±0.19 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3762 22837667 2012 KWKSFLkTFkSLKkTVLHTLLkAISS Peptide K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.79±0.23 µMol/L 1-h Cervix None None CCGGGHHHHHHHHTTTTHHHHTTTCC
3763 22837667 2012 KWkSFLkTFkSLKkTVLHTLLkAISS Peptide K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 20.41±0.64 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3764 22837667 2012 kWkSFLkTFkSLKkTVLHTLLkAISS Peptide K1D/K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 18.07±0.48 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3765 22837667 2012 KWKSFlKTFKSLKKTVLHTLLKAISS Peptide L6D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.23±0.10 µMol/L 1-h Cervix None None CCGGGHHHHHHGGGGHHHHHHHHHCC
3766 22837667 2012 KWKSFLKTFKSlKKTVLHTLLKAISS Peptide L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.63±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHHTTTHHHHHHHHHTC
3767 22837667 2012 KWKSFLKTFKSLKKTVLHTlLKAISS Peptide L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.33±0.06 µMol/L 1-h Cervix None None CCGGGHHHHHTTTHHHHHHHHTTTCC
3768 22837667 2012 KWKSFlKTFKSlKKTVLHTLLKAISS Peptide L6D/L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.01±0.08 µMol/L 1-h Cervix None None CCTHHHHHHHHHHHHHHHHTGGGTCC
3769 22837667 2012 KWKSFLKTFKSlKKTVLHTlLKAISS Peptide L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.14±0.06 µMol/L 1-h Cervix None None CCTTHHHHHHHTTHHHHHHHHTTTCC
3770 22837667 2012 KWKSFlKTFKSlKKTVLHTlLKAISS Peptide L6D/L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 7.80±0.26 µMol/L 1-h Cervix None None CCSGGGHHHHHGGGTHHHHHHHHHTC
3771 22837667 2012 KWKSFlKTFKSlKKTVlHTlLKAISS Peptide L6D/L12D/L17D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 9.69±0.38 µMol/L 1-h Cervix None None CCTHHHHIIIIITHHHHHHHHTTTCC
3772 22837667 2012 KWKSFlKTFKSlKKTVlHTllKAISS Peptide L6D/L12D/L17D/L20D/L21D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 12.88±0.15 µMol/L 1-h Cervix None None CCGGGHHHHHHTTHHHHHHHHTTTCC
1453 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-549 Lung Cancer MTT/MTS assay IC50=9.7 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1463 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-375 Skin Cancer MTT/MTS assay IC50=8.7 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1473 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K MCF-7 Breast Cancer MTT/MTS assay IC50=6.2 µMo/L 36-h Breast None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1483 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K SW-1116 Colorectal Cancer MTT/MTS assay IC50=4.3 µMo/L 36-h Colon None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1493 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K RD Rhabdomyosarcoma Cancer MTT/MTS assay IC50=6.4 µMo/L 36-h Muscle None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1503 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K H-1299 Lung Cancer MTT/MTS assay IC50=4.1 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1513 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K B-16 Skin Cancer MTT/MTS assay IC50=4.4 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1523 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K HeLa Cervical Cancer MTT/MTS assay IC50=2 µMo/L 36-h Cervix None None CCHHHHHTHHHHTTTHHHHHHHHHTC
3755 22837667 2012 KWKSFLKTFKSLKKTVLHTLLKAISS Peptide P 26 Linear L None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.71±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHGGGTHHHHHHHHHTC
3756 22837667 2012 KWKSFLkTFKSLKKTVLHTLLKAISS Peptide K7D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.29±0.03 µMol/L 1-h Cervix None None CCGGGGTTHHHHTTTHHHHHHHHHTC
3757 22837667 2012 KWKSFLKTFKSLKkTVLHTLLKAISS Peptide K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.52±0.05 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGGHHHHHHHHHCC
3758 22837667 2012 KWKSFLKTFKSLKKTVLHTLLkAISS Peptide K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.39±0.02 µMol/L 1-h Cervix None None CCTTHHHHHHHHHHHHHHHHHHHHTC
3759 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.06±0.01 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3760 22837667 2012 KWKSFLKTFKSLKkTVLHTLLkAISS Peptide K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.40±0.09 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGTHHHHHHHHHCC
3761 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.45±0.19 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3762 22837667 2012 KWKSFLkTFkSLKkTVLHTLLkAISS Peptide K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.79±0.23 µMol/L 1-h Cervix None None CCGGGHHHHHHHHTTTTHHHHTTTCC
3763 22837667 2012 KWkSFLkTFkSLKkTVLHTLLkAISS Peptide K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 20.41±0.64 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3764 22837667 2012 kWkSFLkTFkSLKkTVLHTLLkAISS Peptide K1D/K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 18.07±0.48 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3765 22837667 2012 KWKSFlKTFKSLKKTVLHTLLKAISS Peptide L6D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.23±0.10 µMol/L 1-h Cervix None None CCGGGHHHHHHGGGGHHHHHHHHHCC
3766 22837667 2012 KWKSFLKTFKSlKKTVLHTLLKAISS Peptide L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.63±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHHTTTHHHHHHHHHTC
3767 22837667 2012 KWKSFLKTFKSLKKTVLHTlLKAISS Peptide L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.33±0.06 µMol/L 1-h Cervix None None CCGGGHHHHHTTTHHHHHHHHTTTCC
3768 22837667 2012 KWKSFlKTFKSlKKTVLHTLLKAISS Peptide L6D/L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.01±0.08 µMol/L 1-h Cervix None None CCTHHHHHHHHHHHHHHHHTGGGTCC
3769 22837667 2012 KWKSFLKTFKSlKKTVLHTlLKAISS Peptide L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.14±0.06 µMol/L 1-h Cervix None None CCTTHHHHHHHTTHHHHHHHHTTTCC
3770 22837667 2012 KWKSFlKTFKSlKKTVLHTlLKAISS Peptide L6D/L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 7.80±0.26 µMol/L 1-h Cervix None None CCSGGGHHHHHGGGTHHHHHHHHHTC
3771 22837667 2012 KWKSFlKTFKSlKKTVlHTlLKAISS Peptide L6D/L12D/L17D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 9.69±0.38 µMol/L 1-h Cervix None None CCTHHHHIIIIITHHHHHHHHTTTCC
3772 22837667 2012 KWKSFlKTFKSlKKTVlHTllKAISS Peptide L6D/L12D/L17D/L20D/L21D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 12.88±0.15 µMol/L 1-h Cervix None None CCGGGHHHHHHTTHHHHHHHHTTTCC
1453 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-549 Lung Cancer MTT/MTS assay IC50=9.7 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1463 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-375 Skin Cancer MTT/MTS assay IC50=8.7 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1473 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K MCF-7 Breast Cancer MTT/MTS assay IC50=6.2 µMo/L 36-h Breast None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1483 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K SW-1116 Colorectal Cancer MTT/MTS assay IC50=4.3 µMo/L 36-h Colon None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1493 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K RD Rhabdomyosarcoma Cancer MTT/MTS assay IC50=6.4 µMo/L 36-h Muscle None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1503 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K H-1299 Lung Cancer MTT/MTS assay IC50=4.1 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1513 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K B-16 Skin Cancer MTT/MTS assay IC50=4.4 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1523 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K HeLa Cervical Cancer MTT/MTS assay IC50=2 µMo/L 36-h Cervix None None CCHHHHHTHHHHTTTHHHHHHHHHTC
3755 22837667 2012 KWKSFLKTFKSLKKTVLHTLLKAISS Peptide P 26 Linear L None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.71±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHGGGTHHHHHHHHHTC
3756 22837667 2012 KWKSFLkTFKSLKKTVLHTLLKAISS Peptide K7D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.29±0.03 µMol/L 1-h Cervix None None CCGGGGTTHHHHTTTHHHHHHHHHTC
3757 22837667 2012 KWKSFLKTFKSLKkTVLHTLLKAISS Peptide K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.52±0.05 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGGHHHHHHHHHCC
3758 22837667 2012 KWKSFLKTFKSLKKTVLHTLLkAISS Peptide K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.39±0.02 µMol/L 1-h Cervix None None CCTTHHHHHHHHHHHHHHHHHHHHTC
3759 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.06±0.01 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3760 22837667 2012 KWKSFLKTFKSLKkTVLHTLLkAISS Peptide K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.40±0.09 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGTHHHHHHHHHCC
3761 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.45±0.19 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3762 22837667 2012 KWKSFLkTFkSLKkTVLHTLLkAISS Peptide K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.79±0.23 µMol/L 1-h Cervix None None CCGGGHHHHHHHHTTTTHHHHTTTCC
3763 22837667 2012 KWkSFLkTFkSLKkTVLHTLLkAISS Peptide K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 20.41±0.64 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3764 22837667 2012 kWkSFLkTFkSLKkTVLHTLLkAISS Peptide K1D/K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 18.07±0.48 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3765 22837667 2012 KWKSFlKTFKSLKKTVLHTLLKAISS Peptide L6D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.23±0.10 µMol/L 1-h Cervix None None CCGGGHHHHHHGGGGHHHHHHHHHCC
3766 22837667 2012 KWKSFLKTFKSlKKTVLHTLLKAISS Peptide L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.63±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHHTTTHHHHHHHHHTC
3767 22837667 2012 KWKSFLKTFKSLKKTVLHTlLKAISS Peptide L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.33±0.06 µMol/L 1-h Cervix None None CCGGGHHHHHTTTHHHHHHHHTTTCC
3768 22837667 2012 KWKSFlKTFKSlKKTVLHTLLKAISS Peptide L6D/L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.01±0.08 µMol/L 1-h Cervix None None CCTHHHHHHHHHHHHHHHHTGGGTCC
3769 22837667 2012 KWKSFLKTFKSlKKTVLHTlLKAISS Peptide L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.14±0.06 µMol/L 1-h Cervix None None CCTTHHHHHHHTTHHHHHHHHTTTCC
3770 22837667 2012 KWKSFlKTFKSlKKTVLHTlLKAISS Peptide L6D/L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 7.80±0.26 µMol/L 1-h Cervix None None CCSGGGHHHHHGGGTHHHHHHHHHTC
3771 22837667 2012 KWKSFlKTFKSlKKTVlHTlLKAISS Peptide L6D/L12D/L17D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 9.69±0.38 µMol/L 1-h Cervix None None CCTHHHHIIIIITHHHHHHHHTTTCC
3772 22837667 2012 KWKSFlKTFKSlKKTVlHTllKAISS Peptide L6D/L12D/L17D/L20D/L21D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 12.88±0.15 µMol/L 1-h Cervix None None CCGGGHHHHHHTTHHHHHHHHTTTCC
1453 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-549 Lung Cancer MTT/MTS assay IC50=9.7 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1463 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-375 Skin Cancer MTT/MTS assay IC50=8.7 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1473 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K MCF-7 Breast Cancer MTT/MTS assay IC50=6.2 µMo/L 36-h Breast None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1483 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K SW-1116 Colorectal Cancer MTT/MTS assay IC50=4.3 µMo/L 36-h Colon None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1493 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K RD Rhabdomyosarcoma Cancer MTT/MTS assay IC50=6.4 µMo/L 36-h Muscle None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1503 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K H-1299 Lung Cancer MTT/MTS assay IC50=4.1 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1513 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K B-16 Skin Cancer MTT/MTS assay IC50=4.4 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1523 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K HeLa Cervical Cancer MTT/MTS assay IC50=2 µMo/L 36-h Cervix None None CCHHHHHTHHHHTTTHHHHHHHHHTC
3755 22837667 2012 KWKSFLKTFKSLKKTVLHTLLKAISS Peptide P 26 Linear L None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.71±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHGGGTHHHHHHHHHTC
3756 22837667 2012 KWKSFLkTFKSLKKTVLHTLLKAISS Peptide K7D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.29±0.03 µMol/L 1-h Cervix None None CCGGGGTTHHHHTTTHHHHHHHHHTC
3757 22837667 2012 KWKSFLKTFKSLKkTVLHTLLKAISS Peptide K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.52±0.05 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGGHHHHHHHHHCC
3758 22837667 2012 KWKSFLKTFKSLKKTVLHTLLkAISS Peptide K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.39±0.02 µMol/L 1-h Cervix None None CCTTHHHHHHHHHHHHHHHHHHHHTC
3759 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.06±0.01 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3760 22837667 2012 KWKSFLKTFKSLKkTVLHTLLkAISS Peptide K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.40±0.09 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGTHHHHHHHHHCC
3761 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.45±0.19 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3762 22837667 2012 KWKSFLkTFkSLKkTVLHTLLkAISS Peptide K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.79±0.23 µMol/L 1-h Cervix None None CCGGGHHHHHHHHTTTTHHHHTTTCC
3763 22837667 2012 KWkSFLkTFkSLKkTVLHTLLkAISS Peptide K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 20.41±0.64 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3764 22837667 2012 kWkSFLkTFkSLKkTVLHTLLkAISS Peptide K1D/K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 18.07±0.48 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3765 22837667 2012 KWKSFlKTFKSLKKTVLHTLLKAISS Peptide L6D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.23±0.10 µMol/L 1-h Cervix None None CCGGGHHHHHHGGGGHHHHHHHHHCC
3766 22837667 2012 KWKSFLKTFKSlKKTVLHTLLKAISS Peptide L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.63±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHHTTTHHHHHHHHHTC
3767 22837667 2012 KWKSFLKTFKSLKKTVLHTlLKAISS Peptide L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.33±0.06 µMol/L 1-h Cervix None None CCGGGHHHHHTTTHHHHHHHHTTTCC
3768 22837667 2012 KWKSFlKTFKSlKKTVLHTLLKAISS Peptide L6D/L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.01±0.08 µMol/L 1-h Cervix None None CCTHHHHHHHHHHHHHHHHTGGGTCC
3769 22837667 2012 KWKSFLKTFKSlKKTVLHTlLKAISS Peptide L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.14±0.06 µMol/L 1-h Cervix None None CCTTHHHHHHHTTHHHHHHHHTTTCC
3770 22837667 2012 KWKSFlKTFKSlKKTVLHTlLKAISS Peptide L6D/L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 7.80±0.26 µMol/L 1-h Cervix None None CCSGGGHHHHHGGGTHHHHHHHHHTC
3771 22837667 2012 KWKSFlKTFKSlKKTVlHTlLKAISS Peptide L6D/L12D/L17D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 9.69±0.38 µMol/L 1-h Cervix None None CCTHHHHIIIIITHHHHHHHHTTTCC
3772 22837667 2012 KWKSFlKTFKSlKKTVlHTllKAISS Peptide L6D/L12D/L17D/L20D/L21D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 12.88±0.15 µMol/L 1-h Cervix None None CCGGGHHHHHHTTHHHHHHHHTTTCC
1453 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-549 Lung Cancer MTT/MTS assay IC50=9.7 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1463 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-375 Skin Cancer MTT/MTS assay IC50=8.7 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1473 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K MCF-7 Breast Cancer MTT/MTS assay IC50=6.2 µMo/L 36-h Breast None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1483 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K SW-1116 Colorectal Cancer MTT/MTS assay IC50=4.3 µMo/L 36-h Colon None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1493 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K RD Rhabdomyosarcoma Cancer MTT/MTS assay IC50=6.4 µMo/L 36-h Muscle None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1503 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K H-1299 Lung Cancer MTT/MTS assay IC50=4.1 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1513 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K B-16 Skin Cancer MTT/MTS assay IC50=4.4 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1523 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K HeLa Cervical Cancer MTT/MTS assay IC50=2 µMo/L 36-h Cervix None None CCHHHHHTHHHHTTTHHHHHHHHHTC
3755 22837667 2012 KWKSFLKTFKSLKKTVLHTLLKAISS Peptide P 26 Linear L None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.71±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHGGGTHHHHHHHHHTC
3756 22837667 2012 KWKSFLkTFKSLKKTVLHTLLKAISS Peptide K7D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.29±0.03 µMol/L 1-h Cervix None None CCGGGGTTHHHHTTTHHHHHHHHHTC
3757 22837667 2012 KWKSFLKTFKSLKkTVLHTLLKAISS Peptide K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.52±0.05 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGGHHHHHHHHHCC
3758 22837667 2012 KWKSFLKTFKSLKKTVLHTLLkAISS Peptide K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.39±0.02 µMol/L 1-h Cervix None None CCTTHHHHHHHHHHHHHHHHHHHHTC
3759 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.06±0.01 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3760 22837667 2012 KWKSFLKTFKSLKkTVLHTLLkAISS Peptide K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.40±0.09 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGTHHHHHHHHHCC
3761 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.45±0.19 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3762 22837667 2012 KWKSFLkTFkSLKkTVLHTLLkAISS Peptide K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.79±0.23 µMol/L 1-h Cervix None None CCGGGHHHHHHHHTTTTHHHHTTTCC
3763 22837667 2012 KWkSFLkTFkSLKkTVLHTLLkAISS Peptide K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 20.41±0.64 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3764 22837667 2012 kWkSFLkTFkSLKkTVLHTLLkAISS Peptide K1D/K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 18.07±0.48 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3765 22837667 2012 KWKSFlKTFKSLKKTVLHTLLKAISS Peptide L6D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.23±0.10 µMol/L 1-h Cervix None None CCGGGHHHHHHGGGGHHHHHHHHHCC
3766 22837667 2012 KWKSFLKTFKSlKKTVLHTLLKAISS Peptide L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.63±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHHTTTHHHHHHHHHTC
3767 22837667 2012 KWKSFLKTFKSLKKTVLHTlLKAISS Peptide L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.33±0.06 µMol/L 1-h Cervix None None CCGGGHHHHHTTTHHHHHHHHTTTCC
3768 22837667 2012 KWKSFlKTFKSlKKTVLHTLLKAISS Peptide L6D/L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.01±0.08 µMol/L 1-h Cervix None None CCTHHHHHHHHHHHHHHHHTGGGTCC
3769 22837667 2012 KWKSFLKTFKSlKKTVLHTlLKAISS Peptide L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.14±0.06 µMol/L 1-h Cervix None None CCTTHHHHHHHTTHHHHHHHHTTTCC
3770 22837667 2012 KWKSFlKTFKSlKKTVLHTlLKAISS Peptide L6D/L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 7.80±0.26 µMol/L 1-h Cervix None None CCSGGGHHHHHGGGTHHHHHHHHHTC
3771 22837667 2012 KWKSFlKTFKSlKKTVlHTlLKAISS Peptide L6D/L12D/L17D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 9.69±0.38 µMol/L 1-h Cervix None None CCTHHHHIIIIITHHHHHHHHTTTCC
3772 22837667 2012 KWKSFlKTFKSlKKTVlHTllKAISS Peptide L6D/L12D/L17D/L20D/L21D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 12.88±0.15 µMol/L 1-h Cervix None None CCGGGHHHHHHTTHHHHHHHHTTTCC
1453 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-549 Lung Cancer MTT/MTS assay IC50=9.7 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1463 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K A-375 Skin Cancer MTT/MTS assay IC50=8.7 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1473 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K MCF-7 Breast Cancer MTT/MTS assay IC50=6.2 µMo/L 36-h Breast None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1483 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K SW-1116 Colorectal Cancer MTT/MTS assay IC50=4.3 µMo/L 36-h Colon None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1493 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K RD Rhabdomyosarcoma Cancer MTT/MTS assay IC50=6.4 µMo/L 36-h Muscle None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1503 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K H-1299 Lung Cancer MTT/MTS assay IC50=4.1 µMo/L 36-h Lung None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1513 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K B-16 Skin Cancer MTT/MTS assay IC50=4.4 µMo/L 36-h Skin None None CCHHHHHTHHHHTTTHHHHHHHHHTC
1523 21252288 2011 KWKSFLKTFKSLKKTVLHTLLKAISS A12L/A20L 26 Linear L None Free Free Anticancer PeptideV13K HeLa Cervical Cancer MTT/MTS assay IC50=2 µMo/L 36-h Cervix None None CCHHHHHTHHHHTTTHHHHHHHHHTC
3755 22837667 2012 KWKSFLKTFKSLKKTVLHTLLKAISS Peptide P 26 Linear L None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.71±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHGGGTHHHHHHHHHTC
3756 22837667 2012 KWKSFLkTFKSLKKTVLHTLLKAISS Peptide K7D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.29±0.03 µMol/L 1-h Cervix None None CCGGGGTTHHHHTTTHHHHHHHHHTC
3757 22837667 2012 KWKSFLKTFKSLKkTVLHTLLKAISS Peptide K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.52±0.05 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGGHHHHHHHHHCC
3758 22837667 2012 KWKSFLKTFKSLKKTVLHTLLkAISS Peptide K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.39±0.02 µMol/L 1-h Cervix None None CCTTHHHHHHHHHHHHHHHHHHHHTC
3759 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.06±0.01 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3760 22837667 2012 KWKSFLKTFKSLKkTVLHTLLkAISS Peptide K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 1.40±0.09 µMol/L 1-h Cervix None None CCHHHHHHHHHGGGTHHHHHHHHHCC
3761 22837667 2012 KWKSFLkTFKSLKkTVLHTLLKAISS Peptide K7D /K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.45±0.19 µMol/L 1-h Cervix None None CCGGGGTHHHHTTHHHHHHHHHHHCC
3762 22837667 2012 KWKSFLkTFkSLKkTVLHTLLkAISS Peptide K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 4.79±0.23 µMol/L 1-h Cervix None None CCGGGHHHHHHHHTTTTHHHHTTTCC
3763 22837667 2012 KWkSFLkTFkSLKkTVLHTLLkAISS Peptide K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 20.41±0.64 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3764 22837667 2012 kWkSFLkTFkSLKkTVLHTLLkAISS Peptide K1D/K3D/K7D /K10D/K14D/K22D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 18.07±0.48 µMol/L 1-h Cervix None None CCTTTTTHHHHGGGTHHHHHHHHHTC
3765 22837667 2012 KWKSFlKTFKSLKKTVLHTLLKAISS Peptide L6D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.23±0.10 µMol/L 1-h Cervix None None CCGGGHHHHHHGGGGHHHHHHHHHCC
3766 22837667 2012 KWKSFLKTFKSlKKTVLHTLLKAISS Peptide L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.63±0.07 µMol/L 1-h Cervix None None CCTTHHHHHHHHTTTHHHHHHHHHTC
3767 22837667 2012 KWKSFLKTFKSLKKTVLHTlLKAISS Peptide L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 2.33±0.06 µMol/L 1-h Cervix None None CCGGGHHHHHTTTHHHHHHHHTTTCC
3768 22837667 2012 KWKSFlKTFKSlKKTVLHTLLKAISS Peptide L6D/L12D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.01±0.08 µMol/L 1-h Cervix None None CCTHHHHHHHHHHHHHHHHTGGGTCC
3769 22837667 2012 KWKSFLKTFKSlKKTVLHTlLKAISS Peptide L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 3.14±0.06 µMol/L 1-h Cervix None None CCTTHHHHHHHTTHHHHHHHHTTTCC
3770 22837667 2012 KWKSFlKTFKSlKKTVLHTlLKAISS Peptide L6D/L12D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 7.80±0.26 µMol/L 1-h Cervix None None CCSGGGHHHHHGGGTHHHHHHHHHTC
3771 22837667 2012 KWKSFlKTFKSlKKTVlHTlLKAISS Peptide L6D/L12D/L17D/L20D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 9.69±0.38 µMol/L 1-h Cervix None None CCTHHHHIIIIITHHHHHHHHTTTCC
3772 22837667 2012 KWKSFlKTFKSlKKTVlHTllKAISS Peptide L6D/L12D/L17D/L20D/L21D 26 Linear Mix None Amidation Acetylation Anticancer A12L/A20L HeLa Cervical Cancer MTT/MTS assay IC50= 12.88±0.15 µMol/L 1-h Cervix None None CCGGGHHHHHHTTHHHHHHHHTTTCC
4227 16568093 2006 rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK r8-BadBH3 35 Linear Mix None Free Free Antitumor Synthetic Peptide SK-N-AS Brain Tumor MTT/MTS assay 0% apoptosis at 10 µM 8-h Brain None None CCCCCCCCSSCTTHHHHTTTTCSSSHHHHTTTCC
4228 16568093 2006 rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK r8-BadBH3 35 Linear Mix None Free Free Antitumor Synthetic Peptide SK-N-AS Brain Tumor MTT/MTS assay 10% apoptosis at 20 µM 8-h Brain None None CCCCCCCCSSCTTHHHHTTTTCSSSHHHHTTTCC
4229 16568093 2006 rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK r8-BadBH3 35 Linear Mix None Free Free Antitumor Synthetic Peptide SK-N-AS Brain Tumor MTT/MTS assay 30% apoptosis at 50 µM 8-h Brain None None CCCCCCCCSSCTTHHHHTTTTCSSSHHHHTTTCC
4230 16568093 2006 rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK r8-BadBH3 35 Linear Mix None Free Free Antitumor Synthetic Peptide NB69 Brain Tumor MTT/MTS assay 30% apoptosis at 10 µM 8-h Brain None None CCCCCCCCSSCTTHHHHTTTTCSSSHHHHTTTCC
4231 16568093 2006 rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK r8-BadBH3 35 Linear Mix None Free Free Antitumor Synthetic Peptide NB69 Brain Tumor MTT/MTS assay 80% apoptosis at 20 µM 8-h Brain None None CCCCCCCCSSCTTHHHHTTTTCSSSHHHHTTTCC
4232 16568093 2006 rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK r8-BadBH3 35 Linear Mix None Free Free Antitumor Synthetic Peptide NB69 Brain Tumor MTT/MTS assay 80% apoptosis at 50 µM 8-h Brain None None CCCCCCCCSSCTTHHHHTTTTCSSSHHHHTTTCC
4233 16568093 2006 rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK r8-BadBH3 35 Linear Mix None Free Free Antitumor Synthetic Peptide NGP Tumor MTT/MTS assay 20% apoptosis at 10 µM 8-h Not Available None None CCCCCCCCSSCTTHHHHTTTTCSSSHHHHTTTCC
4234 16568093 2006 rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK r8-BadBH3 35 Linear Mix None Free Free Antitumor Synthetic Peptide NGP Tumor MTT/MTS assay >50% apoptosis at 20 µM 8-h Not Available None None CCCCCCCCSSCTTHHHHTTTTCSSSHHHHTTTCC
4235 16568093 2006 rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK r8-BadBH3 35 Linear Mix None Free Free Antitumor Synthetic Peptide NGP Tumor MTT/MTS assay 30% apoptosis at 50 µM 8-h Not Available None None CCCCCCCCSSCTTHHHHTTTTCSSSHHHHTTTCC
4236 16568093 2006 rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK r8-BadBH3 35 Linear Mix None Free Free Antitumor Synthetic Peptide IMR5 Tumor MTT/MTS assay 15% apoptosis at 10 µM 8-h Not Available None None CCCCCCCCSSCTTHHHHTTTTCSSSHHHHTTTCC
4237 16568093 2006 rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK r8-BadBH3 35 Linear Mix None Free Free Antitumor Synthetic Peptide IMR5 Tumor MTT/MTS assay 20% apoptosis at 20 µM 8-h Not Available None None CCCCCCCCSSCTTHHHHTTTTCSSSHHHHTTTCC
4238 16568093 2006 rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK r8-BadBH3 35 Linear Mix None Free Free Antitumor Synthetic Peptide IMR5 Tumor MTT/MTS assay 50% apoptosis at 50 µM 8-h Not Available None None CCCCCCCCSSCTTHHHHTTTTCSSSHHHHTTTCC
4239 16568093 2006 rrrrrrrrGEDIIRNIARHLAQVGDSMDR r8-BidBH3 29 Linear Mix None Free Free Antitumor Synthetic Peptide SK-N-AS Brain Tumor MTT/MTS assay 8% apoptosis at 10 µM 8-h Brain None None CCSSSSSCTTHHHHTTSTTHHHHSGGGCC
4240 16568093 2006 rrrrrrrrGEDIIRNIARHLAQVGDSMDR r8-BidBH3 29 Linear Mix None Free Free Antitumor Synthetic Peptide SK-N-AS Brain Tumor MTT/MTS assay 45% apoptosis at 20 µM 8-h Brain None None CCSSSSSCTTHHHHTTSTTHHHHSGGGCC
4241 16568093 2006 rrrrrrrrGEDIIRNIARHLAQVGDSMDR r8-BidBH3 29 Linear Mix None Free Free Antitumor Synthetic Peptide SK-N-AS Brain Tumor MTT/MTS assay 65% apoptosis at 50 µM 8-h Brain None None CCSSSSSCTTHHHHTTSTTHHHHSGGGCC
4242 16568093 2006 rrrrrrrrGEDIIRNIARHLAQVGDSMDR r8-BidBH3 29 Linear Mix None Free Free Antitumor Synthetic Peptide NB69 Brain Tumor MTT/MTS assay 25% apoptosis at 10 µM 8-h Brain None None CCSSSSSCTTHHHHTTSTTHHHHSGGGCC
4243 16568093 2006 rrrrrrrrGEDIIRNIARHLAQVGDSMDR r8-BidBH3 29 Linear Mix None Free Free Antitumor Synthetic Peptide NB69 Brain Tumor MTT/MTS assay 66% apoptosis at 20 µM 8-h Brain None None CCSSSSSCTTHHHHTTSTTHHHHSGGGCC
4244 16568093 2006 rrrrrrrrGEDIIRNIARHLAQVGDSMDR r8-BidBH3 29 Linear Mix None Free Free Antitumor Synthetic Peptide NB69 Brain Tumor MTT/MTS assay 68% apoptosis at 50 µM 8-h Brain None None CCSSSSSCTTHHHHTTSTTHHHHSGGGCC
4245 16568093 2006 rrrrrrrrGEDIIRNIARHLAQVGDSMDR r8-BidBH3 29 Linear Mix None Free Free Antitumor Synthetic Peptide NGP Tumor MTT/MTS assay 43% apoptosis at 10 µM 8-h Not Available None None CCSSSSSCTTHHHHTTSTTHHHHSGGGCC
4246 16568093 2006 rrrrrrrrGEDIIRNIARHLAQVGDSMDR r8-BidBH3 29 Linear Mix None Free Free Antitumor Synthetic Peptide NGP Tumor MTT/MTS assay 46% apoptosis at 20 µM 8-h Not Available None None CCSSSSSCTTHHHHTTSTTHHHHSGGGCC
4247 16568093 2006 rrrrrrrrGEDIIRNIARHLAQVGDSMDR r8-BidBH3 29 Linear Mix None Free Free Antitumor Synthetic Peptide NGP Tumor MTT/MTS assay 79% apoptosis at 50 µM 8-h Not Available None None CCSSSSSCTTHHHHTTSTTHHHHSGGGCC
4248 16568093 2006 rrrrrrrrGEDIIRNIARHLAQVGDSMDR r8-BidBH3 29 Linear Mix None Free Free Antitumor Synthetic Peptide IMR5 Tumor MTT/MTS assay 23% apoptosis at 10 µM 8-h Not Available None None CCSSSSSCTTHHHHTTSTTHHHHSGGGCC
4249 16568093 2006 rrrrrrrrGEDIIRNIARHLAQVGDSMDR r8-BidBH3 29 Linear Mix None Free Free Antitumor Synthetic Peptide IMR5 Tumor MTT/MTS assay 35% apoptosis at 20 µM 8-h Not Available None None CCSSSSSCTTHHHHTTSTTHHHHSGGGCC
4250 16568093 2006 rrrrrrrrGEDIIRNIARHLAQVGDSMDR r8-BidBH3 29 Linear Mix None Free Free Antitumor Synthetic Peptide IMR5 Tumor MTT/MTS assay 55% apoptosis at 50 µM 8-h Not Available None None CCSSSSSCTTHHHHTTSTTHHHHSGGGCC
4251 16568093 2006 rrrrrrrrGEDIIRNIARHAAQVGASMDR r8-BidBH3Alt 29 Linear Mix None Free Free Antitumor Synthetic Peptide SK-N-AS Brain Tumor MTT/MTS assay 1% apoptosis at 10 µM 8-h Brain None None CTTCCCSSTHHHHHHHHHHHHHHHTTTCC
4252 16568093 2006 rrrrrrrrGEDIIRNIARHAAQVGASMDR r8-BidBH3Alt 29 Linear Mix None Free Free Antitumor Synthetic Peptide SK-N-AS Brain Tumor MTT/MTS assay 2% apoptosis at 20 µM 8-h Brain None None CTTCCCSSTHHHHHHHHHHHHHHHTTTCC
4253 16568093 2006 rrrrrrrrGEDIIRNIARHAAQVGASMDR r8-BidBH3Alt 29 Linear Mix None Free Free Antitumor Synthetic Peptide SK-N-AS Brain Tumor MTT/MTS assay 3% apoptosis at 50 µM 8-h Brain None None CTTCCCSSTHHHHHHHHHHHHHHHTTTCC
4254 16568093 2006 rrrrrrrrGEDIIRNIARHAAQVGASMDR r8-BidBH3Alt 29 Linear Mix None Free Free Antitumor Synthetic Peptide NB69 Brain Tumor MTT/MTS assay 2% apoptosis at 10 µM 8-h Brain None None CTTCCCSSTHHHHHHHHHHHHHHHTTTCC
4255 16568093 2006 rrrrrrrrGEDIIRNIARHAAQVGASMDR r8-BidBH3Alt 29 Linear Mix None Free Free Antitumor Synthetic Peptide NB69 Brain Tumor MTT/MTS assay 1% apoptosis at 20 µM 8-h Brain None None CTTCCCSSTHHHHHHHHHHHHHHHTTTCC
4256 16568093 2006 rrrrrrrrGEDIIRNIARHAAQVGASMDR r8-BidBH3Alt 29 Linear Mix None Free Free Antitumor Synthetic Peptide NB69 Brain Tumor MTT/MTS assay 5% apoptosis at 50 µM 8-h Brain None None CTTCCCSSTHHHHHHHHHHHHHHHTTTCC
4257 16568093 2006 rrrrrrrrGEDIIRNIARHAAQVGASMDR r8-BidBH3Alt 29 Linear Mix None Free Free Antitumor Synthetic Peptide NGP Tumor MTT/MTS assay 1% apoptosis at 10 µM 8-h Not Available None None CTTCCCSSTHHHHHHHHHHHHHHHTTTCC
4258 16568093 2006 rrrrrrrrGEDIIRNIARHAAQVGASMDR r8-BidBH3Alt 29 Linear Mix None Free Free Antitumor Synthetic Peptide NGP Tumor MTT/MTS assay 2% apoptosis at 20 µM 8-h Not Available None None CTTCCCSSTHHHHHHHHHHHHHHHTTTCC
4259 16568093 2006 rrrrrrrrGEDIIRNIARHAAQVGASMDR r8-BidBH3Alt 29 Linear Mix None Free Free Antitumor Synthetic Peptide NGP Tumor MTT/MTS assay 3% apoptosis at 50 µM 8-h Not Available None None CTTCCCSSTHHHHHHHHHHHHHHHTTTCC
4260 16568093 2006 rrrrrrrrGEDIIRNIARHAAQVGASMDR r8-BidBH3Alt 29 Linear Mix None Free Free Antitumor Synthetic Peptide IMR5 Tumor MTT/MTS assay 0% apoptosis at 10 µM 8-h Not Available None None CTTCCCSSTHHHHHHHHHHHHHHHTTTCC
4261 16568093 2006 rrrrrrrrGEDIIRNIARHAAQVGASMDR r8-BidBH3Alt 29 Linear Mix None Free Free Antitumor Synthetic Peptide IMR5 Tumor MTT/MTS assay 1% apoptosis at 20 µM 8-h Not Available None None CTTCCCSSTHHHHHHHHHHHHHHHTTTCC
4262 16568093 2006 rrrrrrrrGEDIIRNIARHAAQVGASMDR r8-BidBH3Alt 29 Linear Mix None Free Free Antitumor Synthetic Peptide IMR5 Tumor MTT/MTS assay 2% apoptosis at 50 µM 8-h Not Available None None CTTCCCSSTHHHHHHHHHHHHHHHTTTCC
4263 None 2004 lKKllKKllKKl DL6K6 12 Linear Mix None Amidation Free Antimicrobial, Antifungal and Anticancer Synthetic Peptide 22RV1 Prostate Cancer MTT/MTS assay LC50>100 µM Not Available Prostate None AU_2004_246909_A1 CGGGHHHHGGGC
4264 None 2004 lKKllKKllKKl DL6K6 12 Linear Mix None Amidation Free Antimicrobial, Antifungal and Anticancer Synthetic Peptide CL-1 Tumor MTT/MTS assay LC50>100 µM Not Available Pancreatic None AU_2004_246909_A1 CGGGHHHHGGGC
4266 None 2004 lKKllKKllKKl DDA-DL6K6-22 12 Linear Mix None Amidation CH3(CH2)10CO Antimicrobial, Antifungal and Anticancer Synthetic Peptide 22RV1 Prostate Cancer MTT/MTS assay LC50<3.125 µM Not Available Prostate None AU_2004_246909_A1 NA NA
4267 None 2004 lKKllKKllKKl DDA-DL6K6-22 12 Linear Mix None Amidation CH3(CH2)10CO Antimicrobial, Antifungal and Anticancer Synthetic Peptide CL-1 Tumor MTT/MTS assay LC50<3.125 µM Not Available Pancreatic None AU_2004_246909_A1 NA NA
4269 None 2004 lKKllKKllKKl MA-DL6K6-23 12 Linear Mix None Amidation CH3(CH2)12CO Antimicrobial, Antifungal and Anticancer Synthetic Peptide 22RV1 Prostate Cancer MTT/MTS assay LC50<3.125 µM Not Available Prostate None AU_2004_246909_A1 NA NA
4270 None 2004 lKKllKKllKKl MA-DL6K6-23 12 Linear Mix None Amidation CH3(CH2)12CO Antimicrobial, Antifungal and Anticancer Synthetic Peptide CL-1 Tumor MTT/MTS assay LC50<3.125 µM Not Available Pancreatic None AU_2004_246909_A1 NA NA
4272 None 2004 lKKllKKllKKl PA-DL6K6-24 12 Linear Mix None Amidation CH3(CH2)14CO Antimicrobial, Antifungal and Anticancer Synthetic Peptide 22RV1 Prostate Cancer MTT/MTS assay LC50<3.125 µM Not Available Prostate None AU_2004_246909_A1 NA NA
4273 None 2004 lKKllKKllKKl PA-DL6K6-24 12 Linear Mix None Amidation CH3(CH2)14CO Antimicrobial, Antifungal and Anticancer Synthetic Peptide CL-1 Tumor MTT/MTS assay LC50=3.125 µM Not Available Pancreatic None AU_2004_246909_A1 NA NA
4275 None 2004 lRRllRRllRRl DL6R6 12 Linear Mix None Free Free Antimicrobial, Antifungal and Anticancer Synthetic Peptide 22RV1 Prostate Cancer MTT/MTS assay LC50=50 µM Not Available Prostate None AU_2004_246909_A1 CGGGHHHHCTTC
4276 None 2004 lRRllRRllRRl DL6R6 12 Linear Mix None Free Free Antimicrobial, Antifungal and Anticancer Synthetic Peptide CL-1 Tumor MTT/MTS assay LC50>100 µM Not Available Pancreatic None AU_2004_246909_A1 CGGGHHHHCTTC
4278 None 2004 DDAlRRllRRllRRl DDA-DL6R6-25 15 Linear Mix None Free Free Antimicrobial, Antifungal and Anticancer Synthetic Peptide 22RV1 Prostate Cancer MTT/MTS assay LC50=3.125 µM Not Available Prostate None AU_2004_246909_A1 CCSTTTHHHHHGGGC
4279 None 2004 DDAlRRllRRllRRl DDA-DL6R6-25 15 Linear Mix None Free Free Antimicrobial, Antifungal and Anticancer Synthetic Peptide CL-1 Tumor MTT/MTS assay LC50=3.125 µM Not Available Pancreatic None AU_2004_246909_A1 CCSTTTHHHHHGGGC
4335 None 2009 YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK EB-Lytic 32 Linear Mix None Free Free Anticancer Synthetic Peptide H-322 Lung Cancer WST-1 assay IC50= 6.8 µM Not Available Lung None US_8436137_B2 CCSCSSTTCSSSSHHHHHHHHHHHHHHHHHHC
4336 None 2009 YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK EB-Lytic 32 Linear Mix None Free Free Anticancer Synthetic Peptide BT-20 Breast Cancer WST-1 assay IC50= 6.5 µM Not Available Breast None US_8436137_B2 CCSCSSTTCSSSSHHHHHHHHHHHHHHHHHHC
4337 None 2009 YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK EB-Lytic 32 Linear Mix None Free Free Anticancer Synthetic Peptide U-251 Brain Tumor WST-1 assay IC50= 12 µM Not Available Brain None US_8436137_B2 CCSCSSTTCSSSSHHHHHHHHHHHHHHHHHHC
4338 None 2009 YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK EB-Lytic 32 Linear Mix None Free Free Anticancer Synthetic Peptide BxPC-3 Pancreatic Cancer WST-1 assay IC50= 12 µM Not Available Pancreatic None US_8436137_B2 CCSCSSTTCSSSSHHHHHHHHHHHHHHHHHHC
4339 None 2009 YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK EB-Lytic 32 Linear Mix None Free Free Anticancer Synthetic Peptide SU.86.86 Pancreatic Cancer WST-1 assay IC50= 12 µM Not Available Pancreatic None US_8436137_B2 CCSCSSTTCSSSSHHHHHHHHHHHHHHHHHHC
4340 None 2009 YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK EB-Lytic 32 Linear Mix None Free Free Anticancer Synthetic Peptide LNCaP Prostate Cancer WST-1 assay IC50= 10 µM Not Available Prostate None US_8436137_B2 CCSCSSTTCSSSSHHHHHHHHHHHHHHHHHHC
4599 21351323 2011 YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK EGFR-lytic 32 Linear Mix None Free Free Antitumor Synthetic Peptide MDA-MB-231 Breast Cancer ELISA IC50 =0.12 µM 60-Min Breast None None CCSCSSTTCSSSSHHHHHHHHHHHHHHHHHHC
4600 21351323 2011 YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK EGFR-lytic 32 Linear Mix None Free Free Antitumor Synthetic Peptide MDA-MB-231 Breast Cancer ELISA IC50 =0.46 µM 15-Min Breast None None CCSCSSTTCSSSSHHHHHHHHHHHHHHHHHHC
4341 None 2009 YRWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK EB(H2R)-lytic 32 Linear Mix None Free Free Anticancer Synthetic Peptide H-322 Lung Cancer WST-1 assay IC50= 3.2 µM Not Available Lung None US_8436137_B2 CCSSSSTTCTTCCTHHHHHHHGGGGHHHHHHC
4342 None 2009 YRWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK EB(H2R)-lytic 32 Linear Mix None Free Free Anticancer Synthetic Peptide BT-20 Breast Cancer WST-1 assay IC50= 1.9 µM Not Available Breast None US_8436137_B2 CCSSSSTTCTTCCTHHHHHHHGGGGHHHHHHC
4343 None 2009 YRWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK EB(H2R)-lytic 32 Linear Mix None Free Free Anticancer Synthetic Peptide U-251 Brain Tumor WST-1 assay IC50= 8.4 µM Not Available Brain None US_8436137_B2 CCSSSSTTCTTCCTHHHHHHHGGGGHHHHHHC
4344 None 2009 YRWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK EB(H2R)-lytic 32 Linear Mix None Free Free Anticancer Synthetic Peptide BxPC-3 Pancreatic Cancer WST-1 assay IC50= 6.6 µM Not Available Pancreatic None US_8436137_B2 CCSSSSTTCTTCCTHHHHHHHGGGGHHHHHHC
4345 None 2009 YRWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK EB(H2R)-lytic 32 Linear Mix None Free Free Anticancer Synthetic Peptide SU.86.86 Pancreatic Cancer WST-1 assay IC50= 7.4 µM Not Available Pancreatic None US_8436137_B2 CCSSSSTTCTTCCTHHHHHHHGGGGHHHHHHC
4346 None 2009 YRWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK EB(H2R)-lytic 32 Linear Mix None Free Free Anticancer Synthetic Peptide LNCaP Prostate Cancer WST-1 assay IC50= 4.8 µM Not Available Prostate None US_8436137_B2 CCSSSSTTCTTCCTHHHHHHHGGGGHHHHHHC
4347 None 2009 NYQWVPYQGRVPYPRGGLLkLLKklLKKLlKL Sema3A(aa363-377) -nLytic 32 Linear Mix None Free Free Anticancer Synthetic Peptide BxPC-3 Pancreatic Cancer WST-1 assay IC50= 12.5 µM 48-h Pancreatic None WO_2010_064207_A2 CCSSCSCSSCCCSSTTTTCTHHHHHHHHHTTC
4348 None 2009 NYQWVPYQGRVPYPRGGLLkLLKklLKKLlKL Sema3A(aa363-377) -nLytic 32 Linear Mix None Free Free Anticancer Synthetic Peptide CFPAC-I Pancreatic Cancer WST-1 assay IC50= 10.6 µM 48-h Pancreatic None WO_2010_064207_A2 CCSSCSCSSCCCSSTTTTCTHHHHHHHHHTTC
4349 None 2009 NYQWVPYQGRVPYPRGGLLkLLKklLKKLlKL Sema3A(aa363-377) -nLytic 32 Linear Mix None Free Free Anticancer Synthetic Peptide Pane- 1 Breast Cancer WST-1 assay IC50= 13.1 µM 48-h Breast None WO_2010_064207_A2 CCSSCSCSSCCCSSTTTTCTHHHHHHHHHTTC
4350 None 2009 NYQWVPYQGRVPYPRGGLLkLLKklLKKLlKL Sema3A(aa363-377) -nLytic 32 Linear Mix None Free Free Anticancer Synthetic Peptide SU.86.86 Pancreatic Cancer WST-1 assay IC50= 7.9 µM 48-h Pancreatic None WO_2010_064207_A2 CCSSCSCSSCCCSSTTTTCTHHHHHHHHHTTC
4351 None 2009 GRVPYPRGGLLkLLKklLKKLlKL Sema3A(aa371-377) -nLytic 24 Linear Mix None Free Free Anticancer Synthetic Peptide BxPC-3 Pancreatic Cancer WST-1 assay IC50= 14.7 µM 48-h Pancreatic None WO_2010_064207_A2 CCCCCCGGGGHHHHHHHHHHHTCC
4352 None 2009 GRVPYPRGGLLkLLKklLKKLlKL Sema3A(aa371-377) -nLytic 24 Linear Mix None Free Free Anticancer Synthetic Peptide CFPAC-I Pancreatic Cancer WST-1 assay IC50= 9.2 µM 48-h Pancreatic None WO_2010_064207_A2 CCCCCCGGGGHHHHHHHHHHHTCC
4353 None 2009 GRVPYPRGGLLkLLKklLKKLlKL Sema3A(aa371-377) -nLytic 24 Linear Mix None Free Free Anticancer Synthetic Peptide Pane- 1 Breast Cancer WST-1 assay IC50= 14.1 µM 48-h Breast None WO_2010_064207_A2 CCCCCCGGGGHHHHHHHHHHHTCC
4354 None 2009 GRVPYPRGGLLkLLKklLKKLlKL Sema3A(aa371-377) -nLytic 24 Linear Mix None Free Free Anticancer Synthetic Peptide SU.86.86 Pancreatic Cancer WST-1 assay IC50= 8.0 µM 48-h Pancreatic None WO_2010_064207_A2 CCCCCCGGGGHHHHHHHHHHHTCC
